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Zusammenfassung	  
Im Zellkern liegt Chromatin als hochorganisierter DNA/Protein-Komplex vor, der 
dynamisch reguliert werden muß. Kompaktierte DNA mit stillgelegten Genen bildet 
heterochromatische Regionen aus, und weniger dicht gepackte DNA genetisch 
aktive euchromatische Regionen. Diese genomischen Bereiche werden von einem 
Netzwerk verschiedenster epigenetischer Mechanismen reguliert. Diese Steuerung 
ist unverzichtbar, da Heterochromatin wichtige Rollen in der Zelldifferenzierung, 
Zellkernarchitektur und Sicherung der genomischen Integrität spielt. 
 
Diese Dissertation besteht aus zwei Reviewartikeln und vier Originalartikeln, die 
verschiedene Aspekte der Funktion und Regulation von zentromerischen und 
perizentromerischen Chromatins erläutern. Im Artikel Nicetto et al. 2013 wird eine 
neue Funktion der Suv4-20h Histonmethyltransferasen in Entwicklungsprozessen 
von Vertebraten beschrieben. Suv4-20h Enzyme werden für die Repression des 
Xenopus laevis Oct-25 Gens benötigt. Das XOct-25 Gen ist ein Homolog des Oct4 
Gens von Säugetieren, welches als Transkriptionsfaktor wichtige Aufgaben für die 
Regulation der Pluriotenz von Stammzellen bewerkstelligt. Die Charakterisierung von 
embryonalen Maus Stammzellen zeigte, dass auch in diesem System Suv4-20h 
Enzyme an der Transkriptionsregulation von Oct4 beteiligt sind. Der Verlust der 
Suv4-20h Methyltransferasen führte im Frosch, sowie in den Maus Stammzellen zu 
Entwicklungsdefekten. Zusammengefasst lassen diese Ergebnisse vermuten, dass 
Suv4-20h vermittelte H4K20me3 an POU-V Pluripotenzgenen ein konservierter 
Regulationsmechanismus zur Gewährleistung korrekter Zelldifferenzierungsprozesse 
ist. 
Jack et al. beschreibt die Charakterisierung der neuen Histonmodifikation 
H3K56me3. Diese ist evolutionär konserviert und wird durch Suv39h Enzyme 
vermittelt. Darüberhinaus konnte gezeigt werden, dass Proteine aus der Gruppe der 
JmjD2-Histondemethylasen die H3K56me3 Modifikation entfernen können. 
Im Artikel Hahn et al. können wir zeigen, das Suv4-20h2 wichtige Rollen in der 
Regulation der Zellkernarchitektur, Chromosomensegregation und Rekrutierung von 
Cohesin spielt. Suv4-20h2 kann durch synergistische Interaktionen mit mehreren 
HP1 Proteinen stabil an perizentromerische Heterochromatinregionen binden und 
diese Chromatinbereiche kompaktieren. Suv4-20h Knockout Zelllinien wiesen 
weniger kompaktiertes Heterochromatin und Defekte in der mitotischen 
Chromosomensegregation auf. Die Untereinheiten des Cohesin Komplex, Smc1 und 
Smc3, können mit Suv4-20h2 interagieren. Die Analyse von Suv4-20h2 Knock-out 
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Zelllinien zeigte, dass Suv4-20h2 für die Rekrutierung von Cohesin an das 
perizentromerische Heterochromatin benötigt wird um, somit die Stabilität des 
Genoms zu wahren. 
Die Zentromerbereiche der Chromosomen werden wahrscheinlich durch 
epigentische Mechanismen definiert. Die zentromerspezifische Histonvariante Cenp-
A muß ins zentromerische Heterochromatin integriert werden um die Ausbildung 
eines funktionalen Zentromers zu ermöglichen. Das M18bp1 Protein wird benötigt 
um Cenp-A Histone ins Chromatin einzubauen. Im Artikel Dambacher et al. 2012 
wird die Assoziation von M18bp1 in Abhängigkeit des  Zellzyklus beschrieben. Eine 
Interaktion von M18bp1 und dem zentromerischen Protein Cenp-C konnte in vivo 
und in vitro nachgewiesen werden. Knock-down von Cenp-C führte zu verminderten 
M18bp1 und Cenp-A Proteinmengen an Zentromeren, was vermuten lässt, dass 
Cenp-C einen wichtigen Faktor in zentromerischen M18bp1 und Cenp-A 
Ladeprozessen darstellt. 
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Summary	  
Chromatin is forming higher order structures in the nucleus of the cell. This three-
dimensional organization, needs to be dynamically coordinated to allow gene 
regulation. For proper cell function, it is important to control the loosely packed, 
transcriptionally active euchromatin and the densely packed, transcriptionally silent 
heterochromatin. Various epigenetic mechanisms are part of a regulatory network 
that defines and modulates these genomic domains. Heterochromatin and its protein 
framework, have been shown to play fundamental roles in lineage decision 
processes, in governing nuclear architecture and guaranteeing genomic integrity.  
 
This thesis consists of two review articles and four published papers dealing with the 
biological relevance of pericentromeric or centromeric chromatin and proteins. 
In Nicetto et al. 2013, a novel function of the heterochromatic histone 
methyltransferase Suv4-20h in vertebrate development is described. A multitude of 
different gene expression patterns, needs to be tightly orchestrated during 
embryogenesis. In Xenopus laevis cell differentiation, Suv4-20h enzymes are shown 
to be required for repression of the Oct-25 pluripotency gene, a homolog of 
mammalian Oct4. Consistently, mouse ESCs lacking Suv4-20h display increased 
Oct4 protein levels before and during in vitro differentiation. As a consequence, 
aberrant and biased differentiation behaviour can be observed, suggesting that 
Suv4-20h-mediated H4K20me3 at specific POU-V pluripotency genes may be a 
conserved regulatory mechanism regulating cell fate decisions.  
Jack et al. reports on histone H3 lysine (K) 56me3 (tri-methylation) as a novel and 
evolutionarily conserved heterochromatin modification. Suv39h enzymes are 
mediating trimethylation of H3K56 in pericentric heterochromatin and the JmjD2 
family of demethylases is capable to remove this modification. 
Higher order chromatin organization needs to be controlled in a complex manner 
throughout the cell cycle. In Hahn et al., the important roles that Suv4-20h2 is playing 
in regulating nuclear architecture, ensuring faithful chromosome segregation and 
cohesin recruitment, are depicted. Moreover, evidence is provided, that Suv4-20h2 
stably binds to pericentric heterochromatin via multiple synergistic interactions with 
HP1 proteins and that Suv4-20h2 is important for the compaction of these regions. 
Suv4-20h knock-out cells show reduced chromatin compaction, defects in 
chromocenter organization and errors in chromosome segregation during mitosis. 
Furthermore, Suv4-20h2 is identified as an interactor of the cohesin subunits Smc1 
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and Smc3. These results indicate that Suv4-20h2 is necessary for efficient cohesin 
recruitment to heterochromatin and to ensure genomic integrity. 
In higher eukaryotes, the centromere regions of chromosomes are likely determined 
by epigenetic mechanisms. The histone variant Cenp-A must be integrated into these 
chromosomal domains to recruit other centromeric proteins that build up a functional 
kinetochore. The Mis18 complex, and in particular its member M18bp1, are known to 
be essential for both incorporation and maintenance of Cenp-A. The publication 
Dambacher et al. 2012 describes a cell cycle-regulated association of M18bp1 with 
centromeric chromatin. An interaction with Cenp-C is shown in in vivo and in vitro 
experiments. Depletion of Cenp-C results in diminished M18bp1 and Cenp-A levels 
at centromeres, indicating that Cenp-C works as an important factor for centromeric 
M18bp1 recruitment and thus for maintaining centromeric Cenp-A deposition. 
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1.	  Introduction	  
Nuclear DNA is packaged with proteins in complex called chromatin. The repeating 
unit of chromatin is the nucleosome, consisting of ~147bp of DNA wrapped around a 
histone octamer (two each of histones H2A, H2B, H3, and H4) (Luger et al. 1997). 
Nucleosomes are bridged by the linker DNA with a variable length of ~20 to 80bp, 
that can serve as a binding surface for the linker histone H1. These interactions 
contribute to stabilizing higher order chromatin folding and compaction (Lu et al. 
2009a). It is important to precisely control the chromatin states and nuclear 
architecture. Specific posttranslational modifications of histones, chromatin 
remodelling, incorporation of histone variants and chemical modifications of the 
underlying DNA are known to modulate chromatin. A coordinated interplay of these 
mechanisms is crucial for proper cell function and the establishment of defined gene 
expression programs in cellular differentiation. 
 
1.1	  Epigenetic	  gene	  regulation	  	  
The following subchapter and Figure 1 have been published in (Hahn et al. 2010), a review 
article, of which I am a joint first author (for author contributions see page 8). Slight changes in 
the text (marked in italics) have been conducted. 
The grade of chromatin compaction can influence DNA accessibility to the 
transcriptional machinery. Euchromatin is loosely packed and transcriptionally active, 
whereas heterochromatin represents a more densely packed chromatin state that is 
characterized by low transcriptional activity. Heterochromatin can be subdivided into 
two categories: facultative heterochromatin for silencing of developmental genes and 
the inactive X chromosome in female mammals, and constitutive heterochromatin, 
which is formed at pericentromeric regions and telomeres. 
Five major epigenetic mechanisms are capable of establishing and stabilizing open 
or closed chromatin structures, thereby regulating transcriptional activity.  
1. Nucleosome remodelers can stimulate transcription by removing nucleosomes 
from promoter regions, allowing transcription factors to gain access to the underlying 
DNA (Korber et al. 2004). Additional functions of nucleosome remodelers include 
histone variant exchange and nucleosome sliding (Varga-Weisz and Becker 2006). 
2. Mammalian cells express three histone H3 variants: H3.1, H3.2, and H3.3. 
Specific enrichment of H3.3 in transcriptionally active genes and regulatory regions, 
and H3.1 in repressed or inactive genetic elements suggest a regulatory function of 
these variants (Mito et al. 2005). Incorporation of histone variants is also important 
for many other chromatin-related processes. Faithful DNA damage repair, for 
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example, depends on the presence of a histone H2A variant, H2A.X, which is 
phosphorylated on damage detection allowing binding of the DNA damage repair 
machinery (Celeste et al. 2002). 
 
 
Figure 1. Major epigenetic mechanisms that regulate chromatin structure (Hahn et al. 2010) 
1. Nucleosomes can prevent binding of transcription factors (TF). One function of 
nucleosome remodeling complexes is to evict nucleosomes to make promoters 
accessible. 2. Distinct histone H3 variants associate with transcriptionally active or 
repressive chromatin domains. 3. Noncoding RNAs (ncRNAs) can recruit histone-
modifying enzymes. For example, interaction of the H3K27-specific histone 
methyltransferase Ezh2 with a ncRNA is important to induce X inactivation. 4. DNA 
methylation is a repressive modification that is recognized by specific binding factors 
(MBD proteins) which recruit other corepressor proteins, e.g., HDACs. 5. Histone post 
translational modifications (PTM) can recruit binding partners that induce active or 
repressive chromatin states. H3K4me3 correlates with transcriptional activity and is 
recognized by components of the TFIID complex. Heterochromatic chromatin structures 
feature the combinatorial mark H3K9me3 and H4K20me3. 
3. Increasing evidence suggests important functions for long noncoding RNAs 
(ncRNAs) in transcriptional regulation. Direct interactions of chromatin-modifying 
enzymes with non-coding RNAs are speculated to facilitate targeting to specific 
genomic loci. A well-studied example is the histone methyltransferase (KMT) Ezh2, 
which was shown to interact with different ncRNAs to induce X inactivation and 
repression of developmental genes (Rinn et al. 2007; Zhao et al. 2008). Small 
ncRNAs, e.g., siRNAs and promoter antisense RNAs, can also trigger formation of 
repressive chromatin structures. 
4. Cytosine bases, preferably in the context of CpG dinucleotides, can be methylated 
to 5-methylcytosine by DNA methyltransferases. DNA methylation is a repressive 
modification that is enriched at promoter regions of genes and noncoding DNA 
5) Histones can be posttranslationally modified. The major
modifications include phosphorylation, acetylation, and methyl-
ation. Combinations of different histone modifications represent
chromatin signals that are recognized by specific binding proteins
that then mediate downstream effects. In the context of transcrip-
tional regulation, histone lysine methylation has been particularly
well characterized. This modification generates a high complexity
of signals as each lysine position can be mono- (me1), di- (me2),
or trimethylated (me3) and distinct binding proteins for each
methylation state can mediate different functions. Transcription-
ally active, euchromatic domains are characterized by histone H3
lysine 4 trimethylation (H3K4me3) at gene promoters and
H3K36me3 across gene bodies (2). The two types of heterochro-
matin arry distinct modification patt rns. Facultative heterochro-
matin is marked by high levels of H3K27me3 (86). In contrast,
constitutive heterochromatin features the combinatorial mark
H3K9me3 and H4K20me3 (52).
The enzymatic systems for many chromatin-modifying ac-
tivities have been identified during the last years; however, still
very little is known about their targeti g to specific genomic
regions. For gene silencing and heterochromatin formation
across repetitive elements, the production of distinct types of
noncoding RNA, antis nse RNA and siRNA, have been im-
plicated in the targeting mechanism.
In mammals, the promoter regions of many genes are tran-
scribed at a low level, giving rise to promoter-associated RNAs
(30). Antisense ncRNAs that are complementary to these pro-
moter transcripts can mediate recruitment of repressive epigenetic
modifications, such as H3K27me3 and H3K9me2. This form of
transcriptional gene silencing involves the small RNA binding
proteins Argonaute 1 and 2, suggesting that epigenetic machiner-
ies interact with components of the RNAi pathway (38, 42).
Targeting of repressive epigenetic modifications to repetitive
elements at pericentric heterochromatin appears to involve
small interfering RNAs. This mechanism is well understood in
the budding yeast, Schizosaccharomyces pombe: bidirectional
transcription of repetitive elements generates double-stranded
RNAs that are cleaved to siRNAs by the endonuclease dicer.
These small RNAs are then loaded onto argonaute 1, which
recognizes the DNA seq ence from which the small RNA was
generated. The histone methyltransferase (HMTase) Clr4 di-
rectly interacts with argonaute 1 and induces repressive H3K9
methylation (29). It is still controversial if this siRNA mech-
anism exists in mammals; however, there are parallels. An
early step in establishing the combinatorial histone modifica-
tions at pericentric heterochr matin is H3K9 trimethylation by
Suv39h1 and Suv39h2, the mammalian Clr4 homologs.
H3K9me3 is recognized by heterochromatin protein 1 (HP1),
which, n urn, recruits other HMTases, Suv4–20h1 and Suv4–
20h2, to mediate H4K20me3 (81, 82). Heterochromatin in
mammals features another important epigenetic modification,
DNA methylation. Interestingly, there is interdependence be-
tween DNA methylation and H3K9me3 (56). However, the
mechanisms are not clear.
An imp rtant hallmark of constitutive heterochromatin is its
ability to spread from a nucleation site into neighboring re-
gions. Position-effect variegation in Drosophila is a well-
established model system that highlights this feature (80). In
this organism, heterochromatin can eventually expand several
hundred kilobases into euchromatic regions. Spreading is
hypothesized to work through the following mechanism:
H3K9me3 on one nucl osome recruits HP1 which can dimer-
ize and interact with Suv39h that establish H3K9me3 on the
neighboring nucleosome. The border between heterochromatic
Fig. 1. Major epigenetic mechanisms that regulate
chromatin structure. 1) Nucleosomes can prevent
binding of transcription factors (TF). One func-
tion of nucleosome remodeling complexes is to
evict nucleosomes to make promoters accessible.
2) Distinct histone H3 variants associate with
transcriptionally active or repressive chromatin
domains. 3) Noncoding RNAs (ncRNAs) can
recruit histone-modifying enzymes. For example,
interaction of the H3K27-specific histone meth-
yltransferase Ezh2 with a ncRNA is important to
induce X inactivation. 4) DNA methylation is a
repressive modification that is recognized by spe-
cific binding factors (MBD proteins) which re-
cruit other corepressor proteins, e.g., HDACs.
5) Histone modifications can recruit binding part-
ners that induce active or repressive chromatin
states. H3K4me3 correlates with transcriptional
activity and is recognized by components of the
TFIID complex. Heterochromatic chromatin struc-
tures feature the combinatorial mark H3K9me3 and
H4K20me3.
Review
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sequences. MBD (methyl binding domain) proteins and MeCP2 can bind methylated 
DNA stretches and in turn recruit corepressor complexes to facilitate transcriptional 
silencing (Sasai and Defossez 2009). 
5. Histones can be posttranslationally modified. The major modifications include 
phosphorylation, acetylation, and methylation. Combinations of different histone 
modifications represent chromatin signals that are recognized by specific binding 
proteins that then mediate downstream effects. In the context of transcriptional 
regulation, histone lysine methylation has been particularly well characterized. This 
modification generates a high complexity of signals as each lysine position can be 
mono- (me1), di- (me2), or trimethylated (me3) and distinct binding proteins for each 
methylation state can mediate different functions. Transcriptionally active, 
euchromatic domains are characterized by histone H3 lysine 4 trimethylation 
(H3K4me3) at gene promoters and H3K36me3 across gene bodies (Barski et al. 
2007). The two types of heterochromatin carry distinct modification patterns. 
Facultative heterochromatin is marked by high levels of H3K27me3 (Trojer and 
Reinberg 2007). In contrast, constitutive also referred to as pericentric 
heterochromatin, features the combinatorial mark H3K9me3 and H4K20me3 
(Lachner et al. 2004). 
 
1.2	  Pericentric	  heterochromatin	  
The following subchapter and Figure 2 have been published in (Dambacher et al. 2010), a review 
article, of which I am joint first author (for author contributions see page 8). Slight changes in 
the text (marked in italics) have been conducted. 
The largest family of repetitive regions consists of major satellite repeats that are the 
main constituents of pericentric heterochromatin. Major satellite repeats have a 
distinct H3K9me3 and H4K20me3 chromatin signature, which is found in almost all 
cell types and developmental stages, suggesting that these modifications have a 
general function in heterochromatin. H3K9me3 is established by Suv39h1 and 
Suv39h2 enzymes (Rea et al. 2000). Two other HMTases, Suv4-20h1 and Suv4-
20h2, establish H4K20me3 (Schotta et al. 2004). Recent data suggest a novel 
modification, H3K64me3 that has a role in pericentric heterochromatin formation 
during the early stages of mouse development (Daujat et al. 2009); however, the 
responsible methyltransferase has not been identified as yet. 
The combinatorial pattern of histone lysine methylation at heterochromatin is 
established in a sequential pathway (Figure 2). In Schizosaccharomyces pombe, 
double-stranded RNA from centromeric repeats is processed by components of the 
RNA interference machinery. 
 17 
 
Figure 2. Pericentric heterochromatin marks are established in a sequential pathway 
(Dambacher et al. 2010) 
The Setdb1/CAF1-HP1a complex presumably induces H3K9me1, which is converted to 
H3K9me3 by Suv39h enzymes. H3K9me3 exerts an effect as a binding platform for HP1 
proteins, which in turn recruit Suv4-20h enzymes to induce H4K20me3. Establishment of 
these modifications is also regulated through interactions with other proteins, for example, 
members of the retinoblastoma (Rb) family. There is also evidence for interaction of DNA 
methyltransferases with Suv39h enzymes; however, this interplay needs further 
characterization. 
This leads to recruitment of Clr4, the S. pombe homolog of Suv39h, to establish 
H3K9 methylation at heterochromatin (Grewal and Jia 2007). In mammals, it is still 
unclear whether a similar link between processing of double-stranded RNA and 
recruitment of Suv39h exists. H3K9me3 is likely to be established in a highly 
coordinated manner during replication of pericentric heterochromatin. Data suggest 
that, in a first step, Setdb1 (SET domain bifurcated 1), in complex with 
heterochromatin protein 1α (HP1α) and CAF1 (chromatin assembly factor 1), induce 
H3K9me1 on non-nucleosomal histone H3 (Loyola et al. 2009). Recently, the 
methyltransferases Prdm3 and Prdm16 have been shown to also play substantial 
roles in the generation of H3K9me1 and heterochromatin integrity (Pinheiro et al. 
2012). Subsequently, Suv39h enzymes, which prefer H3K9me1 as substrate, induce 
H3K9me3, probably even before the H3 molecule is deposited into a nucleosomal 
context (Rea et al. 2000). Nucleosomal H3K9me3 exerts an effect as a binding 
platform for HP1 proteins, which in turn recruit Suv4-20h enzymes to establish 
H4K20me3 (Schotta et al. 2004). The direct interaction of Suv4-20h enzymes with 
HP1 is necessary to induce H4K20me3; however, interactions with other proteins, for 
example, members of the retinoblastoma family, can contribute to the establishment 
of this modification (Gonzalo et al. 2005).  
modifications across the gene body can even affect
processing of the RNA transcript, such as selection of
polyadenylation sites or even splicing (Kolasinska-
Zwierz et al., 2009; Spies et al., 2009). These surprising
connections between chromatin structure and RNA
processing will reveal novel mechanisms for the regula-
tion of cell-type-specific transcription profiles.
Repressive histone lysine methylation marks
Transcriptional repression is important for various
aspects of development. On one hand, cell-type-specific
expression patterns are regulated by silencing of lineage-
inappropriate genes during differentiation, and on the
other hand, large regions of mammalian genomes consist
of non-coding DNA sequences such as satellite repeats,
telomeric repeats, mobile elements and interspersed
repeats, which need to be under tight transcriptional
control to prevent genomic instability. Genome-wide
mapping studies of histone modifications consider only
the nonrepetitive part of the genome and from these data
it seems that H3K27me3 is a major modification that
correlates with the transcriptional repression of genes
(Figure 1). In contrast, repetitive genomic regions are
marked by H3K9me3 and H4K20me3. In the following
sections, we will discuss the establishment and potential
functions of repressive histone modifications at both
highly repetitive genomic regions and at individual
genes.
Silencing of repetitive genomic regions
Pericentric heterochromatin
The largest family of repetitive regions consists of major
satellite repeats that are the main constituents of
pericentric heterochromatin. Major satellite repeats have
a distinct H3K9me3þH4K20me3 chromatin signature,
which is found in almost all cell types and develop-
mental stages, suggesting that these modifications have a
general function in heterochromatin. H3K9me3 is estab-
lished by Suv39h1 and Suv39h2 enzymes (Rea et al.,
2000). Two other HMTases, Suv4-20h1 and Suv4-20h2,
establish H4K20me3 (Schotta et al., 2004). Recent data
suggest a novel modification, H3K64me3 that has a role
in pericentric heterochromatin formation during the
early stages of mouse development (Daujat et al., 2009);
however, the responsible methyltransferase has not been
identified as yet.
The combinatorial pattern of histone lysine methyla-
tion at heterochromatin is established in a seque tial
pathway (Figure 3). In Schizosaccharomyces pombe, double-
stranded RNA from centromeric repeats is proces ed by
components of the RNA interference machinery. This
leads to recruitment of Clr4, the S. pombe homolo of
Suv39h, to establish H3K9 methylation at heterochroma-
tin (Grewal and Jia, 2007). In mammals, it is still unclear
whether a similar link between processing of double-
stranded RNA and recruitment of Suv39h exists.
H3K9me3 is likely to be established in a highly
coordinated manner during replicatio of pericentric
heterochromatin. Recent data suggest that, in a first
step, Setdb1 (SET domain bifurcated 1), in c mplex
with heterochromatin protein 1a (HP1a) and CAF1
(chromatin assembly factor 1), induces H3K9me1 on
non-nucleosomal histone H3 (Loyola et al., 2009). Subse-
quently, Suv39h enzymes, which prefer H3K9me1 as
substrate, induce H3K9me3, probably even before the H3
molecule is deposited into a nucleosomal context
(Rea et al., 2000). Nucleosomal H3K9me3 exerts an effect
as a binding platform for HP1 proteins, which in turn
recruit Suv4-20h enzymes to establish H4K20me3 (Schot-
ta et al., 2004). The direct interaction of Suv4-20h
enzymes with HP1 is necessary to induce H4K20me3;
however, interactions with other proteins, for example,
members of the retinoblastoma family, can contribute to
the establishment of this modification (Gonzalo et al.,
2005).
What are the functions of histone lysine methylation
marks at pericentric heterochromatin? Although consid-
ered highly compact and transcriptionally silent, there
is increasing evidence for contr lled transcription
across pericentric heterochromatin (Eymery et al., 2009).
Promoter elements are still unknown, and owing to
the repetitive nature of these transcripts they have yet to
be characterized. However, it is clear t at tr nscription
from major satellite repeats is tightly controlled, occur-
ring only during distinct cell cycle stages. Suv39h
double-null mutants show enhanced amounts of major
satellite transcripts (Martens et al., 2005), in icating hat
H3K9me3 has an important role in controlling the
transcript levels from these repeat r gions. How this
control is accomplished, whether H3K9me3 or its
binding factors hinder access to RNA Pol II or whether
RNA processing or RNA stability are regulated by this
modification are some challenging questions i this field.
Figure 3 Repressive histo e lysine methylation marks at hetero-
chromatin are established in a sequential pathway. The Setdb1/
CAF1/HP1a complex presumably induces H3K9me1, which is
converted to H3K9me3 by Suv39h enzymes. H3K9me3 exerts an
effect as a binding platform for HP1 proteins, which in turn recruit
Suv4-20h enzymes to ind ce H4K20me3. Establishment of these
modifications is also regulated through interactions with other
proteins, for example, members of the retinoblastoma (Rb) family.
There is also evidence for interaction of DNA methyltransferases
with Suv39h enzymes; however, this interplay needs further
characterization.
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What are the functions of histone lysine methylation marks at pericentric 
heterochromatin? Although considered highly compact and transcriptionally silent, 
there is increasing evidence for controlled transcription across pericentric 
heterochromatin (Eymery et al. 2009). Transcription factor binding sites for e.g. Pax3 
were mapped to major satellite repeats, which could mediate heterochromatin 
silencing. It was suggested, that distinction between euchromatin and 
heterochromatin is likely based on a synergistic organization versus a more random 
distribution of transcription factor binding sites (Bulut-Karslioglu et al. 2012). Suv39h 
double-null mutants show enhanced amounts of major satellite transcripts (Martens 
et al. 2005), indicating that H3K9me3 has an important role in controlling the 
transcript levels from these pericentric repeat regions. How this control is 
accomplished, whether H3K9me3 or its binding factors hinder access to RNA Pol II 
or whether RNA processing or RNA stability are regulated by this modification are 
some challenging questions in this field. Interestingly, pericentric H4K20me3 was 
also described as a late developmental epigenetic marker in mouse embryogenesis 
(Wongtawan et al. 2011). This finding may imply a potential function of histone lysine 
methylation at pericentric heterochromatin in developmental transitions. 
 
1.3	  Chromatin	  changes	  in	  development	  
A detailed review “Epigenetic regulation of development by histone lysine methylation” of which 
I am a joint first author, can be found in Chapter 2.2. 
In mammals, embryonic development starts with the fertilization of the egg, forming 
the zygote. This develops upon continuous cell divisions into a multicellular 
preimplantation embryo. From this blastocyst’s inner cell mass ESCs can be derived. 
Two important characteristics of ESCs are: 1) the capacity for self renewal and 2) 
pluripotency, the ability to give rise to all cell lineages of the three germ layers (Niwa 
2007). The chromatin of stem cells is believed to have a more “open” conformation 
and a higher plasticity, meaning a hyperdynamic chromatin binding of structural 
proteins like HP1, linker histone H1 or core histones (Meshorer and Misteli 2006; 
Meshorer et al. 2006). These features are progessively lost upon transition into the 
multitude of lineage-specific stem cells, progenitors and terminally differentiated 
cells. Differentiation correlates with an increase in heterochromatin formation and is 
accompanied by changes in nuclear and chromatin architecture and distribution of 
heterochromatin proteins (Dialynas et al. 2007; Bhattacharya et al. 2009; Joffe et al. 
2010). Lineage-specific gene transcription needs to be activated while lineage-
inappropriate genes must be silenced. Chromatin regulation is crucial to control 
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these differential gene expression patterns. The best studied groups of proteins 
balancing the developmental regulators are the Trithorax (TrxG) and Polycomb 
(PcG) systems. TrxG and PcG proteins have been shown to play key roles in 
developmental gene regulation (Lee et al. 2006; Schuettengruber et al. 2011). 
Members of these groups can induce, bind and modulate either the active H3K4me3 
or the repressive H3K27me3 marks. 
 
1.4	  Polycomb	  gene	  silencing	  via	  H3K27	  methylation	  	  
The following subchapter and Figure 3 have been published in (Dambacher et al. 2010), a review 
article, of which I am joint first author (for author contributions see page 8). Slight changes in 
the text (marked in italics) have been conducted. 
H3K27 methylation only exists in multicellular organisms and has probably evolved 
as a system to facilitate cell-type differentiation. Surprisingly, in embryonic stem (ES) 
cells, H3K27me3 can coexist in the same region with H3K4me3 (Bernstein et al. 
2006). Genes that carry this ‘bivalent’ modification are mainly developmental 
regulators. Although bivalent genes are repressed, they carry engaged but stalled 
RNA Pol II. In differentiated cells, bivalent chromatin domains are reduced and genes 
that are active or repressed are characterized by H3K4me3 or H3K27me3, 
respectively (Mikkelsen et al. 2007). In ES cells, the major pluripotency genes 
Nanog, Sox2 and Oct4, are highly expressed and marked with H3K4me3. During 
differentiation, these genes transiently acquire a bivalent state before they become 
silenced with H3K27me3 (Pan et al. 2007).  
We think that H3K27me3 has a major role for developmental transitions (Figure 3). In 
pluripotent cells, developmental regulators are repressed by the bivalent 
modifications H3K27me3 and H3K4me3. After lineage decision, these genes are 
either active and carry H3K4me3 or they are inactive and show enriched signals for 
H3K27me3. Apparently, in committed progenitor cells there are at least two 
categories of H3K27me3-repressed genes. One category is lineage-appropriate 
genes that need to be activated in later stages of differentiation. Full activation of 
these genes depends on removal of H3K27me3, likely by histone demethylases like 
UTX and JMJD3 (Agger et al. 2007; Lan et al. 2007) that would then allow binding of 
transcriptional activators. Lineage-inappropriate genes, the second category, need to 
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Figure 3. The role of H3K27me3-mediated gene silencing during developmental transitions 
(Dambacher et al. 2010) 
In pluripotent cells, developmental regulators are repressed and carry bivalent H3K4me3 
and H3K27me3 modifications. Bivalent marks are reduced in committed progenitor cells in 
which two categories of H3K27me3-repressed genes exist. Lineage-appropriate genes are 
activated during terminal differentiation, probably by the active removal of H3K27me3. In 
contrast, lineage-inappropriate genes are stably repressed by H3K27me3 and other 
mechanisms, such as different repressive histone modifications and DNA methylation. 
be stably repressed by H3K27me3 or together with other mechanisms, like DNA 
methylation or different repressive histone modifications. Aberrant activation of 
lineage-inappropriate genes might as well be prevented by the lack of transcriptional 
activators. These processes occur within the spatial context of the nucleus. Lately 
chromosome conformation capture assays provided intriguing insights into large 
scale in vivo genome organization. These data suggest that the three-dimensional 
genome positioning in the nucleus affects gene regulation as well (Ferraiuolo et al. 
2010). 
 
1.5	  Higher	  order	  chromatin	  structure	  
Various mechanisms like looping of chromosome territories (Gondor and Ohlsson 
2009), chromatin interactions with the nuclear lamina (Burke and Stewart 2012) or 
molecular crowding (Hancock 2004) can contribute to nuclear architecture. For 
differential gene expression, the spatial chromatin distribution needs to be 
dynamically reorganized. Pericentric heterochromatin of different chromosomes 
clusters to form higher order chromatin structures, called chromocenters, which can 
be found in most somatic cells. Chromocenters can be visualized as DAPI (4',6-
diamidino-2-phenylindole)-dense regions in microscopy (Vissel and Choo 1989; 
Lehnertz et al. 2003). Initial chromocenter formation in early mouse development 
seems to be dependent on a strand-specific burst in transcription of the pericentric 
satellites (Probst et al. 2010). The organization of chromocenters is dynamic and cell 
patterns differ as Ezh2 is predominantly expressed in
undifferentiated/proliferating cells, whereas Ezh1 is
more abundant on terminal differentiation (Margueron
et al., 2008; Ezhkova et al., 2009).
H3K27 methylation correlates with gene repression
and is enriched at repressed Hox genes and in female
mammals at the inactive X chromosome. Thus, dereg-
ulation of Ezh enzymes in mice is expected to generate
strong phenotypes by affecting the gene activity of
important developmental regulators. Indeed, Ezh2
knockout mice show early embryonic lethality around
E8.5 (O’Carroll et al., 2001). Ezh2 knockout ES cells can
be established and selectively lose H3K27me2 and
H3K27me3 while maintaining H3K27me1. Interestingly,
at some important developmental genes, H3K27me3
is preserved in Ezh2!/! ES cells (Shen et al., 2008),
indicating that Ezh1 and Ezh2 share partially redundant
functions.
To analyze the function of H3K27me3 for develop-
mental transitions, conditional Ezh2 knockout mice were
established (Su et al., 2003). During B cell development,
Ezh2 is highly expressed in early progenitor populations
(pro-B and pre-B cells), whereas Ezh1 is only expressed
in late stages. Inactivation of Ezh2 in the hematopoietic
lineage blocks the transition from pro-B to pre-B cells;
however, later stages of B cell development are not
impaired (Su et al., 2003). In this model system,
transcriptional deregulation has not been investigated
and the reason for the developmental block at the pro-B
cell stage might be the improper processing of antigen
receptor rearrangements.
Ezh2 deletion was also analyzed in skin development,
in which basal layer progenitor stages can be distin-
guished from suprabasal cells that have initiated the
program of terminal differentiation. Again, expression
of Ezh2 is highest in the progenitor population and
decreases with differentiation stage (Ezhkova et al., 2009).
Deletion of Ezh2 in developing skin leads to dramatic
loss of H3K27me3, resulting in accelerated epidermal
differentiation and precocious acquisition of the epider-
mal barrier. Gene expression analysis of wild-type versus
Ezh2-deleted epidermal precursor cells revealed that
although H3K27me3 was almost lost in these cells,
only approximately 90 genes were deregulated (mostly
upregulated). Most of these genes are normally ex-
pressed in the final stages of epidermal development.
The premature activation of the terminal differentiation
program in the absence of Ezh2 suggests that transcrip-
tional activators for epidermal differentiation are already
present in the progenitor stages and that H3K27me3
blocks their access to target promoters (Ezhkova et al.,
2009). Most other genes, which also lose H3K27me3 in
the absence of Ezh2, are not activated, suggesting that
they are repressed by different mechanisms or that
appropriate transcriptional activators are not expressed
in this tissue. The question as to how H3K27me3 can
block the binding of transcription factors has not been
addressed. The intriguing possibility that specific bin-
ders of H3K27me3, for example, Cbx2 in the context of
the PRC1 complex, mediate compaction of the chromatin
structure should be tested in future studies.
We think that H3K27me3 has a major role for develop-
mental transitions (Figure 5). In pluripotent cells, develop-
mental regulators are repressed by the bivalent
modifications H3K27me3 and H3K4me3. After lineage
decision, these genes are either active and carry H3K4me3
or they are inactive and show enriched signals for
H3K27me3. Apparently, in committed progenitor cells
there are at least two categories of H3K27me3-repressed
genes. One category is lineage-appropriate genes that
need to be activated in later stages of differentiation.
Full activation of these genes depends on removal of
H3K27me3, probably by histone demethylases (Agger
et al., 2007; Lan et al., 2007) that would then allow binding
of transcriptional activators. Lineage-inappropriate genes,
the second category, need to be stably repressed by
H3K27me3 together with other mechanisms, such as
different histone methylation marks or DNA methylation.
Aberrant activation of lineage-inappropriate genes might
as well be prevented by the lack of transcriptional
activators. More detailed analyses are required to distin-
guish between these possibilities.
Repression of repetitive elements and gene
regulation by H3K9 methylation
The first H3K9-specific methyltransferases that were
disrupted in mice were the Suv39h1 and Suv39h2
demethylase/
passive removal
lineage
inappropriate
removal of individual repressive
marks tolerable for silencing
lineage
appropriate
Figure 5 The role of H3K27me3-mediated gene silencing during developmental transitions. In pluripotent cells, developmental regulators
are repressed and carry bivalent H3K4me3þH3K27me3 modifications. Bivalent marks are reduced in committed progenitor cells in which
two categories of H3K27me3-repressed genes exist. Lineage-appropriate genes are activated during terminal differentiation, probably by the
active removal of H3K27me3. In contrast, lineage-inappropriate genes are stably repressed by H3K27me3 and other mechanisms, such as
different histone modifications and DNA methylation.
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type specific. An increase in chromocenter clustering can be detected upon cellular 
differentiation (Mayer et al. 2005; Terranova et al. 2005) indicating possible roles in 
developmental regulation. Consistent with this idea, relocalization of genomic 
domains to chromocenters can result in gene repression (Brown et al. 1997; Brown 
et al. 2001) although an explicit silencing mechanism is not known as of yet. Studies 
have also shown a contribution of the methyl CpG binding protein MeCP2 to global 
changes in heterochromatin and nucleolar organization during neuronal 
differentiation (Singleton et al. 2011). A testis-specific histone H1 variant was 
implicated in chromocenter regulation in spermiogenesis (Catena et al. 2006). 
Moreover, chromocenter integrity was recently shown to be depending on the histone 
H3K9-specific methyltransferases Prdm3 and Prdm16 (Pinheiro et al. 2012). 
However, the roles and biological relevance of chromocenters in genome 
organization and gene regulation remain elusive. 
A dramatic reshaping of the nuclear genome organization occurs in mitosis. An 
integral part for correct chromsome segregation is an intact pairing of the sister 
chromatids. This sister chromatid cohesion is mediated by cohesin, a multisubunit 
complex consisting of a heterodimeric ring of Smc1 and Smc3 proteins and 
additional stabilizing proteins Scc1 and Scc3 (Onn et al. 2008). In vertebrates, 
cohesin is loaded in the G1 cell cycle phase and establishes sister chromatid 
cohesion in S-phase. In fission yeast, cohesin can be targeted to heterochromatic 
regions by Swi6/HP1 (Nonaka et al. 2002). In mammals, though, there seems to be 
no interaction between HP1 and cohesin (Koch et al. 2008). However, it was shown 
recently, that upon knock-down of HP1 proteins sister chromatid cohesion is 
defective, concomitant with a loss of cohesin proteins at pericentromeres (Shimura et 
al. 2011). How cohesin is eventually maintained and recruited to mammalian 
pericentric heterochromatin is yet an open question. 
 
1.6	  Centromeres	  and	  heterochromatin	  
Pericentric heterochromatin regions, consisting of major satellite repeats, are 
localized adjacent to centromeres and have a significant function for proper 
chromosome segregation and mitotic sister chromatid cohesion (Bernard et al. 2001; 
Peters et al. 2001; Nonaka et al. 2002; Guenatri et al. 2004). This proximity might be 
important for correct centromere function as studies in yeast suggest (Olszak et al. 
2011), but more detailed analyses are necessary to better understand a possible 
interplay of these chromosomal domains. 
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Centromeres are essential chromosome regions that are crucial for correct spindle 
attachment and chromosome segregation in cell division. In yeast, the incorporation 
of the centromere-specific histone variant CenH3, is DNA sequence dependent. 
However this DNA specificity was lost during evolution (Henikoff et al. 2001) and 
other processes have to maintain the centromere formation process in higher 
organisms. More and more evidence points to epigenetic factors triggering the 
establishment of functional centromeres (Black and Cleveland 2011; Perpelescu and 
Fukagawa 2011). Like pericentric chromatin, centromeric regions consist of arrays of 
short tandem repeats. These minor satellite repeat regions are bound by centromeric 
proteins such as the histone variant Cenp-A (Figure 4A). 
 
Figure 4. Simplified schemes of centromere composition and CENP-A deposition 
A) Chromosomal minor satellite repeats contain Cenp-A nuclesomes. The CCAN protein 
complex is part of the inner kinetochore region. Cenp-C is linking to the outer 
kinetochore, which is crucial for microtubule-anchoring in mitosis B) Cenp-A deposition 
only happens in late mitosis, G1 phase. This conincides with centromere recruitment of 
the Mis18 complex, which is important for Hjurp loading. Phosphorylation of M18bp1, a 
member of the Mis18 complex, likely by Cdk1/2, may regulate centromeric Mis18 
localization. 
Cenp-A incorporation into centromeric chromatin is crucial for centromere and 
kinetochore function and is cell cycle dependent (Figure 4B). In S-phase, Cenp-A 
nucleosomes are diluted between sister chromatids. If this distribution is random or if 
it happens in a semi-conservative way is still unknown. To maintain a functional 
centromere, Cenp-A levels needs to be restored following S-phase, which happens 
after mitosis in early G1 (Jansen et al. 2007). Cenp-A recruitment is facilitated by 
various proteins like the Mis18 complex, Mis12 and the histone chaperone Hjurp 
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(Hayashi et al. 2004; Fujita et al. 2007; Dunleavy et al. 2009; Foltz et al. 2009). It 
seems that actively transcribed chromatin is fundamental for proper Hjurp function 
(Bergmann et al. 2011). For Cenp-A incorporation, mediated by the Hjurp chaperone, 
the Mis18 complex is necessary. This complex consisting of Mis18a, Mis18b and 
M18bp1, is important for the “priming” of these genomic regions (Fujita et al. 2007) 
and subsequent kinetochore assembly. It was demonstrated that the localization of 
the Mis18 complex to centromeres in mitotic telophase to G1 phase is dependent on 
phosphorlylation of M18bp1 (Silva et al. 2012), which may be the crucial regulatory 
step for the consecutive Cenp-A deposition. Since none of the Mis18 complex 
members can interact with Cenp-A, the details of this recruitment mechanism to 
centromeric chromatin are still unclear and may require additional proteins. The 
constitutive centromere-associated network (CCAN) consists of 16 chromatin 
proteins, that localize to the centromeric chromatin and may link Cenp-A to the 
kinetochore (Figure 4A). One of the CCAN members is Cenp-C, a centromere 
protein which was described to bind DNA and to act as a linker to the outer 
kinetochore Mis12 complex (Screpanti et al. 2011). It has been shown that Cenp-C 
and Cenp-T could recruit outer kinetochore proteins to establish an ectopic 
centromere. But detailed deposition mechanisms for Cenp-A or Cenp-C are still not 
clear and future experiments have to explain the establishment and maintenance of 
centromeres and kinetochores. 
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1.7	  Aims	  of	  this	  work	  
The main objective of this thesis was to get a better understanding of the formation 
and biological relevance of centromeric and pericentromeric heterochromatin and its 
protein networks. 
 
Heterochromatin is known to be an important regulator of developmental transitions. 
However, no mechanistic role of Suv4-20h activity in vertebrate development was 
known so far. This study will elaborate on the involvement of Suv4-20h and 
H4K20me3 in the control of development. Suv4-20h depletion in Xenopus laevis 
embryogenesis was analyzed and a mouse ES cell to embryoid body differentiation 
system was established to explore Suv4-20h’s impact on germ layer differentiation. 
 
Beyond developmental gene regulation, heterochromatin is also known to be 
important for genomic integrity and chromatin organization. Pericentromeric 
heterochromatin is established, maintained and regulated by a complex interplay of 
proteins. What are the functions of the heterochromatin protein network and 
how does it contribute to genomic integrity? To address these questions, 
heterochromatin protein dynamics was examined. Furthermore, Suv4-20h knock-out 
cell lines were analyzed, revealing essential tasks of Suv4-20h in chromosome 
segregation, nuclear architecture, chromatin compaction and cohesin recruitment. 
 
The influence of heterochromatin on cellular processes is not arising from histone 
modifying enzymes alone. The histone modifications themselves can affect cellular 
actions by recruiting a plethora of additional regulatory proteins. In this dissertation, 
the novel histone modification H3K56me3 was identified as a conserved 
pericentromeric heterochromatin mark. Moreover, the enzymatic framework 
establishing and removing H3K56me3 could be described. 
 
It is assumed that epigenetic mechanisms “licence” centromeric chromatin for Cenp-
A incorporation into chromatin. The last part of this thesis addresses the role of 
Cenp-C in recruiting M18bp1 to centromeric chromatin. Detailed microscopy 
analyses and protein interaction studies were performed to describe the interplay 
between Cenp-C and M18bp1. 
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2.	  Results	  
 
 
 
2.1 Heterochromatin dysregulation in 
human diseases. 
Review article: Hahn et al. 2010, Journal of Applied Physiology 
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Hahn M, Dambacher S, Schotta G. Heterochromatin dysregulation in human
diseases. J Appl Physiol 109: 232–242, 2010. First published April 1, 2010;
doi:10.1152/japplphysiol.00053.2010.—Heterochromatin is a repressive chromatin
state that is characterized by densely packed DNA and low transcriptional activity.
Heterochromatin-induced gene silencing is important for mediating developmental
transitions, and in addition, it has more global functions in ensuring chromosome
segregation and genomic integrity. Here we discuss how altered heterochromatic
states can impair normal gene expression patterns, leading to the development of
different diseases. Over the last years, therapeutic strategies that aim toward
resetting the epigenetic state of dysregulated genes have been tested. However, due
to the complexity of epigenetic gene regulation, the “first-generation drugs” that
function globally by inhibiting epigenetic machineries might also introduce severe
side effects. Thus detailed understanding of how repressive chromatin states are
established and maintained at specific loci will be fundamental for the development
of more selective epigenetic treatment strategies in the future.
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ABNORMAL GENE EXPRESSION patterns are often implicated in the
development of different diseases, and thus detailed insights
into the underlying mechanisms of gene regulation will be
fundamental in identifying novel interventional treatment strat-
egies. Enormous progress over the last few years, particularly
in the field of epigenetic regulation, has contributed to a better
understanding of how gene activity is controlled.
In the nucleus DNA is packaged with histones and nonhis-
tone proteins in a dynamic structure called chromatin. The
grade of chromatin compaction can influence DNA accessibil-
ity to the transcriptional machinery. Euchromatin is loosely
packed and transcriptionally active, whereas heterochromatin
represents a more densely packed chromatin state that is
characterized by low transcriptional activity. Heterochromatin
can be subdivided into two categories: facultative heterochro-
matin for silencing of developmental genes and the inactive X
chromosome in female mammals, and constitutive heterochro-
matin, which is formed at pericentromeric regions and telo-
meres.
Five major epigenetic mechanisms are capable of establish-
ing and stabilizing open or closed chromatin structures, thereby
regulating transcriptional activity (Fig. 1).
1) Nucleosome remodelers can stimulate transcription by
removing nucleosomes from promoter regions, allowing tran-
scription factors to gain access to the underlying DNA (47).
Additional functions of nucleosome remodelers include histone
variant exchange and nucleosome sliding (93).
2) Mammalian cells express three histone H3 variants: H3.1,
H3.2, and H3.3. Specific enrichment of H3.3 in transcription-
ally active genes and regulatory regions, and H3.1 in repressed
or inactive genetic elements suggest a regulatory function of
these variants (60). Incorporation of histone variants is also
important for many other chromatin-related processes. Faithful
DNA damage repair, for example, depends on the presence of
a histone H2A variant, H2A.X, which is phosphorylated on
damage detection allowing binding of the DNA damage repair
machinery (11).
3) Increasing evidence suggests important functions for long
noncoding RNAs (ncRNAs) in transcriptional regulation. Di-
rect interactions of chromatin-modifying enzymes with non-
coding RNAs are speculated to facilitate targeting to specific
genomic loci. A well-studied example is the histone methyl-
transferase Ezh2, which was shown to interact with different
ncRNAs to induce X inactivation and repression of develop-
mental genes (75, 101). Small ncRNAs, e.g., siRNAs and
promoter antisense RNAs, can also trigger formation of repres-
sive chromatin structures as will be discussed below.
4) Cytosine bases, preferably in the context of CpG dinucle-
otides, can be methylated to 5-methylcytosine by DNA meth-
yltransferases. DNA methylation is a repressive modification
that is enriched at promoter regions of genes and noncoding
DNA sequences. MBD (methyl binding domain) proteins
and MeCP2 can bind methylated DNA stretches and in turn
recruit corepressor complexes to facilitate transcriptional
silencing (78).
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5) Histones can be posttranslationally modified. The major
modifications include phosphorylation, acetylation, and methyl-
ation. Combinations of different histone modifications represent
chromatin signals that are recognized by specific binding proteins
that then mediate downstream effects. In the context of transcrip-
tional regulation, histone lysine methylation has been particularly
well characterized. This modification generates a high complexity
of signals as each lysine position can be mono- (me1), di- (me2),
or trimethylated (me3) and distinct binding proteins for each
methylation state can mediate different functions. Transcription-
ally active, euchromatic domains are characterized by histone H3
lysine 4 trimethylation (H3K4me3) at gene promoters and
H3K36me3 across gene bodies (2). The two types of heterochro-
matin carry distinct modification patterns. Facultative heterochro-
matin is marked by high levels of H3K27me3 (86). In contrast,
constitutive heterochromatin features the combinatorial mark
H3K9me3 and H4K20me3 (52).
The enzymatic systems for many chromatin-modifying ac-
tivities have been identified during the last years; however, still
very little is known about their targeting to specific genomic
regions. For gene silencing and heterochromatin formation
across repetitive elements, the production of distinct types of
noncoding RNA, antisense RNA and siRNA, have been im-
plicated in the targeting mechanism.
In mammals, the promoter regions of many genes are tran-
scribed at a low level, giving rise to promoter-associated RNAs
(30). Antisense ncRNAs that are complementary to these pro-
moter transcripts can mediate recruitment of repressive epigenetic
modifications, such as H3K27me3 and H3K9me2. This form of
transcriptional gene silencing involves the small RNA binding
proteins Argonaute 1 and 2, suggesting that epigenetic machiner-
ies interact with components of the RNAi pathway (38, 42).
Targeting of repressive epigenetic modifications to repetitive
elements at pericentric heterochromatin appears to involve
small interfering RNAs. This mechanism is well understood in
the budding yeast, Schizosaccharomyces pombe: bidirectional
transcription of repetitive elements generates double-stranded
RNAs that are cleaved to siRNAs by the endonuclease dicer.
These small RNAs are then loaded onto argonaute 1, which
recognizes the DNA sequence from which the small RNA was
generated. The histone methyltransferase (HMTase) Clr4 di-
rectly interacts with argonaute 1 and induces repressive H3K9
methylation (29). It is still controversial if this siRNA mech-
anism exists in mammals; however, there are parallels. An
early step in establishing the combinatorial histone modifica-
tions at pericentric heterochromatin is H3K9 trimethylation by
Suv39h1 and Suv39h2, the mammalian Clr4 homologs.
H3K9me3 is recognized by heterochromatin protein 1 (HP1),
which, in turn, recruits other HMTases, Suv4–20h1 and Suv4–
20h2, to mediate H4K20me3 (81, 82). Heterochromatin in
mammals features another important epigenetic modification,
DNA methylation. Interestingly, there is interdependence be-
tween DNA methylation and H3K9me3 (56). However, the
mechanisms are not clear.
An important hallmark of constitutive heterochromatin is its
ability to spread from a nucleation site into neighboring re-
gions. Position-effect variegation in Drosophila is a well-
established model system that highlights this feature (80). In
this organism, heterochromatin can eventually expand several
hundred kilobases into euchromatic regions. Spreading is
hypothesized to work through the following mechanism:
H3K9me3 on one nucleosome recruits HP1 which can dimer-
ize and interact with Suv39h that establish H3K9me3 on the
neighboring nucleosome. The border between heterochromatic
Fig. 1. Major epigenetic mechanisms that regulate
chromatin structure. 1) Nucleosomes can prevent
binding of transcription factors (TF). One func-
tion of nucleosome remodeling complexes is to
evict nucleosomes to make promoters accessible.
2) Distinct histone H3 variants associate with
transcriptionally active or repressive chromatin
domains. 3) Noncoding RNAs (ncRNAs) can
recruit histone-modifying enzymes. For example,
interaction of the H3K27-specific histone meth-
yltransferase Ezh2 with a ncRNA is important to
induce X inactivation. 4) DNA methylation is a
repressive modification that is recognized by spe-
cific binding factors (MBD proteins) which re-
cruit other corepressor proteins, e.g., HDACs.
5) Histone modifications can recruit binding part-
ners that induce active or repressive chromatin
states. H3K4me3 correlates with transcriptional
activity and is recognized by components of the
TFIID complex. Heterochromatic chromatin struc-
tures feature the combinatorial mark H3K9me3 and
H4K20me3.
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and euchromatic domains is likely to be dynamically regulated
by a balance between the antagonizing activities of activating
and repressive factors (19). Heterochromatin spreading also
exists in mammals. However, it is not clear to what extent gene
regulation is affected by its impairment.
Gene silencing through heterochromatin is an important
mechanism to ensure establishment of cell type-specific gene
expression patterns. Dysregulation of heterochromatin can re-
sult in severe developmental defects. In this review we will
discuss human diseases that are connected to defective hetero-
chromatin formation. We will distinguish four different cate-
gories: 1) gene overexpression due to reduced heterochroma-
tin, 2) gene silencing through aberrant heterochromatin forma-
tion, 3) stable heterochromatin at regulatory elements, and
4) global dysregulation of heterochromatin.
Glossary
AS Angelman syndrome
DM1 myotonic dystrophy type 1
FRDA Friedreich’s ataxia
FSHD facioscapulohumeral muscular dystrophy
FXN frataxin
FXS fragile X syndrome
HDAC histone deacetylase
HMTase histone methyltransferase
HP1 heterochromatin protein 1
IAP intracisternal type A particle
ICR imprinting control region
MBD methyl binding domain
ncRNA noncoding RNA
PWS Prader-Willi syndrome
Rb Retinoblastoma protein
SAHF senescence-associated heterochromatic foci
REDUCED HETEROCHROMATIN FORMATION IN
FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Genes are not only controlled by specific transcriptional
activators and repressors. Transcriptional regulation is proba-
bly always adapted to the genomic environment of a particular
gene. In the first part of this review we will highlight a disease
that is caused by reduced formation of heterochromatin across
a repetitive region, leading to aberrant activation of genes that
are in close proximity.
Facioscapulohumeral muscular dystrophy (FSHD) is a fre-
quent (1:20,000) dominant autosomal disease that is character-
ized by progressive, often asymmetric weakness and wasting
of facial, shoulder, and upper arm muscles (45). FSHD is not
caused by mutation of a specific disease gene. Instead, increas-
ing evidence suggests a significant role for a complex epige-
netic mechanism, resulting in perturbation of heterochromatic
gene silencing in the subtelomeric domain of the long arm of
chromosome 4 (24). This region (Fig. 2A) contains several
genes (e.g., FRG1, FRG2, ANT1) and pseudogenes (TUBB4Q,
DUX4c) next to a large array of repetitive sequences (D4Z4).
Each D4Z4 repeat is 3.3 kb in length and harbors two classes
of the GC-rich repeat sequences hhspm3 and LSau as well as
a DUX4 pseudogene. Furthermore, D4Z4 is overall very GC-
rich and has characteristics of CpG islands (35).
Reduced D4Z4 repeat number leads to overexpression of
genes in FSHD patients. In healthy individuals up to 100
tandem copies of the D4Z4 element generate a heterochromatic
domain that silences the nearby genes (Fig. 2A). FSHD patients
have less D4Z4 repeats (1–10 copies) (89). Interestingly,
smaller D4Z4 arrays result in earlier disease onset and en-
hanced severity in patients (74, 85, 97). Genes proximal to
D4Z4 are often inappropriately overexpressed in FSHD pa-
tients (24). As several of these genes might contribute to the
FSHD phenotype, individual overexpression of FRG1, FRG2,
Fig. 2. Reduced heterochromatin formation in fa-
cioscapulohumeral muscular dystrophy (FSHD). A: the
subtelomeric region of chromosome arm 4q contains a
large array of D4Z4 repeats that consists of repetitive
elements (LSau and hhspm3) and the DUX4 pseudo-
gene. In healthy individuals, 11–100 tandem repeats of
D4Z4 induce a local heterochromatic environment that
represses transcription of genes across a region of more
than 200 kb. DNA methylation, H3K9me3 and HP1,
hallmarks of pericentric heterochromatin, can be de-
tected at D4Z4 repeats. There is evidence that DNA
specific binding of YY1 recruits EZH2 to induce
H3K27me3, another repressive modification. In FSHD
patient cells, the reduced D4Z4 array is not able to
nucleate a heterochromatic structure. H3K27me3 is still
detectable in the locus; however, loss of H3K9me3 and
DNA methylation leads to overexpression of genes in
the 4q region. B: models for heterochromatin-mediated
gene silencing in the 4q region. 1) D4Z4 arrays can
induce a local heterochromatic domain that spreads
across the 4q locus, thereby inactivating the genes in
this region. 2) An alternative explanation is the forma-
tion of chromatin interactions between the D4Z4 repeats
and gene promoters, also leading to repression.
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and ANT1 was conducted in the mouse model. Notably, over-
expression of a single gene, FRG1, was sufficient to induce a
muscular dystrophy phenotype that mimics human FSHD (23).
Loss of function experiments in Xenopus laevis, using mor-
pholinos against xFrg1, resulted in disrupted organization and
inhibited growth of the myotome, and consistent with the
mouse data, elevated xFrg1 levels lead to abnormal muscle
formation (31). Not much is known about the molecular
functions of FRG1. The protein localizes to nucleoli and Cajal
bodies and is probably involved in pre-mRNA splicing (90,
91). Interestingly, FRG1 overexpression affects splicing of
muscle-specific genes (23).
Recent studies have examined more FSHD patients, and the
data are very complex. Besides the classic FSHD type with
reduced D4Z4 repeats there is also a phenotypic type where
repeat length is not altered. Finally, there are also FSHD
patients where FRG1 is rather normally expressed and muscle
lineage genes from unrelated loci are dysregulated (39, 46).
These studies indicate that the FSHD phenotype can be caused
by many different defects; however, in this review we will
focus on the mechanism of FRG1 derepression.
Silencing of FRG1 is dependent on heterochromatic histone
methylation marks. The close proximity to D4Z4 repeats and
the dependence on the repeat number suggest that FRG1
expression is affected by epigenetic mechanisms that act in this
environment. Not much is known about epigenetic modifica-
tions in the 4q35 region (Fig. 2A). In early studies the Poly-
comb group protein YY1 has been detected at the D4Z4 repeats
(24) and at the FRG1 promoter (5). Recruitment of YY1
correlates with establishment of a repressive histone modifica-
tion, H3K27me3, at both regions. In mammals, H3K27 meth-
ylation is controlled by the histone methyltransferases EZH1
and EZH2. Although direct evidence is lacking, these enzymes
are likely to be responsible for this modification at 4q35. In
FSHD patients overexpressing FRG1, H3K27me3 can still be
detected at the FRG1 promoter, suggesting that this modifica-
tion is not sufficient to induce silencing (5, 100).
Two other repressive epigenetic modifications, DNA meth-
ylation and H3K9me3, might play important roles in this
context: DNA methylation has been detected at both D4Z4
repeats and at the FRG1 promoter, and compared with healthy
controls, FSHD patients show significant hypomethylation of
these regions (92). Interestingly, hypomethylation is not nec-
essarily dependent on reduced D4Z4 repeats, as patients with
normal repeat numbers can also display hypomethylation. In a
recent publication Zeng et al. could show that H3K9me3 is
highly enriched at D4Z4 repeats (100), suggesting that this
domain has features of constitutive heterochromatin. In line
with this model, the authors could demonstrate that, just as in
pericentromeric heterochromatin, H3K9me3 is induced by
SUV39H enzymes and can recruit HP1 proteins.
Regulation of FRG1 expression by D4Z4 heterochromatin:
spreading vs. locus interactions. How can changes in the D4Z4
repeat number alter epigenetic modifications across the 4q35
region? We hypothesize that the D4Z4 repeat structure induces
a heterochromatin environment, using similar mechanisms as
found at pericentric heterochromatin. Bidirectional transcrip-
tion across D4Z4 might generate double-stranded RNAs (14)
that can be processed by the RNAi machinery. The resulting
small interfering RNAs could recruit SUV39H enzymes to
induce H3K9me3, the binding platform for HP1 proteins.
Spreading of this heterochromatic structure may then establish
repression of neighboring genes, such as FRG1 (Fig. 2B).
Reduced D4Z4 repeats might not be able to nucleate enough
heterochromatin components to facilitate spreading to very
distant loci. This idea is consistent with heterochromatin ex-
pansion in Drosophila where small heterochromatic regions
can spread only around a few kilobases (36); however, special
rearrangements that involve large blocks of pericentric hetero-
chromatin can induce spreading across hundreds of kilobases
(19). There is also an alternative explanation for D4Z4-depen-
dent silencing of FRG1. Chromosome conformation capture
(3C) techniques have revealed interactions between the hetero-
chromatic D4Z4 repeats and the FRG1 promoter (5, 72). These
chromatin interactions might induce repression of FRG1 with-
out the necessity of a spreading mechanism (Fig. 2B). If the
D4Z4 array is small, interactions with FRG1 might be less
frequent and could thus influence the transcriptional status of
FRG1.
In summary, the data suggest that FSHD is connected to
epigenetic dysregulation of D4Z4 repeats; however, at the
current stage of analysis it is not possible to build a consistent
model. In future studies it will be crucial to analyze a broader
spectrum of epigenetic modifications across the entire 4q35
region. Furthermore it would be very helpful to put these data
in context with expression analyses of not only FRG1 but also
all other genes in this locus. It is very likely that FRG1
overexpression only correlates with a subset of FSHD patients
and other genes might also contribute to disease development.
Before specific disease treatment strategies can be developed,
the phenotypic FSHD subtypes need to be much better defined
on the molecular level.
TRIPLET REPEAT INDUCED HETEROCHROMATIN
FORMATION IN FRIEDREICH’S ATAXIA
In the previous section we discussed a disease that is caused
by reduced heterochromatin silencing. However, there are also
human diseases that can be linked to ectopic heterochromatin
formation and aberrant gene silencing. In this section we will
describe how repetitive expansion of small nucleotide stretches,
often triplets, in promoter, intron, or exon regions can lead to
heterochromatin formation and silencing of the associated gene,
resulting in the development of a disease (59).
Friedreich’s ataxia (FRDA) is an autosomal recessive neu-
rodegenerative disease with a frequency of 1:50,000. Patients
suffer from progressive ataxia, muscle weakness, heart disease,
and eventually diabetes (18, 32). FRDA is caused by an
expansion of GAA repeats in intron 1 of frataxin (FXN),
resulting in substantially reduced transcription of this gene (4,
10). FXN is a mitochondrial protein that probably works as an
iron chaperone. Its precise function is not entirely clear; how-
ever, loss of FXN leads to metabolic disturbances, e.g., in-
creased oxidative stress, reduced iron-sulfur clusters, and de-
fects in energy metabolism (67).
GAA repeat expansions cause heterochromatin-induced si-
lencing of frataxin. Healthy individuals carry between 6 and 36
GAA repeats in intron 1 of frataxin (Fig. 3A), while FRDA
patients show expansions ranging from 120–1,700 repeats (10,
15, 18, 61). In FRDA patient cells, frataxin is silenced by GAA
repeat-dependent formation of heterochromatin (16, 34). Inter-
estingly, repeat length correlates with disease severity (21, 62).
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This suggests that increased repeats can more easily or more
strongly induce silencing. A hallmark of many repeat expan-
sion diseases is somatic instability. With increasing age of the
patient, repeats can become longer, which might even accel-
erate disease progression. Several lines of evidence suggest
that this repeat instability is caused by defects during DNA
replication, DNA repair, or recombination (59).
Transcriptional control of FXN in healthy individuals has
not been analyzed in detail, yet. It is not known if binding sites
for specific transcription factors exist (Fig. 3A). Chromatin
immunoprecipitation experiments revealed enrichment of the
repressive histone modifications H3K9me3 and H3K27me3 at
the FXN promoter and in a region upstream of the GAA repeats
(34). Similar to pericentric heterochromatin, there is also en-
richment for HP1 and DNA methylation in FRDA patient cells
(16, 28).
Exon 1 of the frataxin gene contains a binding site for the
chromatin insulator protein CTCF. Interestingly, increased
DNA methylation or alterations in the chromatin structure in
FRDA correlate with loss of CTCF binding (16). CTCF is
speculated to play a role in the regulation of an antisense
transcript, FAST-1 (Fig. 3A), which may originate from an
AluSP sequence more downstream in intron 1 (50), suggesting
that antisense transcription is involved in disease development.
In agreement with these data FAST-1 cannot be detected in
healthy individuals; however, as only a small region of this
transcript is known (Fig. 3A, black arrow), it is formally
possible that in healthy individuals a shorter form of FAST-1
is transcribed.
Although production of the noncoding FAST-1 RNA at the
frataxin locus might influence silencing, heterochromatin for-
mation depends mainly on the GAA repeat expansion. This has
been demonstrated in a transgenic mouse model where short
GAA repeat expansions induce silencing of a linked marker
gene (79). Repression of this transgene correlates with de-
creased promoter accessibility and can be enhanced by HP1
overexpression, typical features of a heterochromatic state.
Importantly, silencing of the GAA repeat transgene did not
depend on the genomic integration site, suggesting that the
heterochromatic state is directly induced by the GAA repeat
region.
How can repeat expansions induce heterochromatin? Dif-
ferent models are discussed to explain how small repeat ex-
pansions can trigger heterochromatin formation (Fig. 3B);
however, there is no ultimate proof for any of them. An
interesting feature of long GAA triplet repeats is the formation
of non-B-DNA structures and sticky DNA in vitro (94). If such
structures, e.g., a DNA triplex, form at the FXN locus, normal
transcription could be inhibited and RNA polymerase might
stall or progress at a much slower rate. In this case cellular
checkpoint mechanisms might trigger heterochromatin forma-
tion.
Another intriguing possibility to explain heterochromatin
formation is antisense transcription across the FXN locus (Fig.
3B). In S. pombe bidirectional transcription generates double-
stranded RNA, which is processed by the RNAi machinery and
can induce heterochromatin formation across the underlying
genomic locus (29). Thus production of the FAST-1 transcript
could be crucial for the silencing mechanism in FRDA. Fur-
thermore there is evidence for antisense transcription in other
repeat expansion diseases (13, 53), indicating that this process
may be of general importance. A major regulator for antisense
transcript production might be CTCF. In FRDA patients, loss
of CTCF binding correlates with accumulation of FAST-1
transcripts, and also in a related disease, myotonic dystrophy
type 1 (DM1), CTCF limits antisense transcription (13). Fur-
ther analyses are required to demonstrate whether CTCF di-
rectly functions in transcriptional control at these loci.
A third model for induction of heterochromatin at trinucle-
otide repeat loci was suggested recently (48) and might play a
Fig. 3. Triplet repeat induced heterochromatin
formation in Friedreich’s ataxia (FRDA).
A: in healthy individuals, intron 1 of the
frataxin gene contains only a small number of
GAA repeats. The frataxin gene is transcribed,
and CTCF binding in exon 1 may be an
important regulatory element for this locus. In
FRDA patient cells, expanded GAA repeats
lead to formation of a heterochromatic do-
main, coinciding with loss of CTCF binding
and silencing of frataxin expression. Interest-
ingly, repression of frataxin correlates with
upregulation of the FAST-1 antisense tran-
script, which may originate from the AluSP
sequence in intron 1. B: models for initiation
of heterochromatin through triplet repeat ex-
pansions. 1) Triplet repeats form unusual
DNA structures that may result in stalling of
the RNA polymerase (RNAPol). This could
trigger a damage signal leading to inactivation
of the locus. 2) Bidirectional transcription
across the frataxin locus may produce double-
stranded RNA, triggering siRNA-mediated
heterochromatin formation. 3) Transcripts
containing large CNG triplet repeats form
hairpin structures that can be cleaved by dicer.
It is currently unclear if the cleavage products
function as siRNAs.
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role in distinct repeat expansion diseases (Fig. 3B). Transcripts
containing expansions of CAG or CUG repeats, as found in
fragile X syndrome (FXS) and DM1, can form stable hairpin
loops that are substrates for dicer (48). Reduced transcript
levels can be explained by dicer-mediated cleavage of the
primary transcripts, leading to lower production of mature
RNA. In analogy to siRNA triggered formation of heterochro-
matin, cleavage products of CNG hairpins might resemble
siRNAs that potentially trigger heterochromatin formation us-
ing a similar mechanism.
Therapeutic strategies for repeat expansion diseases have
focused on the development of treatments to minimize the
adverse effects of missing an important gene. Mitochondrial
dysfunction in FRDA, for example, benefits from an antioxi-
dant therapy. Over the last years it has become clear that
frataxin is silenced by local heterochromatin. This has led,
more recently, to novel therapeutic strategies being developed
that impair heterochromatin formation to allow higher expres-
sion of frataxin. This class of therapeutics, histone deacetylase
inhibitors, is very promising as frataxin levels could be in-
creased in FRDA patient cells (34) and in a mouse model (73).
However, global dysregulation of histone deacetylation might
cause severe side effects. Only a better molecular understand-
ing of the epigenetic machinery that specifically targets repeat
expansion loci will help to ultimately develop specific com-
pounds for treatment of this class of diseases.
EPIGENETIC DYSREGULATION OF IMPRINTING CONTROL
REGIONS IN PRADER-WILLI SYNDROME AND ANGELMAN
SYNDROME
Heterochromatin at regulatory elements can affect transcrip-
tion of many genes in a large genomic domain. In this section
we discuss diseases that are caused by genetic or epigenetic
dysregulation at such regulatory regions.
Genomic imprinting is a mechanism to establish allele-
specific differences in gene expression dependent on the pa-
rental origin (37). Imprinted genes are only expressed from
either the maternal or the paternal chromosome. Regulatory
elements, so-called imprinting control regions (ICRs), display
parental-specific epigenetic profiles. An ICR on one allele can
carry active, euchromatic modifications, whereas the ICR of
the other allele shows features of heterochromatin. The differ-
ent epigenetic profiles of maternal and paternal ICRs conse-
quently affect transcription of multiple neighboring genes in
cis by mechanisms that are not completely understood. Nota-
bly, epigenetic programming at ICRs is mitotically very stable
(17). Genetic or epigenetic alterations that lead to impairment
of an ICR on one allele can result in dysregulation of many
genes on the same chromosome, leading to severe develop-
mental defects and disease.
Two imprinting control regions regulate multiple genes in
the 15q11–13 region. In humans, two distinct diseases, Prader-
Willi syndrome (PWS) and Angelman syndrome (AS), are
both caused by aberrant imprinting of genes in the 15q11–13
chromosomal region. Although the same chromosomal region
is linked with both diseases, the phenotypic appearance of
PWS and AS patients dramatically differs. PWS occurs in
1:15,000–30,000 individuals. Patients display infantile hypo-
tonia, obesity, short stature, small hands and feet, growth
hormone deficiency, mental retardation, and behavioral prob-
lems (9). About 70% of PWS patients carry a deletion of the
paternal 15q11–13 region; about 30% have a maternal disomy
of chromosome 15. The complex phenotypic appearance of
PWS is the result of dysregulation of several genes in
15q11–13 (55). AS patients, in contrast, are characterized by
microcephaly, ataxia, mental retardation, jerky arm move-
ments, absence of speech, and sleep disorders (95). Similar to
PWS about 70% of AS individuals carry 15q11–13 deletions,
which always have a maternal origin. Around 10% of AS
patients carry mutations in the ubiquitin protein ligase UBE3A,
suggesting that dysfunction of this single gene can cause AS
(44, 57). Small percentages of AS patients have imprinting
defects or parental disomy of chromosome 15.
Deletion mapping of AS and PWS patients revealed two
imprinting centers in 15q11–13 that are only 35 kb apart (8).
The PWS-ICR controls numerous genes in this locus, e.g.,
MKRN3, MAGEL2, NDN, SNURF-SNRPN and a stretch of
snoRNA genes, whereas the AS-ICR mainly regulates transcrip-
tion of two very distant genes, UBE3A and ATPC10 (Fig. 4).
Genes under control of the PWS-ICR are expressed only from
the paternal chromosome. In contrast, UBE3A and ATPC10
which are regulated by the AS-ICR show only maternal ex-
pression.
Local heterochromatin formation at the maternal PWS-ICR.
How are these allele-specific expression patterns established?
The AS-ICR seems central to induce silencing of the maternal
PWS-ICR during development (40, 69); however, it might not
be involved in direct transcriptional control of the 15q11–13
region, which is rather regulated by the PWS-ICR. On the
paternal allele, PWS-ICR carries active epigenetic modifica-
tions, i.e., H3K4 methylation (98) and absence of DNA meth-
ylation (20, 25). This stimulates transcription in cis across the
entire 15q11–13 region. Notably, in this case UBE3A is tran-
scribed in the antisense direction, which may inhibit the pro-
duction of sense transcript, and is hypothesized to keep this
gene silent on the paternal chromosome (76). On the maternal
allele, however, the PWS-ICR features heterochromatic mod-
ifications, such as H3K9me3, H4K20me3, and DNA methyl-
ation (20, 25, 96, 98). Genes in the 15q11–13 region are
consequently silenced by DNA methylation in their promoter
regions. The UBE3A gene can be transcribed from the maternal
allele as there is no more antisense transcription (Fig. 4).
It is not very well known how these epigenetic modifications
are established at imprinting control regions. Most data have
been obtained from analyses of mouse models; however, it
seems plausible that the mechanisms are also conserved in
humans. H3K9me3 at the PWS-ICR depends on the histone
methyltransferase G9a and, as G9a can only induce H3K9me1
and H3K9me2, another H3K9-specific HMTase is required for
the full establishment of this modification (99). H4K20me3 at
ICRs is induced by Suv4–20h enzymes using a similar path-
way as found in pericentric heterochromatin (68). DNA meth-
ylation is established independently of the histone modifica-
tions by DNA methyltransferases. The targeting of these en-
zymes to ICRs is still unclear.
DNA methylation has an important dual role at imprinting
centers. It can attract DNA methylation binding proteins, such
as MeCP2, and it can also prevent binding of important
transcriptional regulators, e.g., CTCF (37). It is still largely
unclear how the chromatin state of a relatively small imprinting
control region can induce silencing or transcriptional activation
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of multiple neighboring genes. One possibility is a spreading
mechanism of the active or inactive state. Alternatively, for-
mation of chromatin interactions that bring promoter regions of
the neighboring genes in close proximity to the imprinting
control region might help to transmit epigenetic states onto
these target genes.
Stability of allele-specific expression patterns in imprinting
diseases. How can defective imprinting on only one allele
generate severe diseases as, e.g., AS and PWS? In AS patients,
if the AS-ICR is maternally impaired repressive heterochro-
matin cannot be established on the PWS-ICR (Fig. 4). This
leads to aberrant activation of the PWS-ICR on the maternal
chromosome, which prevents proper sense transcription of
UBE3A (76). In PWS patients, deletion or impairment of the
paternal PWS-ICR, which would normally carry active modi-
fications, prevents transcriptional activity across the entire
15q11–13 region on the paternal chromosome (55). Notably,
all these genes are potentially functional on the maternal
chromosome; however, they cannot be expressed due to re-
pressive histone modifications at the maternal PWS-ICR (Fig.
4). An intriguing possibility to treat this imprinting disease
would be to reactivate these silenced alleles. Apparently, spe-
cific DNA elements in the PWS/AS ICR are necessary to
maintain the allelic imprint by recruiting regulatory proteins
that are involved in targeting epigenetic machineries (41). A
detailed mechanistic knowledge of these mechanisms is re-
quired to develop specific treatment strategies. However, a
balanced treatment with general inhibitors of DNA methylation
(77) or histone methylation (49) might already be able to
improve the situation.
HETEROCHROMATIN DYSFUNCTION INCREASES CANCER
SUSCEPTIBILITY
Heterochromatin has important functions in gene silencing
and genomic stability, two processes that are often impaired in
cancer cells. Dysregulation of heterochromatin is expected to
increase cancer susceptibility by two mechanisms that we will
discuss below: aberrant silencing of tumor-suppressor genes
and increased genomic instability by reduced formation of
pericentric heterochromatin.
Heterochromatin-induced silencing of tumor-suppressor genes
in cancer cells. Numerous reports have provided evidence for
aberrant heterochromatin formation at tumor-suppressor genes
leading to their silencing (12, 83). Stochastic establishment of
epigenetic silencing at such genes could induce mitotically
heritable repression, potentially increasing cancer susceptibil-
ity. Recently, an intriguing possibility of how such aberrant
silencing may be established has been proposed: during DNA
damage repair, repressive modifications accumulate at the
break site, and in a minor proportion of events, these modifications
are not completely removed after successful repair (66).
A well-studied repressive epigenetic modification in the
context of tumorigenesis is DNA methylation, which is often
dysregulated in cancer cells and connected to aberrant silenc-
ing of tumor-suppressor genes (3, 12). Other repressive mod-
ifications, e.g., histone lysine methylation, can also be dysregu-
lated in tumor cells. There is evidence that epigenetic silencing
of tumor-suppressor genes can be mediated by distinct combi-
nations of H3K27me3, H3K9me2 (58), H3K9me3 (54), and
H4K20me3 (51). Reactivation of these aberrantly silenced
genes might support a conventional tumor therapy. Inhibition of
Fig. 4. Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are caused by epigenetic dysregulation of imprinting control regions in chromosomal region
15q11-q13. The 15q11–13 region (not to scale and not all genes are shown) contains 2 imprinting control regions, separated by 35 kb. On the maternal
chromosome, establishment of H3K4me3 at the AS-imprinting control region (ICR) triggers heterochromatic modifications at the PWS-ICR leading to repression
of most genes in the locus; only UBE3A is maternally expressed. On the paternal chromosome, active modifications at the PWS-ICR stimulate transcriptional
activity of 15q11–13 genes. Antisense transcription across UBE3A prevents production of the normal sense transcript, thereby silencing the paternal UBE3A. In
AS patients, inactivation or deletion of the maternal AS-ICR prevents establishment of repressive modification at PWS-ICR. Consequently, 15q11–13 genes are
transcribed and production of the UBE3A antisense transcript leads to complete inactivation of this gene on both alleles. Deletion or inactivation of the paternal
PWS-ICR in PWS patients prevents transcriptional activation of 15q11–13 genes.
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DNA methyltransferases (5-aza-cytidine) and histone deacety-
lases (trichostatin A) can indeed be used to remove these repres-
sive modifications and to consequently reactivate the silenced
genes. A very general methylation inhibitor, 3-deazaneplanocin A
(DZnep), was shown to be effective in removing H3K27me3 (84).
SUV39H1-mediated H3K9me3 in combination with DNA meth-
ylation also plays important roles in aberrant silencing of tumor
suppressor genes (54). Intriguingly, removal of H3K9me3 by
RNAi knockdown of SUV39H1 leads to reactivation of these
genes even though DNA methylation was still present at the
promoter regions (54). In summary, the data suggest that DNA
methyltransferases and histone methyltransferases could be inter-
esting therapeutic targets for cancer treatment.
Reduced formation of pericentric heterochromatin is con-
nected with genomic instability. Heterochromatin has impor-
tant functions in gene regulation, chromosome segregation, and
maintenance of genomic stability. Thus global dysregulation of
heterochromatin might also increase cancer susceptibility. In
agreement with this hypothesis, a strongly reduced level of
H4K20me3 was found to be a hallmark of many human
cancers (22, 87, 88), and reduced levels of HP1 have been
found in highly invasive and metastatic breast cancer cell lines
(43). It is not clear if these findings represent cause or conse-
quence of tumorigenesis; however, several lines of evidence
suggest that impairment of heterochromatin can increase can-
cer susceptibility.
Cause-effect relationships can be best analyzed in the
mouse. Pericentric heterochromatin is impaired in mice lacking
the two Suv39h HMTases (Suv39h dn mice). Interestingly,
these mice are highly susceptible to the development of B cell
lymphomas (70). The actual cause of tumorigenesis is not
clear; however, four heterochromatin-mediated mechanisms
might account for this phenotype.
1) Formation of a stable heterochromatic structure around
centromere regions is important to ensure proper chromosome
segregation. Suv39h deficient fibroblasts display increased an-
euploidy, and Suv39h dn mice develop lymphomas, which
sometimes have a hypertetraploid karyotype, characterized by
nonsegregated chromosomes that remain attached through their
acrocentric regions (70). An intriguing hypothesis of how
aneuploidy accelerates tumorigenesis is that it increases the
loss of heterozygosity of tumor suppressor genes (1).
2) Fully established pericentric heterochromatin might be
important for the proper repair of DNA damage in satellite
regions. Interestingly, DNA damage repair is delayed in
Suv39h dn mutants, suggesting that impaired heterochromatin
is less efficiently repaired (27). It is also possible that DNA
damage repair is faulty in these mutants, which could generate
mutations that support tumorigenesis.
3) Cells in which DNA damage cannot be fully repaired
enter senescence, a stable cell cycle arrest that limits the
proliferation of damaged cells and therefore functions as a
natural barrier for cancer progression. Senescence is connected
to establishment of senescence-associated heterochromatic foci
(SAHF), which stably inactivate E2F target genes, thereby
preventing cell cycle progression. SAHFs have features of
pericentric heterochromatin with enrichment of H3K9me3,
H4K20me3, and HP1 (65). Notably, establishment of the
senescence program is impaired in absence of Suv39h1, lead-
ing to increased tumorigenesis (7).
4) Silencing of mobile elements is another mechanism to
ensure genome stability. Strong activation of the retrovirus-like
intracisternal type A particle (IAP) elements, for example,
results in catastrophic defects during meiosis (6). A lower level
of activation might lead to integration of transposable elements
in tumorigenesis-related genes and could activate oncogenes or
mutate tumor suppressor genes. Heterochromatic histone mod-
ifications H3K9me3 and H4K20me3 play important roles in
silencing LINE-1 and probably other transposable elements.
These repressive modifications are mediated by retinoblastoma
(Rb) family members that can interact with histone methyl-
transferases (26). Consequently, dysregulation of Rb function
removes H3K9me3 and H4K20me3 from LINE-1 elements,
resulting in their activation (63). It remains to be tested if
genomic instability through activated mobile elements is a
major cause of tumorigenesis.
In summary, these connections, which relate to defective
heterochromatin formation, underline the complexity of the
tumorigenesis process. Cancer cells always carry genetic and
epigenetic mutations, and it seems plausible that epigenetic
dysregulation sensitizes cells to accumulate oncogenic genetic
mutations. Epigenetic treatment strategies with general histone
or DNA methylation inhibitors, which aim for reexpression of
tumor suppressor genes, can be very dangerous. Those drugs
might kill tumor cells; however, by the same time they sensi-
tize healthy cells to develop a new tumor.
Perspectives
Enormous progress over the last years has improved our
understanding of how epigenetic mechanisms contribute to the
development of human diseases. These efforts already led to
the development of novel therapeutic strategies, which, how-
ever, may have side effects. To refine these strategies, we need
to better understand the interplay between the epigenetic ma-
chineries, and we need to learn more about selective targeting
mechanisms. Regarding heterochromatin-mediated gene si-
lencing, there is evidence from Drosophila that different chro-
mosomal regions use distinct combinations of epigenetic ma-
chineries (71). We are only beginning to understand this
interplay in mammals, where a higher complexity of enzymatic
systems induces the different epigenetic modifications. Nota-
bly, in the context of human diseases, this high complexity
suggests that disease-critical pathways may exist, whose inhi-
bition or stimulation would not globally impair epigenetic
programming of healthy cells. To identify such pathways, a
consistent and systematic analysis of epigenetic modifications
and transcriptional regulation in healthy vs. patient material is
required.
Identification of epigenetic machineries that work in the
context of a specific disease-related locus is only the first step.
The next question is how these machineries are targeted. Do
these epigenetic enzymes interact with proteins that recognize
a specific DNA sequence and could an inhibitor for this
interaction prevent targeting? Recent data suggest that a dif-
ferent mechanism, binding of noncoding RNAs, assists in
targeting. If we understand how the production of these RNAs
is controlled we might get novel tools for regulating site-
specific targeting of epigenetic modifications (33, 64). Re-
agents that mediate degradation of these ncRNAs, e.g., anti-
sense RNAs, might allow specific reactivation of aberrantly
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silenced genes, such as frataxin in FRDA or tumor suppressor
genes in cancer.
In this review we discuss how heterochromatin dysregula-
tion can generate severe disease phenotypes. Much less is
known about smaller changes in epigenetic programming that
would not necessarily cause pathological effects. We hypoth-
esize that during aging, stochastic errors in establishing or
maintaining epigenetic programming occur during DNA dam-
age repair (66), or can be triggered by environmental factors.
Accumulation of this epigenetic damage may then contribute to
the systemic aging phenotype. Treatment strategies that aim
toward correcting epigenetic programming in human diseases
may also be useful to treat the adverse effects of aging.
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Epigenetic regulation of development by histone
lysine methylation
S Dambacher1, M Hahn1 and G Schotta
Munich Center for Integrated Protein Science (CiPSM) and Adolf-Butenandt-Institute, Ludwig-Maximilians-University, Munich,
Germany
Epigenetic mechanisms contribute to the establishment and
maintenance of cell-type-specific gene expression patterns.
In this review, we focus on the functions of histone lysine
methylation in the context of epigenetic gene regulation during
developmental transitions. Over the past few years, analysis of
histone lysine methylation in active and repressive nuclear
compartments and, more recently, genome-wide profiling of
histone lysine methylation in different cell types have revealed
correlations between particular modifications and the transcrip-
tional status of genes. Identification of histone methyltransferases
(HMTases) and specific binding factors for most methylated
lysine positions has provided a novel insight into the mechanisms
of epigenetic gene regulation. In addition, analyses of HMTase
knockout mice show that histone lysine methylation has
important functions for normal development. In this study, we
review mechanisms of gene activation and repression by histone
lysine methylation and discuss them in the context of the
developmental roles of HMTases.
Heredity (2010) 105, 24–37; doi:10.1038/hdy.2010.49;
published online 5 May 2010
Keywords: epigenetics; histone lysine methylation; heterochromatin; mouse development
Introduction
Development is accomplished by spatial and temporal
regulation of gene expression patterns. The identity of
each cell type is maintained and passed on to daughter
cells by mechanisms that do not alter the DNA sequence
and are therefore regarded as epigenetic. A major
mechanism to establish cell-type-specific expression
patterns is transcriptional regulation. The physiological
template for transcription is chromatin, and therefore
epigenetic mechanisms are thought to modulate its
structure, making DNA more or less accessible to the
transcriptional machinery. Today, we know of five major
mechanisms that alter chromatin architecture: DNA
methylation, post-translational histone modifications,
use of histone variants, chromatin remodeling and
incorporation of non-coding RNA into chromatin. These
mechanisms are generally considered ‘epigenetic’,
although we still lack good understanding as to the
stability of these modifications through mitosis or even
through the germ line.
In this review, we will focus on the functions of histone
lysine methylation during development. In the first part,
we will discuss how histone lysine methylation facilitates
gene activation or repression of genomic regions. In the
context of these activities, we will then discuss the
developmental roles of selected histone methyltrans-
ferases (HMTases).
Activation and repression are facilitated by
histone lysine methylation
Major methylation sites on histones H3 and H4 are
located in the tail (H3K4, H3K9, H3K27, H3K36 and
H4K20) and the nucleosome core region (H3K79).
Although histone methylation was discovered nearly
four decades ago (Allfrey et al., 1964), a correlation
between this modification and gene regulation has only
recently been established. Strahl et al. (1999) showed that
H3K4 methylation was highly enriched in macronuclei of
Tetrahymena, suggesting a role for this modification in
transcriptional activation. Ayear later, H3K9 methylation
was implicated in gene repression when a homolog of
the heterochromatin-associated Drosophila Su(var)3-9,
Suv39h1, was shown to have H3K9-specific methyltrans-
ferase activity (Rea et al., 2000).
Lysine residues can be mono (me1), di (me2) or
trimethylated (me3), and binding of specific proteins,
which recognize methylated lysine positions, can result
in different biological outcomes. The development of
highly specific antibodies that discriminate not only
between lysine positions, but also between methylation
states, allowed the large-scale mapping of individual
histone lysine methylation marks by chromatin
immunoprecipitation on tiling arrays or chromatin
immunoprecipitation followed by sequencing (reviewed
in Lee and Mahadevan, 2009). In combination with gene
expression data, correlations between histone modifica-
tions and gene activity have now been established.
A number of modifications show some correlation with
the transcriptional status of genes; however, only a very
few marks are consistently found on active or inactive
genes. The hallmark of transcriptionally active genes is
H3K4me3 in the promoter region and H3K36me3
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across the gene body (Figure 1). H3K27me3 seems central
for gene repression and covers the gene body and
flanking regions (Figure 1). The average profile of
repressed genes shows enrichment of H3K9me3 and
H4K20me3 at a much lower level when compared
with H3K27me3, suggesting that these marks are less
important for gene silencing (Figure 1). In the next
sections, we will discuss the current view of how
active and repressive modifications are established and
how they contribute to the transcriptional regulation
of genes.
Histone lysine methylation marks in the
context of transcriptional activation
The amount of transcript per cell is controlled through
multiple mechanisms. If we only consider the rate of
transcription, at least two major steps regulate how
much primary transcript is produced. In the first
step, RNA polymerase II (Pol II) is recruited to the
promoter region and forms a pre-initiation complex
(PIC). However, this is not sufficient for transcription,
as RNA Pol II can be stalled at promoters and a
second trigger is therefore required for elongation
(Core and Lis, 2008). Histone lysine methylation is an
important regulatory element for both determining
processes. It exerts an effect by recruiting specific
binding factors, providing stable interaction platforms
for the basic transcriptional machinery and for activities
that regulate the ordered dis- and reassembly of
chromatin during elongation.
Transcription initiation
Active genes carry high levels of H3K4me3 in
the promoter region. This modification is a binding
platform for a number of proteins (Table 1), includ-
ing chromatin remodelers, which help to open the
chromatin structure around the promoter and facili-
tate the binding of the basic transcriptional machinery.
BPTF (bromodomain PHD finger transcription factor), a
subunit of the NURF (nucleosome remodeling factor)
remodeling complex, and Chd1, another chromatin
Figure 1 Profiles of histone lysine methylation at active and inactive
mammalian genes. At active genes, H3K4me3 is highly enriched at
the promoter region, whereas H3K36me3 associates with the gene
body. At repressed genes, H3K27me3 covers the gene body and
flanking regions. H3K9me3 and H4K20me3 are also enriched at
inactive genes, although at a lower level (adapted from Barski et al.,
2007, Pauler et al., 2009 and Cui et al., 2009).
Table 1 Mammalian histone methylation binders and their possible functions
Histone modification Reader Function Reference
H3K4
me2, me3 Chd1 Chromatin remodeling Flanagan et al. (2005)
me3 Bptf Chromatin remodeling Wysocka et al. (2006)
me3 Taf3 TFIID stabilization Vermeulen et al. (2007)
me3 Ing1 Recruitment of HATs Taverna et al. (2006)
me3 Ing2 Recruitment of HDACs Shi et al. (2006)
me3 Ing4 Recruitment of HATs Hung et al. (2009)
me3 Ing5 Recruitment of HATs Champagne et al. (2008)
me3 Jmjd2a H3K9 demethylation Lee et al. (2008b)
me3 Chd7 Chromatin remodeling Takada et al. (2007)
me3 Rag2 VDJ recombination Matthews et al. (2007)
H3K9
me1, me2 G9a-GLP Transcriptional silencing Collins et al. (2008)
me3 HP1 Heterochromatin Lachner et al. (2001)
me3 Tip60 DNA repair Sun et al. (2009)
me3 Chd7 Chromatin remodeling Takada et al. (2007)
me3 Cdyl2 Heterochromatin Fischle et al. (2008)
H3K27
me3 Cbx2,4,7 Polycomb-mediated gene silencing Bernstein et al. (2006b)
me3 Eed Polycomb-mediated gene silencing Margueron et al. (2009)
H3K36
me3 Mrg15 Recruitment of HDACs Zhang et al. (2006)
H3K79
me1, me2 53bp1 DNA damage repair Huyen et al. (2004)
H4K20
me1, me2 L3mbtl1 Chromatin compaction Trojer et al. (2007)
me2 53bp1 DNA damage repair Botuyan et al. (2006)
me3 Jmjd2a H3K9 demethylation Lee et al. (2008b)
Abbreviations: HAT, histone acetyltransferase; HDAC, histone deacetylase.
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remodeler, can bind H3K4me3 (Flanagan et al., 2005;
Wysocka et al., 2006). Although these data implicate
chromatin remodeling in promoter activation, we still
lack detailed mechanistic insight.
Other binding proteins of H3K4me3 seem to be
important for recognition of the promoter region. The
TFIID complex is involved in the first step of PIC
formation, and binds the promoter through multiple
interactions between its subunits, DNA and histone
modifications (Figure 2). The TATA box binding protein
(TBP) subunit, for example, and other associated proteins
recognize the promoter DNA sequence. This can be
either the TATA box itself or associated sequences, such
as initiator and downstream promoter elements. The
chromatin state is recognized by another TFIID subunit,
the double bromodomain protein Taf1, which can bind
acetylated lysines at positions H3K9 and H3K14 (Jacob-
son et al., 2000). More recently, yet another TFIID
component, the PHD domain protein Taf3, was shown
to bind H3K4me3 (Vermeulen et al., 2007). These data
suggest that multiple interactions are necessary for stable
recruitment of the PIC. The next step in the initiation
cascade is binding of RNA Pol II to the promoter region
and phosphorylation of Ser 5 in its carboxy-terminal
domain (CTD) repeats by Cdk7. RNA Pol II is then
able to generate short transcripts; however, interaction
with DSIF (DRB sensitivity-inducing factor) and NELF
(negative elongation factor) can inhibit elongation (reviewed
in Fuda et al., 2009).
Is H3K4me3 at the promoter a cause or a consequence
of transcriptional activity? Currently, there is no general
answer to this question and every promoter might
behave somewhat differently. In vitro data suggest that
this modification has no direct effect on transcription
(Pavri et al., 2006; Kim and Buratowski, 2009); however,
the reduced complexity of in vitro systems might mask
an effect that is relevant in vivo. It is noteworthy that
some inducible promoters carry H3K4me3 even before
RNA Pol II is detectable, indicating that H3K4me3 can
be established in the absence of active transcription
(Edmunds et al., 2008). Several enzymes can induce
H3K4me3 (Table 2), and elucidating how they are
recruited and how their HMTase activity is regulated
will be important in furthering our understanding of this
modification. There is evidence that the CTD exerts an
effect as a recruiting platform for different chromatin-
modifying activities. For example, Mll1, a major H3K4-
specific methyltransferase, interacts with the Ser 5
phosphorylated CTD and establishes or reinforces
H3K4me3 around the promoter region (Milne et al.,
2005).
Transcription elongation
Binding to H3K4me3 might stabilize the PIC at the
promoter and could therefore increase the probability of
initiating transcription. The other mechanism to control
the transcription rate is elongation (Figure 2). RNA Pol II
can be stalled at promoters by interaction with NELF and
DSIF. Elongation is then induced by phosphorylation of
DSIF and RNA Pol II CTD at Ser 2 by the P-TEFb
(positive transcription elongation factor b) complex
(reviewed in Fuda et al., 2009). For RNA Pol II to traverse
nucleosomal templates, the chromatin structure needs to
be relaxed. This is facilitated through eviction of H2A/
H2B dimers by the FACTcomplex (Belotserkovskaya and
Reinberg, 2004). After passage of RNA Pol II, the FACT
complex could also be involved in the reassembly of a
proper chromatin structure (Jamai et al., 2009).
Several histone modifications are established when
RNA Pol II travels through the gene body. The Ser 2
phosphorylated CTD associates with H3K36-specific
MII1
TFIID
RNA Pol ll
RNA Pol ll
Figure 2 Histone lysine methylation marks in the context of transcriptional activation. During initiation, TFIID is targeted to the promoter
region through multiple interactions between its subunits and chromatin modifications (see text for details). RNA Pol II is positioned near the
transcriptional start site and phosphorylated at Ser 5 of its CTD. The Mll1 complex binds to S5-P CTD and introduces H3K4me3 as well as
acetylation of H4. Phosphorylation at Ser 2 of the CTD starts the elongation phase. The FACT complex disrupts nucleosomes in front of
elongating RNA Pol II. Hypb binds to S2-P CTD and induces H3K36me3, which is recognized by Mrg15 leading to deacetylation of histones
due to recruitment of histone deacetylases (HDACs).
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HMTases during elongation (Yoh et al., 2008). H3K36me3
generates a binding platform for the chromo domain
protein Mrg15 (Table 1, Zhang et al., 2006), which in turn
recruits histone deacetylases (Yochum and Ayer, 2002).
H3K36me3 and histone deacetylation are important to
repress transcripts that could be generated from aberrant
initiation of RNA Pol II within the gene body (Carrozza
et al., 2005). Thus, histone modifications in the context of
elongation might indirectly affect the elongation rate and
have important functions for re-establishment of a
proper chromatin structure during and after transcrip-
tion. Interestingly, recent data suggest that histone
Table 2 Mammalian HMTases, their activities and knockout phenotypes
HMTase Activity Reference Viability Phenotype
Ash1l H3K4 Gregory et al. (2007)
Dot1l H3K79 Feng et al. (2002) E9.5–10.5 Growth retardation, angiogenesis defects in the yolk sac,
and cardiac dilation, loss of all H3K79 methylation (Jones et al., 2008)
Ezh1 H3K27 Margueron et al. (2008);
Shen et al. (2008)
Ezh2 H3K27 Cao et al. (2002) E8.5 Arrested development, gastrulation failure (O’Carroll et al. 2001)
G9a H3K9me1/2 Tachibana et al. (2002) E9.5–12.5 Growth retardation, reduction in H3K9 me1, me2 (Tachibana et al., 2002)
GLP H3K9me1/2 Tachibana et al. (2008) E9.5–12.5 Growth retardation, reduction in H3K9 me1, me2 (Tachibana et al., 2005)
Mll1 H3K4 Milne et al. (2002) E12.5–16.5 Patterning defects (Yu et al., 1995; Yagi et al., 1998) DSET mutant viable,
skeletal defects (Terranova et al., 2006)
Mll2 H3K4 Goo et al. (2003) E11.5 Growth retardation, increased apoptosis (Glaser et al., 2006)
Mll3 H3K4 Lee et al. (2006) Viable Partial embryonic lethality, growth retardation, female infertility
(Lee et al., 2006)
Mll4 H3K4 Lee et al. (2006)
Mll5 H3K4 Fujiki et al. (2009) Viable Hematopoietic defects, male infertility (Heuser et al., 2009; Liu et al., 2009;
Madan et al., 2009)
Nsd1 H3K36 Rayasam et al. (2003) E9.5 Growth retardation, apoptosis (Rayasam et al., 2003)
Prdm1 E10.5 Patterning defects (Ohinata et al., 2005)
Prdm2 H3K9me2 Kim et al. (2003) Viable Tumorigenesis (Steele-Perkins et al., 2001)
Prdm3 E13.5–16.5 Broad developmental defects (Hoyt et al., 1997)
Prdm4
Prdm5
Prdm6
Prdm8
Prdm9 H3K4me3 Hayashi et al. (2005) Viable Impaired sex body formation, infertility (Hayashi et al., 2005)
Prdm10
Prdm11
Prdm12
Prdm13
Prdm14 Viable Infertility, devoid of germ cells (Yamaji et al., 2008)
Prdm15
Prdm16
PrSet7 H4K20me1 Nishioka et al. (2002) Eight-cell
stage
G2/M arrest, chromosome condensation defects (Oda et al., 2009)
Setd1a H3K4 Wysocka et al. (2003)
Setd1b H3K4 Lee et al. (2007)
Setd2 H3K36 Sun et al. (2005)
Setd3
Setd4
Setd5
Setd6
Setd7 H3K4me1/2 Wang et al. (2001) Viable 50% embryonic lethality (Kurash et al., 2008)
Setdb1 H3K9 Yang et al. (2002) E3.5–5.5 Defective growth of inner cell mass (Dodge et al., 2004)
Setdb2
Setmar H3K36 Lee et al. (2005)
Smyd1 H3K4me1/2/3 Tan et al. (2006) E10.5 Growth retardation, disrupted maturation of ventricular cardiomyocytes
(Gottlieb et al., 2002)
Smyd2 H3K36 Brown et al. (2006)
Smyd3 H3K4me2/3 Hamamoto et al. (2004)
Smyd4
Smyd5
Suv39h1 H3K9me2/3 Rea et al. (2000) Viable Suv39h dn mice: growth retardation, increased tumor risk
(B-cell lymphomas), male sterility (Peters et al., 2001)
Suv39h2 H3K9me2/3 Rea et al. (2000) Viable
Suv4-20h1 H4K20me2/3 Schotta et al. (2004) Perinatal
lethality
Suv4-20h dn mice: growth retardation, lung defects, impaired B-cell
development (Schotta et al., 2008)
Suv4-20h2 H4K20me2/3 Schotta et al. (2004) Viable
Whsc1 H3K36 Nimura et al. (2009) Perinatal
lethality
Growth retardation, defects in midline fusion, heart lesions
(Nimura et al., 2009)
Whsc1l1
Abbreviations: dn, double null; HMTase, histone methyltransferase.
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modifications across the gene body can even affect
processing of the RNA transcript, such as selection of
polyadenylation sites or even splicing (Kolasinska-
Zwierz et al., 2009; Spies et al., 2009). These surprising
connections between chromatin structure and RNA
processing will reveal novel mechanisms for the regula-
tion of cell-type-specific transcription profiles.
Repressive histone lysine methylation marks
Transcriptional repression is important for various
aspects of development. On one hand, cell-type-specific
expression patterns are regulated by silencing of lineage-
inappropriate genes during differentiation, and on the
other hand, large regions of mammalian genomes consist
of non-coding DNA sequences such as satellite repeats,
telomeric repeats, mobile elements and interspersed
repeats, which need to be under tight transcriptional
control to prevent genomic instability. Genome-wide
mapping studies of histone modifications consider only
the nonrepetitive part of the genome and from these data
it seems that H3K27me3 is a major modification that
correlates with the transcriptional repression of genes
(Figure 1). In contrast, repetitive genomic regions are
marked by H3K9me3 and H4K20me3. In the following
sections, we will discuss the establishment and potential
functions of repressive histone modifications at both
highly repetitive genomic regions and at individual
genes.
Silencing of repetitive genomic regions
Pericentric heterochromatin
The largest family of repetitive regions consists of major
satellite repeats that are the main constituents of
pericentric heterochromatin. Major satellite repeats have
a distinct H3K9me3þH4K20me3 chromatin signature,
which is found in almost all cell types and develop-
mental stages, suggesting that these modifications have a
general function in heterochromatin. H3K9me3 is estab-
lished by Suv39h1 and Suv39h2 enzymes (Rea et al.,
2000). Two other HMTases, Suv4-20h1 and Suv4-20h2,
establish H4K20me3 (Schotta et al., 2004). Recent data
suggest a novel modification, H3K64me3 that has a role
in pericentric heterochromatin formation during the
early stages of mouse development (Daujat et al., 2009);
however, the responsible methyltransferase has not been
identified as yet.
The combinatorial pattern of histone lysine methyla-
tion at heterochromatin is established in a sequential
pathway (Figure 3). In Schizosaccharomyces pombe, double-
stranded RNA from centromeric repeats is processed by
components of the RNA interference machinery. This
leads to recruitment of Clr4, the S. pombe homolog of
Suv39h, to establish H3K9 methylation at heterochroma-
tin (Grewal and Jia, 2007). In mammals, it is still unclear
whether a similar link between processing of double-
stranded RNA and recruitment of Suv39h exists.
H3K9me3 is likely to be established in a highly
coordinated manner during replication of pericentric
heterochromatin. Recent data suggest that, in a first
step, Setdb1 (SET domain bifurcated 1), in complex
with heterochromatin protein 1a (HP1a) and CAF1
(chromatin assembly factor 1), induces H3K9me1 on
non-nucleosomal histone H3 (Loyola et al., 2009). Subse-
quently, Suv39h enzymes, which prefer H3K9me1 as
substrate, induce H3K9me3, probably even before the H3
molecule is deposited into a nucleosomal context
(Rea et al., 2000). Nucleosomal H3K9me3 exerts an effect
as a binding platform for HP1 proteins, which in turn
recruit Suv4-20h enzymes to establish H4K20me3 (Schot-
ta et al., 2004). The direct interaction of Suv4-20h
enzymes with HP1 is necessary to induce H4K20me3;
however, interactions with other proteins, for example,
members of the retinoblastoma family, can contribute to
the establishment of this modification (Gonzalo et al.,
2005).
What are the functions of histone lysine methylation
marks at pericentric heterochromatin? Although consid-
ered highly compact and transcriptionally silent, there
is increasing evidence for controlled transcription
across pericentric heterochromatin (Eymery et al., 2009).
Promoter elements are still unknown, and owing to
the repetitive nature of these transcripts they have yet to
be characterized. However, it is clear that transcription
from major satellite repeats is tightly controlled, occur-
ring only during distinct cell cycle stages. Suv39h
double-null mutants show enhanced amounts of major
satellite transcripts (Martens et al., 2005), indicating that
H3K9me3 has an important role in controlling the
transcript levels from these repeat regions. How this
control is accomplished, whether H3K9me3 or its
binding factors hinder access to RNA Pol II or whether
RNA processing or RNA stability are regulated by this
modification are some challenging questions in this field.
Figure 3 Repressive histone lysine methylation marks at hetero-
chromatin are established in a sequential pathway. The Setdb1/
CAF1/HP1a complex presumably induces H3K9me1, which is
converted to H3K9me3 by Suv39h enzymes. H3K9me3 exerts an
effect as a binding platform for HP1 proteins, which in turn recruit
Suv4-20h enzymes to induce H4K20me3. Establishment of these
modifications is also regulated through interactions with other
proteins, for example, members of the retinoblastoma (Rb) family.
There is also evidence for interaction of DNA methyltransferases
with Suv39h enzymes; however, this interplay needs further
characterization.
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Telomeric silencing
The chromatin structure at telomeres is very similar to
that of pericentric heterochromatin. Telomeric repeats
are enriched for Suv39h-mediated H3K9me3. As in
heterochromatin, H3K9me3 exerts an effect as a bind-
ing platform for HP1 proteins that recruit Suv4-20h
enzymes to induce H4K20me3 (Benetti et al., 2007). At
telomeres, this sequential pathway is affected by the
H3K79-specific HMTase Dot1l. It is noteworthy that
Dot1l-mutant cells lose all H3K79 methylation and
that at telomeres even H4K20me3 is lost (Jones et al.,
2008). Currently, it is not known whether Dot1l or
H3K79 methylation affects the activity or recruitment
of Suv4-20h enzymes.
Transcripts from telomeric repeats (TelRNAs) are
generated by RNA Pol II and are normally polyadeny-
lated (Schoeftner and Blasco, 2008). Interestingly, Tel-
RNAs seem to be a structural constituent of telomeric
chromatin. They can block telomerase activity, and
therefore a possible function of these transcripts is the
regulation of telomere length. In the absence of Suv39h
or Suv4-20h enzymes, TelRNAs are upregulated, sug-
gesting that H3K9me3 and H4K20me3 function as
repressive modifications at telomeres (Schoeftner and
Blasco, 2008).
Gene silencing
Gene activation is largely correlated with the establish-
ment of H3K4me3. In contrast, different modifications
exist to mediate gene silencing. Average chromatin
immunoprecipitation profiles across silenced genes
suggest H3K27me3 as a prominent modification for gene
repression (Figure 1); however, there is also evidence that
H3K9me3 and H4K20me3 are associated with repressed
genes. Interestingly, different studies have found that
there is a large proportion of silent genes that do not
carry any of the tested epigenetic modifications. It is
possible that these genes are passively repressed and that
their silent state is just due to the lack of activating
factors. However, we still lack knowledge about many
histone modifications and their mechanisms of action,
and it could well be that novel mechanisms for
transcriptional silencing will be discovered in the near
future. In the next sections, we will discuss how gene
repression is established by the classic repressive histone
modifications, H3K27me3 and H3K9me3.
Polycomb silencing by H3K27 methylation
H3K27 methylation only exists in multicellular organ-
isms and has probably evolved as a system to facilitate
cell-type differentiation. Surprisingly, in embryonic stem
(ES) cells, H3K27me3 can coexist in the same region with
H3K4me3 (Bernstein et al., 2006a). Genes that carry this
‘bivalent’ modification are mainly developmental reg-
ulators. Although bivalent genes are repressed, they
carry engaged but stalled RNA Pol II. In differentiated
cells, bivalent chromatin domains are reduced and genes
that are active or repressed are characterized by
H3K4me3 or H3K27me3, respectively (Mikkelsen et al.,
2007). It is not clear how bivalent marks are reduced to a
univalent form during differentiation. One possibility is
that during replication the bivalent modification cannot
be ‘copied’ and either H3K4me3 or H3K27me3 is
established on the newly replicated chromatin. Another
postulation is that chromatin modifications at a parti-
cular gene reflect an equilibrium between antagonizing
activities of transcriptional activators and repressors.
Unequal cell division during differentiation of pluripo-
tent progenitor cells might shift this balance to either
side. Bivalent chromatin might also represent a transient
state during differentiation. In ES cells, the major
pluripotency genes Nanog, Sox2 and Oct4, are highly
expressed and marked with H3K4me3. During differ-
entiation, these genes transiently acquire a bivalent state
before they become silenced with H3K27me3 (Pan et al.,
2007).
H3K27 methylation is mediated by the two highly
related enzymes, Ezh1 (enhancer of zeste homolog 1)
and Ezh2 (Table 2). Ezh enzymes form the so-called
polycomb repressive complex 2 (PRC2) with Eed, Suz12
and RbAp46/48 proteins (Margueron et al., 2008). It is
noteworthy that ES cells in which PRC2 complex
members such as Eed or Suz12, are disrupted, largely
lose H3K27me2 and H3K27me3 (Schoeftner et al., 2006;
Chamberlain et al., 2008), suggesting that these proteins
exert an effect as cofactors to fully stimulate enzymatic
activity of Ezh enzymes.
H3K27me3 recruits the PRC1 complex (Ring1a/b,
Bmi1, Ph, Cbx2) through interaction with the Cbx2
chromo domain (Figure 4). Other Cbx2 homologs
bind H3K27me3 and can be part of PRC1-related
complexes (Bernstein et al., 2006b). For the recruitment
of PRC1, binding to H3K27me3 is essential but probably
not sufficient. This became clear through genome-wide
mapping of PRC1 and PRC2 complexes (Ku et al., 2008).
Only a subset of regions with high levels of H3K27me3
also shows enrichment for PRC1 complex members.
However, removal of H3K27me3 leads to complete loss
of PRC1 from its targets (Cao et al., 2002; Leeb et al., 2010).
An important function of PRC1 is the establishment of
a second histone modification, H2A ubiquitylation on
Figure 4 Polycomb-mediated gene silencing. Ezh1/2 enzymes,
Suz12 and Eed, form the PRC2 core complex and induce
H3K27me3. This modification is recognized by the chromo domain
of mammalian Pc homologs, for example Cbx2, which is a subunit
of the PRC1 complex. Ring1a/b, another PRC1 subunit, establishes
H2AK119ub, which inhibits nucleosome disassembly by the FACT
complex.
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lysine 119 (H2AK119ub) by the Ring1a/b subunit (Wang
et al., 2004).
The mechanism for transcriptional repression by the
polycomb system (Figure 4) is still under debate. In vitro
data suggest that PRC1 and PRC2 components can
compact recombinant nucleosomes and block transcrip-
tional elongation on chromatinized templates (Marguer-
on et al., 2008); however, these mechanisms are very
difficult to verify in vivo. A more compact chromatin
structure might as well prevent promoter recognition by
the PIC. Another intriguing finding is that H2AK119ub
prevents recruitment of FACT (Zhou et al., 2008), which
could impair transcriptional elongation. These and
maybe other epigenetic mechanisms, such as binding of
non-coding RNAs (Rinn et al., 2007) and DNA methyla-
tion (Vire et al., 2006), work together in the establishment
of polycomb-mediated gene silencing. However, future
studies are needed to dissect the interplay between these
mechanisms.
Imprinting
Genomic imprinting is a well-characterized system that
mainly uses epigenetic mechanisms to induce stable gene
repression. Imprinted genes are only expressed from one
allele; the other allele is permanently silenced using a
heterochromatin-like mechanism. Silencing is estab-
lished by repressive histone modifications and DNA
methylation over so-called imprinting control regions
(ICRs), which inhibit promoter activation or can block
enhancer action.
Imprinted loci show allelic differences in epigenetic
patterns. The ICR of the silenced allele carries hetero-
chromatin-like modifications (H3K9me3þH4K20me3),
whereas the active allele is marked with H3K4me3
(Fournier et al., 2002; Regha et al., 2007; Pannetier et al.,
2008). Not all imprinted genes are regulated in the same
way, and in different developmental stages distinct
mechanisms might be used to establish gene silencing.
A surprising example is the discovery that imprinting in
extraembryonic cells of the placenta uses a repression
mechanism that mainly involves H3K27me3 (Lewis et al.,
2004; Umlauf et al., 2004).
Histone methylation at ICRs reflects the heterochro-
matic H3K9me3þH4K20me3 modification pattern; how-
ever, there are differences in the enzymatic systems and
probably also in the recruitment mechanisms. In parti-
cular, the nature of the H3K9me3 HMTase in the context
of imprinting is still somewhat unclear as Suv39h
enzymes do not affect histone methylation at ICRs.
Recently, another H3K9-specific HMTase, Setdb1, was
found to associate with a particular imprinted region;
however, no mechanistic studies have been performed to
confirm a function of this enzyme in imprinting (Regha
et al., 2007). As in pericentric heterochromatin, H3K9me3
might serve as a binding platform for HP1 proteins,
which can then recruit Suv4-20h enzymes to induce
H4K20me3 at ICRs. In somatic cells, silencing of
imprinted genes strongly depends on DNA methylation.
We still do not know to what extent histone modifica-
tions contribute to silencing in this context. It could
well be possible that histone methylation at ICRs
functions downstream of DNA methylation (Henckel
et al., 2009). Histone methylation could also represent an
additional layer of complexity to ensure stability of the
repressed state.
Gene silencing by H3K9 methylation
Average histone modification profiles across genes have
revealed a weak correlation between H3K9me3 and gene
repression (Figure 1); however, as discussed above,
imprinted genes are major targets of H3K9me3. There
is also evidence that H3K9me3 is involved in repression
of other genes, for example, nuclear receptor targets
(Wissmann et al., 2007). Importantly, a lower H3K9
methylation state, H3K9me2, might also have repressive
functions. Differentiated cells carry large domains, up to
several megabases long, with high levels of H3K9me2,
and genes within these domains are repressed (Wen et al.,
2009).
In mammals, the different H3K9 methylation states
are mediated by several enzymes (Table 2). H3K9me2
is mainly controlled by G9a and the related G9a-
like protein (GLP), which function as heterodimers
(Tachibana et al., 2005). Suv39h1 and Suv39h2 induce
H3K9me3 at heterochromatin. Little is known about
the HMTases that are responsible for ‘euchromatic’
H3K9me3. The only good candidate for such an enzyme
is Setdb1, which, as a recombinant enzyme, has poor
activity. However, association with the auxiliary factor
mAM confers H3K9me3 activity to this enzyme (Wang
et al., 2003). Setdb1 is an important functional constituent
of the Kap1 corepressor complex that mainly uses
H3K9me3 as a means of gene repression (Sripathy
et al., 2006). To what extent Setdb1 is really responsible
for H3K9me3 in vivo remains to be tested.
Different histone methylation states are thought to
confer distinct functions. For H3K9 methylation, it is still
unclear whether di- or trimethyl states are functionally
distinct. The best characterized binding protein, HP1
(Table 1), has affinity to both H3K9me2 and H3K9me3
in vitro (Lachner et al., 2001). H3K9 methylation seems to
be crucial for HP1 recruitment and binding to hetero-
chromatin, as Suv39h-mutant cells that lose H3K9me3
also lose HP1 from heterochromatin (Lachner et al., 2001).
It is also very likely, however, that additional factors can
stabilize the binding of HP1 at H3K9me2/3 targets. How
silencing is then facilitated by H3K9 methylation is still
unclear. The current model suggests that HP1 binding
induces a higher grade of chromatin compaction, which
would prevent access of transcription factors or RNA Pol
II to DNA.
Developmental functions of HMTases
In the previous sections, we discussed functions of
histone lysine methylation marks in gene activation and
repression, but how important are these mechanisms for
normal development? Over the past few years, knockout
mice for several HMTases have been established and
characterized. In the following sections, we will sum-
marize these data and discuss the functional implications
of histone lysine methylation for cell-type identity and
regulation of developmental transitions.
Gene activation by H3K4 methylation
Activation of genes often correlates with H3K4me3 at the
promoter region. It is not really clear whether H3K4me3
is a consequence of RNA Pol II recruitment or whether
this modification represents a poised state for genes that
can be easily activated. The major enzymes that induce
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H3K4 methylation states in mice are Mll1–5 (mixed
lymphoid leukemia) family members, Setd1a/b enzymes
and Ash1l (Table 2). Mll proteins are regarded as
important regulators of development as homologous
proteins in Drosophila (trithorax) positively regulate
expression of homeotic genes. This function is conserved
in mammals and disruption of individual Mll genes in
mice leads to reduced expression of Hox genes and
developmental defects, as will be outlined below.
Mll1 was the first Mll family member to be function-
ally analyzed in mice. Dependent on the knockout
strategy, Mll1 disruption results in different phenotypes.
Truncation of Mll1 in exon 3b or deletion of exons 9–11
both lead to embryonic lethality between E12.5 and E16.5
(Yu et al., 1995; Yagi et al., 1998). Even heterozygous
Mll1þ/ knockout mice show defects in segment identity
that are caused by reduced expression of distinct Hox
genes (Hoxa-9 and Hoxc-7).
A very powerful model system to analyze develop-
ment and differentiation is the hematopoietic system
with well-defined stem cells, progenitor populations
and differentiated cells. It is noteworthy that Mll1/
embryos fail to generate or expand hematopoietic stem
cells during embryogenesis (Ernst et al., 2004), and,
consistent with these data, conditional inactivation of
Mll1 in adult mice also disrupts the hematopoietic stem
cell compartment (Jude et al., 2007; McMahon et al., 2007).
Although the mechanism is not clear, it seems plausible
that impaired Hox gene regulation might contribute to
these defects in the hematopoietic system (Lawrence
et al., 2005).
To understand the function of Mll1-mediated
H3K4me3, another allele was generated that deletes the
SET domain region (Terranova et al., 2006). In contrast to
all other Mll1 knockout alleles, DSET mutants are fully
viable and show only slight homeotic transformations.
However, in DSET mutants, expression of distinct Hox
genes is also reduced (Hoxd-4 and Hoxc-8), indicating
that the methyltransferase activity of Mll1 is important
for gene activation. On the other hand, the relatively
mild phenotype of DSET and the only modest down-
regulation of Hox genes suggest compensatory mechan-
isms that allow a rather normal development of these
mutants.
Mll1 deficiency does not impair overall H3K4 methy-
lation as several other H3K4-specific methyltransferases
exist in mice that can compensate for the loss of Mll1
(Table 2). Three other Mll family members have been
disrupted in mice (Mll2, Mll3 and Mll5). These mutants
show different phenotypes, suggesting different targets
or functions. Mll2/mice are growth retarded and show
embryonic lethality around E11.5 (Glaser et al., 2006).
In mutant embryos and ES cell lines, a higher apoptosis rate
might be caused by downregulation of the anti-apoptotic
factor Bcl2 (Lubitz et al., 2007). In Mll2/ ES cells, very
few genes are misregulated, suggesting that Mll2 has
very few unique targets in this cell type (Glaser et al.,
2009). One target gene, Magoh2, which is downregulated
in Mll2/ ES cells, loses H3K4me3 at the promoter
region. Interestingly, there is a concomitant increase in
H3K27me3, indicating that chromatin modifications at
Mll target genes are negotiated between antagonizing
activities of the Mll group HMTases and Ezh enzymes.
Mll3 and Mll4 are present in complexes that share the
PTIP (Pax transactivation domain-interacting protein)
subunit, which is not present in Mll1 or Mll2 complexes
(Cho et al., 2007). The difference in complex composition
might also regulate targeting to distinct sets of genes.
Mll3/4 have no apparent effect on Hox gene expression.
Instead, they regulate H3K4 methylation at targets of the
nuclear hormone receptors, retinoic acid receptor and
peroxisome proliferator-activated receptor-g (Lee et al.,
2006, 2008a). Mll3-mutant mice are viable and do not
show severe patterning defects; however, differentiation
to distinct lineages, for example, adipocytes, is partially
impaired, indicating an important function of Mll3 for
normal development (Lee et al., 2008a).
Mll5 was regarded as inactive for a long time as no
methyltransferase activity of the recombinant protein
could be detected. A recent study has since shown that
Mll5 is a histone H3K4-specific methyltransferase whose
activity critically depends on GlcNacylation of Threonin
440 (Fujiki et al., 2009). Mll5 knockout mice are born at
Mendelian ratios; only a few pups die during the first
days postpartum. These data indicate that there are
no severe developmental defects associated with loss
of Mll5; however, closer inspection of the surviving
mutants revealed that hematopoietic development is
impaired and, in particular, the function of hematopoie-
tic stem cells is reduced (Heuser et al., 2009; Madan et al.,
2009; Zhang et al., 2009).
The enzymatic system for H3K4 methylation in
mammals is highly complex. Mll proteins are a part of
large complexes with common components and distinct
interaction partners. Mll1 and Mll2 complexes share the
common Menin subunit. Single Mll1 or Mll2 mutants
impair H3K4 methylation at only a subset of Hox genes.
Disruption of Menin has a much stronger effect and
almost all H3K4 methylation is lost from Hox loci (Wang
et al., 2009). Much less is known about targets of the other
H3K4 HMTases. Although Mll3–5 induce only some
H3K4 methylation outside of the Hox loci, Setd1a/
Setd1b HMTases have major roles in global H3K4
methylation (Wu et al., 2008). These enzymes are a part
of multi-subunit complexes, most similar to the yeast
COMPASS complex, and probably have a very general
function in transcriptional activation. We expect that
knockouts for these enzymes will generate severe
defects, maybe even at the cellular level.
Repression of developmental regulators
by H3K27 methylation
A classical model system for developmental gene
regulation is the regulation of Hox gene expression. In
Drosophila, the major players that determine transcrip-
tional activity of distinct Hox genes are components of
the activating trithorax and the repressive polycomb
system, which are primarily recruited to specific DNA
sequences (polycomb response elements). The founding
member of the PcG family in Drosophila is polycomb, a
chromo domain-containing protein whose targeting
depends on H3K27me3 by E(z) (Cao et al., 2002). In
mammals, many PcG components are conserved; how-
ever, the primary targeting mechanism is still unclear, as
no polycomb response elements have been identified
as yet.
In mice, there are two H3K27-specific HMTases, Ezh1
and Ezh2 (Table 2). Interestingly, their expression
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patterns differ as Ezh2 is predominantly expressed in
undifferentiated/proliferating cells, whereas Ezh1 is
more abundant on terminal differentiation (Margueron
et al., 2008; Ezhkova et al., 2009).
H3K27 methylation correlates with gene repression
and is enriched at repressed Hox genes and in female
mammals at the inactive X chromosome. Thus, dereg-
ulation of Ezh enzymes in mice is expected to generate
strong phenotypes by affecting the gene activity of
important developmental regulators. Indeed, Ezh2
knockout mice show early embryonic lethality around
E8.5 (O’Carroll et al., 2001). Ezh2 knockout ES cells can
be established and selectively lose H3K27me2 and
H3K27me3 while maintaining H3K27me1. Interestingly,
at some important developmental genes, H3K27me3
is preserved in Ezh2/ ES cells (Shen et al., 2008),
indicating that Ezh1 and Ezh2 share partially redundant
functions.
To analyze the function of H3K27me3 for develop-
mental transitions, conditional Ezh2 knockout mice were
established (Su et al., 2003). During B cell development,
Ezh2 is highly expressed in early progenitor populations
(pro-B and pre-B cells), whereas Ezh1 is only expressed
in late stages. Inactivation of Ezh2 in the hematopoietic
lineage blocks the transition from pro-B to pre-B cells;
however, later stages of B cell development are not
impaired (Su et al., 2003). In this model system,
transcriptional deregulation has not been investigated
and the reason for the developmental block at the pro-B
cell stage might be the improper processing of antigen
receptor rearrangements.
Ezh2 deletion was also analyzed in skin development,
in which basal layer progenitor stages can be distin-
guished from suprabasal cells that have initiated the
program of terminal differentiation. Again, expression
of Ezh2 is highest in the progenitor population and
decreases with differentiation stage (Ezhkova et al., 2009).
Deletion of Ezh2 in developing skin leads to dramatic
loss of H3K27me3, resulting in accelerated epidermal
differentiation and precocious acquisition of the epider-
mal barrier. Gene expression analysis of wild-type versus
Ezh2-deleted epidermal precursor cells revealed that
although H3K27me3 was almost lost in these cells,
only approximately 90 genes were deregulated (mostly
upregulated). Most of these genes are normally ex-
pressed in the final stages of epidermal development.
The premature activation of the terminal differentiation
program in the absence of Ezh2 suggests that transcrip-
tional activators for epidermal differentiation are already
present in the progenitor stages and that H3K27me3
blocks their access to target promoters (Ezhkova et al.,
2009). Most other genes, which also lose H3K27me3 in
the absence of Ezh2, are not activated, suggesting that
they are repressed by different mechanisms or that
appropriate transcriptional activators are not expressed
in this tissue. The question as to how H3K27me3 can
block the binding of transcription factors has not been
addressed. The intriguing possibility that specific bin-
ders of H3K27me3, for example, Cbx2 in the context of
the PRC1 complex, mediate compaction of the chromatin
structure should be tested in future studies.
We think that H3K27me3 has a major role for develop-
mental transitions (Figure 5). In pluripotent cells, develop-
mental regulators are repressed by the bivalent
modifications H3K27me3 and H3K4me3. After lineage
decision, these genes are either active and carry H3K4me3
or they are inactive and show enriched signals for
H3K27me3. Apparently, in committed progenitor cells
there are at least two categories of H3K27me3-repressed
genes. One category is lineage-appropriate genes that
need to be activated in later stages of differentiation.
Full activation of these genes depends on removal of
H3K27me3, probably by histone demethylases (Agger
et al., 2007; Lan et al., 2007) that would then allow binding
of transcriptional activators. Lineage-inappropriate genes,
the second category, need to be stably repressed by
H3K27me3 together with other mechanisms, such as
different histone methylation marks or DNA methylation.
Aberrant activation of lineage-inappropriate genes might
as well be prevented by the lack of transcriptional
activators. More detailed analyses are required to distin-
guish between these possibilities.
Repression of repetitive elements and gene
regulation by H3K9 methylation
The first H3K9-specific methyltransferases that were
disrupted in mice were the Suv39h1 and Suv39h2
demethylase/
passive removal
lineage
inappropriate
removal of individual repressive
marks tolerable for silencing
lineage
appropriate
Figure 5 The role of H3K27me3-mediated gene silencing during developmental transitions. In pluripotent cells, developmental regulators
are repressed and carry bivalent H3K4me3þH3K27me3 modifications. Bivalent marks are reduced in committed progenitor cells in which
two categories of H3K27me3-repressed genes exist. Lineage-appropriate genes are activated during terminal differentiation, probably by the
active removal of H3K27me3. In contrast, lineage-inappropriate genes are stably repressed by H3K27me3 and other mechanisms, such as
different histone modifications and DNA methylation.
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enzymes (Peters et al., 2001). Single mutants do not show
obvious defects, possibly due to compensatory effects.
Surprisingly, even Suv39h double mutants are viable,
although they show some prenatal lethality during
embryogenesis. In Suv39h double-null cells, H3K9me3
is lost from heterochromatin; however, total H3K9me3
levels are only reduced by approximately 50%. Suv39h
mainly regulates repetitive regions, such as major
satellite repeats and transposons (Martens et al., 2005),
as no target genes of Suv39h enzymes could be identified
as yet. Alterations in the chromatin structure across
repetitive elements can have drastic effects on overall
genome stability. It is noteworthy that Suv39h double-
null fibroblasts show increased chromosome segregation
defects, indicating that centromere function is impaired.
Genomic instability could also contribute to tumor
development and sterility, which was observed in
Suv39h-mutant mice (Peters et al., 2001). These findings
show that H3K9me3 has important functions for geno-
mic integrity by repression of mobile elements, thereby
ensuring normal development and long-term survival.
Another H3K9-specific HMTase, Setdb1, has been
suggested to induce H3K9me3 for gene repression.
Setdb1 knockout mice show a strong phenotype with
peri-implantation lethality between days E3.5 and E5.5.
The defects are so severe that not even embryonic stem
cell lines could be established from null mutant
blastocysts (Dodge et al., 2004), the reason for which is
not understood. Setdb1-mediated H3K9me3 might have
important roles in later developmental transitions by
regulating targets of transcription factors (Yang et al.,
2002) and nuclear hormone receptors (Takada et al.,
2007). In a very elegant study, Takada et al. (2007) show
that in mesenchymal cells of the bone marrow, non-
canonical Wnt signaling induces phosphorylation of
Setdb1, which leads to the formation of a corepressor
complex with peroxisome proliferator-activated recep-
tor-g. Repression of peroxisome proliferator-activated
receptor-g targets by H3K9me3 drives differentiation of
mesenchymal stem cells into the osteoblastic lineage.
Catalytically inactive Setdb1 mutants could not ensure
repression of peroxisome proliferator-activated receptor-
g targets, leading to differentiation of the mesenchymal
cells into adipocytes. These findings show that
H3K9me3-mediated gene repression is extremely impor-
tant to establish transcriptional programs during lineage
decisions. Conditional inactivation of Setdb1 in different
tissues will surely reveal additional implications of this
essential HMTase for normal development.
H3K9me2 is a mainly euchromatic modification that is
controlled by G9a and GLP HMTases (Table 2). G9a
knockout mice show severe defects during embryogen-
esis, leading to developmental delay and lethality
around day E9.5 (Tachibana et al., 2002). Unlike Suv39h1
and Suv39h2 that work redundantly to induce H3K9me3
at heterochromatin, heterodimer formation between G9a
and GLP is essential to establish H3K9me2. Thus, GLP
mutant embryos show defects that are almost identical to
the G9a knockout, and double inactivation of G9a and
GLP does not cause stronger phenotypes (Tachibana
et al., 2005).
G9a-mutant ES cells show only little transcriptional
deregulation and only one target gene, Mage-2a, has
been shown as a direct target (Tachibana et al., 2002).
Interestingly, G9a-mediated H3K9 methylation has im-
portant functions during the differentiation of ES cells
through the stable inactivation of approximately 120
genes, including the pluripotency genes Oct4 and Nanog
(Feldman et al., 2006; Epsztejn-Litman et al., 2008).
Stability of silencing is ensured through DNA methyla-
tion by Dnmt3a/b, which directly interacts with G9a
(Epsztejn-Litman et al., 2008).
G9a mediates H3K9 methylation in another devel-
opmentally important context: genomic imprinting. In
extraembryonic tissues, imprinting of the Kcnq1 domain
is not dependent on DNA methylation, but the ICR
shows high levels of H3K9me2 and H3K9me3. It is
noteworthy that G9a mutants lose parental-specific
imprinting of the Kcnq1 region selectively in the
extraembryonic tissue through loss of H3K9me2 and
H3K9me3 (Wagschal et al., 2008). Although the average
enrichment of H3K9 methylation states across silenced
genes (Figure 1) has not suggested major roles for this
modification in gene regulation, the abovementioned
examples show that both H3K9me2 and H3K9me3 have
important functions for gene silencing and for the
regulation of developmental transitions.
Concluding remarks
The functional analysis of different HMTases in the
context of knockout mouse models has revealed that
histone lysine methylation has important roles in
facilitating normal development; however, there are still
many open questions. Knockout mice for only approxi-
mately 50% of mouse HMTases have been generated and
analyzed (Table 2), and for many of these proteins we do
not even know their enzymatic activity. Several HMTase
mutants show early embryonic lethality with pleiotropic
defects. A more detailed functional analysis in different
tissues is required to better understand their functional
implications in developmental processes. The paper by
Ezhkova et al. (2009) is a very appropriate example for
such an analysis.
How are different histone lysine methylation marks
interpreted? Are different methylation states really
functionally distinct? We only know binding proteins
for a subset of positions and methylation states (Table 1).
In vitro, most binders analyzed so far show only weak
affinity to their targets, and the different methylation
states cannot be clearly distinguished. Are there other
mechanisms in vivo that could increase the affinity to
their targets?
Epigenetic gene regulation has become a very complex
field. In this review, we have only covered the functions
of histone lysine methylation in transcriptional regula-
tion; however, there is interplay and dependency
between many different epigenetic mechanisms. Chro-
matin remodelers, for example, recognize histone mod-
ifications and can also mediate the exchange of histone
variants (Konev et al., 2007). Non-coding RNAs are able
to recruit histone-modifying activities that ultimately
alter the transcriptional status of targets (Nagano et al.,
2008). Histone modifications can be established in
sequential pathways in which one modification recruits
specific binders and these proteins, in turn, recruit other
modifying activities (Schotta et al., 2004). The future
challenge in epigenetic research will be to understand
this complex network of regulatory mechanisms.
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Abstract
Post-translational modifications (PTMs) of histones exert fundamental roles in regulating gene expression. During
development, groups of PTMs are constrained by unknown mechanisms into combinatorial patterns, which facilitate
transitions from uncommitted embryonic cells into differentiated somatic cell lineages. Repressive histone modifications
such as H3K9me3 or H3K27me3 have been investigated in detail, but the role of H4K20me3 in development is currently
unknown. Here we show that Xenopus laevis Suv4-20h1 and h2 histone methyltransferases (HMTases) are essential for
induction and differentiation of the neuroectoderm. Morpholino-mediated knockdown of the two HMTases leads to a
selective and specific downregulation of genes controlling neural induction, thereby effectively blocking differentiation of
the neuroectoderm. Global transcriptome analysis supports the notion that these effects arise from the transcriptional
deregulation of specific genes rather than widespread, pleiotropic effects. Interestingly, morphant embryos fail to repress
the Oct4-related Xenopus gene Oct-25. We validate Oct-25 as a direct target of xSu4-20h enzyme mediated gene repression,
showing by chromatin immunoprecipitaton that it is decorated with the H4K20me3 mark downstream of the promoter in
normal, but not in double-morphant, embryos. Since knockdown of Oct-25 protein significantly rescues the neural
differentiation defect in xSuv4-20h double-morphant embryos, we conclude that the epistatic relationship between Suv4-
20h enzymes and Oct-25 controls the transit from pluripotent to differentiation-competent neural cells. Consistent with
these results in Xenopus, murine Suv4-20h1/h2 double-knockout embryonic stem (DKO ES) cells exhibit increased Oct4
protein levels before and during EB formation, and reveal a compromised and biased capacity for in vitro differentiation,
when compared to normal ES cells. Together, these results suggest a regulatory mechanism, conserved between
amphibians and mammals, in which H4K20me3-dependent restriction of specific POU-V genes directs cell fate decisions,
when embryonic cells exit the pluripotent state.
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Introduction
Embryonic development is controlled by fine-tuned differen-
tial gene expression. A succession of regulatory protein networks
unfolds the zygotic gene expression program along a hierarchy of
decisions, leading from the embryonic ground state to the
epiblast and then to germ layers, which become patterned into
cell type and organ precursor territories. The pluripotent trait,
key feature of embryonic stem (ES) cells [1], is progressively
restricted and finally lost as soon as embryonic cells become
specified to germ layer fates. Recent studies have revealed that
alterations in chromatin structure, dynamics and composition
represent fundamental processes, which define the epigenetic
landscape that directs cell type specification along this hierarchy
[2,3].
Besides important contributions from ATP dependent chroma-
tin remodelling factors [4,5] and histone variants [6] in
modulating nucleosome dynamics, histone post-translational
modifications (PTMs) have been linked to gene expression [3,7].
The transition from pluripotent to differentiated cells is charac-
terized by a progressive increase in heterochromatin formation, in
a process that changes the hyperdynamic open chromatin
structure into a less accessible architecture [1,8]. At the same
time transcriptional silencing of non-lineage specific genes is
achieved via acquisition of repressive histone marks. In vivo studies
have shown that dynamic alterations in the levels of histone
modifications characterize early stages of development both in
mammals [9–11] and other vertebrates [12–14].
Lysine methylation of histones is catalyzed by SET domain-
containing histone methyltransferases (HMTases), and can be
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linked both to transcriptional activation and repression [15,16].
In particular, repressive histone methyl marks are found on
lysine residues at position 9 and 27 on histone H3 and in
position 20 on histone H4. H3K27 trimethylation is catalyzed
by polycomb repression complex (PRC) 2, which predominantly
represses developmental regulatory genes [17–19]. Trimethyla-
tion of H3K9 and H4K20 relies on Suv39h and Suv4-20h
enzyme activities, respectively [20,21], and predominantly
marks repetitive genomic DNA at pericentromeric and telo-
meric heterochromatin [16,21]. While H3K9-specific HMTases
have been characterized in significant depth [20,22,23], we
know little about the functions of Suv4-20h1 and Suv4-20h2
enzymes with regard to gene regulation. In vivo analysis of
H4K20 methylation states in mouse embryos reveals specific
patterns both in cellular or subnuclear abundance [9,24]. Suv4-
20h DKO pups die perinatally, indicating an essential function
of the two enzymes during embryogenesis [24]. Moreover,
quantitative analysis of histone PTMs in X. laevis revealed a
progressive and significant accumulation of H4K20me3 levels
during embryogenesis, suggesting developmental functions for
these enzymes [13].
To characterize the functional role of H4K20me2/3 during
vertebrate development we have investigated the consequences of
both morpholino-mediated protein knockdown and mRNA-born
overexpression of the Xenopus Suv4-20h1 and h2 homologs in
frog embryos. Our data reveal a specific and selective requirement
for Suv4-20h enzyme acitivities in neuroectodermal differentia-
tion, in a process which involves transcriptional repression of
pluripotency associated POU-V genes, both in Xenopus embryos
and in murine ES cells.
Results
Characterization of Xenopus Suv4-20h1 and h2 enzymes
We initially identified X. laevis Suv4-20h1 and h2 ESTs via
database mining. Mouse and frog Suv4-20h1 and h2 protein
sequences are well conserved, particularly within the SET
domains ($88% identity), even though the xSuv4-20h2 open
reading frame is longer than its mouse homolog due to C-
terminal insertions (supplementary data, Figure S1). XSuv4-
20h1/h2 genes are both maternally and zygotically expressed in a
ubiquitous manner, as shown by RNA in situ hybridisation and
RT-PCR analysis (Figure S2A–S2D). XSuv4-20h1 mRNA
abundance decreases during the initial stages of development
and subsequently rises from mid-gastrula on, reflecting the switch
from maternal-to-zygotic transcription at midblastula. In con-
trast, the initially high xSuv4-20h2 mRNA level falls and stays
low at late stages (Figure S2D).
To test the acivities of these Xenopus HMTases, we first
analyzed their ability to rescue H4K20me3 levels in Suv4-20h1/
h2 DKO mouse embryonic fibroblasts (MEF Suv4-20h DKO;
[24]), which lack this modification. Both frog cDNAs re-
established a proper H4K20me3 pattern, which was strongly
enriched at heterochromatic regions that were identified as
DAPI-dense chromocenters within nuclei (Figure 1A). Thus,
Xenopus laevis Suv4-20h homologs are biologically active and
can direct H4K20 trimethylation. To test, whether they generate
this histone mark in frog embryos, we designed antisense
Morpholino oligonucleotides (MO) to reduce synthesis of
xSuv4-20h1 and h2 proteins from endogenous mRNAs (Figure
S3A, S3B). These MOs specifically inhibited translation of their
cognate templates in vitro (Figure S3C). To avoid possible
functional complementation between the xSuv4-20h enzymes in
vivo, we decided to inject the two MOs simultaneously into both
blastomeres of 2-cell stage embryos and performed western blots
with nuclear protein extracts from these double-morphant
embryos at the tadpole stage (NF30-33). Compared to uninjected
controls or embryos injected with an unrelated control MO
(control-morphants), the double morphants contained significant-
ly less H4K20me2 (p = 0.0011) and H4K20me3 (p = 0.0164),
which was coupled to an increase in H4K20me1 (p = 0.0034)
(Figure 1B and 1C).
This result was confirmed by MALDI-TOF mass spectrom-
etry (Figure S4A). As described in Schneider et al. [13], the
relative abundance of histone modifications was calculated by
quantifying the amount of a specific modification relative to the
amount of all modification states determined for the same
histone peptide. As reported before [13], the H4K20me3 mark
could not be quantitated reproducibly for technical reasons.
Compared to control embryos, however, xSuv4-20h double
morphants contained approximately 2.5-fold less of H4K20me2
(p = 0.0153) and three-fold more H4K20me1 (p = 0.0185), while
the abundance of the unmodified peptide state remained
unaffected. Importantly, the levels of histone H3 methylation
on two tryptic peptides, covering the K9, K27 and K36
positions, were indistinguishable between control and double-
morphant embryos (Figure S4B and S4C). Western blot analysis
with antibodies against trimethylated H3K9 or H3K27 also
showed no difference in the abundance of these two marks
between control embryos and xSuv4-20h double morphants
(Figure S4D).
To further characterize the effects of xSuv4-20h enzyme
depletion on the cellular level, we performed immunohistochem-
istry on sections from tailbud stage embryos (NF30), which were
injected with the xSuv4-20h MO-mix into one of two blastomeres
at 2-cell stage together with fluorescently labelled dextranes as
lineage tracer. While H3 staining was comparable between
injected and uninjected sides under all conditions (Figure S5A),
staining for H4K20me2 and –me3 was clearly reduced on the
double-morphant side of the neural tube (Figure 1D). In
Author Summary
The quest of modern developmental biology is a detailed
molecular description of the process that leads from the
fertilized egg to the complex and highly differentiated
adult organism. This process is controlled largely on the
level of gene expression. While early embryonic cells are
pluripotent and capable of transcribing most of their
genome, older cells have become committed to the germ
layer and differentiation programs during gastrulation.
They express then a subset of genes compatible with their
future physiological function. Young, pluripotent cells and
post-gastrula, committed cells express different networks
of transcription factors and contain chromatin of different
structure and composition. How these two regulatory
layers are interconnected during development is incom-
pletely understood. We describe a novel and unexpected
link between the pluripotency-associated POU-V gene Oct-
25 and xSuv4-20h histone methyltransferases. XSuv4-20h
enzymes are required to repress the Oct-25 gene, a
homolog of mammalian Oct4, in the neuroectoderm of
frog embryos as a prerequisite for neural differentiation.
Consistently, murine Suv4-20h double-null ES cells show
increased Oct4 protein levels before and during in vitro
differentiation and display compromised differentiation in
comparison to wild-type ES cells. Thus, Suv4-20h enzymes
control specific POU-V genes and are involved in germ-
layer specific differentiation.
Suv4-20h Enzymes Promote Neurogenesis
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agreement with our western blot and mass spec results, the
reduction in the di- and tri-methyl mark was coupled to an
increase in H4K20me1 staining. Altogether these results indicate
that xSuv4-20h1 and h2 downregulation leads to a quantitative
reduction of H4K20 di- and trimethyl marks in the frog embryo,
without affecting the bulk abundance of other repressive histone
marks such as H3 K9/K27 methylation.
RNA-based overexpression of Suv4-20h HMTases had the
opposite effect. When injected singly, xSuv4-20h1 or h2 mRNAs
increased both di- and trimethylated H4K20 in a dose-dependent
manner (Figure S8A). A comparable result was achieved by
injection of either mouse Suv4-20h1 or h2 mRNAs (Figure S9A).
Together, these results identify the frog cDNAs as orthologs of
mammalian Suv4-20h enzymes. Loss and gain of function
experiments also indicate that the bulk abundance of di- and
trimethylated H4K20 can be manipulated over a wide range
without compromising embryonic viability.
XSuv4-20h HMTases depletion inhibits eye and
melanocyte formation
We next tested, whether depletion of xSuv4-20h HMTases
affects embryonic development. We injected xSuv4-20h1/h2 MO-
mix into one blastomere of two-cell stage embryos and scored
phenotypic alterations by comparing injected with uninjected
sides. No obvious differences were observed during early
development, including gastrulation, axial extension and dorso-
ventral patterning. From tailbud stages on, two main phenotypes
became manifest. First, in the injected side of xSuv4-20h double
morphants the eye formation was strongly compromised. The eye
rudiments contained no or barely visible retinal pigment and
Figure 1. Functional analysis of xSuv4-20h HMTases. (A) Transiently transfected eGFP-tagged Suv4-20h1 and h2 enzymes from frog or mouse
re-establish H4K20me3 marks in heterochromatic foci of Suv4-20h1/h2 DKO MEFs. (B–D) Bulk histones from tadpoles (NF30-33) injected with
morpholinos targeting translation of endogenous xSuv4-20h1 and h2 mRNA show a strong reduction in H4K20me2 and H4K20me3 levels and a
concomitant increase in the H4K20me1 mark. (B) Western Blot analysis of uninjected embryos, control morphants (ctrl-MO), and double morphants
with antibodies against H4K20 mono-, di- and trimethylation. PanH3 antibody was used as loading control. (C) Western Blot quantification of three
independent biological experiments; data represent mean values, error bars indicate SEM. (D) Immuno-histochemistry on xSuv4-20h double
morphant tadpoles. Panels show details from neural tubes stained with antibodies against the histone epitopes indicated on the side. Whole sections
shown in Figure S5A.
doi:10.1371/journal.pgen.1003188.g001
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typically had no lens (Figure 2A). Secondly, melanophores that are
found on the dorsal part of the head and the lateral portion of the
trunk, were severely reduced in numbers or completely lost from
the double-morphant side (Figure 2A). Both phenotypes had a
penetrance between 80–90% in xSuv4–20h double morphants
(p,0.0001, Fisher’s exact test) in several independent experiments
(Figure 2B). Control-morphant embryos had normal eyes and
melanocytes (Figure 2A) and were indistinguishable from unin-
jected siblings in most cases (Figure 2B).
The distinct eye phenotype prompted us to investigate the
underlying molecular changes. RNA in situ hybridization exper-
iments revealed a clearly reduced expression of the homeobox
transcription factor Rx-1 (Figure 2C) and the paired box
transcription factor Pax-6 (Figure S5D) in xSuv4-20h double
morphants. The reduction of these two master regulators of eye
differentiation explains the morphological eye phenotype, but we
noticed that embryonic transcription was already misregulated
upstream of these factors. The pan-neural markers Nrp1
(Figure 2C) and N-CAM (Figure S5E), which are induced during
gastrula stages, were also strongly reduced in double morphants.
However, several key markers of embryonic patterning were not
perturbed, such as the organizer genes Chordin, Goosecoid and
Xnr-3 at gastrula stages (Figure S5B). The anteroposterior
patterning of the central nervous system (CNS) appeared also to
Figure 2. xSuv4-20h1/h2 double morphants lack eyes and melanophores. (A) Morphological phenotypes of representative tadpoles (NF30-
33) from embryo cohorts injected into one of two blastomeres at two-cell stage with ctrl-MO, xSuv4-20h1/h2 MOs (double morphants), and double
morphants coinjected with 3 ng mouse Suv4-20h1/h2 mRNAs (rescued). Injected body halves were identified by green fluorescence of the coinjected
lineage tracer Fluor 488 Dextran. (B) Penetrance of the eye phenotype. Data from three to five independent experiments; n = total number of
embryos scored. (C) RNA in situ hybridization analysis for Rx-1 in tadpoles (NF30-33), and CNS markers Nrp1 at neural tube stage (NF19-20). For each
condition, numbers refer to embryos showing the displayed morphology or staining, in comparison to the total number of analysed embryos.
doi:10.1371/journal.pgen.1003188.g002
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be normal given the wild-type-like expression patterns of Otx2 and
Krox20 in fore- and hindbrain territories, respectively (Figure
S5C). These results provide first evidence that H4K20 di- and
trimethylation serves to regulate distinct developmental genes in a
selective manner.
Xenopus Suv4-20h activity is required for normal
development
The specificity of the developmental phenotypes arising from
xSuv4-20h enzyme depletion was validated by rescue experiments,
in which we coinjected increasing doses of murine Suv4-20h1/h2
mRNAs together with the xSuv4-20h MO-mix. Due to sequence
divergence, transcripts of the murine orthologs escape inhibition
by the MOs targeting the frog mRNAs. Already 2 ng of murine
Suv4-20h transcripts were sufficient to rescue the eye defect in two
thirds of the double morphant embryos (p,0.0001, Fisher’s exact
test). In most cases, the retinal neuroepithelium regained its
circular structure and near normal size, as well as a central lens
(Figure 2A). The rescue efficiency did not increase with higher
concentrations of mouse transcripts (Figure 2B, columns 4–6). The
number of melanophores was also increased at their proper sites
under rescue conditions (Figure 2A). Furthermore, the expression
domains of Rx-1 and Nrp1 (Figure 2C), as well as Pax-6 and N-
CAM (Figure S5D and S5E) were efficiently restored.
To test, whether this phenotypic rescue requires Suv4-20h
proteins or their enzymatic activity, we generated catalytically
inactive murine Suv4-20h protein variants (Figure S6A), based on
structural predictions [25,26]. Unlike the wild-type proteins,
neither variant restored the H4K20me3 mark at heterochromatic
foci in Suv4-20h DKO MEFs (Figure S6B). When tested side by
side with the wild-type enzymes, the mutants did neither increase
the abundance of the H4K20me2 and -me3 marks in wild-type
frog embryos (Figure S6C, compare lanes 1, 3 and 5), nor rescue
H4K20 methylation levels in xSuv4-20h double morphants
(Figure S6C compare lanes 1, 4 and 6), although being expressed
at similar levels (Figure S6D). Consequently, the inactive variants
also failed to rescue the eye and melanophore phenotype (Figure
S7A–S7C and S7D, compare columns 2–4).
In the course of these experiments we noticed that overexpres-
sion of either frog or mouse Suv4-20h1 and h2 proteins never
caused any obvious morphological or molecular changes in the
embryos (Figures S8B, S8C and S9B, S9C), despite strongly
enhanced H4K20me3 levels in bulk chromatin (Figures S8A and
S9A). In particular, morphological landmarks such as eyes and
melanophores formed normal in size, number and location under
overexpression conditions. Expression domains of marker genes
such as Rx-1 and Pax-6 were unaffected (Figures S8D and S9D).
Thus, H4K20 di- and trimethylation is required for normal
development, but excess deposition of these marks has no apparent
phenotypic consequences.
XSuv4-20h enzymes are required for ectoderm formation
The apparent functional selectivity of the ubiquitously expressed
enzymes encouraged us to test, whether xSuv4-20h HMTases
control additional aspects of germ layer formation and patterning.
Therefore, we compared the expression of key developmental
regulatory genes in uni-laterally injected control-morphants versus
xSuv4-20h double morphants by RNA in situ hybridisation (listed
in Figure 3A).
Based on our previous results, we continued with genes involved
in neurogenesis (Figure 3B). At the open plate stage, primary
neurons are specified in three stripes next to the dorsal midline on
each side. At this time, each stripe expresses the neural specific
regulatory genes Neurogenin-related 1a (Ngnr-1a) and Delta-like
1, as well as the differentiation marker N-tubulin. The expression
of these three genes was extinguished in almost all of the xSuv4-
20h MO-injected sides, while being unaffected by control-MO
(Figure 3B). In addition to these stripes, Delta-like 1 mRNA
delineates the anterior border of the neural plate, and this domain
was also extinguished (Figure 3B). In contrast, mesodermal
expression of Delta-like 1 around the blastoporus remained
unaffected in morphant condition (Figure 3B, arrow). Delta-like
1 and N-tubulin stripes were effectively rescued by coinjection of
wild-type mSuv4-20h1/h2 mRNAs, while Ngnr-1a was restored in
a broad, diffuse manner (Figure 3B, right column). Notably,
inactive mouse Suv4-20h HMTases could not rescue N-tubulin
expression (Figure S7E, middle column). At the same time,
mesodermal control genes like MyoD were unaffected (Figure
S7E, right column) Together, these results implicate xSuv4-20h
enzymes in neuronal fate selection.
Next, we extented our analysis to marker genes expressed in
other germlayers and territories (Figure 3C and Figure S5). The
epidermal keratin gene XK81 demarcates non-neural ectoderm
and was expressed normally on the surface of morphant epidermis;
however, due to a slight retardation in neural tube closure on the
injected side, its expression appears asymmetric in anterior views.
This may indicate an involvement of xSuv4-20h enzymes in
morphogenetic processes during neurulation and/or neural crest
specification. This phenotype led to a mild broadening of the
neural plate markers Sox2 (Figure 3C), Sox3 and Sox11 (Figure
S5F) at apparently normal mRNA levels. Prior to these neural
plate markers, a group of genes including FoxD5, Geminin, Zic1,
Zic2, Zic3 and members of the Iroquois family are induced in the
prospective neuroectoderm and stabilize the neural fate by their
regulatory interactions (reviewed in ref [27]). At midgastrula
(NF11), FoxD5 and Geminin did not respond to xSuv4-20h
enzyme depletion (Figure S5F), but Xiro1, Zic1 (Figure 3C), Zic2
and Zic3 (Figure S5F) mRNAs were strongly reduced. In contrast,
key mesodermal factors such as Xbra, MyoD (Figure 3C) and
VegT (Figure S5F), as well as regulators of endodermal
differentiation like Sox17 a and Endodermin (Figure 3C) were
expressed normally in both morphants and in embryos overex-
pressing frog xSuv4-20h proteins (Figure S8E). Taken together
these results demonstrate that xSuv4-20h HMTases are critical for
neural development, but apparently dispensable for mesoderm
and endoderm formation in X. laevis.
To further verify the specific role of Xenopus Suv4-20h
enzymes in neural development, we considered two different
approaches; in a first series of experiments we performed injections
at 8-cell stage in the animal or vegetal pole blastomeres, selectively
labelling cells predominantly belonging either to mesendoderm
(vegetal injections, Figure 4A) or ectoderm (animal injections,
Figure 4D). Vegetal pole blastomere injections led to no evident
morphological and molecular phenotypes (Figure 4B and 4C).
Conversely, animal injections reproduced the eye and melano-
phore phenotypes from half-injected embryos, while mesodermal
and endodermal structures developed normally (Figure 4E).
Consistent with the morphological defects, Delta-like 1 expression
in the neural plate was suppressed, while MyoD and Sox17 a
genes were unaffected (Figure 4F). These results provide strong
evidence that the neural and melanocyte phenotypes originate in
the ectoderm.
As second approach we took advantage of animal cap (AC)
explants, which form epidermis in isolation but can be neuralized
by the BMP-inhibitor Noggin. Specifically, we tested whether the
downregulation of xSuv4-20h HMTases prevented neural induc-
tion by Noggin. Without Noggin, wt and double morphant
explants were positive for XK81 and negative for Nrp1
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(Figure 5A). They were also negative for Xbra, indicating absence
of contaminating mesoderm. Noggin-mediated Nrp1 expression
was clearly visible in wt caps, but strongly reduced upon co-
injection of xSuv4-20h morpholinos, while XK81 expression was
downregulated in both the samples (Figure 5A). Thus, double
morphant caps are both refractory to neural induction and
restrained in epidermal differentiation. However, they differentiate
into mesoderm upon stimulation with Activin A just like control
explants, as shown by immunostaining for muscle myosin heavy
chain (Figure 5B). These results confirm the crucial role of xSuv4-
20h enzymes in coordinating the formation of ectodermal tissues,
and show that in the absence of the two enzymes neural induction
is impaired.
XSuv4-20h enzymes are required for cell survival and
proliferation
Loss of H4K20 di- and trimethylation is known to compromise
DNA damage repair in mice and to partially block G1/S
transition [24]. This prompted us to test, whether xSuv4-20h
depletion affects apoptosis and cell proliferation in frog embryos.
Immunostaining for activated Caspase3 revealed an increase in
apoptotic cells on the injected side of double morphant embryos
(Figure S10A). Coinjection of xBcl-2 mRNA, an anti-apoptotic
factor, reduced the Caspase3 positive cells to levels of the
uninjected control side, however, without re-establishing a proper
Delta-like 1 and N-tubulin pattern in the double-morphant side.
Overexpression of xBcl-2 mRNA alone had no effect on the
expression of the tested markers (Figure S10A). Thus, although
embryonic frog cells depleted for the H4K20me2/me3 marks
become apoptotic at higher rate than wt cells, the absence of
neurons in the double-morphant neural plate cannot be explained
by selective cell death.
Double morphant embryos stained for the mitotic marker
H3S10P, showed a two-fold reduction (p = 0.0058) in the number
of proliferating cells at midneurula stage, compared to control
morphant embryos (Figure S10B). This mild phenotype might be
correlated with the observed increase in apoptosis. Since neural
induction continues in frogs, even when cell proliferation is
blocked from gastrulation onwards [28], it is unlikely that the
nearly complete loss of N-tubulin positive neurons is brought
about by this mild reduction in cell proliferation. Taken together,
the main xSuv4-20h morphant phenotype represents not a
selective loss of neuroblasts, but a block in neural differentiation.
XSuv4-20h double morphant frog embryos fail to silence
Oct-25 transcription in sensorial ectoderm
So far, our analysis in xSuv4-20h morphant embryos has
indicated a specific and selective loss of gene expression in
ectodermally derived tissues. The earliest affected markers - Zic
and Xiro genes - become induced at early gastrula stage and help
establish the neural plate state [27]. At this time in frog
development, embryonic cells in the animal hemisphere are still
plastic and express members of the POU-V gene family – i.e. Oct-
25, Oct-60 and Oct-91 - that encode paralogs of the mammalian
pluripotency regulator Oct4 [29,30]. Because Oct-25 and Oct-91
regulate germ layer differentiation in Xenopus [31–34], we
investigated their expression (Figure 6A). Oct-25 is initially
expressed throughout the animal hemisphere at early gastrula,
but gets restricted to the presumptive floor plate (notoplate) by
midneurula [31]. On the injected side of the vast majority of
double morphants, however, Oct-25 expression was expanded
from the notoplate down to the ventral midline. Interestingly,
ectopic Oct-25 expression was restricted to the sensorial cell layer
of the ectoderm, which contains neural and epidermal precursor
cells, respectively (Figure 6A, sections). The Oct-60 gene, which is
expressed during oogenesis, was not activated under these
conditions. Oct-91 staining appeared normal in the majority of
the embryos, although some showed a mild upregulation in double
morphants as well (data not shown). The ectopic expression of
Oct-25 is a specific consequence of xSuv4-20h enzyme depletion,
because its normal pattern was re-established in morphants upon
coinjection of mRNAs encoding wild-type, but not inactive, mouse
Suv4-20h proteins (Figure S7E, left column). Notably, the selective
derepression of the Oct-25 gene was also observed in double-
morphant AC explants (Figure 6B), excluding indirect effects from
non-ectodermal tissues.
We then performed qRT-PCR analysis to quantitate the
relative changes in gene expression. It is frequently observed that
embryo cohorts develop in slight asynchrony as a non-specific
consequence of Morpholino injection, possibly obscuring tran-
scriptional responses. To minimize this potential artifact, we
analysed the RNAs of matching pairs of wt and xSuv4-20h
depleted samples by dissecting embryos at early neurula stage
(NF14) into uninjected and injected halves, based on the
coinjected fluorescent lineage tracer (Figure S11A). As shown in
Figure 6C, the Oct-25 mRNA is about three-fold higher in xSuv4-
20h double-morphant halves (p = 0.0123), while being similar
between control-morphant and uninjected halves. In the same
sample, Oct-91 expression was unaffected (Figure 6C). We used
this assay also to confirm the diminished expression of neural plate
marker genes detected earlier by RNA in situ hybridisation. With
the exception of Ngnr 1a, Nrp1 and N-tubulin, mRNA levels were
clearly reduced in the morphant halves (p = 0.0122 and 0.0163,
respectively; Figure S11B).
To gain further information about the complexity of the
underlying transcriptional misregulation, we performed transcrip-
tome analysis in wild-type and double-morphant embryos, again
dissecting embryos in corresponding pairs of injected and
uninjected halves (Figure S12A). Six percent of the 11639
annotated probe sets present on the microarray were significantly
altered in their expression as a consequence of xSuv4-20h enzyme
depletion, about equally split into upregulated (n= 319) and
downregulated (n = 404) probes (Figure S12B and S12C; for a
complete list of the responding probesets see NCBI’s GEO Series
accession number GSE41256). This result suggests that the
observed phenotypes in the double morphants originate from
transcriptional misregulation of distinct genes, rather than from
global, pleiotropic effects. Indeed, Oct-25 mRNA is also specif-
ically upregulated in the microarray data set, where it is among the
Figure 3. xSuv4-20h enzymes are required for differentiation of the neuroectoderm. (A) Schematic illustration of analysed markers of the
different germ layers (germ layer colour code extended to in situ panels). Downregulated genes upon xSuv4-20h depletion are labelled in red. (B)
Expression pattern of the neuroectodermal markers Ngnr 1a (NF12.5), Delta-like 1 (NF13), and N-tubulin (NF15). The pictures show dorsal views of the
open neural plate with anterior to the left. (C) Expression patterns of XK81 (ectoderm), Sox2, Xiro1, Zic1 (neuroectoderm), Xbra, MyoD (mesoderm),
Sox17 a, Endodermin (endoderm) in ctrl-MO injected or double morphant embryos. XK81 - anterior views with dorsal side to the top. Sox2 and MyoD
- dorsal views, anterior to the left. Xiro1 and Zic1 - dorsal views; injected halves are lineage-traced by coinjection of LacZ mRNA and subsequent b–Gal
staining (light blue). Xbra - vegetal view. Sox-17 a - internal stain from the injected side in bisected embryos, animal pole up. Endodermin – internal
stain from the injected side in bisected embryos; anterior to the left.
doi:10.1371/journal.pgen.1003188.g003
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ten most upregulated mRNAs in the double-morphant condition
(Figure S12D).
The sustained expression of Oct-25 in xSuv4-20h morphant
embryos fits the prediction of Oct-25 being a direct target of
H4K20me3 mediated transcriptional silencing. To test this
assumption directly, we carried out chromatin-immunoprecipita-
tion (ChIP) experiments with H4K20me3-specific antibodies at the
neurula stage (NF15-16). For ChIP experiments we used X.
Figure 4. xSuv4-20h1/h2 enzymatic activity is required in the ectodermal germ layer. (A, D) Schematic illustrations of targeting
microinjections into mesendodermal or ectodermal territories at 8-cell stage. (B) Injecting xSuv4-20h MOs into the mesendoderm causes no apparent
morphological phenotype in the embryo. (C) Neural, mesodermal and endodermal marker genes are expressed normally. (E) xSuv4-20h MOs reduce
eyes, cranial and trunk melanophores, when injected into the ectoderm. (F) Expression of all tested markers in mesoderm and endoderm is normal,
except for Delta-like 1, whose expression specifically in the open neural plate is strongly reduced on the injected side. Global morphology was
assessed at hatching stage (NF36), molecular markers at indicated stages during neurulation. Top row images in (B) and (E) depict whole embryos for
overview.
doi:10.1371/journal.pgen.1003188.g004
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tropicalis embryos, since the available genome sequence of this
closely related frog species [35] allowed us to design primer
amplicons for non-exon derived DNA sequences. RNA in situ
hybridization performed on neurula stage X. tropicalis embryos,
confirmed that the expression patterns of Oct-25 and N-tubulin
were up- and down-regulated, respectively, to the same extend as
observed for X. laevis (Figure S13). We retrived the pericentro-
meric major satellite repeat sequence (MSAT3) as positive control
amplicon for the experiment. Genic regions, which are
H4K20me3-free and, thus, could be used as negative controls,
are difficult to predict, since genome-wide analysis in mammalian
cells reported only enrichment of this modification on pericen-
tromeric and subtelomeric heterochromatin [36,37]. As negative
controls we considered: GAPDH, a constitutively expressed
housekeeping gene; thyroid hormone receptor a (thra), a gene
whose expression can be detected at neurula; and thra-induced
bzip protein (thibz) that is expressed from metamorphosis on
(Figure S14A). Statistical analysis of qRT/PCR data indicates that
expression of GAPDH and thra was not significantly altered under
the double-morphant condition (Figure S14B). Therefore, the
relative H4K20me3 levels at these genes were defined as
background, and compared to the levels on other loci (Figure
S14A). The modification strongly decorated the pericentromeric
MSAT3 repeat region (Figure 6D), as expected from the analysis
in murine cells [21]. At the 59UTR amplicon of the Oct-25 gene,
H4K20me3 was significantly enriched compared to the control
genes GAPDH (p= 0.0155), thra (p = 0.0103) and thibz
(p = 0.0128) (Figure S14A and Figure 6D). In a second set of
experiments, we compared the abundance of H4K20me3 between
wild-type and xSuv4-20h double-morphant embryos (Figure 6E).
In morphants, the modification was selectively reduced at the
59UTR amplicon of Oct-25 (p = 0.004). Together, these ChIP
experiments validate the 59 end of the Oct-25 gene as direct target
of xSuv4-20h mediated transcriptional silencing.
Xenopus Oct-25 has been implicated in germ layer formation
[32,34]. We wanted to know, whether the sustained expression of
Oct-25 in xSuv4-20h morphants could cause the observed
downregulation of early neural plate and neural differentiation
markers. This question is difficult to address, since the role of Oct-25
in neural induction is ambiguous - both overexpression and
morpholino knockdown inhibit neural differentiation [32,34]. Thus,
Oct-25 acts in pleiotropic fashion, perhaps switching target genes or
protein interaction partners. In a previous report [38], human Oct4
protein was shown by ChIP analysis to bind to promoters of early
neural markers, including Zic and Sox genes. In order to link
Xenopus Oct-25 mechanistically to these genes, we have mis-
expressed constitutively activating and repressing Oct-25 fusion
proteins in animal caps (Figure S15A). Zic1, Zic3 and Sox2
responded to the Oct-25 variants in a manner consistent with direct
regulator/target gene interaction, i.e. they were hyperactivated by
Oct-25-VP16 (p= 0.0143; 0.0456; 0.01622, respectively) and
suppressed by Oct-25-EnR (p=0.0236; 0.0167; 0.0231, respective-
ly) compared to the uninjected sample. In line with this assumption,
inspection of the X. tropicalis gene sequences detailed the presence of
multiple Oct-25 DNA binding motifs within 2.0 Kb distance from
the transcriptional start site for each of these genes (Figure S16). For
the two Zic genes, which are misregulated in the forming neural
plate of morphant embryos (Figure 3C and Figure S5F), we
confirmed the misregulation by Oct-25 variants via RNA in situ
hybridisation (Figure S15B).
Interestingly, Sox2 expression was affected only in AC explants,
but not in the double morphant embryos. This can be explained
by considering two points: First, in animal caps levels and activities
of the injected Oct-25 protein variants most likely exceed
endogenous Oct-25 protein activity and regulate Sox2 expression
in a dominant fashion. Secondly, formation of neural tissue in the
embryo requires inductive influences including FGF signalling
[39],and Sox2 transcription is stimulated by FGF8 [27], which is
normally expressed in the mesoderm. Thus, the stimulating
influence of FGF signalling on Sox2 transcription in the embryo
may neutralize the repressive influence from deregulated Oct-25
expression, while the repressive activity of the deregulated Oct-25
levels prevails in animal caps in the absence of FGF signalling.
The remaining genes either failed to respond to one of the two
Oct-25 protein variants (Zic2, Xiro1), or did not respond (Ngnr 1a,
N-tubulin). These observations suggest an indirect effect. While it is
possible that additional factors that are misregulated in xSuv4-20h
Figure 5. In vitro induction of xSuv4-20h double-morphant
animal cap explants. (A) Noggin-dependent neuralisation. XK81,
Nrp1 and Xbra expression is monitored in uninjected control caps and
double-morphant caps with or without Noggin mRNA. Note that
explants coinjected with xSuv4-20h MOs together with Noggin mRNA
show reduced Nrp1 expression, but normal downregulation of XK81
mRNA. (B) Muscle induction by Activin A in uninjected, ctrl-MO injected,
and xSuv4-20h double morphant animal caps. Top row demonstrates
comparable expression of myosin heavy chain (MHC-a) in non-dissected
sibling embryos.
doi:10.1371/journal.pgen.1003188.g005
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Figure 6. xSuv4-20h double morphants fail to silence Oct-25 expression in deep-layer ectoderm due to reduced H4K20me3
enrichment at Oct-25 promoter. RNA in situ hybridization analysis for Oct-25, Oct-60 and Oct-91 in embryos (A) and animal caps (B) for ctrl-
morphants or xSuv4-20h double-morphant embryos, injected unilaterally at two-cell stage and fixed at midneurula stage (NF15). Injected sides were
defined by coinjected Alexa-fluorescence prior to in situ hybridisation. (A) Dorsal views of stained embryos with anterior to the left. For Oct-25
Vibratome cross-sections, ctrl-MO and double-morphant embryos are shown. (B) Comparative expression analysis for Oct-25, Oct-60 and Oct-91 in
animal caps from bilaterally injected embryos, fixed at midneurula stage (NF15). (C) qRT-PCR profiles for Oct-25 and Oct-91 in ctrl-MO and xSuv4-20h
double-morphant embryos. Data represent normalized ratios of mRNA levels as means of four independent experiments, error bars indicate SEM. (D,
E) Chromatin immunoprecipitation (ChIP) analysis on Oct-25, GAPDH, thra, thibz genes and major satellite repeat region 3 (MSAT3). (D) H4K20me3
levels on the indicated genes in normal embryos, and (E) in uninjected versus double-morphant embryos. Fold enrichment was calculated as the ratio
between H4K20me3 precipitated material over negative control (No antibody sample). Data represent mean values of three to five independent
experiments, error bars indicate SEM.
doi:10.1371/journal.pgen.1003188.g006
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morphants contribute to the neural phenotype, the combined results
from ChIP experiments and Oct-25 variants define a pathway, in
which xSuv4-20h enzyme dependent repression of Oct-25 is needed
during gastrulation for proper neuroectoderm differentiation.
Deregulated Oct-25 expression in xSuv4-20h double
morphants inhibits neural differentiation
To further analyse the mechanistic interaction between xSuv4-
20h enzymes and Oct-25, we performed rescue experiments with
triple-morphant embryos, in which synthesis of Oct-25 and xSuv4-
20h proteins was simultanously blocked (Figure 7). The Oct-25
morpholino that we used has been shown before to inhibit
efficiently Oct-25 translation from both non-allelic gene copies
[40]. Because global Oct-25 depletion inhibits the formation of
anterior neural structures [40], we employed two different
strategies for the triple-knockdown to circumvent this problem.
In a first series of analysis we injected a single A1 blastomere of 32-
cell stage embryos to target cells that predominantly contribute to
the retina and brain. Also in this experimental series, the
morphology of double morphant eyes was strongly affected
(Figure 7A). 71% of the injected embryos showed a clear reduction
of retinal pigment, the remainders often restricted to the dorsal-
most portion of the eyecup. The majority of the eyes contained no
lens (Figure 7C). When the downregulation of xSuv4-20h enzymes
was coupled to a concomitant knockdown of Oct-25 (triple
morphants), the percentage of embryos showing this defect was
reduced to 49% (p= 0.0188, Fisher’s exact test). The retinal
pigment was rescued in the triple morphants, whose eyes also
regained a properly structured lens (Figure 7C). To confirm the
morphological phenotypes, we investigated the basal neural gene
expression in AC explants. The expression of a subset of genes
involved in the establishment of the neural plate state (Zic1, Zic2,
Xiro1, Sox2 and Sox3) was strongly reduced upon downregulation
of xSuv4-20h enzymes at early neurula (NF14-15), compared to
uninjected animal caps (p = 0.0068; p = 0.0127; p = 0.0113;
p = 0.0321; p = 0.0037, respectively). With the exception of
Sox2, the simultaneous downregulation of xSuv4-20h enzymes
and Oct-25, rescued neural gene expression. In fact, under the
triple morphant condition most of these genes were expressed at
higher levels than normal, suggesting that they are partly repressed
by Oct-25 in unmanipulated explants (Figure 7D). Most impor-
tantly, the combined results of the two triple-knockdown
experiments indicate that both morphological and molecular
features of the xSuv4-20h double morphant phenotype can be
rescued to a significant extent by reducing Oct-25 protein levels.
This result firmly establishes that the sustained and elevated
expression of Oct-25 protein is responsible for the neural
differentiation defect of xSuv4-20h double-morphant embryos.
Murine Suv4-20h1/h2 double-knockout ES cells have
elevated Oct4 levels in undifferentiating and
differentiating conditions
Oct-25 plays multiple roles during early frog development,
including interference with Activin/BMP-dependent mesendo-
derm formation before gastrulation, and with neural induction
during gastrulation [32,34]. A similar role is considered for its
mammalian paralog Oct4, which is required for the pluripotent
state of ES cells, but antagonizes ectodermal differentiation as soon
as these cells exit pluripotency [30,41,42]. Although previous
genome-wide studies of histone modifications in mammalian cells
have not detected H4K20me3 on the Oct4 gene [36,37], this
apparent similarity made us investigate Oct4 protein expression in
wild-type and Suv4-20h1/h2 DKO murine ES cells. We tested
two independently derived DKO cell lines (B4-2 and B7-1), and
compared them with two wild-type controls, i.e. wt26, an isogenic
ES cell line, and the well-characterized GSES-1 cell line [43]. All
four cell lines formed comparable ES cell colonies in LIF-
containing medium (Figure 8A and Figure S17B), although the
two DKO lines grew slightly slower. Upon aggregation they
formed embryoid bodies, which were clearly smaller than those of
the wild-type lines, both at day 2 and day 6 of differentiation
(Figure 8A and Figure S17). After replating the differentiated cells
for one day, the two DKO lines frequently formed again colonies
resembling undifferentiated ES-cells (day 7 in Figure 8A and
Figure S17B). To obtain a quantitative measure of Oct4 gene
expression, we fixed and stained the four cell lines before (day 0)
and during (day 6) differentiation for Oct4 protein and subjected
equal cell numbers to FACS-analysis. The Oct4 signals were quite
similar between wt26 and GSES-1 cells, as they were between the
two DKO lines. In contrast to the wild-type cell lines, however, the
signals of the DKO lines were reproducibly shifted to the right
(Figure 8B and Figure S17C). Based on normalized median
fluorescence intensity, the two DKO lines contained approxi-
mately three-fold higher Oct4 protein amounts than the wild-type
lines at day 0 (p= 0.00604), and still two-fold more at day 6
(p = 0.01266) (n = 3; Figure 8C and Figure S17B). We conclude
that Oct4 expression is being reduced during differentiation in
Suv4-20h1/h2 DKO cells. However, these cells have higher Oct4
levels in the undifferentiated state, and maintain higher levels
during differentiation in comparison to wild-type cells.
Oct4 protein levels are known to be tightly regulated [1] and to
influence lineage decisions during ES cell differentiation [41,42].
We therefore investigated the biological significance of the
elevated Oct4 protein levels in Suv4-20h DKO ES cell lines.
Unfortunately, the applied EB differentiation protocol promotes
predominantly mesendodermal differentiation, which prevented
the analysis of neural markers. Nevertheless, we performed FACS
analysis on wt and Suv4-20h DKO cell lines stained for the
chemokine receptor 4 (CXCR4) protein, whose expression
indicates mesendoderm induction in embryoid bodies. At day 6
of differentiation, wt cell lines showed a robust increase in CXCR4
positive cells compared to day 0 (Figure 8D and data not shown).
In contrast, both Suv4-20h DKO cell lines contained a
significantly lower percentage of CXCR4 positive cells at day 6
when compared to the wild type cell lines (p = 0.03255; Figure 8).
We also noted that replated wt cells frequently formed autono-
mously beating areas at differentiation day 14 (see Video S1),
indicating functional cardiomyocyte formation, while contracting
areas were never observed in the Suv4-20h DKO cells (Video S2;
n = 4 experiments). Finally, qRT-PCR analysis indicated a
reproducible and statistically significant shift in mesendoderm
gene expression in the DKO ES cells, which show enhanced
induction of FoxA2 (p = 0.00706) and reduced levels of Gata4
(p = 0.00037), compared to the wt ES cell lines (Figure S17D).
Together, these results reveal a compromised and biased
differentiation capacity for Suv4-20h DKO ES cell lines, and
provide an entrypoint for further experimentation in the murine
system.
Discussion
In this study, we have investigated the developmental functions
of the histone- methyltransferases Suv4-20h1 and h2 during frog
embryogenesis, which are responsible for the establishment of the
H4K20 di- and trimethylated states. These modifications have
been implicated in heterochromatin formation, DNA damage
repair and G1/S-transition [21,24] and are also involved in
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Figure 7. Oct-25 knockdown in double-morphant embryos rescues xSuv4-20h phenotypes. (A) Schematic illustration of targeting
microinjections of tadpoles injected into the A1 blastomere at 32-cell stage, and morphological phenotypes of representative embryos (NF35-37)
from cohorts injected with Alexa, xSuv4-20h MOs (double morphants) and double morphants plus Oct-25 MO. (B) Penetrance of the eye phenotype.
Data from three independent experiments; n = total number of embryos scored. (C) Vibratome cross-sections of representative embryos injected as in
panel (A). (D) qRT-PCR profiles for the indicated genes in double morphants and double morphants plus Oct-25 MO animal cap explants at NF 14–15.
Data represent normalized mRNA levels as mean of three to four independent experiments; error bars indicate SEM. (E) Model for Xenopus Suv4-
20h1/h2 enzyme function during neuroectoderm differentiation. A global increase in H4K20me3 reduces widespread Oct-25 expression in the animal
emisphere during gastrulation as a prerequisite for neural induction. In H4K20me3 depleted morphant embryos, Oct-25 expression persists in the
ectodermal stem cell compartment (sensorial cell layer), interfering with the transcriptional activation or activities of key regulators of the neural plate
state and neurogenesis. Additional genes that are deregulated like Oct-25 in xSuv4-20h morphant embryos, may also contribute to impaired
ectoderm differentiation.
doi:10.1371/journal.pgen.1003188.g007
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transcriptional regulation [44,45]. Our experiments identify a
specific and selective role of xSuv4-20h HMTases in the formation
of the ectodermal germlayer through control of mRNA expression
of key regulators of the neural plate state and neuronal
differentiation circuits. Indeed, our results indicate for the first
time that H4K20me3 controls transcription in a rather gene-
specific manner. The mRNA profile of double morphant embryos
shows appr. 6% of the annotated probesets to be misregulated,
when H4K20me3 levels have been reduced to appr. 25%. About
half of the responding mRNAs are transcriptionally upregulated
and, thus, their genes may qualify as being directly controlled by
H4K20me3 deposition. Surprisingly, our molecular analysis
revealed that xSuv4-20h enzymes are required to restrict the
expression of the pluripotency-associated Oct-25 gene during
gastrula and neurula stages. In the absence of proper H4K20me3
deposition, the Oct-25 gene becomes transcriptionally derepressed
and interferes with neural differentiation. The successful rescue of
key morphological and molecular aspects of the neural defect in
double-morphant embryos by the simultanous inhibition of Oct-
25 translation establishes this pathway formally. At least in
Xenopus, the regulatory interaction between xSuv4-20h enzymes
and Oct-25 is needed for embryonic cells to exit the pluripotent
state and differentiate as neuroectoderm.
The genetic interaction between Suv4-20h enzymes and POU-
V genes appears also to be conserved in mouse ES cells, although
the H4K20me3 mark has not yet been detected on the Oct4 gene
locus. To this point, we have shown that Suv4-20h DKO ES cells
contain significantly elevated Oct4 protein levels, compared to wt
ES cells. During ES cell differentiation the mammalian Oct4 gene
is known to become repressed by a battery of epigenetic
mechanisms including DNA methylation, incorporation of somatic
linker histones and repressive histone modifications (H3K9me3/
H3K27me3), which cooperate to achieve chromatin compaction
of the Oct4 gene locus [46]. Our finding that Oct4 protein levels
are increased in the DKO ES cells both before and during
differentiation actually suggests that Suv4-20h enzymes regulate
mammalian Oct4 transcription in a way that is at least partly
independent from the other repressive mechanisms targetting this
locus.
Our results in Xenopus rest predominantly on loss of function
analysis, achieved by morpholino-mediated knockdown of endog-
enous xSuv4-20h protein translation. Specifically, we have shown
that our antisense oligonucleotides block translation of xSuv4-
20h1 and h2 isoforms in vitro, and significantly decrease
H4K20me2 and –me3 levels in vivo, without altering the bulk
Figure 8. Suv4-20h double-null ES cells have elevated Oct4 and
lower CXCR4 protein levels before and during differentiation.
Wild-type and Suv4-20h DKO ES cells were grown undifferentiated in
LIF-containing medium, or differentiated in vitro by embryoid body
formation. Wt26 - isogenic wild-type ES cell line; B4-2, B7-1 –
independent Suv4-20h DKO ES cell lines. (A) Morphological appearance
(scale bar 100 mm). Top row: undifferentiated ES cells (day 0); middle:
embryoid bodies at day 6; bottom: cells from embryoid bodies, replated
for 24h. (B) Before (day 0) and during (day 6) differentiation, cell lines
were stained for Oct4 protein and 26104 cells from each condition were
subjected to FACS analysis. Red graph: fluorescence of non-specific
isotype control; black and green graphs represent the Oct4 protein
levels in wild-type and Suv4-20h DKO ES cell lines, respectively. (C)
Suv4-20h DKO cells have higher Oct4 protein levels compared to wild-
type ES cells and maintain these during differentiation. Median
fluorescence intensity was calculated from data in panel (B), error bars
indicate SEM. (D) Suv4-20h DKO cells show a reduction in the
percentage of CXCR4 + cells at differentiation day 6. Data represent
normalized values of percentage of CXCR4+ cells as means of three
independent experiments, error bars indicate SEM.
doi:10.1371/journal.pgen.1003188.g008
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abundance of other repressive histone marks such as H3K9me3
and H3K27me3. The morpholinos produced specific phenotypes,
which were rescued on the morphological and molecular level by
RNA-born co-expression of heterologous xSuv4-20h enzymes and,
thus, originate from deficient H4K20me2/me3 states.
While xSuv4-20h double morphant embryos showed consistent
phenotypes at high penetrance, we were surprised to see that
H4K20me2 and –me3 states could be quantitatively increased in
frog embryos without any obvious morphological or molecular
consequences (Figures S8 and S9). This result can be explained
considering first of all the higher stability of the knockdown by
non-degradable morpholinos compared to the transient protein
upregulation by RNA injection; secondly, demethylation of
higher-methylated states may occur rather rapidly through
H4K20me2 and me3 demethylases at specific sites, where
H4K20me1 is required, e.g. Wnt/b-Catenin inducible genes
[47]. However, we did not observe evidence for compromised
transcription of Wnt target genes under overexpression (Figures S8
and S9) or morphant condition (Figure S5). Since mono- and
dimethylated H4K20 states are quite abundant modifications in
Xenopus embryos (30–40% each; see ref. [13]), it is most likely the
loss of H4K20 trimethylation, which interferes with normal
development.
XSuv4-20h double-morphant embryos were frequently defec-
tive for eye and melanocyte differentiation, indicating a prominent
impairment of neuroectodermal differentiation. This selectivity is
surprising, given that the two HMTases are expressed throughout
the entire embryo (Figure S2). As a matter of fact, the phenotypes
originate in the neuroectoderm, as shown by targeted injection
into animal or vegetal blastomeres of 8-cell stage embryos
(Figure 4). A large panel of marker genes that were investigated
by RNA in situ hybridisation indicates that mesodermal and
endodermal gene expression patterns are not perturbed by xSuv4-
20h enzyme depletion (Figure 3A). This includes markers, which
are required for specification of embryonic axes and formation
and patterning of the mesendodermal germlayers (Figure S5). We
also note that morphant animal cap explants were refractory to
Noggin-dependent neural induction, but could be induced to
differentiated skeletal muscle by a mesoderm inducing signal
(Figure 5). We therefore assume that a major function of xSuv4-
20h enzymes lies in the transcriptional control of genes that
coordinate and execute neuroectodermal differentiation. Consis-
tent with this hypothesis, many of the genes that we found
downregulated in xSuv4-20h morphants, are key regulators of eye
development (Rx-1, Pax-6), neuronal differentiation (Ngnr 1a,
Delta-like 1) or regulators of neural competence and neural plate
state (Zic-1, -2, -3, Xiro-1, Nrp1, N-CAM; [27]).
While these molecular results explain the overt morphological
phenotypes in a consistent manner, it should be noted that these
HMTases are clearly involved in additional cellular aspects. The
mild reduction in mitotic cells and the increased apoptotic rate of
morphant embryos (Figure S10) is reminiscent of findings in Suv4-
20h1/h2 DKO MEFs, which are less resistant to DNA damage
and compromised at the G1/S checkpoint [24]. The data reported
here indicates a need for deeper analysis of the regulatory impact
of Suv4-20h enzymes on transcription in both mammals and non-
mammalian vertebrates.
According to current models, xSuv4-20h enzymes mediate
transcriptional repression, based on the enrichment of the
H4K20me3 mark on heterochromatic foci. Genes that are
regulated by these enzymes should therefore become derepressed
under loss of function condition. Following this logic, many of the
genes, which are misregulated in morphant frog embryos, would
be classified as indirect targets, since they were downregulated.
One very notable exception, which we have validated as direct
target, is Oct-25 (Figure 6). Oct-25 is induced broadly in the
animal hemisphere at the blastula/gastrula transition, before it
becomes restricted to the notoplate at neurula stages [31]. Oct-25
plays multiple roles during early frog development, including
interference with Activin/BMP-dependent mesendoderm forma-
tion before gastrulation, and with neural induction during
gastrulation [31,32,34]. Our study reveals now a new function
for Oct-25, namely to control the transit from a pluripotent cell to
a neural cell that differentiates, when Oct-25 expression has faded.
As depicted in our model (Figure 7E), this function depends on the
precise dose and duration of Oct-25 transcription, which is
controlled by the level of H4K20me3 deposition on the first exon
of the Oct-25 gene through xSuv4-20h enzymes. As we have
shown here, deregulated transcription of Oct-25 in double-
morphant embryos elicits massive consequences on the differen-
tiation of neuroectodermal organs and cell types. We have traced
back the origin of the malformations to the gastrula stage, when a
gene network, defining the neural state, become perturbed by Oct-
25. Some members of this network are good candidates for direct
regulation through Oct-25 (e.g. Zic and Sox genes). However,
since Oct-25 transcription persists ectopically at least until the
mid-neural fold stage in the ectoderm, subsequent gene cascades
involved in regional differentiation of the neuroectoderm could
also be directly misregulated by Oct-25.
The specific and selective deregulation of Oct-25 transcription
in a precise spatial domain, i.e. the sensorial cell layer of the
ectoderm, implies a very intriguing role for xSuv4-20h enzymes.
This domain contains not only the uncommitted precursors of
neuronal and epidermal cell types, but – with regard to the
involuting marginal zone – includes also mesodermal and
endodermal precursor cells. The observed derepression of Oct-
25 in this domain may thus reflect a conserved mechanism, by
which Suv4-20h enzymes control pluripotency in the embryo. As
discussed above, we have found Oct4 protein to be increased in
two independent Suv4-20h double knockout ES cell lines under
LIF-maintained self-renewal conditions, when compared to wt ES
cells (Figure 8 and Figure S17). The DKO cell lines also maintain
higher Oct4 levels during differentiation than wt ES cells, although
their Oct4 levels get diminished in the course of 6 days. Recent
data from several labs suggest that the pluripotency regulators
Sox2 and Oct4 guide ES cells towards specific germ layer
differentiation programs, when they exit the pluripotent state
[41,42]. Indeed, our findings are in agreement with Thomson and
colleagues, who describe Oct4 to antagonize ectodermal specifi-
cation and to direct mesendodermal cell fate decisions. The
conserved Suv4-20h-dependent restriction of Oct4 expression may
thus contribute to the germ-layer specification of embryonic cells,
when they exit the pluripotent state.
Materials and Methods
Ethics statement
Animal work has been conducted in accordance with Deutsches
Tierschutzgesetz; experimental use of Xenopus embryos has been
licensed by the Government of Oberbayern (Projekt/AK ROB:
55.2.1.54-2532.6-3-11).
Expression constructs and in vitro transcription
Full length X. laevis Suv4-20h1a (NM_001092308) and Suv4-
20h2a (NM_001097050) cDNAs in pCMV-SPORT6 were
provided by ImaGenes. Capped mRNAs were synthesized in vitro
with SP6 RNA-Polymerase after HpaI linearization. Both cDNAs
were subcloned via XhoI/EcoRI sites into pBluescript II KS to
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generate digoxygenin-labelled antisense probes with T3 RNA-
Polymerase. Xenopus Bcl-2, Oct-25-VP16 and –EnR constructs
were transcribed with SP6 RNA-Polymerase from NotI- (Bcl-2
and Oct-25-VP16) and SacII- (Oct-25-EnR) linearized pCS2+
plasmids, respectively. Mouse Suv4-20h1 and h2 enzymes were
transcribed with SP6 from PvuI-linearized pCMVmyc-constructs
[24]. Enzymatically inactive mouse Suv4-20h HMTases were
generated via PCR-mutagenesis (see Text S1, Table S1 for
primers). Synthetic mRNAs were injected in the animal pole of
two-cell stage embryos at 2, 3 or 4ng per embryo. Rescue
experiments with wt and mutated mRNAs were performed with
3ng of a 1:1 mix of wt or mutated Suv4-20h1 and h2 mRNAs,
injected into the animal pole of a single blastomere at two-cell
stage. Xenopus Bcl-2 mRNA was injected unilaterally in the
animal pole of two-cell stage embryos at 800 pg per embryo.
Xenopus Oct-25-VP16, -EnR mRNAs were injected in the animal
pole of two-cell stage embryos at 100 pg per embryo.
Cell culture, microscopy, and FACS analysis
Mouse embryonic fibroblasts (MEF) wild type and Suv4-20h
DKO cells [24] were cultivated in High Glucose DMEM with L-
Glutamine and sodium pyruvate, complemented with 10% FCS,
b-mercaptoethanol, non essential amino acids and penicillin/
streptomycin in a 37uC incubator at 5% CO2. Lipofectamine 2000
(Invitrogen) was used for the transfection of plasmid DNAs.
Immunofluorescence analysis was performed as described in the
Text S1.
Mouse ES cells were cultivated on gelatinized plates in High
Glucose DMEM with L-Glutamine and sodium pyruvate,
complemented with 15% FCS, 0.1 mM ß-mercaptoethanol, non
essential amino acids, penicillin/streptomycin and LIF. Cells were
maintained at 37uC in a humidified atmosphere of 5% CO2. ES in
vitro differentiation and FACS analysis were carried out as
described [43] The incubation steps with the primary Oct4 (1:250,
Abcam) or CxCR4 (1:50, BD Pharmingen) antibody and
subsequently a FITC-conjugated secondary antibody (1:250,
Invitrogen) were performed at RT for 45 min with two washing
steps after each antibody incubation. For the isotype controls
purified, IgG was used instead of the Oct4-antibody. All FACS
analyses were performed with an Epics XL (Beckman-Coulter)
using the analysis software FlowJo.
Morpholino oligonucleotides
Translation-blocking Morpholino oligonucleotides targeting
Xenopus Suv4-20h1 (X.laevis and X.tropicalis: 59-GGATTCGCC-
CAACCACTTCATGCCA-39), Xenopus Suv4-20h2 (X.laevis: 59-
TTGCCGTCAACCGATTTGAACCCAT-39: X.tropicalis: 59-
CCGTCAAGCGATTTGAACCCATAGT-39) and Xenopus
Oct-25 (X.laevis: 59-TTGGGAAGGGCTGTTGGCTGTACAT-
39) mRNAs were supplied by Gene Tools LLC. Each Morpholinos
recognizes the two non-allelic isoforms of each gene in X.laevis (see
Figure S3A, S3B). GeneTools’ standard control Morpholino was
used to monitor non-specific effects. Morpholino activity was tested
by in vitro translation (SP6-TNT Kit, Promega), adding 2 pg of
control Morpholino or 1 pg of Suv4-20h1 and/or h2 Morpholinos
per TNT reaction. Unless stated otherwise, embryos were injected
at a dose of 60–80 ng per embryo (30–40 ng each of Suv4-20h1 and
h2Morpholinos, or 60–80 ng control Morpholino per embryo). For
8-cell stage experiments, morpholinos were injected in two
neighbouring, animal or vegetal blastomeres on one side of the
embryos, at half the dose (i.e. 40 ng total). For morphogical epistasis
experiments, Xenopus Suv4-20h1 and h2 Morpholinos (5 ng each
per embryo) and Oct-25 Morpholino (1 ng per embryo) were
injected into A1 blastomere at 32-cell stage.
Embryo handling
Xenopus laevis eggs were collected, fertilized in vitro, and handled
following standard procedures; embryos were staged according to
Nieuwkoop and Faber (1967). The embryos were injected with
maximally 10 nl volume. When required, they were sorted into left
side or right side injected cohorts before fixation, based on the
coinjected lineage tracer Alexa Fluor-488 Dextran (Invitrogen).
Alkaline-phosphatase stained and refixed embryos were either
sectioned after embedding in paraffin (10 mm), or in gelatine/
albumin mixture supplemented with 25% glutaraldehyde before
sectioning (30–50 mm) with a Vibratome 1000 (Technical Products
International, INC.) as described [48]. Animal caps were manually
dissected at NF9 and transferred singly into wells of a 96-well
plate, coated with 1% agarose and filled with 1X Steinberg’s
solution, 0.1% BSA with or without Activin A (1:10 diluted
conditioned cell culture supernatant). For neural induction,
embryos were injected into the animal pole with Noggin mRNA
(60 pg per embryo) alone or together with xSuv4-20h1 and h2
morpholinos (40 ng each per embryo) at two- to four-cell stage.
For mesoderm induction, embryos were injected animally 4 times
with 2.5 nl of control morpholino (80 ng per embryo) or a mix of
xSuv4-20h1 and h2 morpholinos (40 ng each) at two or four cell
stage. For Oct-25-VP16 and –EnR overexpression experiments,
embryos were injected animally 4 times with 2.5 nl of each
mRNAs (100 pg per embryo). For epistasis experiments on animal
caps, embryos were injected 4 times with 2.5 nl of xSuv4-20h1 and
h2 Morpholinos (40 ng each per embryo) and Oct-25 Morpholino
(30 ng per embryo) at two or four cell stage.
Analysis of histone modifications in Xenopus embryos
Nuclei extraction from Xenopus embryos and mass spectrom-
etry analysis of histone modifications were performed as described
[13]. Histone marks were quantitated as relative abundances of a
specific modification state as a fraction of the amount of all
modifications found for this peptide (for details see ref 13).
RNA in situ hybridization and immunocytochemistry
Whole-mount RNA in situ hybridizations were performed as
described (Sive et al. 2000). Embryos were photographed under
bright light with a Leica M205FA stereomicroscope. The following
antibodies were used for immunocytochemistry: H3S10P antibody
(1:300, Upstate Biotechnology), active Caspase3 antibody (1:500,
Promega), and myosin heavy chain antibody MF20 (1:100
hybridoma cell culture supernatant), anti-mouse or anti-rabbit
alkaline phosphatase-conjugated secondary antibodies (1:1000,
Chemicon).
Western blots and immunostaining
Embryonic histones were purified via acidic extraction of nuclei
as described [13], size-separated by SDS-PAGE and blotted onto
PVDF membranes (Roth). Membranes were blocked with 3%
BSA (Roth) in PBS and subsequently incubated o/n at 4uC with
polyclonal rabbit antibodies against H4K20me1 (1:6000),
H4K20me2 (1:1000), H4K20me3 (1:500) [21,24] and pan H3
(1:25000, Abcam). Infrared (IR) 680 or 800 conjugated Goat anti
Rabbit IgG (1:5000, Li-Cor) were used as secondary antibodies
(incubation o/n at 4uC). Signals were detected with an ODYSSEY
Infrared Imaging System. To extract exogenous myc-tagged fusion
proteins embryos were treated as described in the Text S1.
Proteins were separated by SDS-PAGE, BSA-blocked PVDF
membranes were incubated o/n at 4uC with anti-myc 9E10
antibody (1:50), followed by anti-mouse HRP- conjugated
antibody (1:3000, Jackson Immunoresearch). Proteins were
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detected with ECL plus western blotting detection reagents (GE
Healthcare). Histological sections were stained with pan H3
(1:2000, Abcam), H4K20me1 (1:5000), H4K20me2 (1:2000),
H4K20me3 (1:5000) antibodies [24].
Quantitative RNA analysis
Total cellular RNA was isolated with TRizol (Qiagen) and
phenol/chloroform extraction. On-column RNA clean-up, in-
cluding a DNAse digestion step, was performed using RNeasy-
Mini-Kit (Qiagen). Samples for qRT-PCR and microarray
profiling were collected as described in the Text S1.
Microarray expression analysis
Microarray data were processed using R/Bioconductor (www.
bioconductor.org). If not indicated otherwise, we used standard
parameters in all functions calls. Expression values were calculated
using ‘gcrma’. Probe sets were kept for differential expression
analysis if there were more ‘present’ calls (calculated using
‘mas5calls’) in one of the treatment groups than non-‘present’
calls, if their expression level variance was higher than 0 across all
arrays and if the probe set had an Entrez identifier annotation
according to the Entrez database with a date stamp of 2011-
Mar16. One gene to many probe set relationships were resolved
by retaining only the probe set with the highest variance across all
arrays. Differential expression statistics were obtained using a
linear model (library ‘limma’). A significant response was defined if
the local false discovery (‘locfdr’ package) rate calculated on the
moderated t statistic was smaller than 0.2. The data discussed in
this publication have been deposited in NCBI’s Gene Expression
Omnibus and are accessible through GEO Series accession
number GSE41256 (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE41256).
ChIP experiments
ChIP experiments were performed using Xenopus tropicalis as
described [49], with minor changes (see Text S1 for details).
Identification of Oct-25 binding sites
A published weight matrix (PMID:17567999) was used to scan
2 kb upstream regions of selected X. tropicalis genes (Xenbase
version 7.1) for binding site occurrence. Scanning was performed
using RSA matrix-scan (PMID:18802439) with default parame-
ters.
Supporting Information
Figure S1 Xenopus laevis versus Mus musculus Suv4-20h proteins
sequence alignment. Amino acid sequence alignment for Mus
musculus (Refseq. NM_001167885.1) versus Xenopus laevis Suv4-20h1
(Refseq. NM_001092308) (A) and Mus musculus (Refseq.
NM_146177.2) [24]versus Xenopus laevis Suv4-20h2 (Refseq
NM_001097050) proteins (B). (C) Aminoacid sequence conserva-
tion (% identity) of the SET domain between mouse and Xenopus
proteins.
(PDF)
Figure S2 Xenopus laevis Suv4-20h expression during early
development. XSuv4-20h1 (A) and xSuv4-20h2 (B) mRNA
expression was detected by RNA in situ hybridization at the
indicated developmental stages. (C) Total RNA was extracted
from animal cap (AC), marginal zone (MZ) and vegetal pole (VP)
explants of NF9 embryos; semiquantitative PCR shows relative
levels of xSuv4-20h1 and xSuv4-20h2 transcripts in the three
explants. ODC was used as loading control, -RT as negative
control. (D) qRT-PCR profiles of xSuv4-20h enzymes. The chart
shows the expression of the two enzymes relative to ODC at the
indicated developmental stages.
(PDF)
Figure S3 Morpholino specificity. 25-mer xSuv4-20h1 mor-
pholino (A) and xSuv4-20h2 morpholino (B) oligonucleotides
perfectly target to the start codon of the respective two non-
allelic isoforms. Sequence differences between the two morpho-
linos confer specificity of each oligonucleotide for either xSuv4-
20h1 or xSuv4-20h2 mRNA. (C) In vitro TNT assay performed
as described in Materials and Method section. xSuv4-20h1 and
h2 MOs specifically inhibited translation of their cognate
templates.
(PDF)
Figure S4 Quantification of histone methylation states in xSuv4-
20h morphants by MALDI-TOF mass spectrometry. Bulk histones
from NF30-33 embryos were isolated and analysed as described in
Materials and Methods. (A) H4 peptide 20–23, (B) H3 peptide 9–
17 and (C) H3 peptide 27–40 in uninjected, ctrl-MO and double
morphant embryos. The values represent mean of three
independent experiments; error bars indicate SEM. Star - for
technical reasons H4K20me3 mark was quantitated only in some
samples (star). (D) Western Blot analysis of uninjected, control
morpholino (ctrl-MO) and xSuv4-20h1, h2 morpholino injected
embryos using antibodies against H3K27me3 and H3K9me3.
PanH3 antibody was used as loading control.
(PDF)
Figure S5 Germ layer marker gene expression in xSuv4-20h
double morphants. (A) Immuno-histochemistry on ctrl-MO and
xSuv4-20h double-morphant tadpoles. Panels show representa-
tive cross-sections of neural tubes stained with antibodies against
the histone epitopes indicated on top. Inj – injected side. Squares
on double-morphant sections represent the croped pictures
shown in Figure 1D. (B-F) RNA in situ hybridization analysis of
ctrl-MO injected and double morphant embryos at the indicated
stages using probes against Chordin, Xnr-3 and Gooscoid (B),
Krox20 and Otx2 (C), Pax-6 (D), N-CAM (E), FoxD5, Geminin,
Zic2, Zic3, Sox3, Sox11 and VegT (F). Chordin, Xnr-3 and
Gooscoid – dorsal side views; animal pole is on the top. Krox20 -
dorsal views, anterior on the left. Otx2 - anterior views, dorsal on
the top. Pax-6 – head region; rescued embryos included. N-CAM
- dorsal views of stained embryos with the anterior on the left;
rescued embryos included. FoxD5, Geminin, Zic2, Zic3 - dorsal
views; injected halves are lineage-traced by coinjection of LacZ
mRNA and subsequent b–Gal staining (light blue). Sox2, Sox3 -
dorsal views, anterior to the left. VegT - internal stain in bisected
embryos.
(PDF)
Figure S6 Functional SET domains are required for proper
Suv4-20h activity. (A) Schematic of Mus musculus Suv4-20h1 and
h2 SET domain mutations. (B) Immunofluorescence of wild-type
and Suv4-20h DKO MEFs transfected with the indicated
constructs. (C) Western Blot analysis of NF11.5 uninjected
embryos (lane 1), xSuv4-20h1, h2 double morphants (lane 2),
active and inactive mouse Suv4-20h1, h2 mRNAs injected
embryos (lane 3, 5 respectively) and double morphant embryos
cojnected with active or inactive mSuv4-20h1, h2 mRNAs (lane 2,
4 respectively), using antibodies against H4K20 mono-, di- and
trimethylation. PanH3 antibody was used as loading control. (D)
Anti-myc western blot with the same samples used in B. Asterisks
indicate unspecific bands.
(PDF)
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Figure S7 A functional SET domain is required for morpho-
logical and molecular rescue of double-morphants phenotypes. (A–
C) Morphological phenotypes of NF30-33 double morphants (A),
embryos injected with xSuv4-20h1, h2 morpholinos and active
(active rescue, B), or inactive (inactive rescue, C) mouse Suv4-
20h1, h2 mRNAs. Embryos were coinjected in one half at two cell
stage with Alexa Fluor 488 Dextran as lineage tracer (green
channel) to identify the injected side and sort embryos. (D)
Penetrance of the eye phenotype in the indicated samples.
Displayed are the results from two independent experiments. (E)
RNA In situ hybridization analysis of NF15 uninjected, double
morphants, active and inactive rescue embryos using probes
against Oct-25, N-tubulin and MyoD. The pictures show dorsal
view of stained embryos, anterior is on the left.
(PDF)
Figure S8 Xenopus laevis Suv4-20h1 or h2 mRNA overexpres-
sion. (A) Overexpression of frog Suv4-20h1 and h2 enzymes causes
an upregulation of H4K20me2 and H4K20me3 marks. Bulk
histones from uninjected embryos or embryos bilaterally injected
with increasing amounts of Suv4-20h1 or h2 mRNAs were isolated
at NF11.5 and analysed by Western blot. Pan H3 antibody was
used as loading control. (B, C) Morphological phenotypes of
NF30-33 embryos injected with xSuv4-20h1 (B) or h2 (C) mRNA.
(D) RNA In situ hybridization of NF30-33 uninjected embryos (top
row) and embryos injected with Suv4-20h1 (middle row) or h2
(bottom row) mRNA using probes against Rx-1 and Pax-6.
Pictures show the head of stained embryos. (E) RNA In situ
hybridization analysis of uninjected embryos (top row) and
embryos injected with xSuv4-20h1 (middle row) or h2 (bottom
row) mRNA using probes against Ngnr-1a, Delta-like 1, N-
tubulin, Xbra, MyoD, Sox17 a and Endodermin. Pictures show
dorsal views of stained embryos, anterior is on the left; Xbra
pictures show vegetal views of NF11 embryos; MyoD pictures
show dorsal views of NF15 embryos, with the head on the left. For
Sox-17 a and Endodermin sagittal sections of NF15 embryos were
created; pictures show internal view of the injected halves, with
anterior on the left.
(PDF)
Figure S9 Mus musculus Suv4-20h1 or h2 mRNA overexpression.
(A) Western Blot analysis of uninjected embryos or embryos
injected with Mus musculus Suv4-20h1 or h2 mRNAs at different
concentrations. Bulk histones from NF11.5 embryos were isolated
and analyzed as described in Materials and Methods section. Pan
H3 antibody was used as loading control. (B, C) Morphological
phenotypes of NF30-33 embryos injected with mouse Suv4-20h1
(B) or h2 (C) mRNA. (D) RNA In situ hybridization analysis of
uninjected embryos (top row) and embryos injected with mSuv4-
20h1 (middle row) or h2 (bottom row) mRNA using probes against
Ngnr 1a, Delta-like 1 and Rx-1. Rx-1 pictures show the head of
NF30-33 stained embryos. Ngnr 1a (NF12.5) and Delta-like 1
(NF13) pictures show dorsal view of stained embryos, anterior is on
the left.
(PDF)
Figure S10 Cell proliferation and apoptosis in xSuv4-20h
double morphants. (A) Double morphants show increased number
of apoptotic cells during neurulation. Top row – immunocyto-
chemistry for active Caspase3 in unilaterally injected embryos
(NF15). Middle and bottom rows - RNA in situ hybridisation for
Delta-like 1 (NF13) and N-tubulin mRNAs (NF15). Pictures show
dorsal views, with anterior to the left. (B) Proliferation assay –
immunocytochemistry for the mitotic histone modification
H3S10P in Crtl-MO versus double morphant embryos. The chart
shows a two-fold difference in the number of H3S10P positive cells
on the injected side of double morphants. Data represent mean
values of four embryos per condition from two independent
experiments; error bars indicate SEM.
(PDF)
Figure S11 qRT-PCR analysis. (A) Schematic representation of
mRNA purification from NF14-15 embryos for qRT-PCR
experiments. (B) qRT-PCR profiles for the indicated genes in
Ctrl-MO injected and xSuv4-20h double morphant embryos.
Data represent normalized ratios of mRNA levels as means of four
independent experiments, error bars indicate SEM.
(PDF)
Figure S12 Microarray analysis. (A) Schematic representing
mRNA purification from NF 14–15 embryos for microarray
experiments. (B) Pie-chart showing number of up- (green) and
down- (red) regulated genes. (C) Histogram summarizing the fold
expression change of the analysed 9752 active genes. Indicated in red
are responder genes (153up, 169 down). (D) Table presenting the 10
most upregulated genes. For each gene, the gene name, symbol, the
log fold change (logFC) and the fold change are indicated.
(PDF)
Figure S13 Oct-25 and N-tubulin gene expression in X.
tropicalis Suv4-20h double morphant embryos. RNA in situ
hybridization analysis of ctrl-MO injected and double morphant
embryos at neurula stage (NF14-15) using probes against Oct-25
and N-tubulin. The pictures show dorsal views of the open neural
plate with anterior to the left. Dashed line: embryonic midline.
(PDF)
Figure S14 Genes analysed by ChIP. (A) Schematic represen-
tation of the genes and the amplicons analysed in ChIP
experiments. Black boxes: exons; white boxes: untranslated
regions; line connecting boxes: introns. For each gene the position
of the amplicon(s) used in the experiments is indicated below the
gene structure. (B) qRT-PCR profiles for GAPDH and thra genes
in Ctrl-MO injected and xSuv4-20h double-morphant embryos.
Data represent normalized ratios of mRNA levels as means of five
independent experiments, error bars indicate SEM.
(PDF)
Figure S15 Regulation of early neural marker genes by Oct-25-
VP16 and Oct-25-EnR fusion proteins. (A) qRT-PCR on animal
cap (AC) explants cut from uninjected embryos and embryos
overexpressing Oct-25-VP16 or Oct-25-EnR mRNAs. The chart
shows the relative expression of the indicated genes compared to
H4 gene levels. Data represent normalized ratios of mRNA levels
as means of three or four independent experiments, error bars
indicate SEM. (B) In situ hybridization on uninjected AC or
explants overexpressing Oct-25-VP16/EnR for Zic1 (upper row,
206 magnification) and Zic3 genes (lower row, 506 magnifica-
tion).
(PDF)
Figure S16 Oct-25 binding sites on Zic1, Zic3 and Sox2 genes.
Oct-25 hypothetical binding sites on Zic1, Zic3 and Sox2 have
been identified as described in the Material and Methods section.
The schematic representation of the genes shows: black boxes:
exons; white boxes: untranslated regions; line connecting boxes:
introns. For each gene the position of the binding sites, the
identified sequence and the similarity to the published weight
matrix (weight) are indicated in the underneath table. For Zic3 the
six highest identified sequences are shown.
(PDF)
Figure S17 ES cell analysis. (A) Morphological appearance of
differentiated day 2 embryoid bodies: B4-2 and B7-1 cell lines
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formed smaller bodies than those of the wild-type line wt26. (B)
GSES-1 morphology and in vitro differentiation at the indicated
days. Scale bar: 100 mm. (C) FACS profiles of GSES-1 cell line
before (day 0) and during (day 6) differentiation. Red graphs:
fluorescence of non-specific isotype control; black graphs: Oct4
protein levels in GSES-1 cells; green dashed graphs: Oct4 protein
levels in mutant B7-1 cell line. (D) qRT-PCR profiles for the
indicated genes in wild-type (wt) and Suv4-20h DKO cell lines at
differentiation day 6. FoxA2 and Gata4 expression levels are
misregulated in Suv4-20h DKO cells upon differentiation.
(PDF)
Table S1 List of oligonucleotide sequences used in this study.
(PDF)
Text S1 Supporting information on experimental procedures.
This file contains additional information on statistical analysis,
extraction of Myc-tagged fusion protein from embryos, qRT-PCR
samples preparation, Vibratome sections of Oct-25 stained
embryos, Immunostaining, Immunofluorescence microscopy of
MEF cells and ChIP (chromatin immunoprecipitation) analysis.
(DOC)
Video S1 Videorecording of wild-type ES cells at day 14 of
differentiation. The video shows several areals of autonomously
beating cardiomyocytes.
(M4V)
Video S2 Videorecording of Suv4-20h DN ES cells at day 14 of
differentiation. In contrast to differentiated wild-type ES cells,
spontanous contractions of cardiomyocytes are not observed.
(M4V)
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RT-PCR - qRT-PCR (Xenopus)
Geminin for 5'-tgaagtggctgttgatccag-3'
Geminin rev 5'-tcttcgttcctctgcaacct-3'
H4 for 5'-gaccgcggtcacctacacc-3'
H4 rev 5'-ctggcgcttcagaacataca-3'
MyoD for 5'-aggaaggccgccactatga-3'
MyoD rev 5'-gttgcgcaggatctccactt-3'
Ngnr 1a for 5'-acctgcactctgcgcttgat-3'
Ngnr 1a rev 5'-gcgcaaggtctcatcttgg-3'
Nrp1 for 5'-gccatgctgcaaaacttctt-3'
Nrp1 rev 5'-cccaccttatagccctccat-3'
N-tubulin for 5'-tgctgatctacgcaaactgg-3'
N-tubulin rev 5'-ctgtcagggctcggtattgt-3'
Oct-25 for 5'-caggttccagggttgcag-3'
Oct-25 rev 5'-gtccttgaggtgcaggaaag-3'
Oct-91 for 5'-ggacaacagtcgctgtagca-3'
Oct-91 rev 5'-cactgctcagcccatcacta-3'
ODC for 5'-acaaagaaacccaaaccaga-3'
ODC rev 5'-caaacaacatccagtctccaa-3'
Sox2 for 5'-tgcgtccaacaaccagaata-3'
Sox2 rev 5'-agttgtgcatcttggggttc-3'
Sox3 for 5'-atgaacggctggactaatgg-3'
Sox3 rev 5'-tacctgtgctggatctgctg-3'
Sox11 for 5'-cgagaaaatccccttcatca-3'
Sox11 rev 5'-aggatccactttgggctttttc-3'
Sox17 alpha for 5'-tactgcaactaccccagtgc-3'
Sox17 alpha rev 5'-agagcccgtccttctcaata-3'
Xiro 1 for 5'-ccataaccaccaccaccttc-3'
Xiro 1 rev 5'-tgtctgagtgcttgggactg-3'
XK81 for 5'-ccgttggtgttgaacaagtg-3'
XK81 rev 5'-gcagctcaatttccaagctc-3'
xlSuv4-20h1 for 5'-gttggcatgaagtggttgg-3'
xlSuv4-20h1 rev 5'-gcagacaatcggtttccatt-3'
xlSuv4-20h2 for 5'-ccggatgtttcttccagaga-3'
xlSuv4-20h2 rev 5'-ccaccaggagttcaatcttttc-3'
Zic1 for 5'-acagatgaggctgggcttc-3'
Zic1 rev 5'-cagttggctggaggcataat-3'
Zic2 for 5'-tcggtaggacggagcaatac-3'
Zic2 rev 5'-ttcataggggagtactggttgtg-3'
Zic3 for 5'-ggtggtgcagcctttaactc-3'
OLIGONUCLEOTIDES SEQUENCES
Zic3 rev 5'-tggcaaaaagtccatgttga-3'
ChIP-qPCR
GAPDH for 5'-ctgtgctactggtgcttttcc-3'
GAPDH rev 5'-taagcacaggcagcccttac-3'
Oct-25 5'-UTR for 5'-ctccgacttatttgggtgga-3'
Oct-25 5'-UTR rev 5'-tctaacctggatgggaggtg-3'
Oct-25 exon 1 for 5'-agagtccccagaacccaaat-3'
Oct-25 exon 1 rev 5'-aagggctaccagtccatgtg-3'
Oct-25 intron 1 for 5'-aaagctaccggctgattgg-3'
Oct-25 intron 1 rev 5'-agcgtgcaggattaggtcat-3'
Oct-25 exon 4 for 5'-aggggacgctggaaagttac-3'
Oct-25 exon 4 rev 5'-ccttggctatttgcaccatc-3'
MSAT 3 for 5'-ccaccgtttgtcgtagacc-3'
MSAT 3 rev 5'-tgctggggcaattaactg-3'
Thibz for 5'-gctgtcggaactctcactcc-3'
Thibz rev 5'-gcgtctcttgtcccagtagc-3'
Thr alpha for 5'-atttgctttcatgccttgct-3'
Thr alpha rev 5'-tatgaaacggagcgacacaa-3'
mutagenesis PCR
mSuv4-20h1 Y299A for 5'-cctggagaagaaatttcttgttacgcaggagatggcttttttggagaaa-3'
mSuv4-20h1 Y299A rev 5'-tttctccaaaaaagccatctcctgcgtaacaagaaatttcttctccagg-3'
mSuv4-20h2 Y217A for 5'-ggatgaagtgacttgcttcgcaggtgagggcttcttcgg-3'
mSuv4-20h2 Y217A rev 5'-ccgaagaagccctcacctgcgaagcaagtcacttcatcc-3'
mSuv4-20h1 N264A for 5'-ggctcggtcctgctgcatttatagcccatgattgcagacctaactg-3'
mSuv4-20h1 N264A rev 5'-cagttaggtctgcaatcatgggctataaatgcagcaggaccgagcc-3'
mSuv4-20h2 N182A for 5'-ggcccagctgccttcatcgcccatgactgcaaaccc-3'
mSuv4-20h2 N182A rev 5'-gggtttgcagtcatgggcgatgaaggcagctgggcc-3'
qRT-PCR (ES cells)
Actin for 5'-ggtcatcactattggcaacg-3'
Actin rev 5'-tccatacccaagaaggaagg-3'
Eomesodermin for 5'-atcgaccataaccccttcgcc-3'
Eomesodermin rev 5'-cgtaccgacctccagggacaac-3'
FoxA2 for 5'-gtgaagatggaagggcacgagc-3'
FoxA2 rev 5'-gccgcggacatgctcatgta-3'
GAPDH for 5'-tcaagaaggtggtgaagcag-3'
GAPDH rev 5'-gttgaagtcgcaggagacaa-3'
Gata4 for 5'-agggtgagcctgtatgtaatgc-3'
Gata4 rev 5'-attcaggttcttgggcttcc-3'
Sox17 for 5'-acgcaagcggttggcacag-3'
Sox17 rev 5'-cgaagggccgcttctctgc-3'
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SUPPLEMENTARY INFORMATIONS ON EXPERIMENTAL PROCEDURES 
 
Statistical analysis 
The statistical analysis was performed using two-tailed, Paired Student’s t-test, 
unless differently specified. 
 
Myc-tagged fusion protein extraction from embryos 
25 embryos per condition were lysed in 100µl of 100mM NaCl, 10mM Tris pH 7.5 
buffer supplemented with 1mM NaF, 20mM beta-glycerol, 0.1mM Sodium Vanadate, 
10mM Na Butyrate, 0,5% NP-40 and EDTA-free protease inhibitor cocktail tablets 
(Roche). Embryos were centrifuged 15min at 14,000g at 4 °C; the supernatant was 
collected and 2X Loading buffer (Roti-Load1; carlroth.de) was added. Samples were 
subsequently analysed by western blot. 
 
qRT-PCR samples preparation 
Two-cell stage embryos were injected with ctrl-MO (80ng) or xSuv4-20h1 and h2 
morpholinos (40ng each) mixed with Alexa 488 in only one blastomere only. At 
neurula stage (NF15), injected embryos were cut along the midline into pools of 
injected and uninjected halves based on alexa fluorescence. As control, embryos 
unilaterally injected only with Alexa 488-Dextran were processed in parallel. Six 
halves each from corresponding embryos were pooled into injected and uninjected 
sample pairs and used for RNA extraction. RNA samples from two independent 
experiments were subjected to microarray analysis, while RNA samples from four 
independent replicates were used to perform qRT-PCR analysis. For qRT-PCR 
profiles of ES cell lines, 10^6 cells at day 0 and embryoid bodies at day 6 of 
differentiation were harvested and stored at -80°C. Total cellular RNA was extracted 
from independent experiments. For both frog and mouse samples, cDNA synthesis 
was performed using DyNAmo cDNA synthesis kit (Finnzymes), following the 
manufacturers’ protocol. For microarray analysis, cDNA probes were prepared 
according to standard Affimetrix protocol.  For each experiment a control RNA aliquot 
was processed without reverse transcriptase (–RT sample). Real time PCR was 
performed using the Power SYBR Green PCR Master mix and run in LightCylcer® 
480 System (Roche). Primer sequences are listed in Supplement Table S1. C(t) 
values for each sample were normalized to histone H4 as reference gene. The fold 
change between samples was then calculated by normalizing ctrl-MO injected 
embryos or xSuv4-20h double-morphant embryos to the uninjected samples by the 
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ΔΔC(t) method. Finally the ratio between injected and uninjected side within each 
sample was calculated to estimate the up- or downregulation of a gene’s mRNA 
level. For qRT-PCR profiles of ES cell lines, C(t) values for each sample were 
normalized to the two reference genes, GAPDH and Actin. ΔΔC(t) method was 
applied to calculate fold change difference between samples. 
 
Vibratome sections of Oct-25 stained embryos 
Embryos were rinsed in gelatine/albumin mixture (2.2g of gelatine dissolved in 500ml 
1X PBS subsequently supplemented with 135g of albumin (Roth) and 90g of 
Sucrose). 1/20 vol of glutaraldehyde were added to 2ml of albumin/gelatine mixture. 
The solution was quickly vortexed and poured in a small plastic tray to create a 
bottom layer. Embryos were placed and properly oriented on the solidified layer. A 
second layer of albumin/gelatine mixture plus glutaraldehyde was prepared and 
poured on the embryos. The mixture was hardened at least for 30min. The 
gelatinized block with embedded embryos was cut out under a dissecting microscope 
and glued onto a metal support. 30-50µm sections were created using a Vibrotome 
1000 (Technical Products International, INC.). Sections were transferred on slides, 
slightly dried, covered with X-TRA Kit mounting medium (Medite) and analysed with 
Leica M205FA Fluorescence Stereomicroscope. 
 
Immunostaining 
Immunostaining was performed according to Sive et al. (2000). Chromogenic 
reactions with BCIP/NBT (biomol) were stopped by rinsing embryos in PBS. Embryos 
were refixed in MEMFA and bleached in 1% H2O2, 5% Formamid, 0.5X SSC on a 
light box for at least 4 hours. For immunostaining of paraffin embedded samples, 
embryos were fixed in MEMFA for one hour at room temperature and then 
transferred in ice-cold Dent’s Fixative o/n at -20°C. Prior embedding embryos were 
rehydrated for 30min in 100mM NaCl, 100mM Tris/HCl pH 7.4. After dehydration with 
increasing ethanol concentrations, embryos were incubated for two hours in Xylene. 
Subsequently embryos were soaked in paraffin at 55°C twice for two hours, followed 
by proper orientation in moulds and paraffin hardening on cooling plates. Embryos 
were sectioned into slices of 10µm, which were dried on glass slices for 2 hours at 
37°C. Paraffin was removed washing the samples twice with X-tra Solv (Medite), 
then with decreasing ethanol concentration and finally with 1X PBS. Heat-induced 
epitope retrieval was performed incubating the slides in citrate buffers solution for 1 
hour at 90°C followed by cooling down to room temperature. Endogenous peroxidase 
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inactivation was achieved by 10min incubation with 3% peroxidase inactivating 
solution (35% hydrogen peroxidase, Roth, 1/10 Methanol in PBS). Unspecific 
antibody binding sites were blocked by incubation for 1 hour with 2% biotin-free 
albumin (Roth) in PBS. Primary antibodies, diluted in blocking-solution, were 
incubated o/n at 4°C. Secondary antibody incubation was preceded by washes in 
PBST (1X PBS + 0.1% Tween20); subsequently, slices were incubated 1 hour at 
room temperature with biotinylated anti-Rabbit secondary antibody. After several 
washes in PBST, slices were incubated for 1 hour in the dark at room temperature in 
High Sensitivity Streptavidin-HRP solution (Thermo Scientific), diluted 1:500 in 
blocking solution. Staining was stopped after about 10min at room temperature in 
DAB substrate chromogen solution by washing the samples in double distilled water. 
For counterstaining haemalaun (Roth) was used (6 min at room temperature in 1:3 
haemalaun-solution); slices were then blued with 10min under running tap water. 
Increasing ethanol concentrations and X-tra Solv were used for dehydration. Finally 
slides were embedded using X-TRA Kit mounting medium (Medite) and analyzed 
with Leica DM microscope. 
 
Immunofluorescence microscopy of MEF cells 
Wt or Suv4-20 DKO MEFs were fixed with 3.7% (w/v) paraformaldehyde in PBS for 
10min at room temperature, PBS washed and permeabilized in 0.1% (w/v) NaCitrate 
containing 0.1% (v/v) Triton X-100 for 5min. After washing in PBS-T (PBS, 0.1% [v/v] 
Tween-20), cells were blocked for 30min in blocking buffer (PBS, 2.5% [w/v] BSA, 
0.1% [v/v] Tween-20) at room temperature. The cells were incubated with primary 
antibody (H4K20me3, diluted in blocking buffer; [24]) overnight at 4°C. After washing 
with PBS-T, the secondary antibody (Cy3-conjugated anti-rabbit; Jackson 
ImmunoResearch, diluted in PBS-T) was added for 1 hour at room temperature. After 
several washes in PBS-T, the cells were embedded in Vectashield containing DAPI 
(Vector Laboratories) and stored at 4°C for further analysis. 
 
Chromatin Immunoprecipitation experiments 
Aliquots of 50 Xenopus tropicalis injected and uninjected embryos were fixed at NF 
14-15 in 5ml 1% formaldehyde in PBS for 5min at 20°C on a rolling wheel. 
Crosslinking was stopped by a 10min wash with 0.125M glycine/PBS, followed by 
three washes in PBS. Fixed embryos were transferred in 1.5ml eppendorf tubes, 
frozen in liquid nitrogen and stocked at -80°C. At experimental day1, embryos were 
thawed for 15min on ice.   
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Two 15ml conical tubes of blocked protein-G and –A (Protein-A and –G Sepharose 
4, Fast Flow, GE Healthcare) beads were prepared by incubating the proper amount 
of beads (plus an extra 50µl) with 15ml of 5% BSA in PBS. The tubes were incubated 
at 4 °C while mixing for at least 1 hour.  
Two 50-embryos aliquots (100 embryos/condition) were used in each experiment. 
600µl of 4°C RIPA [49] buffer was added to each 50 embryos aliquot. Samples were 
homogenized with a pellet pestle by gently disrupting the embryos until no large 
embryo fragments are visible. Embryos were incubated on ice at least 10min and 
subsequently centrifuged at 14,000rpm for 10min at 4°C. The supernatant was 
discarded and the wall of the tubes was wiped with a kimwipe to remove lipid 
residue. 650µl of 4°C RIPA buffer was added to each sample; the pellet was re-
homogenized vigorously. Samples were subsequently sonicated using the Bioraptur 
(Diagenode) for 25 cycles each composed by 30sec pulse and 30sec rest. Sampels 
were centrifuged at 14,000rpm for 10min at 4°C. 600µl sheared chromatin from the 
two 50-embryos aliquots per sample were pooled together and transferred into a pre-
chilled, clean 1.5 microcentrifuge tube. Input samples were then prepared: combining 
5µ of sheared chromatin plus 195µl TES [49]. Input sample was frozen at -80°C and 
processed once the immunoprecipitations were completed. 
One of the two 15ml conical tubes containing the blocked protein-G and –A beads 
was centrifuged at 1000rpm for 5min at 4°C. Excess of 5% BSA/PBS was removed 
and the beads were gently resuspended by pipetting. Pre-clearing step was achieved 
by dispensing 50µl blocked beads to each sample of sheared chromatin and 
incubating each sample at 4°C with mixing for 1-1.5 hour. Samples were 
subsequently centrifuged at 1000rpm for 1min at 4°C. Each 1.2ml sheared chromatin 
sample was separated into two samples by transferring 580µl of pre-cleared, 
sheared chromatin in two new 1.5ml pre-chilled, clean microcentrifuge tubes. Each 
new tube was filled with RIPA buffer and the immunoprecipitation was achieved by 
adding the appropriate amount of antibody to only one of the two tubes, keeping the 
second one as negative control. Samples were incubated overnight at 4°C with 
mixing. 
At experimental day2 the second 15ml conical tube containing the blocked protein-G 
and –A beads was centrifuged at 1000rpm for 5min at 4°C. Excess 5% BSA/PBS 
was removed, the beads were gently resuspended by pipetting. 50µl blocked beads 
was added to each sample. Samples were incubated at 4°C with mixing for 1.5 hour 
and afterwards centrifuged at 100rpm for 1min at 4°C. Beads were subsequently 
washed: each wash consisted of a 1-minute spin at 1000rpm in a 4°C centrifuge to 
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pellet the immunocomplexes, removal of supernatant with a 20-gauge needle, 
addition of 1ml wash buffer and incubation at 4°C with mixing for 5min. Samples 
were washed for a total of 8 times, using 2 washes each with buffers I through IV. 
Following the washes, the supernatant was aspirated with a 26-gauge needle 
inserted into the beads to completely remove any residual wash buffer. 200µl TES 
buffer was added to the beads. Elution was achieved by incubating the samples at 
65°C for 1 hour in a table shaker (1000rpm). During this time the frozen input 
samples were thawed and vortexed to resuspend any precipitated SDS. All the 
different samples (input, IP and negative control) were processed in the same 
manner for the rest of the procedure.  
After elution samples were centrifuged at 14,000rpm at RT for 1min. 200µl of the 
eluted supernatant was transferred to a new 1.5ml microcentrifuge tube. RNase 
treatment was achieved by adding 2µl of 10 mg/ml stock RNase A (Quiagen) to wach 
samples and by incubating the samples for 45min at 37°C. Subsequently, 12µl of 
Proteinase K/Glycogne solution was added to each sample. Samples were incubated 
at 68°C for 4 hours while shaking (1300rpm) to reverse crosslinks and digest 
proteins. DNA was purified on column using the QIAquick® PCR purification kit 
(Qiagen) following the manufacturer’s protocol. DNA was eluted in 33µl of EB buffer. 
qPCR was performed using the Light Cycler 480 System (Roche). Data were 
analysed using the Light Cycler 480 Software Release 1.5.0 SP1 (Roche). 
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Abstract
Histone lysine (K) methylation has been shown to play a fundamental role in modulating chromatin architecture and
regulation of gene expression. Here we report on the identification of histone H3K56, located at the pivotal, nucleosome
DNA entry/exit point, as a novel methylation site that is evolutionary conserved. We identify trimethylation of H3K56
(H3K56me3) as a modification that is present during all cell cycle phases, with the exception of S-phase, where it is
underrepresented on chromatin. H3K56me3 is a novel heterochromatin mark, since it is enriched at pericentromeres but
not telomeres and is thereby similar, but not identical, to the localization of H3K9me3 and H4K20me3. Possibly due to H3
sequence similarities, Suv39h enzymes, responsible for trimethylation of H3K9, also affect methylation of H3K56. Similarly,
we demonstrate that trimethylation of H3K56 is removed by members of the JMJD2 family of demethylases that also target
H3K9me3. Furthermore, we identify and characterize mouse mJmjd2E and its human homolog hKDM4L as novel,
functionally active enzymes that catalyze the removal of two methyl groups from trimethylated H3K9 and K56. H3K56me3 is
also found in C. elegans, where it co-localizes with H3K9me3 in most, but not all, tissues. Taken together, our findings raise
interesting questions regarding how methylation of H3K9 and H3K56 is regulated in different organisms and their functional
roles in heterochromatin formation and/or maintenance.
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Introduction
Histones, the building blocks of chromatin, are subject to several
posttranslational modifications including methylation, acetylation
and phosphorylation that carry important functional information
[1]. Over the last decades, it has become increasingly obvious that
such chemical histone tags contribute to the regulation of DNA-
related processes in a highly selective and specialized manner [2].
These posttranslational histone modifications (PTMs) either change
nucleosome structure directly by affecting histone-DNA contacts or
indirectly by recruiting PTM-binding proteins that act on the
underlying chromatin structure, as has been proposed in the
‘‘histone code’’ hypothesis [3]. Although most marks are found on
the flexible histone tail regions, some modifications have also been
identified on core residues. One such core PTM, histone H3 lysine
56 acetylation (H3K56ac) [4], occurs in the a-N-helical region near
the entry-exit sites of the DNA superhelix and is conserved from
yeast to man [5]. It is most abundant during S phase [6,7] and has
been shown to play a pivotal role in DNA damage response [6],
chromatin integrity [8,9] and replication-coupled nucleosome
assembly [10]. In a previous mass spectrometry-based study, we
were not only able to verify the existence of H3K56 acetylation in
humans but were also able to identify low levels of mono- and
trimethylation of lysine 56 on histone H3 (H3K56me1 and
H3K56me3, respectively) [11]. Recently, it was demonstrated that
monomethylation of H3K56 regulates DNA replication through
interaction with the replication processivity factor PCNA and is
catalyzed by the lysine methyltransferase (KMT) G9a (KMT1C)
[12]. The involvement of H3K56me1 in such an important
biological event led us to ask how trimethylation of this residue
might be regulated and impact cellular processes. Despite the known
in vivo existence of H3K56me3 [11], no further information
concerning this novel histone H3 core modification has been
established. We set out to learn more about its functional role by
deciphering its chromatin localization and by identifying enzymes
that set (‘‘writer’’) and erase (‘‘eraser’’) this mark.
Materials and Methods
Cell lines
Human HeLa Kyoto cells [13], and mouse C127 (ATCC CRL-
1616) cell lines were grown inDMEMmedium (PAA) supplemented
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with 10%FCS (Sigma) and 1%penicillin/streptomycin at 37uCand
5% CO2. Wild type, Suv39hDKO [14] and SUV4-20hDKO [15]
mouse embryonic fibroblast (MEF) cell lines were grown in DMEM
medium (PAA) supplemented with 18% FCS (Sigma), 1% penicil-
lin/streptomycin, 1% non-essential amino acids (Invitrogen),
50 mM b-mercaptoethanol and 0.4% LIF at 37uC and 5% CO2.
Cells were transfected using FuGene HD (Roche Applied Science)
according to the manufacturer’s instructions.
Antibodies
Polyclonal rabbit antibody against H3K56me3 was developed
by Pineda Antiko¨rper-Service (Berlin, Germany) using a peptide
with the following amino acid sequence for immunization and
affinity purification: NH2-CRRYQ-K(me3)-STEL-CONH2. Com-
mercially available antibodies used in this study include: Primary
antibodies: aH3 (C-terminus, Abcam), aH4 (Antikoerper-online),
aH3K4me2 (Abcam), aH3K4me3 (Abcam), aH3K9me1 (Milli-
pore), aH3K9me2 (Active Motif), aH3K9me3 (Active Motif and
[16]; specificity tests are shown in Figure S1), aH3K27me2
(Millipore), aH3K27me3 (Millipore), aH3K36me1 (Millipore),
aH3K36me2 (Active Motif), aH3K36me3 (Abcam), aH4K20me1
(Millipore), aH4K20me2 (Millipore), aH4K20me3 (Abcam),
aH3K56me1 (Millipore), aH3K56me2 (Active Motif), aH3K56ac
(Active Motif). Secondary antibodies: for immunoblots (Amer-
sham), for IF microscopy (Dianova).
Peptide competition experiment
aH3K56me3 antibody in 1:1000 or 1:100 dilutions was
preincubated with 2 mg/ml of peptides (Table S1) before usage
in either immunoblots or immunofluorescence (IF) microscopy,
respectively. Peptides were N-terminally biotinylated and synthe-
sized with higher than 80% purity by The Rockefeller University,
GeneScript or the MPI for Biochemistry Munich. In case of
immunoblots, acid extracted histones [17] and recombinant
histone H3 [18] were used.
Figure 1. Determination of aH3K56me3 specificity and suitability in diverse applications. (A) Immunoblot peptide competition
experiment. aH3K56me3 antibody was preincubated with competitor peptides before addition to immunoblots containing recombinant H3 protein
(R) or acid extracted HeLa Kyoto histones (H) (top). Ponceau staining (bottom) serves as loading control. (B) IF microscopy peptide competition
experiment. aH3K56me3 antibody (green) was preincubated with competitor peptides before addition to fixed HeLa Kyoto cells. DAPI (blue) stains
DNA. Scale bar = 5 mm. (C) Spot-blot with different concentrations (5–1000 ng) of H3 peptides to determine aH3K56me3-binding affinities. (D)
Immunoblot of sequential tryptic digest of HeLa Kyoto-derived mononucleosomes using aH3K56me3 (top), aH3K9me3 (middle) and aH3 (bottom).
FL = full-length histone H3, GD = N-terminally deleted globular domain of histone H3.
doi:10.1371/journal.pone.0051765.g001
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Tryptic digest of mononucleosomes
66107 HeLa Kyoto cells were incubated in PBS, 0.3% Triton
X-100 and Protease Inhibitor Cocktail (Roche, Germany) for
10 min at 4uC. Nuclei were pelleted, washed once in PBS,
resuspended in EX100 buffer (10 mM Hepes pH 7.6, 100 mM
NaCl, 1.5 mM MgCl2, 0.5 mM EGTA, 10% (v/v) glycerol,
10 mM b-glycerol phosphate, 1 mM DTT, Protease Inhibitor
Cocktail (Roche, Germany)) and CaCl2 concentration adjusted to
2 mM. Resuspended nuclei were digested with 1.5 U MNase
(Sigma) for 20 min at 26uC. The reaction was stopped by addition
of EGTA to a final concentration of 10 mM followed by
centrifugation for 10 min at 1000 rcf, 4uC. Mononucleosome
containing supernatant was retained. NH4HCO3 was added at a
final concentration of 50 mM or until a pH of 7–8 was
reached.1.6 mg Trypsin (Promega) was added and the reaction
was incubated at 25uC. Samples were collected at different time
points and the reaction stopped by adding an equal volume of 1%
trifluoroacetic acid. Fragments were size separated on a 15% SDS-
PAGE probed with indicated antibodies.
Spot-blot
Peptide dilutions containing 2, 10, 50, 200 and 1000 ng in
sterile water were spotted on nitrocellulose membrane and allowed
to air-dry. The membrane was then blocked in PBS-Tween (0.1%)
with milk powder (5%), followed by immunoblotting with
aH3K56me3.
Immunofluorescence (IF) microscopy and cell cycle
analysis
Mammalian cells. Preparation of mammalian cells and
chromosome spreads for IF microscopy was done as previously
reported [19]. Staining of S-phase cells was performed as
Figure 2. H3K56me3 is evolutionary conserved, has a cell-cycle independent appearance and is part of pericentromeric
heterochromatin. (A) Immunoblot with acid extracted histones from human (HeLa Kyoto), mouse (MEF) and fly (S2) cell lines using aH3K56me3
(top) and, as loading control, aH4 (bottom) antibodies. (B) IF analysis of H3K56me3 (top) and H3K56ac (bottom) appearance in G1/G2 and S-phase
cells. C127 cells were pulse-labeled with EdU (red) to visualize replication foci and to identify cells in S-phase. Cells were co-stained with aH3K56me3
or aH3K56ac (green) and DAPI (DNA, blue). Scale bar = 5 mm. (C) IF microscopy of MEF cells in interphase and different stages of mitosis co-stained
with aH3K56me3 (red), aH4K20me3 (red) and DAPI (DNA, blue). Scale bar = 5 mm. (D) IF of chromosome spread from nocodazole-arrested HeLa cells
with aH3K56me3 (red) and DAPI (DNA, blue) staining. Scale bar = 5 mm.
doi:10.1371/journal.pone.0051765.g002
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described in [18]. Wide-field IF imaging of EdU-stained C127
cells was performed on a PersonalDV microscope system (Applied
Precision) equipped with a 606/1.42 PlanApo oil objective
(Olympus), CoolSNAP ES2 interline CCD camera (Photometrics),
Xenon illumination and appropriate filtersets. Iterative 3D
deconvolution of image z-stacks was performed with the Soft-
WoRx 3.7 imaging software package (Applied Precision).
Confocal imaging of chromosome spreads was performed on a
TCS SP5 II microscope system (Leica Microsystems, Wetzlar,
Germany), equipped with a 636/1.3 HCX PL APO glycerol
immersion objective. Z-stacks were recorded and subsequently
deconvolved with Huygens Essential Software (SVI, Hilversum,
The Netherlands).
Image stacks of immunostained MEF cells were collected using
a Leica TCS SP5 confocal microscope with Plan Apo Lambda
Blue 636/1.4 NA oil or 636/1.3 glycerol immersion objective.
C. elegans. Methanol/acetone fixation for immunostaining
was performed as follows. Adult hermaphrodites were dissected in
1x sperm salts with and frozen on dry-ice for 20–30 minutes. The
slides were fixed in methanol followed by acetone, 2 minutes each
wash, at 220uC. Slides were then washed once for ten minutes in
PBST prior to incubation with primary antibody [1:200 or 1:100
(direct labeling) aH3K56me3, 1:1000 aH3K9me3 (Abcam
ab8898)]. Remainder of staining protocol was conducted as
described previously [20]. Microscopy and imaging were con-
ducted as described previously [21].
Images were capture with a Hamamatsu Orca-Erga close-
coupled-device (CCD) camera mounted on an Olympus BX61
motorized Z-drive microscope using a 60X APO oil immersion
objective. These images are projections of optical sections with a Z
spacing of 0.2 micrometers. Scale bars were added using ImageJ
(available at http://rsb.info.nih.gov/ij; developed by Wayne
Rasband, National Institutes of Health, Bethesda, MD) and a
template image created in Slidebook.
Quantitative PCR
qPCR was carried out as previously described [22] using Fast
SYBR Green Master Mix (Applied Biolabs). Results were
normalized to HPRT1 and GAPDH levels.
Cloning of GFP-jmjC constructs
pDONR entry clones of the Jmjd2 subgroup [23] were
recombined into the target vector pEGFP-N1-GW using LR
clonase II enzyme mix (Invitrogen) according to the manufactur-
er’s protocol.
C. elegans RNAi
RNA interference by feeding was performed with the Ahringer
laboratory RNAi feeding library [24] in two generations as
described previously [21].
Results
Development of a specific aH3K56me3 antibody
To gain insight into the biological function(s) of H3K56
trimethylation, we raised a polyclonal antibody against
H3K56me3 (aH3K56me3) and determined its specificity in
various assays. Since H3K56me1 has previously been reported
to be catalyzed by the H3K9me1-specific KMT G9a, maybe due
to a conserved lysine-serine-threonine (K/S/T) motif at the site of
both residues [12], we put special emphasis on testing a potential
cross-reactivity of this antibody with H3K9me3. First, we
performed peptide competition experiments using peptides span-
ning diverse regions of histone H3 with or without different
methylation states. Specific antibody recognition of H3K56me3 in
immunoblotting (Figure 1A) and immunofluorescence (IF) micros-
copy (Figure 1B) was efficiently competed out only with
H3K56me3-containing peptides, but not with peptides containing
other methylated or unmethylated histone regions. Next, we
determined the relative binding affinity of aH3K56me3 to its
epitope by a peptide Spot-blot containing various concentrations
of different histone peptides and observed that aH3K56me3
detected as low as 50 ng of H3K56me3 peptides (Figure 1C).
Notably, aH3K56me3 does not recognize any other trimethylated
peptides except H3K56me3. For further support of antibody
specificity, we generated mononucleosomes from HeLa cells that
were subsequently digested with different concentrations of
Trypsin in order to generate histones lacking their flexible tail
regions. In this way, we were able to determine if the antibody
epitope resides in the H3 core region or N-terminal tail. In
Figure 3. Loss of Suv39h enzymes affect H3K56me3. IF
microscopy of wild type (WT), Suv39h double-null (Suv39h DKO) and
Suv4-20h double-null (Suv4-20h DKO) MEF cells using various H3K56 (A)
and H3K9 (B) methyl-specific antibodies (Ab-Cy3, red) and DAPI (DNA,
blue). Scale bar = 5 mm. (C) Immunoblots using acid extracted histones
from HeLa Kyoto (positive control), wild type MEF, Suv39h DKO and
Suv4-20h DKO cells. Blots were incubated with aH3K56me3 (left, top) or
aH3K9me3 (right, top) antibodies, respectively. Blots shown at the
bottom were incubated with aH4 to ensure equal loading.
doi:10.1371/journal.pone.0051765.g003
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immunoblots, aH3K56me3, but not the control aH3K9me3
antibody, recognized both full-length (FL) and the N-terminus
deleted globular domain (GD) of histone H3 (Figure 1D),
demonstrating that aH3K56me3 specifically binds to a modifica-
tion in the core region of H3. In summary, these experiments
provide compelling evidence that aH3K56me3 is highly specific
for this particular modification and can be applied in diverse
biochemical assays.
H3K56me3 is evolutionary conserved and localizes to
pericentromeric heterochromatin outside of S-phase
Having demonstrated the high specificity of aH3K56me3, we
first examined the evolutionary occurrence of this novel mark by
isolating histones from cell lines of diverse origins. Immunoblotting
revealed that H3K56me3 was present in human, mouse and fly
(Figure 2A), suggesting that this modification is conserved within,
at least, metazoans.
Given that H3K56ac is highly conserved and that methylation
and acetylation of the same residue are mutually exclusive we
wanted to investigate if there were correlations between the
appearance of one mark and disappearance of the other. While in
yeast H3K56ac has been shown to be cell cycle dependent,
showing a significant increase during S-phase, [6,9,25], its cell
cycle distribution in mammals remains controversial [26–28], with
a high possibility of its occurrence in all cell cycle phases [29].
Therefore, we analyzed cell cycle appearance and nuclear
localization of both acetylation and methylation of H3K56 in
mammalian cells. To distinguish S-phase from interphase, mouse
C127 cells were pulse-labeled with the thymidine analog EdU,
which was chemically coupled to a fluorescent dye using a ‘‘click-
chemistry’’ approach [30]. Co-staining of EdU-labeled cells with
aH3K56me3 revealed that, during interphase, H3K56me3 is
found predominantly at DAPI-dense heterochromatic chromo-
centers and shows strongly diminished signal intensity in S-phase
cells (Figure 2B top). Although, we observed a more or less equal
appearance of H3K56ac signal in interphase and S-phase cells
(Figure 2B, bottom), it is clearly distinct from the H3K56me3
signal. We also found H3K56me3 to be present throughout
mitosis (Figure 2C), where it co-localizes with heterochromatin
Figure 4. Jmjd2E demethylase affects H3K56me3. (A) IF microscopy of HeLa Kyoto cells transfected with mJmjd2E-GFP (green, left) or jmjc-
domain mutated mJmjd2E-GFP (mutant, green, right) and stained with various H3K56 and H3K9 PTM-specific antibodies (red) and DAPI (DNA, blue).
Arrows indicate transfected GFP-positive cells. Scale bar = 10 mm. See also Figure S2A for IF results of cells transfected with other GFP-tagged
mJMJD2 family members (mJmjd2a-d). (B) List of PTMs analyzed in IF after expression of mJmjd2E in HeLa Kyoto cells indicating changes in
fluorescence intensities. See also Figure S2B for examples of IF results summarized in this table. (C) qPCR analysis with cDNAs from different human
cell lines and tissues using primer pair specific for human Jmjd2E (hKDM4DL). Data were normalized to HPRT1 and GAPDH expression levels. (D) IF
microscopy of HeLa Kyoto cells transfected with human GFP-hKDM4L (green) and stained with various H3K56 and H3K9 methyl-specific antibodies
(red) and DAPI (DNA, blue). Arrows indicate transfected and GFP-positive cells. Scale bar = 10 mm.
doi:10.1371/journal.pone.0051765.g004
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foci, in an even more precise manner than the constitutive
heterochromatin marker H4K20me3 [31]. To determine
H3K56me3 localization in greater detail, human metaphase
chromosomes were analyzed in IF microscopy. In accordance
with H3K56me3 presence at chromocenters in interphase and
heterochromatin foci in mitotic cells, this modification was present
in a non-random manner and found predominantly at pericen-
tromeric heterochromatin regions that include major satellite
repeats (Figure 2D). Interestingly, H3K56me3 is, in contrast to
H3K9me3, rarely found at telomeres [32], suggesting that the
functional roles of these two modifications in heterochromatic
regions might be different.
Mammalian methyltransferase Suv39h affects
trimethylation of H3K56
To assess the functional relevance of posttranslational histone
modifications, it is important to know their responsible enzymes.
Several lysine methyltransferases (KMTs) that catalyze the
methylation of histone lysine residues have been identified
previously [33,34]. Possibly due to the fact that both regions
surrounding H3K56 and H3K9 contain a conserved K/S/T
motif, monomethylation of H3K56 has been shown to be
catalyzed by the H3K9me1-specific KMT G9a [12]. Additionally,
both H3K9me3 and H3K56me3 localize to similar, albeit not
identical, nuclear domains suggesting that H3K9 and H3K56
might share the same KMTs responsible for their trimethylation.
Therefore, we first tested the H3K9me3-specific KMTs Suv39h1/
2 (KMT1A and B) [35] for their ability to affect the methylation
status of H3K56. Interestingly, we observed a complete loss of
both H3K56me3 and H3K9me3 signals at chromocenters in
Suv39h double-null MEF cells (Suv39h DKO, [14]). Accompa-
nied with this loss of trimethyl signals, we observed an increase of
the respective monomethyl marks at chromocenters (Figure 3A
and B). This dramatic change in PTM localization upon the
simultaneous lack of Suv39h1/2 suggests that these enzyme are
involved in catalyzing trimethylation of both H3K9 and H3K56,
the latter in either a direct or indirect manner. Since H3K56me3
showed a somewhat similar nuclear appearance as H4K20me3
Figure 5. H3K56me3 is conserved in Caenorhabditis elegans. Shown are representative IF microscopy pictures from adult C. elegans
hermaphrodite tissues. In all images H3K56me3 is shown in green, H3K9me3 in red, and DAPI (DNA) in blue. Scale bar = 5 mm. A) H3K56me3 co-
localizes with H3K9me3 in the early germline, late pachytene and in a 100-cell embryo (top picture). Interestingly, although H3K56me3 and H3K9me3
are both present in oocytes, only H3K56me3, but not H3K9me3, staining could be observed in sperm. (bottom, split channels) (B) H3K56me3 and
H3K9me3 co-localize throughout all stages of mitosis.
doi:10.1371/journal.pone.0051765.g005
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(Figure 2C), we wondered whether Suv4-20h1/h2 enzymes,
responsible for methylating lysine 20 on histone H4 [15,31],
might also target H3K56. Suv4-20h double null MEF cells (Suv4-
20h DKO, [15]) showed no difference in abundance or
localization of H3K56 methylation when compared to wild type
cells (Figure 3A and B), demonstrating that these enzymes do not
influence H3K56 methylation status. Similar results were also
obtained with immunoblots, showing that the H3K56me3 signal is
diminished in Suv39h DKO, but not Suv4-20 DKO acid
extracted histones (Figure 3C).
Jmjd2E/KDM4DL is a novel lysine-demethylase specific
for H3K9 and H3K56 trimethylation
Having shown that the same enzymes that methylate H3K9 also
affect trimethylation of H3K56, we wondered whether the erasure
of these modifications is catalyzed by identical lysine demethylases
(KDMs) as well. Histone lysines are demethylated by two different
classes of enzymes that are distinguished by their enzymatic active
domains and methylation-state specificities [36]. We focused our
attention on the Jumonji C-terminal domain (JmjC) family of
KDMs, since they are able to remove all methyl-states, including
trimethylation [37]. We therefore tested a panel of GFP-tagged
members of the JMJD2 group-containing demethylases that are
thought to partially work on H3K9me3 [23]. Over-expression of
the respective mKDM in human cells was monitored by GFP
signal in IF microscopy and effects on histone methylation were
analyzed by co-staining with different histone PTM antibodies.
This screen led to the identification of all members of the mJMJD2
family (mJmjd2A-E) able to affect H3K56me3 (Figure S2A and
Figure 4A). Since all members have previously been shown also to
act on H3K9me3 [38], our results point once again towards a
possible link between these two heterochromatic marks due, to a
shared sequence motif (K/S/T). As one example, over-expression
of mJmjd2D or mJmjd2E [39] strongly diminished H3K9me3, as
well as H3K56me3 signals, in HeLa Kyoto cells (Figure 4A, left
and Figure S2A). The loss of the respective trimethyl signal was
accompanied with an increase in the monomethyl, but not
dimethyl state, suggesting that these enzymes remove two methyl
groups in total. Since over-expression of mJmjd2D-GFP caused
severe cellular defects, its role on H3K56me3 was not further
investigated and we focused subsequent analyses on mJmjd2E that
acted solely on H3K9 and H3K56 trimethylation and not on other
histone trimethylation marks (Figure 4B and Figure S2B). The
observed changes in H3K9 and H3K56 methylation states upon
mJmjd2E-GFP over-expression were dependent on the enzymatic
active jmjC domain, since point mutations in that region
completely abolished mJmjd2E’s demethylase activity (Figure 4A,
right). In the mouse, mJmjd2E is predicted to constitute a
pseudogene and we therefore decided to analyze expression and
function of the yet uncharacterized human homolog hKDM4DL.
hKDM4DL mRNA is expressed predominantly in testis, with only
residual levels present in U2OS (osteosarcoma) and HL60
(promyelocytic leukemia) cell lines and human brain tissue
(Figure 4C). Over-expression of GFP-hKDM4DL in HeLa Kyoto
cells showed identical results as seen for the mouse homolog, loss
of H3K56 and H3K9 trimethylation with an accompanied gain of
the respective monomethylation mark (Figure 4D). Taken
together, we have identified the JMJD2 family to facilitate
demethylation of H3K9 and H3K56 trimethyl states. Additionally,
we showed that mJmjd2E, and its previously uncharacterized
human homolog hKDM4DL, specifically remove two methyl
groups from trimethylated H3K56 or H3K9 residues, depending
on their catalytically active jmjC domain.
H3K56me3 is a novel chromatin mark in C. elegans
In order to learn more about H3K56me3 evolutionary
conservation as a novel heterochromatic histone modification
and its functions, we conducted IF microscopy analysis of wild type
(WT) C. elegans hermaphrodite germlines and embryos (Figure 5A).
H3K56me3 is present in both early germline and embryonic
nuclei, as marked by DAPI morphology (Figure 5A, right). In
almost all cells analyzed, we observed an H3K56me3 signal that
strongly co-localized with H3K9me3 in most tissues (Figure 5A).
Surprisingly, H3K56me3 staining was present in both types of
germline cells, oocytes and sperm, whereas the H3K9me3 signal
was restricted to oocytes only (Figure 5A, bottom). These data
mirror previously obtained H3K9me3 results [40] and suggest that
H3K56me3 might have an important H3K9me3-independent
function in sperm development. Next, we wondered whether,
similar to mammalian cells, H3K56 is trimethylated in cells during
mitosis in C. elegans. Indeed, H3K56me3 is part of all mitotic stages
and overlaps with H3K9me3 signals (Figure 5B), demonstrating
the evolutionary high conservation of this novel mark.
Next, we sought to shed light on the enzymatic regulation of
H3K56 trimethylation in C. elegans and performed an RNAi-based
survey of known or predicted methyltransferases, including H3K9-
specific enzymes [41]. The screen included RNAi targeting MET-
2, a homolog of mammalian euchromatic H3K9 HMT SETDB1
[40–42], MET-1, a homolog of yeast Set2, an H3K36-specific
methyltransferase, whose activity was reported to be required for
normal levels of H3K9me3 [41], and SET-25, a distant homolog
G9a, recently reported to deposit H3K9me3 in C. elegans embryos
[42]. We also included RNAi against previously uncharacterized
Figure 6. C. elegans RNAi screen to identify H3K56me3-specific
KMTs. Shown are representative IF images from adult C. elegans
hermaphrodite somatic intestinal nuclei following RNAi treatment.
H3K56me3 (left) or H3K9me3 (right) staining is shown in green and
DAPI (DNA) is shown in blue. CAPG-1 co-staining was used as a staining
control (data not shown). Results show that met-1 and met-2 depletion
severely affect both H3K56me3 and H3K9me3, while reduction of
additional KMTs (set-6, set-25 and set-32) has a stronger effect on
H3K56me3 levels compared to H3K9me3. Scale bar = 5 mm.
doi:10.1371/journal.pone.0051765.g006
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SET domain containing proteins predicted to encode divergent
H3K9-specific methyltransferases (set-6, -12, -15, -20, and -32).
For control, we performed RNAi targeting an H3K4-specific
methyltransferase SET-2, a homolog of SET1/MML. We
conducted our screen in the intestine, where the large size of
nuclei makes scoring easier. This screen identified several genes
whose activity is required for normal levels of H3K56me3 and/or
H3K9me3, some of which have been previously implicated in
H3K9 methylation. H3K56me3 levels were severely reduced in
met-2 and set-25 RNAi, consistent with the requirement for these
genes for H3K9me3 levels in C. elegans embryos [42]. Interestingly,
H3K9me3 levels were less affected in these conditions, indicating
possible differences between the enzymes responsible for these
marks and/or differences in antibody sensitivities. H3K56me3
levels were also reduced in met-1 RNAi, and to a lesser extent in
set-6and set-32 RNAi. H3K9me3 levels were also reduced in met-2
and set-12 RNAi, possibly due to indirect affects (Figure 6).
H3K9me3 levels were never reduced to background levels,
perhaps due to partial redundancy between these enzymes.
Knockdown of other known H3K9 methyltransferases or the
H3K4 KMT set-2 resulted in DAPI perturbations, but showed no
effect on H3K56me3 staining (Figure 6).
In sum, H3K56me3, its relationship to H3K9me3, and its
regulation by several H3K9 methyltransferases are conserved in C.
elegans. However, some degree of divergence in the factors
regulating H3K56me3 may have occurred in C. elegans.
Discussion
Our study establishes the existence of a novel pericentric
heterochromatin mark, H3K56me3, in several metazoan species.
This novel modification is present in all cell cycle phases, with the
exception of S-phase, where it is underrepresented. Enzymes
targeting H3K9 also act on H3K56, as the KMTs Suv39h1/2 are
important for trimethylation of both residues and KDM JMJD2
family members remove these modifications. Mouse Jmjd2E and
its so far uncharacterized human homolog hKDM4DL are
involved in the process of demethylating H3K56me3 to a
monomethylated status. In C. elegans, H3K56me3 is a conserved
feature of mitotic chromosomes that primarily co-localizes with
H3K9me3 and is regulated by some but not all H3K9
methyltransferases.
Of particular interest is our observation in mammalian cells that
H3K56me3 is found in chromocenters containing pericentric
heterochromatin, but only outside of S-phase. During that
particular cell cycle phase, H3K56me3-specific IF microscopy
signals are strongly diminished. Such an effect can be caused either
by a replication-specific removal of the trimethylation mark or by
occlusion of the epitope through adjacent modifications, such as
phosphorylation of H3S57, or association with a binding protein.
As H3K56 is targeted by the lysine acetyltransferases CBP or
GCN5 [26,43] prior to being deposited onto DNA during
replication [7,44,45], it is highly likely that newly synthesized
H3 histones with K56ac replace ‘‘old’’ H3K56me3-containing
ones. Given that H3K56me3 has been recently shown to prevent
binding of PCNA that specifically associates with the mono-
methylation state [12], it is plausible that H3K56me3 needs to be
removed during replication to allow proper action of PCNA at the
replication forks. With regard to adjacent modification sites, a
serine and a threonine, potential phosphorylation sites, are located
next to lysine 56. Although H3S57 phosphorylation was reported
to exist in mammals in vivo [46], no data on its appearance during
cell cycle, on responsible enzymes and its function in mammals are
available due to the lack of a specific antibody. One study,
applying yeast mutants proposes a potential functional interplay
between H3K56 and S57 in replicative stress recovery and
transcriptional elongation [46]. However, because H3S57ph has
thus far not been identified in yeast in vivo, it is not possible to
relate such observations to the mammalian system. Concerning
putative H3K56me3-specific binding partners, we applied peptide
pull-down experiments followed by MS identification of precip-
itated proteins (data not shown). Although we repeated such
experiment many times, we were not able to consistently pull-
down any candidates when compared to unmodified control
peptide pull-downs. It is likely that H3K56me3 is not directly
recognized by any ‘‘reader’’ protein but, instead functions
indirectly by preventing acetylation of H3K56 and its associated
signaling pathways. Alternatively, since H3K56me3 is localized in
the a-N-helical region near the entry-exit sites of the DNA
superhelix, it is possible that the correctly folded three-dimensional
structure of this region (alone or in combination with DNA or
other histones) is crucial for reader binding. Therefore, the use of
peptides in such pull-down experiments will not suffice in reader
binding. H3K56me3 histones or even nucleosomes containing this
PTM will be needed for the identification of its potential reader(s)
in the future.
Our finding that H3K56me3 constitutes another heterochro-
matin mark is in perfect agreement with previously published data,
since H3K56 is monomethylated by G9A [12] that was initially
described as a KMT responsible for H3K9me1 and H3K9me2
[47]. It is therefore plausible that H3K9me3-specific KMT(s)
might also act on H3K56. We report here that the loss of Suv39h
enzymes leads to diminished trimethylation of both H3K56 as well
as H3K9. Based on our experimental set-up using Suv39h double-
null cells, it is at the moment not possible to exclude that loss of
H3K56me3 stems from an indirect effect. The chance of
H3K9me3 influencing trimethylation of H3K56 by an, as yet,
unknown mechanism, is conceivable albeit unlikely. Several
observations argue for a direct enzymatic action of Suv39h on
H3K56; the presence of a ‘‘K/S/T’’ motif in both regions and the
fact that G9a, another H3K9-specific KMT is the responsible
enzyme for H3K56me1 [12]. Therefore, we propose that Suv39h
enzymes directly trimethylate H3K56 leading to a pericentric
heterochromatin localization.
Although like both H3K9me3 and H4K20me3, H3K56me3
also constitutes a mark found in DAPI-dense regions, these
modifications are not identical in their localization when looked at
in greater detail. H3K9me3 stains telomeric repeats [32] and our
results indicate that the majority of H3K56me3 does not. In
contrast to H4K20me3, we found H3K56me3 in distinct
chromatin foci during all mitotic phases, indicating that this novel
mark is found in much more distinct heterochromatic loci. We
plan to investigate this finding in future studies.
Besides our discovery of a novel histone modification site, our
study raises one important question for many researchers dealing
with PTMs and their biological functions. The finding that some
enzymes might have several targets is supported by another recent
study showing that pericentric localization of H3K64me3, another
H3 core modification, also depends on Suv39h activity [48].
Therefore, the observed severe knock-down [14] and over-
expression [49] phenotypes that were previously assigned to the
sole loss or gain of H3K9me3, respectively, have to be reevaluated,
since Suv39h enzymes affect not only H3K9, but also H3K64 as
well as H3K56 trimethylation, It is possible that the assigned role
of H3K9me3 in protecting genome stability and heterochromatic
gene silencing [50] is in part shared by H3K56me3.
In agreement with the finding that H3K9-specific KMTs act on
H3K56, we demonstrated a strong correlation between both
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residues as to their KDM-specificity. Our study expands the list of
known histone target residues of enzymes belonging to the JMJD2
family of demethylases since we could show that they act not only
on H3K9me3 and, in some cases, H3K36me3 [38], but also on
H3K56me3. Of particular interest is our characterization of
mJmjd2E, a predicted pseudogene and its human homolog
hKDM4DL, which codes for a, so far, uncharacterized protein.
Because of hKDM4DL’s strongest expression in human testis, it
will be of great interest to determine if and why removal of the
trimethylation of H3K9 and H3K56 is important in this special
tissue. Perhaps it is crucial during the process of histone-protamine
exchange and/or relaxation of pericentric heterochromatin in
humans; a statement that will be difficult to address since the
mouse enzyme is predicted to be a pseudogene and not expressed.
hKDM4DL might, therefore, constitute a human or primate-
specific protein. If so, then functional studies on hKDM4DL in
testis will be hard, if not impossible to perform.
Our study clearly puts forward H3K56me3 as a novel
modification, but we were unable to address its functional
relevance. Usually, knock-down of the enzymes targeting the
respective modification provide insights into its biological role; but
since H3K9 and H3K56 methylations are affected by the same
enzymatic machinery in mammals, we do not have any technical
tool at hand to pinpoint, in vivo, one particular phenotype to
H3K56me3. However, identification of genes that affect the two
modifications slightly differently in the C. elegans intestine opens up
the possibility of future functional studies, at least in this particular
organism.
Interestingly, we identified MET-1, a H3K36 KMT homolog,
as needed for wild type levels of both H3K9me3 and H3K56me3.
It was previously suggested that H3K36 methylation might be a
prerequisite for H3K9me3 in worms [41], and perhaps it is
similarly required for H3K56me3 as well. Previous studies
reported that H3K9me3 in the germline is independent of
MET-2 [40], however H3K9me3 levels are significantly reduced
in MET-2-depleted embryos [42]. These results indicate that
different KMTs might be primarily used in different tissues.
Consistent with this hypothesis, depletion of MET-2 and SET-25
significantly reduces H3K9me3 levels in embryos [42], and
H3K56me3 levels in the intestine (this study), but their effect is
less pronounced for H3K9me3 levels in the intestine. Future
studies will be needed to reveal how the preference for different
KMTs is regulated in different tissues.
We identified multiple KMTs required for normal levels of both
H3K9me3 and H3K56me3. One possible explanation for the
requirement of two or more methyltransferases is that one of these
KMTs deposits mono- (and perhaps di-) methylation, while the
second KMT deposits trimethylation, in a manner dependent on
prior mono- or dimethylation. This model is similar to what was
previously reported for MET-2 and SET-25 in embryos [42].
Alternative possibilities include indirect effects, perhaps involving
non-histone targets for these proteins.
Early EM studies revealed that C. elegans embryos lack electron-
dense material, classically associated with heterochromatin [51].
In addition, while in mammalian cells H3K9me3 co-localizes with
DAPI-bright regions of pericentric heterochromatin, in C. elegans,
H3K9me3 localizes to DAPI-faint regions [40], leading to the
suggestion that C. elegans lacks heterochromatin or that hetero-
chromatin is different in this species [40]. C. elegans chromosomes
are holocentric, and in the absence of a localized centromere, the
phrase ‘‘pericentric ‘‘ does not apply. Instead, the brightest foci of
H3K9me3 in C. elegans nuclei associate with the nuclear lamina
[42]. H3K9me3 is coincident with H3K27me3 and nuclear
lamina protein LEM-1, all of which are enriched along
chromosome arms [42,52]. Therefore, these regions most likely
are similar to mammalian heterochromatin near the nuclear
periphery, or lamin associated domains, LADs [53]. Our results
show that H3K56me3 colocalizes with H3K9me3 in worms,
suggesting that H3K56me3 likely marks these lamin associated
domains.
In agreement with a specialized role of H3K56me3 in testis is
the finding that sperm cells in C. elegans contain solely trimethyla-
tion of H3K56 but not of H3K9. It will be of interest to see if
H3K56me3 has an evolutionary conserved role in germline
development, although its functional implication might be
different in different metazoans.
Supporting Information
Figure S1 Immunoblot peptide competition experi-
ments to determine specificity of aH3K9me3 antibodies
used in this study. aH3K9me3 antibodies from (A) Active
Motif or (B) the Jenuwein laboratory [16] were pre-incubated with
2 mg/ml competitor peptides before addition to immunoblots
containing recombinant H3 protein (R) or acid extracted HeLa
Kyoto histones (H) (top). Ponceau staining (bottom) serves as
loading control.
(TIF)
Figure S2 Members of the JMJD2 family of demethy-
lases affect H3K56me3. (A) IF microscopy of HeLa Kyoto cells
that were transfected with GFP-tagged mJmjd2a-d and human
Jmjd2d homolog hKDM4 (green) and co-stained with
aH3K56me3 antibody (red) and DAPI (DNA, blue). Arrows
indicate transfected and GFP-positive cells. Scale bar = 10 mm.
See also Figure 4A for detailed PTM analysis of HeLa cells
transfected with mJmjd2E-GFP. (B) IF microscopy of HeLa Kyoto
cells that were transfected with mJmjd2E-GFP (green) and co-
stained with various histone PTM-specific antibodies (red) and
DAPI (DNA, blue). Arrows indicate transfected and GFP-positive
cells. Scale bar = 10 mm. See also Figure 4B that contains a listing
of the results depicted here.
(TIF)
Table S1 List of peptides used in peptide competition
experiments.
(DOCX)
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Peptide Sequence 
H3K56me0 VALREIRRYQKSTELLIRKL 
H3K56me1 VALREIRRYQK(me1)STELLIRKL 
H3K56me2 VALREIRRYQK(me2)STELLIRKL 
H3K56me3 VALREIRRYQK(me3)STELLIRKL 
H3K9me0 ARTKQTARKSTGGKAPRKQL 
H3K9me1 ARTKQTARK(me1)STGGKAPRKQL 
H3K9me2 ARTKQTARK(me2)STGGKAPRKQL 
H3K9me3 ARTKQTARK(me3)STGGKAPRKQL 
H3K4me3 ARTK(me3)QTARKSTGGKAPRKQL 
H3K64me3 YQKSTELLIRK(me3)LPFQRLVRE 
H3K79me3 LVREIAQDFK(me3)TDLRFQS 
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Suv4-20h2 mediates chromatin
compaction and is important for cohesin
recruitment to heterochromatin
Matthias Hahn,1,2,9 Silvia Dambacher,1,2,9 Stanimir Dulev,1,2 Anastasia Yurievna Kuznetsova,3
Simon Eck,4,5 Stefan Wo¨rz,4,5 Dennis Sadic,1,2 Maike Schulte,1,2 Jan-Philipp Mallm,5,6
Andreas Maiser,1,7 Pierre Debs,8 Harald von Melchner,8 Heinrich Leonhardt,1,7
Lothar Schermelleh,1,7,10 Karl Rohr,4,5 Karsten Rippe,5,6 Zuzana Storchova,3 and Gunnar Schotta1,2,11
1Munich Center for Integrated Protein Science (CiPSM), Ludwig Maximilians University; 2Adolf-Butenandt-Institute, 80336
Munich, Germany; 3Max Planck Institute of Biochemistry, 82152 Martinsried, Germany; 4Department of Bioinformatics
and Functional Genomics, Biomedical Computer Vision Group, Institut fu¨r Pharmazie und Molekulare Biotechnologie
(IPMB), BioQuant, University of Heidelberg, 69120 Heidelberg, Germany; 5Deutsches Krebsforschungszentrum (DKFZ)
Heidelberg, 69120 Heidelberg, Germany; 6Research Group Genome Organization and Function, BioQuant, 69120
Heidelberg, Germany; 7Department of Biology II, Biozentrum, 82152 Munich, Germany; 8Department of Molecular
Hematology, University of Frankfurt Medical School, 60590 Frankfurt am Main, Germany
Cohesin plays an important role in chromatid cohesion and has additional functions in higher-order chromatin
organization and in transcriptional regulation. The binding of cohesin to euchromatic regions is largely mediated
by CTCF or the mediator complex. However, it is currently unknown how cohesin is recruited to pericentric
heterochromatin in mammalian cells. Here we define the histone methyltransferase Suv4-20h2 as a major
structural constituent of heterochromatin that mediates chromatin compaction and cohesin recruitment. Suv4-
20h2 stably associates with pericentric heterochromatin through synergistic interactions with multiple hetero-
chromatin protein 1 (HP1) molecules, resulting in compaction of heterochromatic regions. Suv4-20h mutant cells
display an overall reduced chromatin compaction and an altered chromocenter organization in interphase referred
to as ‘‘chromocenter scattering.’’ We found that Suv4-20h-deficient cells display chromosome segregation defects
during mitosis that coincide with reduced sister chromatid cohesion. Notably, cohesin subunits interact with
Suv4-20h2 both in vitro and in vivo. This interaction is necessary for cohesin binding to heterochromatin, as Suv4-
20h mutant cells display substantially reduced cohesin levels at pericentric heterochromatin. This defect is most
prominent in G0-phase cells, where cohesin is virtually lost from heterochromatin, suggesting that Suv4-20h2 is
involved in the initial loading or maintenance of cohesion subunits. In summary, our data provide the first
compelling evidence that Suv4-20h2 plays essential roles in regulating nuclear architecture and ensuring proper
chromosome segregation.
[Keywords: Suv39h; Suv4-20h2; chromocenter clustering; chromosome segregation; cohesin; heterochromatin]
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Pericentric heterochromatin in mammalian cells is formed
from large arrays of noncoding satellite repeat sequences.
Heterochromatic domains from different chromosomes can
join into large clusters (so-called chromocenters) that can be
visualized as DAPI-dense regions in interphase cells. Peri-
centric heterochromatin is largely transcriptionally inert
but serves important functions in ensuring genomic sta-
bility and accurate chromosome segregation (Peters et al.
2001; Ting et al. 2011; Zhu et al. 2011). Thus, dysregulation
of heterochromatin organization leads to severe diseases
and developmental defects (Hahn et al. 2010).
The major constitutive heterochromatin proteins that
are thought to establish the proper chromatin structure
at pericentric heterochromatin are heterochromatin pro-
tein 1 (HP1) isoforms and the histone methyltransferases
Suv39h and Suv4-20h (Supplemental Fig. S1A). Suv39h
enzymes induce histoneH3Lys 9 trimethylation (H3K9me3)
at heterochromatic regions (Peters et al. 2001). This modi-
fication is recognized by HP1 molecules, which recruit
9These authors contributed equally to this work.
10Present address: Department of Biochemistry, University of Oxford,
Oxford OX1 3QU, United Kingdom.
11Corresponding author
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Suv4-20h histone methyltransferases that subsequently
establish H4K20me3 (Schotta et al. 2004, 2008). It is
assumed that HP1 is a major regulator of heterochroma-
tin organization and compaction. However, this view is
challenged by the fact that HP1 proteins only transiently
associate with heterochromatin (Cheutin et al. 2003).
Therefore, other more constitutive components might
contribute to regulating heterochromatin organization.
During mitosis, pericentric heterochromatin is impor-
tant to facilitate sister chromatid cohesion. This is ac-
complished by cohesin complexes that connect sister
chromatids at pericentric regions until anaphase onset
(Salic et al. 2004; Tang et al. 2004). The cohesin ring
consists of a Smc1–Smc3 dimer that is connected through
the a-kleisin subunit Scc1/Rad21 (Nasmyth 2011). Cohe-
sin is loaded onto chromatin in early G1 phase. Sites of
cohesin loading can differ from regions with the highest
cohesin enrichment, and therefore the cohesin rings are
assumed to slide several kilobases from the loading site
(Lengronne et al. 2004), where they might be fixed by
interactions with other proteins, such as CTCF (Parelho
et al. 2008; Rubio et al. 2008; Wendt et al. 2008). Due to
the large size and compact structure of pericentric re-
gions, there must be loading sites within heterochroma-
tin, and it is therefore likely that core heterochromatin
proteins assist in stable cohesin recruitment within these
domains. In agreement with this hypothesis, cohesin is
recruited to heterochromatic regions by Swi6/HP1 in
fission yeast (Nonaka et al. 2002). However, HP1 proteins
do not interact with cohesin in mammalian cells (Koch
et al. 2008), and it is currently unknown how recruitment
and maintenance of cohesin at pericentric heterochroma-
tin is mediated.
In this study, we discovered an interaction between the
histone methyltransferase Suv4-20h2 and cohesin. We
found that Suv4-20h2 is required for cohesin recruitment
to pericentric heterochromatin. Suv4-20h-deficient cells
have strongly reduced cohesin levels at pericentric het-
erochromatin, resulting in chromosome segregation de-
fects. Thus, our data demonstrate a novel role of the
Suv39h–Suv4-20h pathway in cohesin recruitment to
pericentric heterochromatin.
Results
Suv4-20h2 is a stable component of pericentric
heterochromatin
We first set out to determine whether any of the hetero-
chromatin core proteins could play structural roles in
heterochromatin. We assessed their mobility in embry-
onic stem (ES) cells by fluorescence recovery after photo-
bleaching (FRAP) analysis specifically at pericentric het-
erochromatin (Supplemental Fig. S1B). Consistent with
previous reports (Cheutin et al. 2003), we found that
HP1a is a very mobile protein (Fig. 1A). This is a common
feature of all HP1 variants, as the other isoforms—HP1b
and HP1g—also displayed the same fast recovery kinetics
(K Rippe, pers. comm.). The histone methyltransferases
Suv39h1 and Suv4-20h1 showed intermediate mobility.
Surprisingly, Suv39h2 and Suv4-20h2 stably associate
with heterochromatin, as both proteins showed almost
no recovery on the minute time scale (Fig. 1A). In ad-
dition, we determined the mobility parameters of the
core heterochromatin proteins in another cell system:
mouse embryonic fibroblast cells (MEFs). Interestingly,
the recovery kinetics of all proteins were slower as
compared with ES cells, which is in agreement with the
hypothesis that heterochromatin is less plastic in differ-
entiated cells (Meshorer et al. 2006). Similarly to ES cells,
we found that Suv39h2 and Suv4-20h2 exhibit the stron-
gest binding to heterochromatin (Fig. 1A). These experi-
ments were complemented by fluorescence correlation
spectroscopy (FCS) measurements of Suv4-20h2 at en-
dogenous expression levels (Supplemental Fig. S2). For
these assays, we generated a Suv4-20h2EGFP knock-in ES
cell line that expresses Suv4-20h2 at nearly endogenous
levels (Supplemental Fig. S2B) and displays clear enrich-
ment of Suv4-20h2 and H4K20me3 at pericentric hetero-
chromatin (Supplemental Fig. S2C). FCS mobility mea-
surements confirm that at endogenous expression levels,
the mobile Suv4-20h2 binds more tightly to chromatin
than HP1, since its apparent diffusion coefficient, which
includes the binding contribution, is reduced (Supple-
mental Fig. S2D). Furthermore, the immobile pool of
Suv4-20h2 was ;10 times higher than that of HP1, as
determined from continuous photobleaching experi-
ments (Supplemental Fig. S2E). Taken together, our
data suggest that the histone methyltransferases Suv39h2
and Suv4-20h2 could play structural roles in pericentric
heterochromatin.
Stable binding of Suv4-20h2 is mediated through
synergistic HP1 interactions
The stable binding of Suv4-20h2 to heterochromatin was
also demonstrated in a previous study for human SUV4-
20H2 (Souza et al. 2009), suggesting that this feature of
Suv4-20h2 is evolutionarily conserved. However, as the
bulk of HP1 only transiently associates with heterochro-
matin, it is surprising that Suv4-20h2 can stably bind
heterochromatin. Therefore, we asked how this stable
association of Suv4-20h2 is mediated. The C terminus of
Suv4-20h2 is responsible for heterochromatin targeting
(Schotta et al. 2004). In order to better define the targeting
domain, we generated a panel of EGFP-tagged Suv4-20h2
truncation proteins as subfragments of the C terminus
(Fig. 1B). Fragment M12, which comprises only 62 amino
acids of the Suv4-20h2 C terminus, showed clear peri-
centric enrichment (Fig. 1B; Supplemental Fig. S2F). We
further subdivided this fragment and found that two
nonoverlapping truncations—M13 and M14—were both
able to localize to pericentric heterochromatin as well
(Fig. 1B; Supplemental Fig. S2F). These data indicate that
at least two independent heterochromatin targeting mod-
ules exist in Suv4-20h2. We then asked whether the M12
region is really crucial for mediating pericentric recruit-
ment of Suv4-20h2 and tested the localization of a Suv4-
20h mutant protein lacking the M12 region. We did not
detect enrichment of this mutant protein at pericentric
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Figure 1. Suv4-20h2 is a stable component of pericentric heterochromatin. (A) FRAP analysis of core heterochromatin proteins. EGFP-
tagged proteins were expressed in wild-type ES cells and MEFs. Laser bleaching and analysis of fluorescence recovery were carried out
specifically at pericentric heterochromatin. FRAP recovery experiments for multiple cells (indicated in the legend) were averaged and
fitted to a reaction diffusion model. Error bars represent the standard deviation of the FRAP measurements in each series. (B) Distinct
regions in the C terminus mediate heterochromatin localization of Suv4-20h2. (Top panel) Schematic showing Suv4-20h2 truncation
proteins that were expressed as EGFP fusion proteins in wild-type MEFs. (Bottom panel) Confocal sections of MEFs expressing EGFP-
tagged Suv4-20h2 truncations. Bars, 5mm. (C) In vitro interaction test of Suv4-20h2 truncation proteins and HP1 isoforms. GST-tagged
Suv4-20h2 truncation proteins were bound to GST beads and incubated with recombinant HP1a, HP1b, and HP1g, respectively. Bound
proteins were separated on SDS page and probed with HP1 isoform-specific antibodies. The asterisk indicates cross-reacting bands with
the HP1g antibody. (D) FRAP kinetics of Suv4-20h2 truncation proteins at pericentric heterochromatin. The C-terminal fragment M12
is as stable as the full-length Suv4-20h2 protein. Subfragments of M12 (M13 and M14) show a much faster recovery. FRAP recovery
experiments for multiple cells (indicated in the legend) were averaged and fitted to a reaction diffusion model. Error bars represent the
standard deviation of the FRAP measurements in each series. (E) Suv4-20h2 is more dynamic in HP1a mutant cells. Suv4-20h2 full-
length and truncation proteins were expressed in wild-type and HP1a knockout cells. FRAP kinetics at heterochromatin of all Suv4-
20h2 truncations are faster in HP1amutant cells. FRAP recovery experiments for multiple cells (indicated in the legend) were averaged
and fitted to a reaction diffusion model. Error bars represent the standard deviation of the FRAP measurements in each series.
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heterochromatin (Fig. 1B). Thus, we conclude that the
region comprising amino acids 350–412 represents the
heterochromatin targeting domain in Suv4-20h2.
Heterochromatin targeting of Suv4-20h2 depends on
HP1 proteins (Schotta et al. 2004). We found that Suv4-
20h2 can interact with all three mammalian HP1 iso-
forms in living cells (Supplemental Fig. S3). In vitro
interaction assays revealed that all Suv4-20h2 trunca-
tions that localize to heterochromatin can directly in-
teract with HP1 isoforms (Fig. 1C). Suv4-20h2 fragment
M12 could not be generated as a soluble recombinant
protein. However, as fragmentM5 interacts with HP1 and
fragment M7 does not show interaction with HP1, we
conclude that the HP1 interaction domain resides within
fragment M12. This is further supported by our finding
that fragments M13 and M14, which are subregions of
fragment M12, strongly interact with HP1 (Fig. 1C).
Interestingly, HP1a and HP1g appear as the major in-
teraction partners with both M13 and M14, whereas
HP1b only interacts with fragment M14 (Fig. 1C). These
data are in line with recent reports on HP1 interaction
networks that demonstrate that HP1a and HP1g share
similar interaction partners that do not necessarily over-
lap with HP1b interactors (Vermeulen et al. 2010). In
summary, these data demonstrate that Suv4-20h2 has
multiple independent HP1 interaction sites within its C
terminus.
We further characterized the Suv4-20h2 truncations by
measuring their mobility in heterochromatin using FRAP
analysis. Full-length Suv4-20h2 stably binds to hetero-
chromatin and showed a recovery of only ;10% at 3 min
post-bleaching (Fig. 1D). The Suv4-20h2-M12 truncation
behaved virtually identical to the full-length protein, in-
dicating that this fragment comprises the essential domain
that ‘‘clamps’’ Suv4-20h2 onto heterochromatin (Fig. 1D).
We therefore refer to this region as the Suv4-20h2 ‘‘clamp
domain.’’ Notably, the mobility of the M12 subfragments
M13 and M14 was much higher. While the mobility of
fragment M14 was in the range of HP1, M13 was more
stably bound than HP1 (Fig. 1D), suggesting that distinct
regions in Suv4-20h2 mediate the stable association with
heterochromatin through interactions with HP1 proteins.
To test this hypothesis, we measured the mobility of
the individual Suv4-20h truncations in fibroblasts with
reduced HP1 levels. HP1a knockout cells retained both
H3K9me3 and H4K20me3 at pericentric heterochroma-
tin, indicating that the recruitment of Suv39h and Suv4-
20h enzymes to heterochromatin is not generally im-
paired (Supplemental Fig. S4A). Indeed, the localization of
the Suv4-20h2 truncations was not altered in the absence
of HP1a (Supplemental Fig. S4B). However, the FRAP
recovery kinetics of full-length Suv4-20h2 and trunca-
tions M12 and M13 were clearly enhanced (Fig. 1E). We
did not observe faster recovery of fragment M14, as the
FRAP kinetics of this fragment were already in the range
of HP1 in wild-type cells. In summary, our data suggest
that Suv4-20h2 is bound to heterochromatin through at
least two independent interaction sites by HP1 proteins.
As the individual interactions can only generate inter-
mediate stability (M13 and M14), we postulate that
synergistic interaction with multiple HP1 proteins in the
Suv4-20h2 clamp domain ensures its stable association
with heterochromatin.
Suv4-20h2 regulates chromatin compaction
The tight interaction of Suv4-20h2 with heterochromatin
suggests a direct involvement in regulating the structure
of pericentric heterochromatin. To verify this hypothesis,
we performed micrococcal nuclease (MNase) chromatin
accessibility assays in wild-type, Suv4-20h2 knockout,
and Suv4-20h double-knockout ES cells (Schotta et al.
2008). Notably, we detected higher chromatin accessibil-
ity in both Suv4-20h2 knockout and Suv4-20h double-
knockout cells (Fig. 2A,B). The increased accessibility
clearly involves heterochromatic regions, as demon-
strated by Southern blotting of the digested DNA with
major satellite probes (Fig. 2A,B). A similar increase in
chromatin accessibility was also observed in Suv4-20h-
deficient MEF cells, suggesting that Suv4-20h2 plays
general roles in regulating chromatin structure (Supple-
mental Fig. S5). Importantly, re-expression of Suv4-
20h2, which restores H4K20me3 (Nicetto et al. 2013),
and even of the Suv4-20h2 clamp domain (M12) rescues
the accessibility phenotype of Suv4-20h double-knock-
out cells (Supplemental Fig. S5), indicating that Suv4-
20h2 can induce chromatin compaction through its
clamp domain.
Superresolution three-dimensional (3D) structured illu-
mination microscopy (3D-SIM) is a recently developed
technique that allows imaging of subcellular structures
below the optical diffraction limit (Schermelleh et al.
2008). Using this technique, we detected a slightly re-
duced chromatin density in Suv4-20h double-knockout
cells around the nuclear envelope (Fig. 2C; Supplemental
Fig. S6). We quantified these data by measuring the DAPI
intensity of the nuclear periphery compared with the
overall DAPI intensity of the nuclei (Supplemental
Fig. S6B). These data indicate that wild-type nuclei have
a generally higher chromatin density in the nuclear periph-
ery as compared with Suv4-20h double-knockout cells
(Supplemental Fig. S6C). Interestingly, this reduction in
peripheral heterochromatin correlates with changes in the
distribution of nuclear pores, which are more stochastically
arranged in Suv4-20h double-knockout nuclei (Fig. 2C).
Strong overexpression of Suv4-20h2 results in dramatic
changes of the nuclear structure, most notably in increased
chromatin compaction around chromocenters, nucleoli,
and the nuclear envelope (Fig. 2C; Supplemental Fig. S6A).
The increased density of the peripheral heterochromatin
upon overexpression of Suv4-20h2 is again reflected in
the altered distribution of nuclear pores, which tend to be
excluded from the highly compacted regions. In order to
quantify the effect of Suv4-20h2 on nuclear pore orga-
nization, we developed an automatic 3D image analysis
approach to measure nuclear pore parameters in our
3D-SIM images (Supplemental Fig. S6D). In agreement
with the qualitative analysis of the nuclear pore stain-
ing, we found that the percentage of regions with low
nuclear pore density (sparse nuclear pore regions) was
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Figure 2. Suv4-20h2 mediates chromatin compaction. (A) MNase accessibility assay. Nuclei from wild-type, Suv4-20h2 knockout, and
Suv4-20h double-knockout ES cells were isolated and incubated with increasing amounts of MNase. (Top panel) The digested DNAwas
purified, separated on agarose gels, and stained with ethidium bromide. (Bottom panel) Heterochromatic regions were visualized by
Southern blotting using a major satellite-specific probe. (B, left panel) Overlay of DNA electropherograms obtained from Bioanalyzer
runs of the MNase-digested DNA from wild-type, Suv4-20h2 knockout, and Suv4-20h double-knockout ES cells. The first and the last
sharp peaks represent the markers of the Agilent DNA 12000 kit. (FU) Fluorescence units. (Right panel) Intensity line scan of major
satellite Southern blots. Gray values correspond to signal intensities of the Southern blot. (C) 3D-SIM sections of wild-type and Suv4-
20h double-knockout fibroblasts as well as wild-type cells overexpressing Suv4-20h2-EGFP. Immunofluorescence staining with an anti-
NPC antibody marks nuclear pores. Insets show enlargements of the nuclear envelope. Quantifications of peripheral heterochromatin
density and nuclear pore distribution are shown in Supplemental Figure S6.
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reduced in Suv4-20h double-knockout cells and in-
creased in cell overexpressing Suv4-20h2 (Supplemen-
tal Fig. S6E).
We further asked which part of Suv4-20h2 would be
responsible for the compaction phenotype. Overexpres-
sion of the N terminus containing the SET domain does
not lead to obvious alterations of the nuclear structure
(Supplemental Fig. S7). In contrast, the C terminus of
Suv4-20h2 is very potent in inducing chromatin compac-
tion (Supplemental Fig. S7). The Suv4-20h2 clamp do-
main does not show a compaction phenotype. Interest-
ingly, these data show that Suv4-20h2 has important roles
in regulating nuclear architecture, which is independent
of its function as a histone methyltransferase.
Chromocenter scattering in Suv4-20h-deficient cells
Our data so far demonstrate that Suv4-20h2 is a major
regulator at different levels of chromatin organization
in vivo. On the one hand, the observed alterations in
chromatin accessibility suggest that Suv4-20h2 regulates
compaction of chromatin fibers. On the other hand, the
structural changes in Suv4-20h-deficient and overex-
pressing cells indicate that Suv4-20h2 might even medi-
ate long-range interactions between chromatin domains.
We therefore investigated whether organization of peri-
centric heterochromatin is altered in Suv4-20h double-
knockout cells. In mouse cells, heterochromatic regions
of different chromosomes interact and form clusters,
which are well discernible by DAPI staining. How this
clustering is mediated is unknown. In order to visualize
pericentric heterochromatin very precisely, we performed
fluorescence in situ hybridization (FISH) detection of
major satellite repeats in G0-arrested cells to investigate
the steady-state situation of heterochromatin in the
absence of cell cycle perturbations (Fig. 3A). Stacks of
confocal images were evaluated using an image seg-
mentation procedure to detect and measure individual
FISH foci (Supplemental Fig. S8). In wild-type cells, we
detected;25–30 foci (Fig. 3A,B), which is consistent with
previous data on chromocenter clustering in mouse
fibroblasts (Guenatri et al. 2004). Suv4-20h double-knock-
out cells, in contrast, showed chromocenter scattering, as
we observed significantly more foci per nucleus (Fig.
3A,B; Supplemental Fig. S9). At the same time, the
average focus volume was smaller in the mutant cells
(Fig. 3B). Notably, re-expression of full-length Suv4-20h2
in Suv4-20h double-knockout cells (DKO+FL) restores
the altered nuclear organization of pericentric hetero-
chromatin close to wild-type levels (Fig. 3B). Re-expres-
sion of the Suv4-20h2 clamp domain (M12) did not lead
to a significant rescue (Fig. 3B; Supplemental Fig. S9),
suggesting that although the clamp domain of Suv4-20h2
is necessary and sufficient to induce chromatin com-
paction as measured by MNase accessibility, additional
features of the full-length protein are required to mediate
long-range chromatin interactions like chromocenter
clustering. Therefore, we asked whether chromocen-
ter organization can be restored by a Suv4-20h2 mu-
tant protein lacking methyltransferase activity (Nicetto
et al. 2013). Re-expression of Suv4-20h2N182A,Y217A
(SET*) could not significantly reduce chromocenter
Figure 3. Suv4-20h-deficient cells display chromo-
center scattering. (A) FISH analysis of major satellite
repeats in G0-phase wild-type, Suv4-20h double-
knockout, and Suv4-20h2 rescue cells expressing
Suv4-20h2 full-length protein (DKO+FL) or the
Suv4-20h2 clamp domain (DKO+M12). (B) Quanti-
fication of major satellite FISH analyses. Chromo-
center foci were counted and measured using an
image segmentation analysis of confocal 3D stacks.
Box plots showing the numbers of chromocenters
and the chromocenter volume in wild-type (n = 43),
Suv4-20h double-knockout (n = 35), DKO+FL (n =
28), and DKO+M12 (n = 24) nuclei. The mean
number of foci per nucleus is significantly different
between wild-type and Suv4-20h double-knockout
as well as between Suv4-20h double-knockout and
DKO+FL. Detailed statistical tests are provided in
the Supplemental Material and in Supplemental
Figure S9.
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scattering (Supplemental Fig. S10), indicating that estab-
lishment of H4K20me3 is important for normal chro-
mocenter organization.
Based on our data, we propose that Suv4-20h2 canmedi-
ate interactions between chromatin fibers by binding to
H3K9me3-rich and HP1-rich domains. Loss of Suv4-20h
enzymes would lead to a compromised heterochromatin
organization, although H3K9me3 and HP1 are still present
at heterochromatic regions.
Suv4-20h-deficient cells display chromosome
segregation defects
Defects in heterochromatin organization often coincide
with genomic instability. Therefore, we examined Suv4-
20h mutant cells for chromosome segregation defects
by analyzing mitotic figures. Significantly more mitotic
abnormalities, such as anaphase bridges and lagging
chromosomes, could be observed in the Suv4-20h dou-
ble-knockout cells (Fig. 4A). These defects can be res-
cued by expression of Suv4-20h2 full-length protein
(DKO+FL) and even by expression of the Suv4-20h2 clamp
domain (DKO+M12), demonstrating that Suv4-20h2 is
important for proper chromosome segregation (Fig. 4A).
An analysis of different mitotic stages revealed that the
segregation defects are not due to an altered progression
through mitosis (Supplemental Fig. S11). Therefore, we
tested whether key checkpoint proteins (AurB and Sgo1)
or HP1 were altered in the absence of Suv4-20h enzymes.
No obvious difference for either of these proteins was
observed. However, we found that the centromere dis-
tance, as measured by the distance between adjacent
CenpA foci, was wider in Suv4-20h double-knockout
cells (Fig. 4B). Statistical evaluation confirmed an, on
average, 100-nm increased centromere distance in mi-
totic spreads of Suv4-20h double-knockout cells (Fig. 4C).
Figure 4. Suv4-20h mutants display chromosome segregation defects. (A) Suv4-20h mutant cells have mitotic chromosome
segregation defects. Mitotic cells of wild-type (n = 1497), Suv4-20h double-knockout (n = 1242), and rescue MEFs (DKO+FL, n = 768;
DKO+M12, n = 687) were assessed for anaphase bridges and lagging chromosomes (the right panel shows representative pictures of
these defects). P-values of Student’s t-test are indicated. Error bars correspond to standard deviation. (B) Mitotic marker analysis.
Chromosome spreads of wild-type and Suv4-20h double-knockout cells were stained for specific markers that are known to be
important for chromosome segregation. Representative pictures of mitotic chromosomes are shown. (C) Mean distance of CenpA foci
in wild-type (n = 458), Suv4-20h double-knockout (n = 348), DKO+FL (n = 242), and DKO+M12 (n = 318) mitotic chromosomes. P-values
of Student’s t-test are indicated.
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Re-expression of Suv4-20h2 (DKO+FL) or of the Suv4-
20h2 clamp domain (DKO+M12) lead to centromere
distances comparable with wild-type cells (Fig. 4C).
These data indicate that Suv4-20h2 is important for
mediating normal sister chromatid cohesion. Reduced
cohesion in Suv4-20h double-knockout cells in turn leads
to mitotic abnormalities such as lagging chromosomes
and anaphase bridges.
Suv4-20h2 interacts with cohesin
We thus hypothesized that in addition to having a struc-
tural role in heterochromatin, Suv4-20h2 may recruit
additional proteins that facilitate sister chromatid co-
hesion. We performed GST pull-down assays to identify
potential interaction partners of Suv4-20h2 using two
different C-terminal truncation proteins (Supplemental
Fig. S12A). The first region, M5, comprises the clamp
domain, whereas the second fragment, M7, contains the
very C terminus that does not localize to heterochroma-
tin (see Fig. 1B). We could clearly precipitate all HP1
isoforms with fragment M5 (Fig. 5A), confirming the
direct interaction of HP1 with the Suv4-20h2 clamp
domain. Interestingly, additional proteins consistently
found to coprecipitate with Suv4-20h2-M5 were subunits
of the cohesin complex (Fig. 5A; Supplemental Table S1).
The GST pull-down experiments were performed using
sonicated nuclear extracts that contain genomic DNA
and large chromatin fragments. In order to test whether
cohesin indirectly associates with Suv4-20h2 through
DNA, we repeated the GST pull-down assays using
extracts that were treated with benzonase to degrade all
forms of RNA and DNA. Accordingly, extracts treated
with benzonase were devoid of any contaminating DNA
(Supplemental Fig. S12B). When using benzonase-treated
extracts in GST pull-down assays, we clearly detected
binding of both HP1 and cohesin subunits to Suv4-20h2-
M5 (Fig. 5B). Similar results were obtained when extracts
were treated with ethidium bromide, which disrupts
DNA–protein interactions (Fig. 5B).
In order to verify that Suv4-20h2 interacts with cohesin
subunits in vivo, we performed coimmunoprecipitation
experiments using a Suv4-20h2HA-Flag knock-in cell line.
In this cell line, the endogenous Suv4-20h2 locus is
modified to produce a HA-3xFlag-tagged fusion protein,
ensuring endogenous expression levels (Supplemental
Fig. S12C). We developed a two-step extraction protocol
to remove the bulk of cohesin through digestion of the
DNAwith benzonase (fraction I), followed by salt extrac-
tion of Suv4-20h2 and the remaining cohesin (fraction II).
Flag affinity purification of Suv4-20h2 from fraction II
extracts coprecipitated cohesin subunits (Fig. 5C). In the
reverse experiment, cohesin subunit Smc1 could copre-
cipitate Suv4-20h2HA-Flag (Fig. 5C). We did not detect
interaction of unrelated proteins such as Suz12, confirm-
ing the specificity of the Suv4-20h2-cohesin interaction.
In the pull-down experiments, we found that Suv4-20h2
fragment M5, containing the clamp domain, interacts
with cohesin subunits. To test whether the clamp domain
is important to mediate interaction with cohesin, we
Figure 5. Suv4-20h2 interacts with cohesin
subunits. (A) GST pull-down of Suv4-20h2
truncation proteins. Suv4-20h2 truncations—
heterochromatin-associated (M5) and disperse
nuclear (M7)—were expressed as recombi-
nant GST-tagged proteins, incubated with
nuclear extracts, and bound to affinity beads.
Mass spectrometry identification of bound
proteins revealed HP1 isoforms and two co-
hesin subunits to specifically interact with
Suv4-20h2 fragment M5 (summary of tripli-
cate experiments). The number of unique
spectra that were identified for each protein
in the mass spectrometry analysis is indicated
(Scaffold analysis). The full list of identified
proteins is shown in Supplemental Table S1.
(B) GST pull-down experiments. Benzonase-
treated nuclear extracts contain no detect-
able DNA contamination. Ethidium bromide
treatment disrupts protein–DNA interac-
tions. Western blots for GST pull-down ex-
periments using recombinant GST, Suv4-
20h2-M5, and Suv4-20h2-M7 were probed
for GST, HP1a, and Smc1. The Input lane
contains the nuclear extract. Degradation
products of the GST-tagged proteins are in-
dicated by asterisks. (C) Suv4-20h2 and co-
hesin interact in vivo. Fractionated nuclear
extracts were prepared from wild-type (wt)
and Suv4-20h2HA-Flag knock-in (KI) ES cells. Suv4-20h2 and Smc1 were precipitated from fraction II extracts using Flag and Smc1
antibodies, respectively. Bound proteins were visualized by Western blotting using Flag, Smc1, Smc3, and Suz12 antibodies.
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performed immunoprecipitation experiments in cells
expressing full-length Suv4-20h2 or Suv4-20h2-DM12,
which lacks the clamp domain. We detected interaction
of cohesin with full-length Suv4-20h2 but not with Suv4-
20h2-DM12 (Supplemental Fig. S12D), suggesting that the
clamp domain is important to facilitate interaction with
cohesin.
Reduced heterochromatin-associated cohesin
in Suv4-20h-deficient cells
To test whether Suv4-20h2 plays a role in recruiting
cohesin to heterochromatin, we performed chromatin
immunoprecipitation (ChIP) experiments for cohesin
subunits and tested their enrichment at major satellite
repeats and control regions outside of pericentric het-
erochromatin. In wild-type cells, heterochromatin is en-
riched for repressive histone modifications (H3K9me3
and H4K20me3) and cohesin subunits (Fig. 6A; Supple-
mental Fig. S13). Strikingly, in Suv4-20h double-knockout
cells, cohesin subunits were strongly reduced at major
satellite repeats (Fig. 6A; Supplemental Fig. S13) but not
at the control regions where cohesin is recruited through
different mechanisms (Parelho et al. 2008; Rubio et al.
2008; Wendt et al. 2008). We observed reduced heterochro-
matin-associated cohesin in two independent Suv4-20h2
Figure 6. Suv4-20h2 is important for cohesin recruitment to pericentric heterochromatin. (A) Suv39h double-knockout and Suv4-20h
double-knockout cells display reduced cohesin levels at pericentric heterochromatin. ChIP analysis of histone modifications and the
cohesin subunits Smc3 in wild-type, Suv39h double-knockout, and Suv4-20h double-knockout cells at major satellite repeats. Merge of
two experiments in two independent cell lines with three technical replicates each. Error bars represent standard deviation over all
experiments. (B) Cohesin levels are not generally impaired in Suv4-20h double-knockout cells. Protein extracts of proliferating (left
panel) or G0-arrested (right panel) wild-type and Suv4-20h double-knockout cells were tested for cohesin levels by Western blot for
Smc1 (cohesin) and tubulin (loading control). Two different amounts of cell extracts were loaded. (C) Cohesin establishment can be
mediated by the Suv4-20h2 clamp domain. ChIP analysis of H4K20me3 and cohesin (Smc3) at major satellite repeats. Expression of full-
length Suv4-20h2 (DKO+FL) restores H4K20me3 and cohesin in Suv4-20h double-knockout cells. Cohesin is partially rescued by
expression of the Suv4-20h2 clamp domain (DKO+M12). Merge of two independent experiments with three technical replicates. Error
bars represent standard deviation over all experiments. (D) FACS analysis of wild-type cells in G0, S, and M phase. Cells were isolated as
described and stained with propidium iodide prior to FACS analysis. (E) Suv4-20h enzymes are essential for cohesin recruitment to
heterochromatin. Wild-type, Suv4-20h double-knockout, and rescue cell lines (DKO+M12 and DKO+FL) were harvested in G0, S, and
M phase. ChIP analysis for H3K9me3, H4K20me3, and cohesin (Smc3) at major satellite repeats was performed in two independent
experiments with three technical replicates. Error bars represent standard deviation over all experiments.
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knockout and two independent Suv4-20h double-knockout
cell lines (Supplemental Fig. S13). Cohesin levels are not
generally reduced in Suv4-20h double-knockout cells
(Fig. 6B), suggesting specific defects in recruitment of
cohesin to heterochromatin. Association of Suv4-20h2
with pericentric heterochromatin depends on Suv39h-
mediated H3K9me3 and HP1 association. Therefore, we
tested cohesin levels in Suv39h double-knockout cells
that have lost both H3K9me3 and H4K20me3 at peri-
centric heterochromatin (Fig. 6A). Importantly, reduced
cohesin levels could also be detected in two indepen-
dent Suv39h double-knockout cell lines (Fig. 6A; Sup-
plemental Fig. S14), demonstrating that the Suv39h–
Suv4-20h pathway is important for cohesin recruitment
to heterochromatin.
We then asked whether Suv4-20h2 is responsible for
cohesin recruitment to heterochromatin by rescue exper-
iments in Suv4-20h double-knockout cells. Expression
of full-length Suv4-20h2 (DKO+FL) could rescue both co-
hesin and H4K20me3 at major satellite repeats (Fig. 6C).
Interestingly, the Suv4-20h2 clamp domain (DKO+M12)
could also increase cohesin levels at heterochromatin,
although this truncation protein lacks the SET domain
and thuswas unable to restoreH4K20me3 (Fig. 6C). Cohesin
at control regions was not affected in the different rescue
experiments (Supplemental Fig. S15). We conclude that
Suv4-20h2 plays an important role in recruiting cohesin
to heterochromatic regions through interactions with co-
hesin subunits.
Suv4-20h2 is important for the initial recruitment
of cohesin to pericentric heterochromatin
Finally, we investigated whether Suv4-20h2 is involved
in the initial recruitment/maintenance of cohesin at
heterochromatin. Loading of cohesin onto chromatin
occurs in early G1 phase (Watrin et al. 2006). In the
subsequent cell cycle stages, cohesin ismaintained on the
chromosomes until mitosis. During metaphase, cohesin
is removed from chromosome arms by proteolytic cleav-
age (Hauf et al. 2001). Only cohesin at pericentric het-
erochromatin is maintained until the onset of anaphase
to ensure sister chromatid cohesion (Salic et al. 2004;
Tang et al. 2004). In order to investigate whether Suv4-
20h2 is implicated in cohesin loading or maintenance, we
analyzed cohesin levels in different cell cycle stages. We
synchronized cells in G0, S, and G2/M phase (Fig. 6D;
Supplemental Fig. S16) and prepared chromatin for ChIP
analysis. We found that cohesin levels varied only slightly
over the cell cycle in wild-type cells (Fig. 6E). In contrast,
in Suv4-20h double-knockout cells, cohesin was basically
absent from heterochromatic regions in G0 phase, sug-
gesting that Suv4-20h enzymes are crucial for loading
and/or maintaining cohesin at heterochromatin. At later
stages in the cell cycle (S and G2/M phase), cohesin levels
increased (Fig. 6E), indicating that additional, Suv4-20h-
independent recruitment mechanisms exist during S phase.
The loss of heterochromatin-associated cohesin in Suv4-
20h double-knockout cells could be rescued by expressing
the clamp domain (M12) or full-length Suv4-20h2 (Fig. 6E),
whereas cohesin recruitment at unrelated control regions
was not affected in the rescue cells (Supplemental Fig. S17).
Thus, our data demonstrate that Suv4-20h2 is an important
factor for cohesin loading onto heterochromatin.
Discussion
Heterochromatin is a very abundant chromatin state in
mammalian cells, as >30% of the mammalian genome
is composed of repetitive sequences that need to be si-
lenced. Heterochromatin is therefore characterized by
low transcriptional activity and features a less accessible
chromatin structure. These special properties of hetero-
chromatin are established in a step-wise manner. First,
specific proteins need to recognize heterochromatic se-
quences (Bulut-Karslioglu et al. 2012). Second, hetero-
chromatin becomes marked with distinct histone mod-
ifications that recruit additional binding proteins to
ultimately mediate the special properties of this chroma-
tin state. In vivo, heterochromatin is not a stiff entity, but
rather a dynamic equilibrium of a protein interaction
network. Thus, it can both reduce chromatin accessibil-
ity under steady-state conditions and open up chromatin
structure in response to specific stimuli; for example,
DNA damage (Goodarzi et al. 2008). Here we demon-
strate that Suv4-20h2 is an important constituent of this
interaction network for regulating chromatin accessibil-
ity and long-range chromatin interactions. In ES cells and
fibroblasts, these functions do not seem to be shared with
Suv4-20h1, which features a different heterochromatin
targeting domain that is not homologous to the Suv4-
20h2 clamp domain and does not bind so tightly to
heterochromatin (Supplemental Fig. S18A).
How is Suv4-20h2 integrated into this network and
how can it affect heterochromatin structure? Heterochro-
matin displays abundant H3K9me3, which provides a
binding interface for HP1 proteins. Although HP1 shows
only a weak affinity to H3K9me3 in vitro, the high den-
sity of H3K9me3 can lead to a high HP1 abundance in
heterochromatin. We found that Suv4-20h2 features mul-
tiple HP1 interaction sites in its clamp domain, which can
explain its stable association with regions that feature
high HP1 concentrations. The interaction with multiple
HP1 proteins raises an interesting hypothesis that Suv4-
20h2 might bridge H3K9me3- and HP1-rich chromatin
fibers to render chromatin less accessible. In agreement
with this view, we found that chromatin in cells lacking
Suv4-20h2 is indeed more accessible to nucleases. No-
tably, the level of Suv4-20h2 can alter the balance within
the heterochromatin interaction network and may
therefore modulate the functions of its interacting pro-
teins, like HP1. Another protein that may be affected by
Suv4-20h2 is the linker histone H1. This is inferred by
the observed alterations in the nucleosome repeat length
in Suv4-20h double-knockout cells (Fig. 2B), which is
a typical feature of cells with reduced levels of histone
H1 (Fan et al. 2005). The current knowledge of the
topology of the heterochromatin interaction network is
insufficient to distinguish direct effects from indirect
effects. However, our data demonstrate that Suv4-20h2
Hahn et al.
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is a central node within this network, and therefore
changes of Suv4-20h2 levels lead to drastic alterations in
nuclear architecture.
Interestingly, the clamp domain of Suv4-20h2 is neces-
sary and sufficient for chromatin compaction, as Suv4-
20h double-knockout cells expressing this domain dis-
play normal chromatin accessibility. However, the clamp
domain is not sufficient to mediate long-range chromatin
interactions and condensation of large chromatin do-
mains. Therefore, other domains in Suv4-20h2, such as
an active SET domain, or recruitment of additional pro-
teins are required for these functions. An intriguing
possibility is that heterochromatin-associated cohesin,
which is recruited by Suv4-20h2, is implicated in these
long-range interactions (Hadjur et al. 2009; Kagey et al.
2010; Degner et al. 2011). Recent evidence suggests that
cohesin may be involved in regulating the condensation
of heterochromatic domains. Cohesin is present in a bal-
ance between a chromatin-associated form and a free
form that is adjusted by a loading–releasing cycle (Kueng
et al. 2006; Gause et al. 2010). Perturbation of this balance
by knockdown of the cohesin-releasing factor WAPL
leads to increased cohesin association with chromatin
and a dramatic chromatin compaction phenotype (Seitan
and Merkenschlager 2012). However, we could not detect
significant perturbations in chromocenter organization in
cells lacking the cohesin subunit Scc1/Rad21 (Supple-
mental Fig. S19). Therefore, we expect that other proteins
that interact with Suv4-20h2 outside of the clamp do-
main are necessary to mediate chromocenter clustering.
Although cohesin appears to be dispensable for nu-
clear architecture in interphase cells, heterochromatin-
associated cohesin is absolutely crucial for sister chro-
matid cohesion during mitosis. How cohesin is loaded
onto chromatin and how the cohesin ring stabilizes
interactions between chromatids are currently unclear
(Nasmyth 2011). We found that the Suv39h–Suv4-20h
pathway is important for the loading of cohesin to
pericentric heterochromatin (Fig. 7). Our data are consis-
tent with a study demonstrating that Suv39h-deficient
cells display defects in sister chromatid cohesion and
chromosome segregation (Koch et al. 2008). Although
Koch et al. (2008) could not demonstrate that cohesin
levels in Suv39h double-knockout cells were reduced,
this may be due to their semiquantitative ChIP analysis,
which is not suitable for highly repetitive sequences. We
clearly detected reduced cohesin levels at major satellite
repeats in different Suv39h double-knockout, Suv4-20h
double-knockout, and Suv4-20h2 knockout cell lines. In
none of these cell lines, cohesin was completely lost from
heterochromatin, suggesting additional loading pathways.
Based on our data, we conclude that the primary function
of Suv39h enzymes is to prepare pericentric heterochro-
matin for HP1 recruitment, which is a prerequisite for
stable association of Suv4-20h2. Cohesion recruitment is
then facilitated through interactions of cohesin subunits
with Suv4-20h2 and possibly additional factors. Suv4-20h1
does not interact with cohesin and is therefore unlikely
to contribute to cohesin recruitment (Supplemental Fig.
S18C). Interestingly, cohesin recruitment can be mediated
at least partially through the Suv4-20h2 clamp domain. As
this domain can interact with cohesin and also induce
chromatin compaction, it is not possible to distinguish
which of the two functions is more relevant for cohesin
recruitment to heterochromatin.
The cell cycle analysis revealed that Suv4-20h2 is
essential for cohesin loading in G0 phase. During later
stages of the cell cycle, Suv4-20h2-independent pathways
can recruit cohesin to heterochromatin. This would ex-
plain why mitosis is not completely blocked and why
comparably mild mitotic phenotypes were detected in
Suv4-20h-deficient cells. Importantly, our data are consis-
tent with other reports that demonstrate that the fidelity
ofmitosis is already compromised when heterochromatin-
associated cohesin levels are only reduced (Eckert et al.
2007). A low level of mitotic defects can therefore ensure
survival of the cells but contributes to genomic instability.
Dysregulation of pericentric heterochromatin has been
suggested to play important roles in cancer development
and progression (Hahn et al. 2010; Zhu et al. 2011).
Cancer cells are frequently characterized by genomic
instability and cohesion defects (Thompson et al. 2010),
but the mechanisms are still poorly understood. Previous
analyses have shown that a reduced level of H4K20me3,
which is an indirect measure for the presence of Suv4-20h
enzymes, characterizes different human tumors (Fraga
et al. 2005). In light of our data, we hypothesize that Suv4-
20h2 might be an important cohesin recruitment factor
in human cells. Its dysregulation could lead to reduced
levels of heterochromatin-associated cohesin, which in
turn contributes to the genomic instability that is char-
acteristic of many human tumors and could explain the
negative survival prognosis with tumors that have low
H4K20me3 levels (Van Den Broeck et al. 2008; Schneider
et al. 2011).
Materials and methods
FRAP
FRAP measurements were performed in MEF and ES cell lines
after transient expression of EGFP-tagged proteins. Analysis of
the recovery curves of the intensity integrated over the region of
interest (ROI) was done using FREDIS software (Muller et al.
2009). For Figure 1, the averaged recovery curves were fitted to
a diffusion model or a reaction diffusion model that incorporates
both diffusion and binding processes.
HP1 interaction test
GST fusion proteins of Suv4-20h2, HP1a, HP1b, and HP1g were
expressed in Escherichia coli and purified using glutathione-
S-sepharose beads (Amersham Biosciences). The GST tag was
subsequently removed using PreScission protease. Interaction
tests were performed by incubating 5 mg of GST-Suv4-20h2
fusion protein with 5 mg of either HP1a, HP1b, or HP1g for 1 h
at room temperature on a rotating wheel.
Chromatin accessibility assay
Nuclei of wild-type, Suv4-20h2 knockout, and Suv4-20h2 dou-
ble-knockout ES cells and wild-type, Suv4-20h double-knockout,
Suv4-20h2 recruits cohesin to heterochromatin
GENES & DEVELOPMENT 869
 Cold Spring Harbor Laboratory Press on May 13, 2013 - Published by genesdev.cshlp.orgDownloaded from 
DKO+FL, and DKO+M12 fibroblast cell lines were digested with
different amounts of MNase (Sigma) according to Gilbert et al.
(2007). Genomic DNAwas purified and separated on a 1% agarose
gel or loaded onto a DNA LabChip (Agilent Technologies).
3D-SIM
Superresolution 3D-SIM of immunofluorescently labeled and
DAPI-stained nuclei was performed as previously described
(Schermelleh et al. 2008) on a DeltaVision OMX V3 system
(Applied Precision) equipped with a 1003/1.40 NA PlanApo oil
immersion objective (Olympus) and Cascade II:512 EMCCD
cameras (Photometrics) using 405-nm and 592-nm diode laser.
Mitotic abnormalities
To quantify the number of abnormal mitotic figures in MEF
cells, mitotic cells were collected by shake-off, spun onto a glass-
bottomed 96-black well plate (Greiner Bio-One) for 5 min at
400g, fixed in 4% formaldehyde, and stained with VectaShield
containing DAPI.
Coimmunoprecipitation
Nuclei of wild-type and Suv4-20h2HA-Flag ES cells were sequen-
tially extracted with low-salt (fraction I) and high-salt (fraction II)
immunoprecipitation buffer and incubated with 5 mg of either
Figure 7. Model for Suv4-20h2-mediated chromatin compaction. (A) Functional domains in Suv4-20h2. The SET domain is the
catalytic domain that induces H4K20me3. Establishing this modification is important to mediate chromocenter clustering. The clamp
domain is essential to recruit Suv4-20h2 to pericentric heterochromatin. The clamp domain also mediates the Suv4-20h2-cohesin
interaction and thus the recruitment of cohesin to heterochromatin. (B) Model showing the role of the Suv39h–HP1–Suv4-20h pathway
for chromatin compaction and cohesin recruitment to pericentric heterochromatin. Based on our data, we propose that Suv4-20h2 can
mediate interactions between chromatin fibers by binding to H3K9me3-rich and HP1-rich domains. The loss of Suv4-20h enzymes
leads to a compromised heterochromatin organization (reduced chromatin compaction and chromocenter scattering) although
H3K9me3 and HP1 are still present at heterochromatic regions. In G0/G1 cells, the interaction with Suv4-20h2 is important for
cohesin recruitment to pericentric heterochromatin. Cohesin is not completely lost from mitotic chromosomes due to alternative,
Suv4-20h-independent loading pathways during S/G2 phase.
Hahn et al.
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Flag M2 antibody (Sigma) or Smc1 antibody (Bethyl Laboratories)
coupled to ProteinA/G magnetic beads (Dynabeads, Invitrogen)
overnight at 4°C on a rotating wheel. Bound proteins were
separated on SDS–polyacrylamide gels and analyzed by Western
blotting.
ChIP
ChIP experiments were performed as in Samoshkin et al. (2012)
using the following antibodies: anti-H3K9me3 (Abcam, #ab8898),
anti-H4K20me3 (Active Motif, #39180.3918; or Millipore,
#07-463), anti-Rad21 (Abcam, #ab992), and anti-Smc3 (Abcam,
#ab9263).
Automatic 3D quantification of FISH foci
Major satellite FISH experiments were performed according to
Markaki et al. (2013). To determine quantitative information of
FISH major satellite repeats from the acquired two-channel 3D
confocal microscopy images, we developed a fully automatic 3D
image analysis approach consisting of 3D cell nuclei segmenta-
tion and 3D foci segmentation.
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SUPPLEMENTAL DATA 
Figure S1. FRAP analysis of heterochromatin core proteins. 
(A) Heterochromatin is marked by two prominent histone modifications, H3K9me3 
and H4K20me3. Suv39h enzymes are recruited by currently unknown mechanisms 
to pericentric heterochromatin and induce H3K9me3. This modification is then bound 
by HP1 proteins. Suv4-20h proteins bind to heterochromatin in an HP1-dependent 
manner and induce H4K20me3. (B) FRAP analysis in wild type fibroblast cells 
expressing HP1α-EGFP or Suv4-20h2-EGFP. Red circle marks the bleached region 
which corresponds to pericentric heterochromatin. 
 
Figure S2. Mobility of Suv4-20h2 at endogenous expression level 
(A) Suv4-20h2 knock-in strategy to express C-terminally tagged Suv4-20h2-EGFP 
from the endogenous locus. The region of the targeting construct is shown as bold 
line. After homologous recombination, exon 8 contains an insertion of the EGFP 
open reading frame just before the regular STOP codon, followed by a neomycin 
resistance cassette. (B) Western blot of Suv4-20h2EGFP and wild type ES cells using 
an antibody specifically recognizing Suv4-20h2 (Dambacher et al. 2012). (C) 
Confocal microscopy section of Suv4-20h2EGFP knock-in cells. The EGFP-tagged 
Suv4-20h2 is clearly enriched at pericentric heterochromatin, together with 
H4K20me3. (D) Quantification of the transiently bound pool Suv4-20h2 and HP1 
isoforms via FCS in terms of the apparent diffusion coefficient. (E) Immobile fraction 
of Suv4-20h2 and HP1β as measured by continuous photobleaching. (F) Western 
blot of wild type fibroblast cells which were transiently transfected with EGFP-tagged 
Suv4-20h2 truncations. Due to variations in transfection efficiency the expression 
levels of the different truncations cannot be directly compared. The minus sign (-) 
denotes an empty lane. 
 
 
Figure S3. In vivo HP1 interaction test. 
BHK cells containing a lac operator repeat array were co-transfected with expression 
vectors for lacR-GBP, Suv4-20h2-EGFP and HP1 isoforms as mCherry fusions. The 
lacR-GBP fusion protein binds to the lac operator array and recruits Suv4-20h2-
EGFP. All HP1 isoforms interact with Suv4-20h2 in vivo and show co-localization at 
the lac operator arrays. Histograms display the percentage of cells where HP1 
proteins co-localize with EGFP and Suv4-20h2-EGFP, respectively. 
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Figure S4. HP1α knock-out cells display normal heterochromatin marks. 
(A) Wild type and HP1α KO MEFs were stained for HP1α, H3K9me3 and 
H4K20me3. HP1α is not detectable in the HP1α KO cells. H3K9me3 and H4K20me3 
are enriched at heterochromatin in both wild type and mutant cells (scale bars, 5µm). 
(B) Localization of Suv4-20h2 truncation proteins in HP1α KO cells. Confocal 
sections of HP1α KO fibroblasts expressing EGFP-tagged Suv4-20h2 truncations are 
shown (scale bars, 5µm). 
 
Figure S5. Suv4-20h2 mediates chromatin compaction. 
(A)  MNase accessibility assay using fibroblast cell lines. Nuclei from wild type, Suv4-
20h2 DKO and rescue cells expressing full length Suv4-20h2 (DKO+FL) or Suv4-
20h2-M12 (DKO+M12) were isolated and incubated with increasing amounts of 
MNase. The digested DNA was purified, separated on agarose gels and stained with 
ethidium bromide (upper panel). Heterochromatic regions were visualized by 
Southern blotting using a major satellite-specific probe (lower panel). (B) Overlay of 
DNA electropherograms obtained from Bioanalyzer runs of the MNase-digested DNA 
from wild type, Suv4-20h2 DKO and rescue cells (left panel). The first and the last 
sharp peak represent the markers of the Agilent DNA 12000 kit (FU = fluorescence 
units). Intensity linescan of major satellite Southern blots (right panel). Gray values 
correspond to signal intensities of the southern blot.  
 
Figure S6. Reduced peripheral heterochromatin and altered arrangement of 
nuclear pores in Suv4-20h DKO cells. 
(A) 3D-SIM analysis of nuclear structure (DAPI) was performed in wild type, Suv4-
20h DKO and wild type cells over-expressing Suv4-20h2. Inserts are enlargements  
of the nuclear periphery. (B) Nuclear periphery of central sections of the 3D-SIM 
images was automatically segmented to measure DAPI intensities. Example images 
for segmented wild type and Suv4-20h DKO nuclei are shown. The area highlighted 
in blue was used to measure the DAPI intensity of peripheral heterochromatin. (C) 
The relative intensities of peripheral heterochromatin were calculated over several 
3D-SIM images as ratio of peripheral DAPI intensity vs. total nuclear DAPI intensity. 
The  P values of Student’s t-test are indicated. (D) Automated 3D image analysis of 
nuclear pores. 3D-SIM images were automatically segmented based on the DAPI 
channel to identify the nucleus and the anti-NUP staining to identify nuclear pores. 
Image shows an example wild type nucleus as 3D visualization of the segmentation 
result. Black spots – nuclear pores on the top surface; gray spots – nuclear pores on 
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the bottom surface. (E) Quantification of the nuclear pore segmentation. The average 
nuclear pore density is not significantly different between wild type and Suv4-20h 
DKO cells, or cells over-expressing Suv4-20h2 (P values of Student’s t-test). 
Regions with a low density of nuclear pores (sparse nuclear pore regions: less than 2 
pores in a radius of 0.5µm) are less abundant in Suv4-20h DKO cells and are 
strongly increased in cells over-expressing Suv4-20h2 (P values of Chi-square with 
Yates correction). 
 
Figure S7. Large-scale chromatin compaction upon over-expression of Suv4-
20h2. 
Mouse embryonic fibroblast cells were transfected with constructs expressing EGFP 
or EGFP-tagged Suv4-20h2 truncations. 3D-SIM analysis of nuclear structure (DAPI) 
was then performed in EGFP-positive cells. Over-expression of Suv4-20h2 full length 
and C-terminus (aa 280-468) lead to large-scale chromatin compaction (increased 
chromatin density of peripheral heterochromatin and around nucleoli). Neither the N-
Terminus (aa1-280) of Suv4-20h2 nor the clamp domain (M12) lead to obvious 
alterations in nuclear structure.  
 
Figure S8. 3D image segmentation of major satellite FISH experiments. 
Example results of 3D nuclei segmentation (green) and 3D foci segmentation (red) 
for nuclei of three different cell types: wild type cells (first row), Suv4-20h DKO cells 
(second row), and Suv4-20h DKO cells which re-express Suv4-20h2 (third row). The 
first and second column show contours of the 3D segmentation results overlaid with 
the original images (maximum intensity projections, MIPs) of the FISH and DAPI 
channel, respectively. The third column shows 3D visualizations of the segmentation 
results. 
 
Figure S9. Statistical tests for 3D image segmentation results. 
Results of statistical relevance tests performed on the quantified number n of foci per 
nucleus: (A) Shapiro-Wilk test testing the null hypothesis that n is normally distributed 
for wild type cells, Suv4-20h DKO cells and rescue cells (DKO+FL). For DKO+M12 
the null hypothesis is rejected. Therefore a two-sample Wilcoxon Rank Sum Test 
was performed showing no significant differences between DKO and DKO+M12. (B) 
F-test for homogeneity of variances of n (null hypothesis) between different cell 
types, (C) Welch-test for homogeneity of means of n (null hypothesis) between 
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different cell types, indicating that the difference in FISH foci numbers is significantly 
different between wild type and Suv4-20h DKO cells.  
 
Figure S10. The functional SET domain and the clamp domain of Suv4-20h2 are 
important to mediate chromocenter clustering. 
Quantification of FISH analyses of major satellite repeats in G0 phase Suv4-20h 
DKO and Suv4-20h2 rescue cells expressing Suv4-20h2 with deletion of the clamp 
domain (DKO+ΔM12) or Suv4-20h2 containing mutations that render the SET 
domain inactive (DKO+SET*). Chromocenter foci were counted and measured using 
an image segmentation analysis of confocal 3D stacks. Boxplots showing the 
numbers of chromocenters in Suv4-20h DKO (n=28), DKO+ΔM12 (n=25) and 
DKO+SET* (n=25) nuclei. The mean number of foci per nucleus is not significantly 
different between the three cell lines (statistical tests which correspond to the 
analysis in Figure S9 are shown in the right panel). 
 
Figure S11. Mitotic stages in wild type and Suv4-20h DKO MEFs. 
Progression through mitosis is normal in Suv4-20h DKO cells. Different mitotic 
stages were counted for wild type (n=285) and Suv4-20h DKO (n=335) MEFs (P-
prophase, PM/M-prometaphase/metaphase, A-anaphase, T-telophase). 
 
Figure S12. Suv4-20h2 GST pulldown and knock-in strategy. 
(A) GST pulldown experiments were performed as described in materials and 
methods. Proteins which bound to the GST beads were eluted and loaded on a 
protein gel followed by silver staining. Recombinant GST, Suv4-20h2-M5 and Suv4-
20h2-M7 proteins are marked with an arrow head, degradation products of the 
recombinant proteins are marked with asterisks. (B) PCR analysis for major satellite 
repeats with DNA isolated from sonicated extracts that were used for GST pulldown 
experiments and DNA isolated from benzonase-treated extracts. Undigested 
genomic DNA was used as control (gDNA). (C) Knock-in strategy for the Suv4-20h2 
locus. The region of the targeting construct which was used for homologous 
recombination in wild type ES cells is shown as thick line. The knock-in allele 
contains the coding sequence for a HA-3xFLAG tag immediately after the last codon 
of Suv4-20h2. A FRT-flanked neomycin selection cassette was used for positive 
selection of the knock-in clones. (D) The clamp domain in Suv4-20h2 is important for 
cohesin interaction. Nuclear extract was prepared from wild type fibroblast cell lines 
expressing EGFP, Suv4-20h2-EGFP or Suv4-20h2-DM12-EGFP. Suv4-20h2 was 
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precipitated from these extracts using EGFP affinity beads. Bound proteins were 
visualized by western blotting using Suv4-20h2 and Smc1 antibodies. 
 
Figure S13. Cohesin ChIP in wild type, Suv4-20h2 KO and Suv4-20h DKO cells. 
ChIP analysis for histone modifications (H3K9me3, H4K20me3) and cohesin 
subunits (Rad21, Smc3) in wild type (E19-8, W9), Suv4-20h2 KO (E29-7, E27-5) and 
Suv4-20h DKO (E94-4, E35-3) cell lines. Major satellite repeats represent pericentric 
heterochromatin. Control regions where cohesin is enriched independently from 
H3K9me3-H4K20me3 (pos controls: Chr.6, Chr.7, Chr.10) and where cohesin is not 
present (neg. controls: Chr.5, Chr. 6-1, Chr.10-1) are shown. Merge of two 
experiments with three technical replicates, each. Error bars represent standard 
deviation. 
 
Figure S14. Cohesin ChIP in wild type and Suv39h DKO cells. 
ChIP analysis for histone modifications (H3K9me3, H4K20me3) and the cohesin 
subunit Smc3 in wild type (W9) and two independent Suv39h DKO cell lines. Major 
satellite repeats represent pericentric heterochromatin. Control regions where 
cohesin is enriched independently from H3K9me3-H4K20me3 (pos controls: Chr.6, 
Chr.7, Chr.10) and where cohesin is not present (neg. controls: Chr.5, Chr. 6-1, 
Chr.10-1) are shown. Merge of three technical replicates (two independent 
experiments for E124-1). Error bars represent standard deviation. 
  
 
Figure S15. Cohesin ChIP in wild type and Suv4-20h rescue cells. 
ChIP analysis for histone modifications (H3K9me3, H4K20me3) and cohesin (Smc3) 
were performed in wild type cells and Suv4-20h DKO cells which express full length 
Suv4-20h2-EGFP (DKO+FL) or Suv4-20h2-M12 (DKO+M12). The control region 
Chr.6 displays detectable levels of H4K20me3 upon re-expression of Suv4-20h2 in 
DKO cells, which is probably an over-expression effect. Merge of two experiments 
with three technical replicates, each. Error bars represent standard deviation. 
 
Figure S16. FACS analyses of cell cycle synchronized fibroblasts. 
FACS analysis of cells in G0, S and M phase. Cells were isolated as described and 
stained with propidium iodide prior to FACS analysis. 
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Figure S17. Cohesin ChIP in wild type and Suv4-20h rescue cells in different 
cell cycle stages. 
ChIP analysis for histone modifications (H3K9me3, H4K20me3) and the cohesin 
subunit Smc3 were performed in wild type, Suv4-20h DKO and rescue cell lines 
expressing full length Suv4-20h2 (DKO+FL) or the Suv4-20h2 clamp domain 
(DKO+M12). 
 
Figure S18. Suv4-20h1 does not interact with cohesin. 
(A) Suv4-20h1 is a heterochromatin-associated protein. EGFP-tagged full length (C0) 
and different truncations of Suv4-20h1 were expressed in wild type fibroblast cells. 
Fragment C4 is the smallest truncation which is still able to localize to 
heterochromatin. This truncation contains one classical PxVxL HP1 interaction motif. 
(B) Knock-in strategy for the Suv4-20h1 locus. The region of the targeting construct 
which was used for homologous recombination in wild type ES cells is shown as 
thick line. The knock-in allele contains the coding sequence for a HA-3xFLAG tag 
immediately after the last codon of Suv4-20h1. A FRT-flanked neomycin selection 
cassette was used for positive selection of the knock-in clones. (C) Suv4-20h1 does 
not interact with cohesin. Nuclear extracts were prepared from wild type (wt) and 
Suv4-20h1HA-FLAG knock-in ES cells (KI). Suv4-20h1 was precipitated from these 
extracts using a FLAG antibody. Bound proteins were visualized by western blotting 
using FLAG and Smc1 antibodies. 
 
Figure S19. Cohesin is not important to mediate chromocenter clustering. 
(A) Inducible deletion of Scc1/Rad21. Scc1f/+; Cre-ERT2 and Scc1f/f; Cre-ERT2 (cko) 
cells (Seitan et al. 2011). Fibroblasts  were arrested in G0 by serum deprivation. 
Addition of 4-OHT activates the Cre recombinase which leads to conversion of the 
Scc1 flox to a Scc1 mutant allele. Three weeks after addition of 4-OHT total cell 
extracts were prepared and analyzed for Scc1 protein levels compared to tubulin 
loading control. In 4-OHT-induced Scc1 cko cells Scc1 protein is not detectable. The 
reduced signal intensity in lane 2 (induced Scc1f/+ cells) is due to reduced loading. 
(B) Quantification of FISH analyses of major satellite repeats in G0 phase non-
induced (control) vs. 4-OHT induced Scc1 cko cells. Chromocenter foci were counted 
and measured using an image segmentation analysis of confocal 3D stacks. 
Boxplots showing the numbers of chromocenters in Scc1 control (n=25) and Scc1 
cko (n=28) nuclei. The mean number of foci per nucleus is not significantly different 
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between the two cell lines (statistical tests which correspond to the analysis in Figure 
S9 are shown in the right panel). 
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Cloning of Suv4-20h2-ΔM12: 
Internal deletion mutants of the Suv4-20h2 cDNA were created by inverse PCR on 
the Suv4-20h2 wild type plasmid pDONR207-Suv4-20h2 using a reverse primer 
upstream and a forward primer downstream of the M12 region. Primer overhangs 
were designed to create 15 bp complementary ends on both sides of the PCR 
product to allow seamless recircularization using the Infusion HD cloning kit 
(Clontech). 
 
Cell culture 
MEF and ES cells were cultivated in High Glucose DMEM with L-Glutamine 
complemented with sodium pyruvate, fetal calf serum, beta-mercaptoethanol, non-
essential amino acids (PAA) and penicillin/streptomycin (PAA) in a 37°C incubator at 
5% CO2. For ES cell culture medium was supplemented with leukemia inhibitory 
factor (LIF). Cells were transfected using Lipofectamine 2000 (Invitrogen) or TransIT-
LT1 (Mirus). ES cells were seeded on matrigel (BD Biosciences) coated slides 24h 
before FRAP analysis. 
 
FRAP 
FRAP measurements were conducted in MEF and ES cell lines after transient 
expression of EGFP-tagged proteins using a Leica TCS SP5 confocal laser scanning 
microscope (CLSM) equipped with a HCX PL APO lambda blue 63x/1.4 NA oil 
immersion objective or an UltraVIEW VoX spinning disk microscope system 
(PerkinElmer). The region of interest (ROI) with an effective diameter of 1.9 µm was 
subjected to high intensity laser pulses to irreversibly bleach EGFP. Post-bleach 
images were collected at different time intervals with the laser intensity attenuated to 
the same level as in the pre-bleach images. Analysis of the recovery curves of the 
intensity integrated over the ROI was done using FREDIS software (Muller et al. 
2009). For Figure 1 the averaged recovery curves have been fitted to a diffusion 
model or a reaction-diffusion model that incorporates both diffusion and binding 
processes. 
 
Fluorescence Correlation Spectroscopy  
For FCS experiments a Zeiss LSM 710 ConfoCor3 was used. Before measurements, 
the system was calibrated with Alexa Fluor 488 C maleimide (Invitrogen) and from 
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these measurements the effective focal volume was determined. Similar laser 
intensities were used for all experiments with an acquisition time of 60 s. For each 
FCS measurement a continuous photobleaching (CP) fit was applied to determine 
the immobile fraction as described previously (Wachsmuth et al. 2003; Muller et al. 
2009). FCS data were analyzed as previously described (Erdel et al. 2010) with 
minor alterations. Since bleaching occurred during the measurements, especially in 
heterochromatin regions, only intensity fluctuations that were monitored 10 s after 
starting the acquisition were used for fittings. Then a moving average trend 
correction was applied and an autocorrelation function was fitted for anomalous 
diffusion. Over 15 individual cells per genotype were measured and averaged to 
derive the mobility data from the FCS based experiments. FCS data for HP1 were 
taken from (Muller et al. 2009). 
 
HP1 interaction test 
GST fusion proteins of Suv4-20h2, HP1α, HP1β and HP1γ were expressed in E. coli 
and purified using Glutathione-S-Sepharose beads (Amersham Biosciences). GST-
tags of HP1α, HP1β and HP1γ were removed by PreScission (GE Healthcare) 
cleavage. Interaction tests were performed by incubating 5µg GST-Suv4-20h2 fusion 
protein with 5µg of either HP1α, HP1β and HP1γ in IP buffer [50 mM Tris pH 7.5, 150 
mM NaCl, 1 mM EDTA, 0.1% NP40, 20% glycerol and proteinase inhibitor cocktail 
(Roche)] for 1h at room temperature on a rotating wheel. Then 60µl Glutathione-S- 
Sepharose beads were added and incubated for 1h at 4°C on a rotating wheel. The 
beads were washed 3x with IP buffer containing 300 mM NaCl and eluted with 50 µl 
SDS sample buffer. Proteins were separated on SDS-polyacrylamidgels and 
detected by immunoblotting using isoform-specific HP1 antibodies (Euromedex). 
 
Chromatin accessibility assay 
Cytoplasm of wild type, Suv4-20h2 KO and Suv4-20h2 DKO ES cells and wild type, 
Suv4-20h DKO, DKO+FL and DKO+M12 fibroblast cell lines was removed by 
spinning through a Ficoll gradient. Isolated nuclei were resuspended in Ex100 buffer 
[10 mM HEPES pH 7.6, 100 mM KCl, 1.5 mM MgCl2 0.5 mM EGTA, 10% Glycerol, 
proteinase inhibitor cocktail (Roche)] and digested with different amounts of MNase 
(Sigma) in the presence of 3mM CaCl2. Digest was stopped after 9 min by addition of 
1/10 volume MNase stop buffer [0.5 M EDTA, 10% SDS]. Genomic DNA was purified 
and then separated on a 1% agarose gel, followed by blotting onto a Nylon 
membrane [Roti-Nylon plus, Roth] via capillary transfer. Hybridization with a 32P-
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labeled major satellite probe was performed using standard conditions. MNase 
digestion patterns were further analyzed using the Agilent 2100 bioanalyzer (Agilent 
Technologies). 100ng of each sample were loaded onto a DNA LabChip using the 
Agilent DNA 12000 kit and analysis was performed using the 2100 expert software 
(Agilent Technologies). Southern blot quantification was performed using the line 
selection and plot profile function of ImageJ. 
 
Lac-recruitment assay 
EGFP-tagged proteins were recruited via a lac I repressor-GFP binding domain 
fusion protein to telomeres and promyelocytic leukemia nuclear bodies in a 
telomerase-negative U2OS cell carrying three integrations of lacO arrays as 
described (Jegou et al. 2009). 24 h after transfection, cells were fixed and mounted 
with Prolong (Invitrogen). Images were taken with a Leica SP5 microscope and 
pictures were analyzed with ImageJ. Signal intensity of mCherry was measured at 
lacO arrays and regions adjacent to the lacO arrays. Positive recruitment was 
defined as the signal increase at the lacO array by >1.5 fold as compared to adjacent 
regions.  
 
3D-structured illumination microscopy 
Fibroblasts were seeded on No. 1.5H precision coverslips (thickness 0.170±0.005 
mm; Marienfeld Superior), fixed with 4% formaldehyde, permeabilized with 0.5% 
Triton X-100, stained with 2 µg/ml 4’,6-diamidino-2-phenylindole (DAPI) and 
embedded in Vectashield mounting medium (Vector Labs). Nuclear pore complexes 
(NPCs) were immunostained with monoclonal anti-Nup153 antibodies (QE5, Abcam) 
and Alexa Fluor 594 conjugated secondary antibodies (Invitrogen). Super-resolution 
3D-structured illumination microscopy (3D-SIM) was performed as previously 
described (Schermelleh et al. 2008) on a Delta Vision OMX V3 system (Applied 
Precision) equipped with a 100x /1.40 NA PlanApo oil immersion objective (Olympus) 
and Cascade II:512 EMCCD cameras (Photometrics), using 405 nm and 592 nm 
diode lasers. In brief, a fine-striped interference pattern of illumination was generated 
by coherent laser light directed through a movable optical grating. Raw image stacks 
with 15 images per plane (5 phase shifts, 3 angles) and a z-distance of 125 nm were 
acquired and computationally reconstructed (SoftWoRX, Applied Precision) to obtain 
a super-resolution image dataset with a two-fold resolution improvement in x, y and z 
direction (eight-fold volumetric resolution improvement) compared to conventional 
diffraction-limited optical sectioning microscopy (Gustafsson et al. 2008). Images 
 155 
from the different color channels were registered with alignment parameter obtained 
from calibration measurements with 0.2 µm diameter TetraSpeck beads (Invitrogen). 
 
Mitotic abnormalities 
To quantify the number of abnormal mitotic figures in MEF cells, mitotic cells were 
collected by shake-off, spun onto glass-bottomed 96-black well plate (Greiner Bio-
One) for 5min at 400g, fixed in 4% formaldehyde and stained with Vectashield 
containing DAPI. 
To quantify mitotic stages MEF cells were grown for 48h cells on cover slips and 
fixed with 4% formaldehyde. After mounting with Vectashield containing DAPI cells 
were classified according to DAPI stain and mitotic spindle morphology into different 
stages: P-prophase; PM/M–prometaphase/metaphase; A-anaphase; T-telophase. 
  
Immunofluorescence analysis 
Immunofluorescence analyses were performed as described (Dambacher et al. 
2012) using the following antibodies: CENP-A (C51A7, Cell Signaling Technology), 
AuroraB (Abcam ab2254), H4K20me3 (Schotta et al. 2008), Sgo1 (Whelan et al. 
2012), Nup-153 (QE5, Abcam) and secondary antibodies conjugated to Cy5 
(Dianova). 
For chromosome spreads, untreated or nocodazole arrested (final concentration 200 
nM, 4 h) mitotic cells were collected by shake-off, swollen for 10 min at room 
temperature in 75 mM KCl and spun onto microscope slides using a Cytospin 
centrifuge (Fischer). Cells were extracted for 5 min at room temperature with KCM-
buffer [120 mM KCl, 20 mM MgCl2, 10 mM, Tris pH 8.0, 0.5 mM EDTA, 0.1% Triton 
X-100]  and fixed in 2% formaldehyde. Slides were blocked for 30 min in KCM/0.1% 
Tween-20/2.5% BSA, and sequentially incubated with primary and secondary 
antibodies. After washing with KCM/0.1% Tween-20 chromosomes were mounted 
with Vectashield containing DAPI. 
A Leica TCS SP5 confocal laser scanning microscope with a HCX PL APO CS 
63x/1.3 NA glycerol immersion objective and a Zeiss LSM510 confocal microscope 
were used to obtain the images. Sequential excitation at 405 nm, 488 nm, 543 nm 
and 633 nm was provided by diode, argon and helium-neon gas lasers, respectively. 
Emission detection ranges of the PMTs were adjusted to minimize crosstalk between 
the channels. Images were further analyzed using ImageJ software. 
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HP1 knock-out cell line 
The W205C07 gene trap ESC line carrying a null mutation in the first intron of the 
HP1α gene was isolated from a large scale genetrap screen (Hansen et al. 2003) 
carried out in 129S2/SvPAS ES cells with the retroviral gene trap vector Rosabgeo. 
The W205C07 ESCs were converted into mice by standard procedures using 
C57BL6J host blastocysts. The 129/C57BL6J F1 offspring were back-crossed on 
C57BL6J for over 10 generations. The HP1α homozygous mutants are viable and 
show no obvious phenotype (PD and HvM, unpublished). Mouse Embryonic 
Fibroblasts (MEFs) were derived by standard procedures from E13.5 embryos and 
immortalized using the 3T3 protocol. 
 
GST pull-down assays 
GST fusions of Suv4-20h2 truncations were expressed from pGEX6P1 vector in E. 
coli and purified using Glutathione-S-Sepharose beads (Amersham Biosciences). 
Nuclei of wild type ES cells were isolated by spinning through a Ficoll gradient. For 
the Benzonase treatment cells were resuspended in low salt IP buffer [50 mM Tris 
pH 7.5, 150 mM KCl, 1 mM EDTA, 20% glycerol, 0.1% NP40] and digested with 
Benzonase (Merck Chemicals) for 15 min at 30°C, then adjusted to 500 mM KCl, 
incubated on ice for 30 min followed by 3x 10 sec sonication at an amplitude of 30 in 
a Branson sonifier. For the salt extract, proteins were extracted with high salt IP 
buffer [50 mM Tris pH 7.5, 500 mM KCl, 1 mM EDTA, 20% glycerol, 0.1% NP40, 
proteinase inhibitor cocktail (Roche)] incubated on ice for 30 min, followed by 3x 10 
sec sonication at an amplitude of 30 in a Branson sonifier. Both nuclear extracts 
were diluted to a final concentration of 250 mM KCl with no salt IP buffer; precipitated 
or non-soluble proteins were then removed by centrifugation. 5µg of either GST or 
the different GST-Suv4-20h2 fusion proteins were incubated with the Benzonase 
treated nuclear extract or salt extract supplemented with 50µg/ml EtBr over night at 
4°C on a rotation wheel. Precipitates were again removed by centrifugation before 
60µl Glutathione-S-Sepharose beads were added and incubated for another hour at 
4°C. Beads were washed with IP buffer containing 300 mM KCl; subsequently, the 
bound proteins were eluted with 50µl SDS sample buffer. Proteins were separated 
on a SDS-polyacrylamid gel, visualized by silver staining and identified by mass-
spectrometry analysis. 
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Co-immunoprecipitation 
Nuclei of wild type and Suv4-20h2HA-FLAG  ES cells were isolated by spinning through 
a Ficoll gradient. The nuclear pellet was resuspended in low salt IP Buffer [50mM 
Tris pH 7.5, 150mM KCl, 1mM EDTA, 20% glycerol, 0.1% NP40, proteinase inhibitor 
cocktail (Roche)]. Fraction I extract was isolated after digestion for 15 min at 37°C 
with Benzonase (Merck) in low salt IP buffer, followed by mild sonication 1x 10 sec at 
amplitude 20 in a Branson sonifier. Insoluble proteins were separated by spinning for 
10 min at 13000 rpm at 4°C. The protein pellet was further extracted with high salt IP 
Buffer [50mM Tris pH 7.5, 500mM KCl, 1mM EDTA, 20% glycerol, 0.1% NP40, 
proteinase inhibitor cocktail (Roche)] on ice for 30 min followed by 3x 10 sec 
sonication at an amplitude of 30 in a Branson sonifier. Fraction II extract was then 
diluted to a final concentration of 250mM NaCl with no salt IP Buffer and precipitated 
or insoluble proteins were removed by centrifugation (30min, 13000rpm, 4°C). The 
different extracts were incubated with either 5µg Flag M2 antibody (Sigma) or Smc1 
antibody (Bethyl Labs) coupled to ProteinA/G magnetic beads (Dynabeads 
Invitrogen) o/n at 4°C on a rotating wheel. The beads were washed 5x in IP buffer 
containing 300mM KCl and eluted with SDS sample buffer. Proteins were separated 
on SDS-polyacrylamidgels and analyzed by western blotting using antibodies for 
Flag M2 (Sigma), Smc1 (Bethyl labs), Smc3 (Abcam), Suz12 (Cell Signalling) and 
Suv4-20h2 (Dambacher et al. 2012). Immunoprecipitation experiments of EGFP-
tagged proteins were performed using GFP-Trap A beads (ChromoTek). 
 
Chromatin immunoprecipitation (ChIP) 
ChIP experiments were performed according to standard methods. Chromatin was 
sonicated to an average size of 300-600 bp. 50 µl Dynabeads Protein A/G  beads 
(Dynabeads, Invitrogen) were pre-bound with 3-5 µg antibody (anti-H3K9me3 Abcam 
#ab8898, anti-H4K20me3 Active Motif #39180.3918 or Millipore #07-463, anti-Rad21 
Abcam #ab992, anti-Smc3 Abcam #ab9263) and added to the chromatin. After 16 h 
incubation at 4°C on a rotating wheel beads were collected by DynaMag magnet (or 
Dynal MPC) for 1 min. Beads were washed with Sonication buffer [50 mM Hepes pH 
7.9, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% 
SDS, 0.5 mM PMSF, Protease inhibitor cocktail (Roche)], wash buffer A [Sonication 
buffer supplemented with 500mM NaCl], wash buffer B [20 mM Tris, pH 8.0, 1 mM 
EDTA, 250 mM LiCl, 0.5% NP-40, 0.5% Na-deoxycholate, 0.5 mM PMSF, Roche 
protease inhibitor cocktail] and TE buffer pH 8.0 [10 mM Tris-Cl pH 8.0, 1 mM EDTA 
pH 8.0  (supplemented with 50 mM NaCl)]. 200 µl of elution buffer [50 mM Tris pH 
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8.0, 1 mM EDTA, 1% SDS, 50mM NaHCO3] was added to the beads for 20 min at 
65°C in two rounds. Eluates were purified after crosslink reversal using the GenElute 
PCR Clean-Up Kit (Sigma). 
 
Cell cycle arrest 
MEF cells were plated onto 150 mm plates at 40-50% confluency and treated with 2 
mM thymidine. After 18 h cells were washed 3x with medium, and after 8 h the 
second thymidine block was applied. Cells were released after 17 h by 3 washes with 
medium and harvested 3 h after the release. For mitotic arrest MEF cells were first 
treated with thymidine (2 mM) for 20h. Then cells were washed 3x with medium, and 
after 3 h nocodazole was added to 100 ng/ml. Cells were harvested 11 h after the 
thymidine release by mitotic shake-off. Cells were arrested in G0 by 48 h serum 
starvation. The Scc1/Rad21 conditional knock-out  cell line (Scc1lox/lox; Cre-ERT2) 
was arrested in G0 by serum starvation and after 72 h treated with ethanol (Scc1 
control) or induced with 250 nM final concentration of 4-OHT (solubilized in ethanol) 
for 21 days (Scc1 cko). The medium was exchanged every 3 days. 
 
FACS 
Cells were stained with propidium iodide (PI) to analyze the cell cycle phase by DNA 
amount. Trypsinized MEF cells were fixed with 70% methanol for 30 min on ice and 
PBS washed. PI staining was performed at 37°C for 30 min in a buffer containing 10 
mM Tris pH 7.5, 5 mM MgCl2 and 200 µg RNAse A. 
 
Suv4-20h1 and Suv4-20h2 knock-in cell lines 
The Suv4-20h1HA-FLAG and Suv4-20h2HA-FLAG targeting constructs were obtained using 
the recombineering cloning technique described previously. The NotI-linearized 
targeting vector was electroporated into feeder-independent wild type ES cells. Cells 
were selected in 180 µg/ml G418 (PAA) and 2 µM Ganciclovir (Invivogen). Single 
colonies were picked and screened by nested PCR to obtain the final ES cell clones. 
The same strategy was used for generating Suv4-20h2EGFP knock-in ES cells, except 
that the targeting construct contained the EGFP open reading frame fused to the last 
codon of Suv4-20h2. Primers used for cloning and PCR screening are listed in Table 
S1. 
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Automatic 3D Quantification of FISH Foci 
To determine quantitative information of FISH major satellite repeats from the 
acquired two-channel 3D confocal microscopy images, we developed a fully 
automatic 3D image analysis approach consisting of 3D cell nuclei segmentation and 
3D foci segmentation. First, 3D cell nuclei segmentation is performed by Otsu 
thresholding based on the information in the DAPI channel. This enables to 
determine relevant parameters (e.g., number and mean volume of FISH foci) for 
each nucleus individually. To ensure a valid statistical analysis, cell nuclei at the 
image border which are only partially visible are automatically excluded using a 
threshold on the number of border voxels of the segmented nucleus volume. Second, 
after cell nuclei segmentation, 3D foci segmentation is performed in the FISH 
channel using global thresholding and morphological opening. As a result, 
quantitative information of FISH foci (e.g., volume, 3D position, and 3D shape) is 
obtained. In addition, the 3D regions of segmented FISH foci are used to quantify 
heterochromatin concentrations in the DAPI channel.  
In a subsequent statistical analysis, we further investigated the mean number of foci 
per nucleus denoted by n and the quantified foci volumes denoted by v. We 
subdivided the results into 3 groups w.r.t. the experimental setup: (1) wild type cells, 
(2) Suv4-20h DKO cells, (3) re-express Suv4-20h2 cells. To ensure that our findings 
(Fig. 5c) are statistically relevant, we first performed a Shapiro-Wilk test, which 
indicated that in all groups n is normally distributed, and an F-Test which revealed 
that the variance of n differs significantly for groups (1) vs. (3). Therefore, we used a 
Welch-test which showed that the mean values of n for groups (1) vs. (2) and (3) vs. 
(2) differ significantly, while the mean values of n of groups (1) vs. (3) do not differ 
significantly. To investigate the foci volumes, we computed histograms of v for each 
group. It can be seen, that group (2) contains significantly more small foci with a 
volume < 2500 voxels, while groups (1) and (3) contain more foci with a larger 
volume. 
 
Quantification of peripheral heterochromatin and nuclear pores 
To determine quantitative information about the nuclear pores from the two-channel 
3D SIM images, we developed an automatic 3D image analysis approach consisting 
of 3D cell nuclei segmentation and 3D model-based segmentation of the pores. First, 
the 3D cell nuclei are segmented in the DAPI channel by multi-level 3D Otsu 
thresholding and by using 3D grayscale morphological filters. Second, the 3D nuclear 
pores are localized and segmented in the NPC channel using an automatic 3D 
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approach based on a 3D anisotropic Gaussian parametric intensity model (Worz et 
al. 2010), which is accurate for small subcellular structures. As a result, quantitative 
information about each of the segmented nuclear pores (e.g., volume, 3D position, 
and distance to neighboring pores) is obtained with subvoxel accuracy. By using the 
results of 3D cell nuclei segmentation, relevant parameters like, e.g., the mean 
volume or mean distance to neighboring pores, are determined individually for each 
cell nucleus. 
To quantify the amount of heterochromatin near the nuclear lamina, 2D slices along 
the z-axis from the segmented 3D cell nuclei volumes are extracted. For each 
extracted slice, a region-of-interest is defined near the nuclear lamina within a 150 
nm radius from the contour of the segmented nucleus. Then, within the region-of-
interest the total amount of signal intensity in the DAPI channel is determined.  
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Table S1. Mass-spec list of the Suv4-20h2 GST pulldown assays. The number of 
unique spectra that were identified for each protein in the mass-spec analysis is 
indicated (Scaffold analysis). 
gene name GS
T 
M5 M7 delt
a Suv420
h2 
histone-lysine N-methyltransferase SUV420H2 4 112 62 108 
Lmnb1 lamin-B1 1 82 75 81 
Top2a DNA topoisomerase 2-alpha 0 49 0 49 
Cbx5 chromobox protein homolog 5 0 41 0 41 
Hnrnpu heterogeneous nuclear ribonucleoprotein U 2 43 4 41 
CBX1 chromobox protein homolog 1 0 40 0 40 
Plec plectin 0 40 8 40 
CBX3 chromobox protein homolog 3 1 40 0 39 
Jup junction plakoglobin 4 37 13 33 
Mybbp1
a 
myb-binding protein 1A 0 30 0 30 
Ahnak AHNAK nucleoprotein 4 34 13 30 
Krt31 keratin, type I cuticular Ha1 0 29 0 29 
Ddx21 nucleolar RNA helicase 2 0 28 0 28 
Nop58 nucleolar protein 58 0 23 0 23 
Ncl nucleolin 1 24 1 23 
Nop56 nucleolar protein 56 0 23 12 23 
543042
1N21Ri
k 
type II hair keratin 1 20 2 19 
Eef2 elongation factor 2 0 19 8 19 
Hnrnpa
3 
heterogeneous nuclear ribonucleoprotein A3 4 23 12 19 
Ddx5 probable ATP-dependent RNA helicase DDX5 4 22 1 18 
Cltc clathrin heavy chain 1 0 18 3 18 
Vcl vinculin 0 18 4 18 
Acly ATP-citrate synthase 0 18 5 18 
Nup93 nuclear pore complex protein Nup93 0 16 0 16 
Fasn fatty acid synthase 0 16 3 16 
Nolc1 nucleolar and coiled-body phosphoprotein 1 0 15 0 15 
Hsp90b
1 
endoplasmin 2 17 8 15 
Nup107 nuclear pore complex protein Nup107 0 14 0 14 
Tpr nuclear pore complex-associated protein Tpr 0 14 0 14 
Nedd4 E3 ubiquitin-protein ligase NEDD4 0 14 3 14 
Ddx3x ATP-dependent RNA helicase DDX3X 2 15 0 13 
Smarca
5 
SWI/SNF-related matrix-associated actin-dependent 
regulator of chromatin subfamily A member 5 
0 12 0 12 
Ranbp2 E3 SUMO-protein ligase RanBP2 0 12 3 12 
Vcp transitional endoplasmic reticulum ATPase 2 14 6 12 
Spna2 spectrin alpha chain, brain 0 12 6 12 
Vdac2 voltage-dependent anion-selective channel protein 2 3 14 1 11 
Myh9 myosin-9 0 11 3 11 
Atrx transcriptional regulator ATRX 0 10 0 10 
Ddost dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase 48 kDa subunit 
0 10 0 10 
Las1l protein LAS1 homolog 0 10 0 10 
Nup85 nuclear pore complex protein Nup85 0 10 0 10 
Nup98 nucleoporin 98 0 10 0 10 
Snrnp20
0 
U5 small nuclear ribonucleoprotein 200 kDa helicase 0 10 0 10 
Ephx1 epoxide hydrolase 1 4 14 1 10 
Vars valyl-tRNA synthetase 0 10 2 10 
Col1a1 collagen alpha-1(I) chain 2 12 4 10 
Actn1 alpha-actinin-1 2 12 6 10 
Hnrnpul
2 
heterogeneous nuclear ribonucleoprotein U-like protein 
2 
0 9 1 9 
Trim28 transcription intermediary factor 1-beta 0 9 1 9 
Eef1b2 elongation factor 1-beta 3 12 3 9 
Spnb2 spectrin beta chain, brain 1 0 9 4 9 
Krt77 keratin, type II cytoskeletal 1b 4 13 6 9 
Nat10 N-acetyltransferase 10 0 8 0 8 
Orc1 origin recognition complex subunit 1 0 8 0 8 
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Pwp2 periodic tryptophan protein 2 homolog 0 8 0 8 
Eprs bifunctional aminoacyl-tRNA synthetase 0 8 1 8 
Nup205 nucleoporin 205 0 8 1 8 
Canx calnexin 2 10 5 8 
Krt78 keratin Kb40 4 12 6 8 
Hist1h3
e 
histone H3.2 1 9 9 8 
Rif1 telomere-associated protein RIF1 1 8 0 7 
Mcm3 DNA replication licensing factor MCM3 0 7 0 7 
Tcof1 treacle protein 0 7 0 7 
Vdac1 voltage-dependent anion-selective channel protein 1 3 10 1 7 
Eif3c eukaryotic translation initiation factor 3 subunit C 0 7 1 7 
Smc1a structural maintenance of chromosomes protein 1A 0 7 1 7 
Rpl5 60S ribosomal protein L5 2 8 0 6 
Mki67 antigen KI-67 0 6 0 6 
Ptbp1 polypyrimidine tract-binding protein 1 0 6 0 6 
Ruvbl1 ruvB-like 1 0 6 0 6 
Sf3b1 splicing factor 3B subunit 1 0 6 0 6 
Tmpo lamina-associated polypeptide 2 0 6 0 6 
Uqcrc1 cytochrome b-c1 complex subunit 1, mitochondrial 0 6 0 6 
Alb serum albumin 2 8 2 6 
Ndufs1 NADH-ubiquinone oxidoreductase 75 kDa subunit, 
mitochondrial 
0 6 2 6 
Top2b DNA topoisomerase 2-beta 2 8 3 6 
Rrbp1 ribosome-binding protein 1 0 6 3 6 
Snd1 staphylococcal nuclease domain-containing protein 1 0 6 3 6 
Stt3a dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit STT3A 
0 6 3 6 
Aldh18a
1 
delta-1-pyrroline-5-carboxylate synthase 0 6 4 6 
LOC100
047183 
 0 6 4 6 Krt75 keratin, type II cytoskeletal 75 1 7 5 6 
Insrr insulin receptor-related protein 2 8 7 6 
Krt13 keratin, type I cytoskeletal 13 0 6 7 6 
Hnrnpl heterogeneous nuclear ribonucleoprotein L 2 7 0 5 
Ddx17 probable ATP-dependent RNA helicase DDX17 0 5 0 5 
Mcm5 DNA replication licensing factor MCM5 0 5 0 5 
Numa1 nuclear mitotic apparatus protein 1 0 5 0 5 
Otc ornithine carbamoyltransferase, mitochondrial 0 5 0 5 
Pdcd11 protein RRP5 homolog 0 5 0 5 
Sf3a1 splicing factor 3A subunit 1 0 5 0 5 
Sf3b2 splicing factor 3b, subunit 2 0 5 0 5 
Wdr3 WD repeat-containing protein 3 0 5 0 5 
Ddx3y ATP-dependent RNA helicase DDX3Y 2 7 1 5 
Lyz1 lysozyme C-1 3 8 2 5 
Sfn 14-3-3 protein sigma 0 5 2 5 
Dnmt3b DNA (cytosine-5)-methyltransferase 3B 0 5 3 5 
Hnrnpa
2b1 
heterogeneous nuclear ribonucleoproteins A2/B1 4 9 6 5 
Fam161
b 
protein FAM161B 1 5 0 4 
261010
1N10Ri
k 
U2 snRNP-associated SURP motif-containing protein 0 4 0 4 
Acin1 apoptotic chromatin condensation inducer in the 
nucleus 
0 4 0 4 
Ddx18 ATP-dependent RNA helicase DDX18 0 4 0 4 
Fads2 fatty acid desaturase 2 0 4 0 4 
Flnc filamin-C 0 4 0 4 
Krt33a keratin, type I cuticular Ha3-I 0 4 0 4 
Lama3 laminin subunit alpha-3 0 4 0 4 
LOC100
046628 
 0 4 0 4 Nnt NAD(P) transhydrogenase, mitochondrial 0 4 0 4 
Nvl nuclear valosin-containing protein-like 0 4 0 4 
Prpf6 pre-mRNA-processing factor 6 0 4 0 4 
Rpl22 60S ribosomal protein L22 0 4 0 4 
Rpl23 60S ribosomal protein L23 0 4 0 4 
Tln1 talin-1 0 4 0 4 
Wdr36 WD repeat domain 36 0 4 0 4 
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D1Pas1 putative ATP-dependent RNA helicase Pl10  4 0 4 Fscn1 fascin 2 6 1 4 
Hnrnph
1 
heterogeneous nuclear ribonucleoprotein H 2 6 1 4 
Hspb1 heat shock protein beta-1 0 4 1 4 
Actn4 alpha-actinin-4 0 4 2 4 
Dst dystonin 0 4 2 4 
Gemin5 gem-associated protein 5 0 4 2 4 
Hspa4 heat shock 70 kDa protein 4 0 4 2 4 
Odf2l outer dense fiber protein 2-like 0 4 2 4 
Bicd1 protein bicaudal D homolog 1 0 4 3 4 
Sarnp SAP domain-containing ribonucleoprotein 0 4 3 4 
Vps35 vacuolar protein sorting-associated protein 35 4 8 4 4 
Gucy2c heat-stable enterotoxin receptor 2 6 4 4 
Krt35 keratin, type I cuticular Ha5 2 6 4 4 
Plk2 serine/threonine-protein kinase PLK2 2 6 6 4 
241000
2O22Ri
k 
UPF0533 protein C5orf44 homolog 1 4 0 3 
Fam98c uncharacterized protein LOC73833 1 4 0 3 
Rpl28-
ps3 
 1 4 0 3 Shisa9 protein shisa-9 1 4 0 3 
Abcc2 canalicular multispecific organic anion transporter 1 0 3 0 3 
Alyref THO complex subunit 4 0 3 0 3 
Cacna2
d4 
voltage-dependent calcium channel subunit alpha-
2/delta-4 
0 3 0 3 
Dsg1a desmoglein-1-alpha 0 3 0 3 
E2f2 transcription factor E2F2 0 3 0 3 
Eed polycomb protein EED 0 3 0 3 
Eftud2 116 kDa U5 small nuclear ribonucleoprotein 
component 
0 3 0 3 
Fam65b protein FAM65B 0 3 0 3 
Grpel1 grpE protein homolog 1, mitochondrial 0 3 0 3 
Hdac2 histone deacetylase 2 0 3 0 3 
Kif1b kinesin-like protein KIF1B 0 3 0 3 
Lgals3b
p 
galectin-3-binding protein 0 3 0 3 
Nup160 nuclear pore complex protein Nup160 0 3 0 3 
P2rx3 P2X purinoceptor 3 0 3 0 3 
Pcnxl3 pecanex-like protein 3 0 3 0 3 
Pml protein PML 0 3 0 3 
Smc3 structural maintenance of chromosomes protein 3 0 3 0 3 
Smg6 telomerase-binding protein EST1A 0 3 0 3 
Tnr tenascin-R 0 3 0 3 
Vezt vezatin 0 3 0 3 
Vps16 vacuolar protein sorting-associated protein 16 homolog 0 3 0 3 
Wdr46 WD repeat-containing protein 46 0 3 0 3 
Yes1 tyrosine-protein kinase Yes 0 3 0 3 
Arid5a AT-rich interactive domain-containing protein 5A 0 3 1 3 
Ddx58 probable ATP-dependent RNA helicase DDX58 0 3 1 3 
Gdf15 growth/differentiation factor 15 0 3 1 3 
Hinfp histone H4 transcription factor 0 3 1 3 
Sf3b3 splicing factor 3B subunit 3 0 3 1 3 
Slc25a1
3 
calcium-binding mitochondrial carrier protein Aralar2 0 3 1 3 
Stag2 cohesin subunit SA-2 0 3 1 3 
Taf1 transcription initiation factor TFIID subunit 1 0 3 1 3 
Lrpprc leucine-rich PPR motif-containing protein, 
mitochondrial 
1 4 2 3 
Herc2 E3 ubiquitin-protein ligase HERC2 0 3 2 3 
Rere arginine-glutamic acid dipeptide repeats protein 0 3 2 3 
Hnrnpa
b 
heterogeneous nuclear ribonucleoprotein A/B 4 7 3 3 
Fras1 extracellular matrix protein FRAS1 2 5 3 3 
Hnrnpd heterogeneous nuclear ribonucleoprotein D0 2 5 3 3 
Chrna1
0 
neuronal acetylcholine receptor subunit alpha-10 0 3 3 3 
Dock9 dedicator of cytokinesis protein 9 0 3 3 3 
Erc1 ELKS/Rab6-interacting/CAST family member 1 0 3 3 3 
Hnrnpa
0 
heterogeneous nuclear ribonucleoprotein A0 0 3 3 3 
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Pard6g partitioning defective 6 homolog gamma 0 3 3 3 
Prpf8 pre-mRNA-processing-splicing factor 8 0 3 3 3 
Ube2t ubiquitin-conjugating enzyme E2 T 0 3 3 3 
Vash1 vasohibin-1 1 4 4 3 
Mei4 UPF0623 protein 0 3 4 3 
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Table S2. Primer sequences. 
cloning primer   
Suv39h2 f  ggggacaagtttgtacaaaaaagcaggcttaactatggcggcggccagggcc 
 r ggggaccactttgtacaagaaagctgggtcgttgaggtaacctctgcaa 
M12,M13+M14 pGex6P1 
direct cloning 
  
Suv4-20h2 pGex6P1: 350f 
BamHI 
f GGGATCCgtcctccgcactgcctgtgt 
Suv4-20h2 pGex6P1: 385f 
BamHI 
f GGGATCCcgctggaccccacaacag 
Suv4-20h2 pGex6P1: 412r 
EcoRI 
r GGAATTCctaggctaggcgggtaagttc 
Suv4-20h2 pGex6P1: 385r 
EcoRI 
r GGAATTCctagcgagtctgggggcgcag 
M7 f ggggacaagtttgtacaaaaaagcaggcttaaccatgacccgcctagccccagc
c  r ggggaccactttgtacaagaaagctgggtctggctcaccactattgat M12 f ggggacaagtttgtacaaaaaagcaggcttaaccatggtcctccgcactgcctgt 
 r ggggaccactttgtacaagaaagctgggtcggctaggcgggtaagttc 
M13 f ggggacaagtttgtacaaaaaagcaggcttaaccatggtcctccgcactgcctgt 
 r ggggaccactttgtacaagaaagctgggtcgcgagtctgggggcgcag 
M14 f ggggacaagtttgtacaaaaaagcaggcttaaccatgcgctggaccccacaaca
g  r ggggaccactttgtacaagaaagctgggtcggctaggcgggtaagttc delta M12 f attgcctcctccagccctgccagctgct 
 r gctggaggaggcaatgaagcctggc 
HP1 beta f ggggacaagtttgtacaaaaaagcaggcttaactatggggaaaaagcaaaac 
 r ggggaccactttgtacaagaaagctgggtcattcttgtcgtcttttttgtc 
HP1 gamma f ggggacaagtttgtacaaaaaagcaggcttaaaaatggcctccaataaaactac 
 r ggggaccactttgtacaagaaagctgggtcttgtgcttcatcttcaggac 
HP1 alpha f ggggacaagtttgtacaaaaaagcaggcttaagacatgggaaagaagacc 
 r ggggaccactttgtacaagaaagctgggtcgctcttcgcgctttctttttc 
Suv4-20h1_10 
 
f GGGGACAAGTTTGTACAAAAAAGCAGGCTACaacatggtggt
gaatggcaggag 
 
Suv4-20h1_883 
 
r GGGGACCACTTTGTACAAGAAAGCTGGGTCtgcgttcagtctt
agagactgatc 
 
Suv4-20h1_392 
 
r GGGGACCACTTTGTACAAGAAAGCTGGGTCcttacttgcattgt
ctttttcctg 
 
Suv4-20h1_392 
 
f GGGGACAAGTTTGTACAAAAAAGCAGGCTTAaccatgtctaat
cgaaaatcttcagttggtgtg 
 
Suv4-20h1_847 
 
r GGGGACCACTTTGTACAAGAAAGCTGGGTCgtcatcatcgaa
gtcatcctcgc 
 
Suv4-20h1_496 
 
r GGGGACCACTTTGTACAAGAAAGCTGGGTCctccctttctttctt
aattggc 
 
  
ChIP primer  
Major satellites f GACGACTTGAAAAATGACGAAATC 
 r CATATTCCAGGTCCTTCAGTGTGC 
Chr. 6 f GATGGGAAAGCGTTGTTAGC 
chr6:90702961+9070304
6 
r AAGGACAGCTCCTTTTTCAGG 
Chr. 7 f AATTTCACTGCGATCCTTGC 
chr7:45669448+4566954
2 
r GCCGGAATTATGGCTCTATG 
Chr. 10 f TTCTGCTAAAGCCTGGACTTG 
chr10:76574384+765745
31 
r TGCTTGCAAGTGGCTAAGG 
Chr. 5 f ATGCTCACGTCCTTGTCCAGAA 
chr5:147617294+147617
396 
r TCTGGCAGCCTTCAACGTTTGT 
Chr. 6-1 f TGCAGGTGGGATTAACTGTG 
chr6:122673061+122673
143 
r CTACCCACCCCCTATTCTCC 
Chr10-1 f TGGGTGCCGTATGCCACATTAT 
chr10:79154346+791544
81  
r TTTCTGGCCATCCGCACCTTAT 
   
genotyping primer for 
Suv4-20h2 knock-in 
cells 
  
MGC_tag_1f f CACTCCCACTGTCCTTTCCTAA 
MGC_tag_1r r CAAACTCACAGAGAGCCACCTA 
MGC_tag_2f f TCGCATTGTCTGAGTAGGTGTC 
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CENP-C facilitates the recruitment of M18BP1
to centromeric chromatin
Silvia Dambacher,1,2,† Wen Deng,1,3,† Matthias Hahn,1,2,† Dennis Sadic,1,2 Jonathan J. Fröhlich,1,2 Alexander Nuber,1,2
Christian Hoischen,4 Stephan Diekmann,4 Heinrich Leonhardt1,3 and Gunnar Schotta1,2,*
1Ludwig Maximilians University and Munich Center for Integrated Protein Science (CiPSM); Munich, Germany; 2Adolf-Butenandt-Institute; Munich, Germany;
3Department of Biology II; Ludwig Maximilians University; Munich, Germany; 4Leibniz Institute for Age Research; Fritz Lipmann Institute; Jena, Germany
†These authors contributed equally to this paper.
Centromeres are important structural constituents of chromosomes that ensure proper chromosome segregation during
mitosis by providing defined sites for kinetochore attachment. In higher eukaryotes, centromeres have no specific DNA
sequence and thus, they are rather determined through epigenetic mechanisms. A fundamental process in centromere
establishment is the incorporation of the histone variant CENP-A into centromeric chromatin, which provides a binding
platform for the other centromeric proteins. The Mis18 complex, and, in particular, its member M18BP1 was shown to be
essential for both incorporation and maintenance of CENP-A.
Here we show that M18BP1 displays a cell cycle-regulated association with centromeric chromatin in mouse
embryonic stem cells. M18BP1 is highly enriched at centromeric regions from late anaphase through to G1 phase. An
interaction screen against 16 core centromeric proteins revealed a novel interaction of M18BP1 with CENP-C. We mapped
the interaction domain in M18BP1 to a central region containing a conserved SANT domain and in CENP-C to the
C-terminus. Knock-down of CENP-C leads to reduced M18BP1 association and lower CENP-A levels at centromeres,
suggesting that CENP-C works as an important factor for centromeric M18BP1 recruitment and thus for maintaining
centromeric CENP-A.
Introduction
Centromeres are sites for kinetochore attachment during mitosis. In
order to prevent chromosome segregation defects, cells have to
ensure that each chromosome has one functional centromere.
Centromeres have no fixed DNA sequence that can be recognized
by specific binding proteins, therefore it is assumed that epigenetic
mechanisms ensure maintenance of the centromeric structure. The
histone H3 variant CENP-A is a central component of centromeric
chromatin. CENP-A aids in recruiting numerous proteins that
build the constitutive centromere-associated network (CCAN),1-3
an essential step in establishing a proper kinetochore structure.4
Two proteins directly bind CENP-A and have the potential to
bridge centromeric chromatin with kinetochore components. The
first protein, CENP-C, recognizes the C-terminal region of CENP-
A through an internal region.5 The C-terminus of CENP-C
mediates its dimerization,6,7 the extreme N-terminus interacts with
the Mis12 complex, which, in turn, bridges to outer kinetochore
components.8 The second protein directly recognizing CENP-A is
CENP-N,9 which also interacts with other centromeric compo-
nents. Notably, disruption of either CENP-C or CENP-N leads to
reduced levels of CENP-A at centromeres, suggesting that both
proteins have additional functions in establishment or maintenance
of centromere identity.5,9
The incorporation of CENP-A into the centromere is a strictly
cell cycle-regulated process. During replication of centromeres,
CENP-A is equally distributed onto the daughter strands, diluting
the amount per centromere to 50%. To preserve centromere
function, CENP-A needs to be subsequently replenished.
Expression levels of CENP-A peak in G2 phase, though
incorporation into the centromere only occurs in late mitosis
and early G1 phase.10-13 The histone chaperone that mediates
incorporation of CENP-A is the Holliday junction-recognizing
protein (HJURP).14,15 HJURP can incorporate CENP-A only in
domains that show a signature of actively transcribed chromatin.16
Therefore, centromeric chromatin needs to be prepared (licensed),
by currently unknown mechanisms. Mis18a, Mis18β and
M18BP1 which form the Mis18 complex in humans have been
suggested to play an important role in this licensing mech-
anism.17-19 Disruption of Mis18 complex components leads to
failure in CENP-A incorporation,17,19 which could be explained
by lack of HJURP recruitment to centromeres.20,21 Neither of the
Mis18 complex proteins directly interact with CENP-A,9
therefore, an important question within the understanding of
CENP-A establishment is how this complex is specifically targeted
to centromeric chromatin.
Here we show that M18BP1 is a cell cycle-regulated component
of centromeric chromatin. By screening 16 CCAN proteins we
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identify CENP-C as a novel interaction partner of M18BP1. We
mapped the interaction domain to a central region of M18BP1
encompassing the conserved SANT domain. CENP-C facilitates
the recruitment of M18BP1 to centromeric chromatin during
specific stages of the cell cycle, as RNAi depletion of CENP-C leads
to reduced levels of centromeric M18BP1. In summary, our work
identifies CENP-C as an important centromere component that
recruits M18BP1 to centromeric chromatin.
Results
M18BP1 is a centromere-associated protein in mouse ES (mES)
cells. In HeLa cells, prominent centromeric association of Mis 18
complex members was observed from late mitosis (ana/telophase)
until the end of G1 phase.17 In order to determine the localization
of M18BP1 in mouse cells we generated M18BP1 knock-in mES
cells (K1B2) by introducing an EGFP tag into the endogenous
M18BP1 locus (Fig. S1A). The K1B2 cells express M18BP1 at
near endogenous levels (Fig. S1B), suggesting that the transcriptional
regulation of M18BP1 is not impaired by the alterations to this
locus. We determined the localization of M18BP1-EGFP in these
cells by comparing the EGFP signal with CENP-A staining to ask
whether M18BP1 localizes to the centromeres. Three classes of
staining patterns could be observed (Fig. 1A): (1) diffuse nuclear;
(2) weak centromeric; and (3) strong centromeric foci. We then
asked which cell cycle stage would correspond to the strong
centromeric association of M18BP1. K1B2 cells show the typical
cell cycle profile of mES cells, that is, the majority of cells are in S
phase with an additional high percentage of cells in G2/M phase. In
contrast to other frequently analyzed cell types, such as HeLa cells
and mouse fibroblasts, the population of G1 cells is comparably low
in mES cells. We visualized the different cell cycle stages in K1B2
cells using specific markers. First we expressed RFP-tagged PCNA
in K1B2 cells, which is an indicator of different S phase stages.22
All K1B2 cells which showed defined PCNA dots, indicative of
ongoing replication showed weak or diffuse M18BP1-EGFP signals
(Fig. 1B). A significant number of cells outside S phase showed
comparatively stronger signals, suggesting that centromeric
Figure 1. M18BP1 associates with centromeres in a cell-cycle dependent manner. (A) Localization of endogenously tagged M18BP1-EGFP in the K1B2
mES cell line. K1B2 cells were stained for CENP-A and confocal stacks were recorded. Maximum intensity projections are shown. M18BP1-EGFP showed
different patterns: strong enrichment at centromeres (s), weak enrichment (w), no enrichment/diffuse nuclear (d). Scale bars are 20 mm. (B) M18BP1
distribution during S phase. K1B2 cells were transfected with a RFP-PCNA expression construct to detect cells in different S phase stages. M18BP1-EGFP
showed intermediate to low centromeric enrichment throughout S phase. Cells which are not in S phase fall into two different staining patterns: M18BP1
is highly enriched at centromeres (presumably G1) and cells with low/no centromeric M18BP1 signals (presumably G2). (C) M18BP1 distribution in G2/M
phase. K1B2 cells were stained with H3S10P antibodies to visualize different stages of G2 and M phase. Starting from early G2 phase (weak H3S10P
signal) to M phase (strong H3S10P signal) M18BP1 appeared to be largely absent from centromeres. (D) M18BP1 localization in different mitotic stages.
In metaphase cells, M18BP1 is absent from centromeres, however, starting from late anaphase, M18BP1 showed strong signals at centromeric regions.
Scale bars in (B–D) are 5 mm.
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M18BP1 association is low throughout S phase (Fig. 1B) and is
only enriched in G1 or G2/M phase. We therefore tested whether
M18BP1 begins to be enriched after S phase, in G2/M. In order to
visualize G2/M cells, we performed immunofluorescence staining
for H3S10 phosphorylation.23 All K1B2 cells that were positive for
H3S10P showed only weak centromeric M18BP1 signals
(Fig. 1C, early G2), leading to the conclusion that the highly
enrichedM18BP1 signals appear in G1 phase cells. Interestingly, in
G2 phase cells, M18BP1 does not seem to associate with all
centromeres as we detect numerous CENP-A spots without
M18BP1 enrichment (Fig. S2). Late G2 and prometaphase cells
did not show significant centromeric signals for M18BP1 (Fig. 1C,
late G2/M). Finally, we tested at which step after mitosis M18BP1
starts being localized to centromeric regions by examining distinct
mitotic stages in K1B2 cells. Notably, we find that metaphase cells
still display very low M18BP1 signals, though as soon as cells enter
anaphase/telophase, M18BP1 is highly enriched at centromeres
(Fig. 1D). In those cells centromeric CENP-A signals are still
relatively low as deposition of new CENP-A only occurs at later
stages in the cell cycle.12 In summary, our localization analysis
demonstrates that in mES cells, M18BP1 is not constitutively
enriched at centromeric chromatin but rather associates with
centromeres from anaphase continuing to G1 phase. This is the
time when CENP-A incorporation takes place.
Centromere interaction screen for M18BP1. M18BP1 is
known to be important for preparing centromeric chromatin for
CENP-A incorporation. However, still very little is known about
how M18BP1 actually recognizes centromeric chromatin. We
pursued the idea that M18BP1 might be recruited through
interaction with components of the CCAN network. To test this
hypothesis we performed an F3H interaction screen of M18BP1
with proteins of the CCAN network. The F3H interaction assay
utilizes a BHK cell line with a lac operator repeat array stably
integrated into its genome (Fig. 2A). This cell line was transfected
with an expression vector encoding the lac repressor (lacI) which
directly binds to the lac operator sequence fused with a GFP
binding protein (GBP). These cells further expressed the EGFP
tagged bait protein (M18BP1-EGFP) and individual RFP/
mCherry tagged prey proteins (CCAN proteins). M18BP1-
EGFP is bound by the lacI-GBP fusion protein at the lac operator
arrays and can be detected at the well-discernible nuclear lacO
focus. Prey protein interaction with M18BP1 is identified by
localization to this nuclear focus (Fig. 2A). The red/green signal
intensity ratio provides a measure for the strength of the tested
interaction.
We tested M18BP1 for interaction with 16 proteins of the
CCAN network using the F3H assay. In agreement with previous
analyses we did not detect a direct interaction with CENP-A
(Fig. 2B). Interestingly, we found a strong interaction with
another protein of the inner centromere, CENP-C. None of the
other CCAN proteins that we tested showed significant
interaction with M18BP1 (Fig. 2C).
M18BP1 harbors two evolutionarily conserved domains, the
SANT domain in the C-terminal part of the protein and the
SANTA domain which is toward the N-terminus. To test which
region of M18BP1 participates in the interaction with CENP-C
Figure 2. F3H interaction screen for M18BP1 interaction partners. (A) Scheme depicting the F3H screening strategy. Cells containing a lac operator array
were transfected with plasmids expressing a lac repressor-GBP fusion protein, M18BP1-EGFP and mCherry/RFP-CCAN proteins. The lac repressor binds to
the lac operator array and through the GBP recruits M18BP1-EGFP. CCAN proteins interacting with M18BP1 are consequently enriched at the lac operator
array. (B) Representative examples for M18BP1 interacting (CENP-C) and non-interacting (CENP-A and CENP-W) proteins are shown. Scale bar is 5mm.
(C) Summary of interaction tests between M18BP1 and CCAN proteins. Interactions were tested with the F3H assay using M18BP1-EGFP and 16 RFP or
mCherry fusions with CCAN proteins. From all 16 tested CCAN proteins, only CENP-C showed a clear interaction with M18BP1.
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we tested a panel of M18BP1 truncated proteins (Fig. 3A). The
N-terminus of M18BP1 (M1, aa1–440) showed no interaction
with CENP-C, but the C-terminus (M2, aa441–998) clearly
interacted (Fig. 3B). The central region (M3, aa325–800) and a
truncated protein lacking the SANTA domain (M4, aa441–800)
displayed clear interactions with CENP-C. In order to then test
whether the SANT domain is sufficient for the CENP-C
interaction, we assessed a truncated protein harboring only the
SANT domain (M5, aa735–800). This failed to interact with
CENP-C, suggesting that additional parts of M18BP1 participate
in this interaction. We scrutinized these observations by
quantifying the interactions in several hundred cells per construct
through measurement of the ratio between red and green intensity
values at the M18BP1-EGFP foci. Although, by confocal imaging
we can detect red/green colocalization of M18BP1-M4 and
CENP-C in 73% of the cells (Fig. 3B), the average red/green
signal ratio is relatively low (Fig. 3C). This, however, can be
explained by relatively low expression levels of RFP-CENP-C in
the combination with M18BP1-M4. In summary, our F3H data
show that CENP-C interacts with a central region of M18BP1
comprising the SANT domain.
M18BP1 directly interacts with CENP-C. We then aimed
to further define the M18BP1-CENP-C interaction. First, we
wanted to analyze whether M18BP1 co-localizes with CENP-C.
To do this, we transfected K1B2 cells with a plasmid expressing
RFP-tagged CENP-C and performed confocal imaging. We
found many cells showing a clear overlap between M18BP1-
EGFP and RFP-CENP-C signals. However, there was also a large
percentage of cells with prominent CENP-C signals, with no
M18BP1 co-localization (Fig. 4A). These data suggest that the
interaction between these two proteins is highly regulated in vivo.
In order to test whether CENP-C and M18BP1 can interact
in vivo, we performed co-immunoprecipitation experiments. We
transfected HEK293 cells with expression plasmids for CENP-C-
EGFP and myc-M18BP1, prepared nuclear extract and purified
CENP-C-EGFP using GFP trap affinity beads. In the bound
material we could clearly detect co-purification of the EGFP-
tagged CENP-C and the myc-tagged M18BP1 (Fig. 4B). We
then wanted to further map the interaction domains between
M18BP1 and CENP-C using in vitro binding assays. CENP-C
has several conserved domains which have already been implicated
in different biochemical interactions and in vivo functions, such as
Figure 3. Mapping of the M18BP1-CENP-C interaction domains by F3H. (A) Scheme of M18BP1 truncations used in the interaction tests.
(B) Representative F3H images of the negative control (GFP only) and EGFP tagged M18BP1 truncations tested with RFP-CENP-C. Overlap of red and
green signals at the nuclear lacO focus indicates interaction. (C) Quantification of the F3H M18BP1-CENP-C interaction data. Intensities of red and green
signals at the nuclear lacO focus were measured in several hundred cells each. The ratio between red and green signals was determined to measure the
strength of the tested interactions.
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connection to the outer kinetochore proteins, CENP-A binding
and CENP-C dimerization (Fig. 4C, schematic). We generated in
vitro translated proteins of three CENP-C truncations and tested
their interaction with recombinant GST tagged M18BP1
truncations (M1-M5). In these assays we could only detect
significant interaction of M18BP1 with CENP-C #3, containing
the CENP-C motif and the cupin domain (Fig. 4C). These data
provide an extension of the F3H analysis; confirming that the
large central region of M18BP1 is required for CENP-C binding.
CENP-C is required for the recruitment of M18BP1 to
centromeres. Our data show that M18BP1 interacts with CENP-
C in vitro and in vivo. CENP-C itself binds to centromeres
through direct interaction with CENP-A. We therefore hypothe-
sized that CENP-C facilitates the recruitment of M18BP1 to
centromeric chromatin. In order to test this hypothesis we
performed CENP-C knock-down experiments in K1B2 cells in
which we could easily assess the localization of endogenously
expressed M18BP1-EGFP. We prepared pLKO-based lentiviral
vectors with three independent shRNA oligos against CENP-C
and one control oligo containing an unrelated sequence (Table S1).
CENP-C knock-down cells were analyzed by qPCR five days post
infection to determine the knock-down efficiency of the individual
oligos. Importantly, all three knock-down oligos resulted in
effective downregulation of CENP-C mRNA (Fig. 5A) and protein
(Fig. S3), with shCENP-C #3 showing the strongest knock-down.
Crucially, the expression level of M18BP1 was unchanged. CENP-
C knock-down did not lead to significant changes in the cell cycle
profile of K1B2 cells, however, we did notice an increase in the
number of cells with sub-G1 DNA content (Fig. S4) as well as
reduced cell numbers at day five after knock-down (Fig. S5),
indicating elevated cell death upon CENP-C knock-down.
To test whether CENP-C affects the localization of M18BP1 we
investigatedM18BP1-EGFP and CENP-A patterns in the CENP-C
knock-down cells. In control knock-down cells, M18BP1-EGFP
Figure 4. M18BP1 and CENP-C interact in vitro. (A) Co-localization of RFP-CENP-C and M18BP1-EGFP. K1B2 cells were transfected with a RFP-CENP-C
expression construct. Maximum intensity projections of two representative staining patterns are shown. Scale bar is 5mm. (B) Co-immunoprecipitation of
CENP-C and M18BP1. HEK293FT cells were transfected with expression plasmids for EGFP-CENP-C and myc-M18BP1. Nuclear extracts from these cells
were incubated with agarose beads (control) and GFP-Trap affinity beads to enrich for EGFP-CENP-C and interacting bound proteins. Protein gel blot
analysis shows the nuclear extract (Inp), proteins bound to agarose beads (mock) and proteins that were enriched with GFP-Trap agarose beads (IP). An
empty lane is indicated by “-”. EGFP-CENP-C and myc-M18BP1 were detected using antibodies against GFP and myc, respectively. (C) Interaction tests
between M18BP1 and CENP-C truncations. The scheme shows the domain structure of mouse CENP-C and the truncation constructs that were used in
this assay. Recombinant GST-tagged M18BP1 truncations (M1-M5) were incubated with in vitro translated myc-CENP-C truncation proteins and bound to
GST beads. The bound CENP-C protein truncations were detected using myc antibody. Only the C-terminal CENP-C fragment showed clear interaction
with M18BP1. The M18BP1 fragments M1-M5 are depicted in Figure 3A.
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shows the typical distribution of different centromere enrichment
levels: strong, weak and diffuse nuclear (Fig. 5B, arrows). We
observed that the number of cells with centromeric association of
M18BP1 was reduced in all three knock-down cell lines (Fig. 5B).
In order to quantify this phenotype we determined the distribution
of M18BP1 staining patterns in control and CENP-C knock-down
cells. Importantly, in all knock-down cell lines the percentage of
cells with “weak” M18BP1-EGFP enrichment at centromeres was
reduced, whereas M18BP1-EGFP “diffuse” cells were increased
(Fig. 5C). In knock-down shCENP-C #3 we even detected reduced
numbers of M18BP1 ‘strong’ cells, suggesting that more efficient
CENP-C knock-down more severely impairs centromeric M18BP1
recruitment. We then asked whether the reduced centromeric
M18BP1 recruitment corresponds to specific cell cycle stages by
co-staining of control and CENP-C knock-down cells with specific
cell cycle markers (Fig. S6). In shControl cells we could reproduce
the results of our initial cell cycle analysis in K1B2 cells: G1 cells
showed strong centromeric signals, G2 cells showed weak signals.
Importantly, upon CENP-C knock-down we detected G1 and G2
phase cells which had clearly lost centromeric M18BP1 (Fig. S6),
indicating that the role of CENP-C in ensuring centromeric
M18BP1 localization is not restricted to a particular cell cycle stage.
M18BP1 was proposed to ‘prime’ centromeres for deposition of
CENP-A.17,19 In order to investigate whether reduced centromeric
M18BP1 recruitment would also lead to less efficient CENP-A
incorporation, we divided CENP-A staining patterns into low,
medium and high and determined the percentage of cells showing
these patterns in control and CENP-C knock-down cells. In
particular knock-down shCENP-C #3 which had the strongest
effect on centromeric M18BP1 recruitment lead to significantly
reduced CENP-A levels (Fig. 5C).
In summary our data demonstrate that the interaction between
CENP-C and M18BP1 is an important recruitment mechanism
for M18BP1 to centromeric chromatin, which appears necessary
for the correct deposition of CENP-A.
Discussion
The deposition of CENP-A into centromeric chromatin is
essential to ensure proper segregation of chromosomes. The
Figure 5. CENP-C knock-down leads to impaired centromeric recruitment of M18BP1. (A) RT-qPCR for CENP-C and M18BP1 five days after knock-down.
Expression levels in the control knock-down cell line (shControl) and the three CENP-C knock-down cell lines (shCENP-C #1-#3) were normalized to the
geometric mean of GAPDH and Actin. (B) Representative maximum intensity projections of confocal stacks of control and CENP-C knock-down cells that
were stained for CENP-A. Arrows point to example cells for the three classes of M18BP1 signals: strong (s), weak (w) and no enrichment/diffuse nuclear
(d). Scale bars are 10mm. (C) Quantification of the M18BP1 signals in control vs. CENP-C knock-down cell lines. M18BP1 and CENP-A staining patterns
were classified in several hundred cells. The bar graph depicts the percentages of each class.
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Mis18 complex member M18BP1 was shown as an essential
factor to prepare centromeric chromatin for CENP-A deposition
and to ensure its maintenance.17,19,24 Our data constitute the first
analysis of endogenously expressed M18BP1 in mES cells. We
report that M18BP1 associates with centromeric chromatin
during distinct cell cycle stages. M18BP1 shows highest
abundance at centromeres from anaphase through to late G1
phase. These data are in agreement with observations in human
cells, where M18BP1 also associates with centromeres starting
from late telophase through to G1 phase17 and suggest that
M18BP1-mediated processes might be evolutionarily conserved in
higher mammals.
We have furthered the understanding of how M18BP1 is
recruited to centromeres through identification of a novel
interaction between the C-terminus of CENP-C with a central
region in M18BP1, which contains a SANT domain. The SANT
domain is highly conserved and found in many chromatin-
associated proteins, but very little is known about its potential
functions. It has been implicated in the mediation of protein-
protein interactions and binding to histone modifications.25 We
do not detect a direct interaction between the isolated M18BP1
SANT domain and CENP-C, however, it is possible that this
domain is only functional in a larger protein context. More
detailed experiments are necessary to further understand the
functional roles of this domain in M18BP1. Our interaction data
are consistent with a very recent study which appeared during the
preparation of this manuscript.26 Moree et al. found that X. laevis
xM18BP1 isoforms interact with xCENP-C, and they could also
show that human M18BP1 interacts with human CENP-C. In
their study the interaction domain with xM18BP1 was mapped to
the C-terminus of xCENP-C containing the CENP-C motif and
the cupin domain. Mouse CENP-C (906aa) is much smaller than
xCENP-C (1400aa), however, the major domains, such as
CENP-A binding domain, CENP-C motif and cupin domain
are conserved. We could show that in the mouse the interaction
with M18BP1 is also mediated through a C-terminal fragment of
CENP-C containing the CENP-C motif and the cupin domain,
and thus the M18BP1 interaction site in CENP-C seems to be
evolutionarily conserved.
Our data moreover demonstrate an important function for
CENP-C in mediating the centromeric recruitment of M18BP1.
When CENP-C protein levels are reduced to around 40–50%
(shCENP-C #1 and #2) we found reduced numbers of “weak”
centromeric M18BP1 cells. The numbers of “strong” centromeric
M18BP1 cells, a staining pattern which we found characteristic
for G1 phase cells, seemed to be unaltered. More severely reduced
CENP-C levels (shCENP-C #3) resulted in lower numbers of
cells with “weak” and “strong” centromeric M18BP1. Our cell
cycle marker analysis revealed that the role of CENP-C in
mediating centromeric M18BP1 recruitment is not restricted to
selective cell cycle stages. However, we cannot exclude the
possibility that CENP-C has additional functions that indirectly
regulate the centromeric association of M18BP1 during distinct
cell cycle phases. In this context it is interesting to note that
when we transiently express CENP-C in K1B2 cells, we find a
high percentage of cells in which CENP-C is abundantly
associated with centromeres, but M18BP1 does not co-localize.
It is therefore plausible to assume that further regulatory
mechanisms exist, e.g., post-translational modifications, which
influence the in vivo interaction between these two proteins. Both
M18BP1 and CENP-C can be phosphorylated and sumoylated
at multiple sites.27-30 It will be challenging to understand how
these modifications are regulated and how they influence inter-
actions between the different centromeric proteins in a cell cycle-
dependent manner.
The centromeric recruitment of M18BP1 appears important
for correct deposition of CENP-A. In particular strong depletion
of CENP-C with knock-down oligo shCENP-C #3 leads to
reduced levels of centromeric CENP-A. These data are consistent
with Moree et al., which demonstrate in the Xenopus system that
upon xCENP-C depletion, centromeric deposition of new
CENP-A is impaired.26 The failure to correctly establish CENP-
A might be due to loss of centromeric M18BP1 at critical cell
cycle stages. In human cells, CENP-A deposition is mediated by
HJURP during G1 phase. Loss of M18BP1 leads to reduced
HJURP association with centromeres and consequently to
reduced deposition of newly synthesized CENP-A.14,15 In our
mES cell system strong CENP-C knock-down results in cells
which lose M18BP1 during G1 phase when CENP-A deposition
normally occurs. We therefore postulate that those cells will also
have problems in correctly establishing centromeric CENP-A
patterns. We do not detect a large number of cells which have lost
CENP-A upon CENP-C knock-down. We think that this could
be explained by the high cell lethality of the CENP-C knock-
down. Therefore, at the current stage of analysis, we cannot
distinguish whether critically low CENP-A levels would induce
apoptosis in ES cells, or whether CENP-C has additional
functions that could be critical for survival of ES cells. Also, the
functions of M18BP1 need to be investigated in more detail to
understand how the centromeric recruitment of this molecule
drives the subsequent deposition of CENP-A during G1 phase
and whether M18BP1 features additional roles during other cell
cycle stages when its centromeric recruitment is much lower but
still detectable.
Materials and Methods
M18BP1 knock-in cell line. The M18BP1-EGFP targeting
constructs were obtained using the recombineering cloning
technique described previously.31 To generate retrieval and
mini-targeting vectors, PCR fragments were amplified from the
BAC clone RP23–396P24 (Children's Hospital Oakland
Research Institute). For the retrieval plasmid, PCR fragments
were cloned into the pL253 plasmid using NotI, HindIII and
SpeI. A genomic region of 7 kb, spanning the last exons of
M18BP1, was retrieved from the BAC clone using recombineer-
ing in EL350 bacteria. The mini-targeting plasmid was
constructed by generating PCR fragments flanking the M18BP1
stop codon. These PCR fragments were cloned together with the
floxed Neomycin selection cassette from pL452 (EcoRI-BamHI
fragment) into pBluescript IISK+ using NotI, EcoRI, BamHI and
SalI. In a subsequent cloning step, the EGFP tag was inserted with
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EcoRI. For the final targeting vector, the 7 kb region was mini-
targeted by recombineering with the NotI-SalI fragment contain-
ing the EGFP and floxed Neomycin selection cassette from the
mini-targeting plasmid.
To generate M18BP1 knock-in cells, the NotI-linearized
targeting vector was electroporated into feeder-independent wild
type mES cells. Cells were selected in 180 mg/ml G418 (PAA) and
2 mM Ganciclovir (Invivogen). Single colonies were picked and
screened by nested PCR to obtain the final mES cell clone
(K1B2). Primers used for cloning and PCR screening are listed in
Table S1.
Cell culture and transfections. BHK cells containing a lac
operator repeat array32 were cultured in DMEMmedium with 10%
FCS and seeded on coverslips in 6-well plates for microscopy. After
attachment cells were co-transfected with expression vectors for the
indicated fluorescent fusion proteins and a LacI-GBP fusion33,34
using polyethylenimine (Sigma). After about 16 h cells were fixed
with 3.7% formaldehyde in PBS for 10 min, washed with PBST
(PBS with 0.02% Tween), stained with DAPI and mounted in
Vectashield medium (Vector Laboratories).
Mouse ES cells were cultivated on gelatinized plates in High
Glucose DMEM with L-Glutamine and sodium pyruvate,
complemented with 15% FCS, β-mercaptoethanol, non essential
amino acids (PAA), penicillin/streptomycin (PAA) and LIF in a
37°C incubator at 5% CO2. For transfection with Lipofectamine
2000 (Invitrogen), mES cells were seeded on matrigel (BD
Biosciences) coated coverslips.
HEK 293FT cells (Invitrogen) were cultivated on gelatinizes
plates in High Glucose DMEM with L-Glutamine and sodium
pyruvate (PAA) complemented with 10% FCS, β-mercaptoeth-
anol, non essential amino acids (PAA) and penicillin/streptomycin
(PAA) in a 37°C incubator at 5% CO2. The cells were transiently
transfected one day after seeding using standard calcium
phosphate transfection.
Microscopy. F3H samples were analyzed with a confocal
fluorescence microscope (TCS SP5, Leica) equipped with a 63  /
1.4 numerical aperture Plan-Apochromat oil immersion objective
as described.34 DAPI, EGFP and mCherry/RFP were excited by
405 nm diode laser, 488 nm argon laser and 561 nm diode-
pumped solid-state laser, respectively. Images were recorded with
a frame size of 512  512 pixels.
K1B2 cells were imaged using a Leica TCS SP5 confocal laser
scanning microscope with a HCX PL APO CS 63x/1.3 NA
glycerol immersion objective. Sequential excitation at 405 nm,
488 nm, 543 nm and 633 nm was provided by diode, argon and
helium-neon gas lasers, respectively. Emission detection ranges of
the photomultipliers were adjusted to avoid crosstalk between the
channels. Maximum intensity projections of the confocal sections
were generated using ImageJ software.
Intensity ratio measurement. Images were acquired with an IN
Cell Analyzer 2000 (GE Healthcare) using a 40  air objective
and analyzed with the IN Cell Analyzer 1000 Workstation 3.7
(GE Healthcare). Green and red fluorescence intensities at the lac
spots were quantified. After background subtraction, intensity
ratios of red (prey) to green (bait) were calculated and plotted
using Excel software (Microsoft).
Lentiviral knockdown and infection of K1B2 cells. Lentiviral
shRNA sequences (Table S2) were selected from the TRC
library35 or designed using the TRC shRNA designer (http://
www.broadinstitute.org/rnai/public/).
For lentiviral knock-downs one non-targeting shRNA and
three shRNAs targeting mouse CENP-C mRNA (NCBI RefSeq
NM_007683.3) were cloned into the lentiviral knock-down
vector pLKOmod136 with MluI/XmaI.
For restricting lentiviral transduction to mouse cells, we
replaced the commonly used VSVg protein during viral packaging
with the ecotropic envelope protein of Moloney Murine
Leukemia Virus. The new packaging vector pLP-ecoenv was
generated by removing the VSVg sequence of pLP-VSVg
(Invitrogen) by EcoRI digest, followed by T4 polymerase filling
of the remaining vector and ligation of a EcoRI/NotI cut and T4
polymerase filled PCR product of the M-MLV ecotropic envelope
sequence
(Primers: eco env fw 5'-CGAATTCGCCGCCACCATGG
CGCGTTCAACGCTCTCAAAA-3'; eco env rw 5'-TACGC
GGCCGCTATGGCTCGTACTCTAT-3').
Lentiviral production was performed by seeding 4 million
HEK293FT cells (Invitrogen) one day before transfection in
gelatinized 10 cm dishes. On the following day, cells were
transiently cotransfected with 8 mg psPAX2, 8 mg pLP-ecoenv and
8 mg of the respective pLKOmod1 vector using standard calcium
phosphate transfection. Conditioned medium containing recom-
binant lentiviruses was harvested 48 h post transfection, aliquoted,
snap frozen and stored at -80°C until further use.
K1B2 cells were transduced by seeding 3  106 cells onto
gelatinized 15 cm dishes containing mES cell medium supple-
mented with 4 mg/ml Polybrene (Sigma) and up to 20%
conditioned virus medium. After 24 h the medium was replaced.
48 h post transduction, cells with stable integration of the
pLKOmod1 vector were selected in mES cell medium containing
1.4–2 mg/ml puromycin (PAA) and then maintained in this
selection medium until analysis.
Knock-down efficiency was determined at day five post
infection by qRT-PCR and protein gel blotting. The following
antibodies were used: CENP-C (Abcam ab50974), Suv4–20h2
(Hahn et al., in preparation).
RT-qPCR for monitoring M18BP1 and CENP-C expression
levels. RNA of control and CENP-C knock-down cells was
harvested at day 5 after transduction using RNeasy (Qiagen). 1.25
mg RNA was used for cDNA synthesis using Superscript III Kit
(Invitrogen) and random hexameric primers (NEB). QPCR reactions
were performed in technical triplicates using a Roche Light Cycler
480 with FAST SYBR1 Master Mix (Applied Biosystems), and
gene-specific primers (Table S3). Ct-values were normalized to the
geometric mean of Actin and GAPDH for each individual cDNA
and fold changes where calculated by the 2-DDCt-method.37
Immunofluorescence. Immunofluorescence analyses were per-
formed as described38 using the following antibodies: CENP-A
(C51A7, Cell Signaling Technology), H3S10P (06–570, Upstate)
and Alexa 647 (A31573, Molecular Probes).
Plasmids. Encoding sequences of CENPs were amplified by
PCR (Expand high fidelityPLUS PCR System, Roche, Penzberg,
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Germany). As forward primers we used 5'-GGGGACAAGT-
TTGTACAAAAAAGCAGGCTTCGAAAACCTGATTTTCAG-
GGCGCCACC-3'as flanking regions followed by 20–26 bases of
coding regions starting with 5-ATGG-3'and as reverse primers we
used 5'-GGGGACCACTTTGTACAAGAAAGCTGGGT-3'as
flanking regions followed by 20–26 bases of coding sequences
without stop codon. CENP encoding PCR fragments were
transferred into vector pDONR221 by BP recombination reaction
(Invitrogen, Carlsbad, CA, USA). After verification by DNA
sequencing (MWG Biotech, Ebersberg, München, Germany),
genes were transferred by LR recombination reactions to various
modified pEGFP-C and pmCh-C (BD Biosciences, Clontech, Palo
Alto, CA, USA) based destination vectors. The resulting expression
vectors encode CENPs fused to the C-termini of EGFP and
mCherry with SGTSLYKKAGFENLYFQGAT as linker sequence
and TQLSCTKW added to the C-terminal ends of the FP-CENPs
fusions. Complete sequences are provided upon request. Correct full
length expression of fusion constructs was confirmed by protein gel
blots.
Full-length open reading frames of mouse M18BP1, the
M18BP1 truncations and the mouse CENP-C truncations were
PCR amplified from mouse cDNA derived from mES cells and
cloned into the pDONR/Zeo GATEWAY entry vector
(Invitrogen) using Gateway BP Clonase II enzyme mix
(Invitrogen). PCR primers are listed in Table S4. Entry clones
were recombined into target vectors pEGFP-N1-GW,
pCMVmyc-GW and pGEX6P1-GW39 using LR Clonase II
enzyme mix (Invitrogen).
In vitro binding assays. Recombinant M18BP1 protein
truncations (C1 aa1–440, C2 aa441–998, C3 aa325–800, C4
aa441–800, C5 aa735–800) were expressed as GST tagged
versions in E. coli and purified on Glutathione-S-Sepharose (GE
Healthcare). In vitro translation of CENP-C protein truncations
(aa1–367, aa368–656, aa657–906) was performed using TnT1
Quick Coupled Transcription/Translation System (Promega).
10ml of the in vitro translated myc-tagged CENP-C and 5mg
M18BP1 GST-fusion protein coupled to Glutathione-S-
Sepharose were incubated in IP buffer (50 mM Tris pH7.5,
150 mM NaCl, 1 mM EDTA, 0.1% NP40, 20% glycerol and
proteinase inhibitor cocktail (Roche)) overnight at 4°C on a
rotating wheel. The beads were washed four times with IP buffer
containing 1 M NaCl and resuspended in 50 ml SDS loading
buffer (Roth). Bound proteins were separated on SDS poly-
acrylamidgels and detected by immunoblotting using a-myc
antibody (9E10).
Co-immunoprecipitation in HEK293FT cells. HEK293FT
cells (Invitrogen) were co-transfected with plasmids expressing
EGFP-CENP-C and myc-M18BP1. Isolated nuclei were resus-
pended in high salt IP buffer (50 mM Tris pH 7.5, 500 mM
NaCl, 1 mM EDTA, 0.1% NP40, 20% glycerol) with 4 strokes
through a 19.5G syringe needle. After incubation on ice for
30 min the solution was sonicated 3x10” at an amplitude of
30 in a Branson sonifier. The nuclear extract was diluted to a
final concentration of 150 mM NaCl with no salt IP buffer
and precipitates were removed by centrifugation. The extract
was incubated overnight at 4°C on a rotating wheel with GFP-
Trap beads (ChromoTek) and agarose beads. The beads were
washed five times with IP buffer containing 300 mM NaCl and
afterwards resuspended in SDS loading buffer (Roth). Proteins
were separated on SDS-polyacrylamidgels and analyzed by
protein gel blotting using a-myc (9E10) and a-GFP (Roche
# 11814460001) antibodies.
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Supplementary Figure S1. Generation of M18BP1-EGFP knock-in cells. 
(A) Targeting strategy for the M18BP1-EGFP knock-in allele. Part of the M18BP1 locus containing the 
last exons (11-14) is depicted in the scheme. The last exon contains the regular STOP codon (red line), 
followed by the 3’ UTR. The targeting construct comprises the region shown by the thick black line. 
The knock-in allele contains the EGFP tag just before the regular STOP codon, followed by the loxP 
flanked Neomycin selection cassette. (B) RT-qPCR quantification of M18BP1 expression levels in the 
parental wild type mES cell line and the K1B2 cell line which carries the M18BP1-EGFP knock-in 
allele. Average expression levels from triplicate experiments, normalized to Actin and GAPDH are 
shown. 
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Supplementary Figure S2. Centromeric localization of M18BP1. 
Localization of endogenously tagged M18BP1-EGFP in the K1B2 mES cell line. K1B2 cells were 
stained for CENP-A and confocal stacks were recorded. Maximum intensity projections of individual 
cells representing the different M18BP1 staining patterns: strong enrichment at centromeres (s), weak 
enrichment (w), no enrichment/diffuse nuclear (d) are shown. 
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Supplementary Figure S3. CENP-C protein levels in control vs. CENP-C knock-down cells. 
Five days after infection with the lentiviral knock-down vectors, control and CENP-C knock-down 
cells were harvested and nuclear extracts from these cells were probed for CENP-C, and Suv4-20h2 
which served as loading control, by western blotting. Compared to shControl cells, all three knock-
down oligos lead to reduced CENP-C protein levels, with shCENP-C #3 showing the strongest effect. 
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Supplementary Figure S4. Cell cycle profiles of K1B2 and CENP-C knock-down cells. 
Five days after infection with the lentiviral knock-down vectors, control and CENP-C knock-down 
cells were harvested, fixed and stained for DNA content with propidium iodide (PI). FACS analysis 
revealed a normal cell cycle profile, however, the CENP-C knock-down cells tend to show higher 
levels of sub-G1 cells, indicative of cell death. This effect is most apparent with knock-down shCENP-
C #3, which shows the strongest reduction of CENP-C mRNA levels. 
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Supplementary Figure S5. Relative cell numbers of shControl and shCENP-C knock-down 
populations. 
Five days after infection with the lentiviral knock-down vectors, control and CENP-C knock-down 
cells were harvested and counted. The cell number of the control population was set to 100%. The bar 
graph shows relative cell numbers for the individual shCENP-C knock-down populations. 
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Supplementary Figure S6. Cell cycle analysis in CENP-C knock-down cells. 
(A) Five days after infection with the lentiviral knock-down vectors, control and CENP-C knock-down 
cells were stained with H3S10P antibodies to detect cells in G2 phase. Maximum intensity projections 
of representative examples for G2 phase cells are shown. Control cells display a ‘weak’ centromeric 
staining pattern, in the CENP-C knock-down sample we observe cells which have lost the centromeric 
M18BP1 signals. (B) Four days after infection with the lentiviral knock-down vectors, control and 
CENP-C knock-down cells were transfected with PCNA-RFP expression plasmids. G1 cells which are 
characterized by small nuclei and diffuse PCNA signals were examined for M18BP1-EGFP 
localization. Control cells show ‘strong’ centromeric M18BP1-EGFP signals. In the CENP-C knock-
down population we can detect G1 phase cells which have lost or strongly reduced centromeric 
enrichment of M18BP1. 
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Supplementary Table 1. Primers used for cloning the M18BP1-EGFP targeting construct.  
 
primer orientation primer sequence 5'-3' 
cloning 
fragment 
AB f ATAGCGGCCGCCTAACTCAAATGCAAAACC 
cloning 
fragment 
AB r CGCAAGCTTTGATTAATAGTTTTTCACTAT 
cloning 
fragment 
YZ f TCCAAGCTTCCATGACTTGCTCACCTTG 
cloning 
fragment 
YZ r TGCACTAGTTATGAAAGAACTCTCATAATG 
cloning 
fragment 
CD f ATAGCGGCCGCTCTCCACCACCAACACGGA 
cloning 
fragment 
CD r TCGGAATTCGTCAGAATTGGAAAAGTAAT 
cloning 
fragment 
EF f CGAGGATCCTGATAGACGACTTGCAGGAAT 
cloning 
fragment 
EF r TCTGTCGACAGTCCACAATCTTAACTCTG 
nested 
PCR 
outer f ACCGCTTCCTCGTGCTTTAC 
nested 
PCR 
outer r AAAGCCAAGCTCACTGTTTC 
nested 
PCR 
inner f GATTGGGAAGACAATAGCAGGCATG 
nested 
PCR 
inner r GCGCAAGTAAATCATCAAAAGGCTG 
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Supplementary Table 2. ShRNA oligonucleotide sequences. 
 
name species direction sequence – in 5’ to 3’ direction (targeted sequence 
in bold)  
TRC code targeted 
mRNA 
fw CGCGTCCGGCAACAAGATGAAGAGCACCAACTCGAGT
TGGTGCTCTTCATCTTGTTGTTTTTGGAAA 
non 
targeting 
shRNA 
none 
rw CCGGTTTCCAAAAACAACAAGATGAAGAGCACCAACT
CGAGTTGGTGCTCTTCATCTTGTTGCCGGA 
SHC202V none 
fw CGCGTCCGGGCATGTTGGCCAAGATATATTCTCGAGA
ATATATCTTGGCCAACATGCTTTTTGGAAA 
shCENP-C1 
#1 
Mm 
rw CCGGTTTCCAAAAAGCATGTTGGCCAAGATATATTCTC
GAGAATATATCTTGGCCAACATGCCCGGA 
from TRC 
designer 
NM_0076
83.3 
fw CGCGTCCGGGTTCGTCGATCTAATAGAATACTCGAGTA
TTCTATTAGATCGACGAACTTTTTGGAAA 
shCENP-C 
#2 
Mm 
rw CCGGTTTCCAAAAAGTTCGTCGATCTAATAGAATACTC
GAGTATTCTATTAGATCGACGAACCCGGA 
from TRC 
designer 
NM_0076
83.3 
fw CGCGTCCGGGACATCACCGAATGTTCATTTCTCGAGAA
ATGAACATTCGGTGATGTCTTTTTGGAAA 
shCENP-C 
#3 
Mm 
rw CCGGTTTCCAAAAAGACATCACCGAATGTTCATTTCTC
GAGAAATGAACATTCGGTGATGTCCCGGA 
from TRC 
designer 
NM_0076
83.3 
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Supplementary Table 3. Primers used for quantitative PCR.  
 
gene mRNA direction sequence in 5’ to 3’ direction 
fw aagccgacccatctcaatag CENP-C 
 
NM_007683.3 
rw taagatccatggggacaagc 
fw ggtcatcactattggcaacg beta Actin NM_007393.3 
rw tccatacccaagaaggaagg 
fw ctccaaaaggccagcatcacg M18BP1 NM_172578.2 
rw ttgccggaggtaggctgttcc 
fw tcaagaaggtggtgaagcag GAPDH NM_008084.2 
rw gttgaagtcgcaggagacaa 
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Supplementary Table 4. Primers used for cloning of M18BP1 and CENP-C truncation 
constructs. 
 
gene mRNA direction sequence in 5’ to 3’ direction 
fw ggggacaagtttgtacaaaaaagcaggcttaactatgattgtaacacctttga M18BP1 NM_172578.2 
rw ggggaccactttgtacaagaaagctgggtcgtcagaattggaaaagtaa 
fw ggggacaagtttgtacaaaaaagcaggcttaactatgattgtaacacctttga M18BP1 
(aa1-
440) 
NM_172578.2 
rw ggggaccactttgtacaagaaagctgggtctcttgctgtttcctgtctg 
fw ggggacaagtttgtacaaaaaagcaggcttaactatgcaggaaacagcaagag M18BP1 
(aa441-
998) 
NM_172578.2 
rw ggggaccactttgtacaagaaagctgggtcgtcagaattggaaaagtaa 
fw ggggacaagtttgtacaaaaaagcaggcttaactatgactgttgtaaaagaag M18BP1 
(aa325-
800) 
NM_172578.2 
rw ggggaccactttgtacaagaaagctgggtcatgttttcgggatccttgg 
fw ggggacaagtttgtacaaaaaagcaggcttaactatgcaggaaacagcaagag M18BP1 
(aa441-
800) 
NM_172578.2 
rw ggggaccactttgtacaagaaagctgggtcatgttttcgggatccttgg 
fw ggggacaagtttgtacaaaaaagcaggcttaactatggaccatctacctggtt M18BP1 
(aa735-
800) 
NM_172578.2 
rw ggggaccactttgtacaagaaagctgggtcatgttttcgggatccttgg 
fw ggggacaagtttgtacaaaaaagcaggcttaactatggcctcgttccatctggatc CENP-C 
(aa1-
367) 
NM_007683.3 
rw ggggaccactttgtacaagaaagctgggtctttattttcaggagatcgacaa 
fw ggggacaagtttgtacaaaaaagcaggcttaactatgcaatctgagactgccaaaac CENP-C 
(aa368-
656) 
NM_007683.3 
rw ggggaccactttgtacaagaaagctgggtcttcataattcttgaacctggaag 
fw ggggacaagtttgtacaaaaaagcaggcttaactatgccagggagcagtaattctg CENP-C  
(aa657-
906) 
NM_007683.3 
rw ggggaccactttgtacaagaaagctgggtccctttttatttgagtaaaaagaag 
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3.	  Discussion	  
Heterochromatin has important functions for gene regulation and maintenance of 
genomic integrity, thus heterochromatin dysregulation can result in severe diseases 
(Hahn et al. 2010). The underlying epigenetic mechanisms of heterochromatin 
formation and regulation have been studied intensively in the last decades, but still 
many open questions remain to be answered. The goal of this dissertation was to 
identify and describe new mechanisms that regulate centromeric and pericentromeric 
heterochromatin during organismal development. The results were presented in two 
review articles and four papers, all in peer-reviewed scientific journals. 
 
3.1	  Suv4-­‐20h	  enzymes	  and	  H4K20me3	  in	  embryonic	  development	  
Heterochromatin formation and its relevance for developmental gene regulation has 
been a subject of detailed studies in the recent years. However, these analyses 
mostly emphasized on TrxG- and PcG-mediated control of developmental transitions. 
One focus of this PhD thesis was to identify which roles Suv4-20h enzymes and the 
pericentromeric heterochromatin mark H4K20me3 might play in the regulation of 
developmental processes. In this context, Xenopus laevis was a perfect model 
organism offering an efficient tool kit for manipulating and studying embryogenesis. 
Suv4-20h enzymes and H4K20 methylation are well known for contributing to the 
establishment of pericentric heterochromatin (Lachner et al. 2004; Schotta et al. 
2004; Schotta et al. 2008). Furthermore they have been implicated in contributing to 
cellular processes like general transcriptional regulation (Kapoor-Vazirani et al. 2011; 
Magklara et al. 2011). However, in Nicetto et al. 2013, we could show a novel 
function of Suv4-20h-dependent H4K20me3, namely the specific regulation of the 
pluripotency gene XOct-25. This is the Xenopus homolog of the mammalian Oct4 
gene, a master regulator of stem cell self-renewal and differentiation. Morpholino 
knock-down experiments of the X(enopus)Suv4-20h1 and XSuv4-20h2 homologs 
resulted in defective eye and melanocyte development. Those phenotypes are 
indicative of failures in neuroectodermal differentiation. By closer examination of 
global transcription changes in XSuv4-20h-depleted embryos the pluripotency-
related XOct-25, was identified as one of the top10 upregulated genes. Our analyses 
showed that XSuv4-20h enzymes are required for the restriction of XOct-25 
expression to the sensorial cell layer of the ectoderm during gastrulation. A combined 
depletion of XOct-25 and XSuv4-20h could however rescue the morphological 
defects and to a large extent the misregulated neuronal gene expression. These 
results imply, that XSuv4-20h and X-Oct25 may act in the same pathway. ChIP 
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experiments verified that the 5’UTR region of XOct-25 was enriched with H4K20me3, 
whereas in XSuv4-20h morphants, H4K20me3 levels were significantly decreased. 
These findings suggest that XOct-25 is a direct target of XSuv4-20h regulation. To 
address the question, whether the genetic interaction between Suv4-20h and XOct-
25/Oct4 exists in mammals as well, we analyzed Oct4 levels and the differentiation 
behaviour of murine ESCs lacking Suv4-20h enzymes. It was described before, that 
mammalian Oct4 is not only silenced by transcriptional control mechanisms but also 
by epigenetic silencing mechanisms like DNA methylation (Li et al. 2007), histone 
deacetylation (Feldman et al. 2006) or G9a-mediated H3K9me2 (Tachibana et al. 
2002; Feldman et al. 2006). However, no link to Suv4-20h-mediated H4K20me3 
regulation was known. We could demonstrate that mouse ES cells with a Suv4-20h1 
and Suv4-20h2 double knock-out have higher Oct4 levels as wild type cells. We used 
embryoid body (EB) formation as a system to check Oct4 expression levels in 
differentiation and to test whether abrogation of Suv4-20h results in defective lineage 
specification. Embryoid bodies are spontaneously formed colonies of ES cells upon 
withdrawal of LIF (Keller 1995). They can undergo differentiation into all three germ 
layers and are therefore commonly used to test pluripotency and differentiation 
behaviour of ESC lines. We could demonstrate that after differentiation, Suv4-20h-
mutant EBs were smaller in size and showed higher Oct4 levels as control cells. 
Furthermore, unlike the wild type EBs, Suv4-20h DKO EBs didn’t form autonomously 
beating regions, indicating defects in cardiomyocyte formation. In addition, we 
established a qPCR marker analysis, which showed enhanced induction of FoxA2, 
and downregulation of Gata4 in Suv4-20h DKO ES cells. This shift in mesendoderm 
marker expression and the perturbed formation of functional cardiomyocyte 
demonstrated the comprised differentiation capacity of Suv4-20h DKO ESCs. 
Altogether our results emphasize the importance of Suv4-20h-dependent XOct-25 
and mouse Oct4 regulation in accurate germ layer specification and cell 
differentiation. These findings are similar to previously published data showing that 
Oct4 suppresses neuroectodermal and promotes mesendodermal differentiation in 
mouse ESCs (Thomson et al. 2011). We therefore hypothesize that Suv4-20h 
enzymes are contributing, at least partially, to germ layer-specification of ESCs. 
 
3.2	  H3K56me3:	  a	  novel	  pericentric	  heterochromatin	  mark	  
As we have shown in chapter 2.3, histone modifications can play essential roles in 
differentiation. They are also accounting for various other processes such as DNA 
damage repair or replication. Deciphering the complex code of covalent histone 
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modifications is challenging, since the number and types of modifications is huge and 
still new ones are being discovered (Tan et al. 2011). It is critical to learn, how those 
modifications are generated, how they can be controlled and what impact they have 
on the living cell. One recently discovered histone modification is methylation of 
H3K56, a histone core residue (Garcia et al. 2007). H3K56 is a residue which is 
known to play roles in DNA damage response (Masumoto et al. 2005; Vempati et al. 
2010; Wurtele et al. 2012) and chromatin integrity (Celic et al. 2006; Driscoll et al. 
2007). H3K56me1 is generated by the G9a methyltransferase (Yu et al. 2012) which 
also accounts for H3K9me1 and H3K9me2 (Tachibana et al. 2002) possibly due to 
the conserved lysine-serine-threonine (K-S-T) motif in histone H3. However the 
mechanisms controlling H3K56me3 and its functional relevance remained unclear. 
We have addressed this question, by generation of a H3K56me3 antibody, verifying 
its specificity and investigating its localization in different microscopy experiments. 
Our data show, that H3K56me3 is an evolutionarily conserved modification. It is 
enriched at pericentromeric heterochromatin throughout the cell cycle, except the S 
phase. The reduced H3K56me3 levels in this cell cycle stage might be explained by 
a masking of the trimethylation by binding of protein interactors. However, we were 
not successful in isolating consistent binders of H3K56me3 in peptide pull down 
experiments. An active removal of H3K56 trimethylation during replication might also 
account for the reduced levels in S phase. Furthermore, H3K56 is a target of 
acetyltransferases, that modify this residue in S phase, before histones are 
integrated into DNA (Recht et al. 2006; Rufiange et al. 2007; Williams et al. 2008). 
Newly synthesized histones carrying H3K56ac could therefore simply exchange 
H3K56me3 histones in the newly replicated DNA. The K-S-T motif at the H3K56 
position is target of the H3K9 histonemethyltransferase G9a. For this reason we 
assumed that H3K9me3-specific KMTs and KDMs could also target H3K56. 
Consistent with that idea, we found a loss of H3K56me3 in Suv39h knock-out mouse 
fibroblasts, accompanied by an increase in H3K56me1. These findings demonstrated 
that it is highly likely that Suv39h enzymes mediate trimethylation of H3K56. 
H3K56me1 was shown to bind to PCNA and to be crucial for DNA replication in S 
phase (Yu et al. 2012). This need of H3K56me1 for faithful replication would support 
the hypothesis, that it is important to control the H3K56me3 state, that does not allow 
PCNA binding. To test, if the H3K56me3 mark can be actively removed by a member 
of the jmjC-class of histone demethylases [reviewed in (Pedersen and Helin 2010)], 
we generated a GFP-tagged expression vector collection from a pDONR library of 
jmjC proteins (Fodor et al. 2006). The over-expression of the JmjD2 family of 
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proteins in mouse and human cells resulted not only in a loss of H3K9me3 (Fodor et 
al. 2006) but also H3K56me3, likely due to the conserved K-S-T motif. A notable 
observation was, that the yet uncharacterized hKDM4DL (homolog to mouse 
pseudogene JmjD2e) is strongly expressed in testis and can demethylate H3K9me3 
and H3K56me3 residues. This demonstrates clearly, that histone modifying enzymes 
may have more than one target, a finding which is supported by a recent paper 
showing another heterochromatin mark H3K64me3 being Suv39h-dependent (Daujat 
et al. 2009). H3K56me3 is localizing to pericentromeric heterochromatin in 
interphase nuclei as H3K9me3 and H4K20me3 also do. However in mitotic 
chromosome spreads H3K56me3 and H4K20me3 localizations differ, which implies 
disparate functions and will be interesting to analyze in subsequent studies. Our data 
furthermore show, that H3K56me3 exists in C.elegans, where it co-localizes with 
H3K9me3-positive regions and seems to be regulated by some but not all H3K9-
specific KMTs. Although we could not describe the functional relevance of 
H3K56me3, our findings open new possibilities for further studies. Standard 
approaches like knock-downs of the responsible KMTs and KDMs however, will be 
hard to evaluate, since these would also affect the H3K9 and H3K64 methylation 
states, making it hard to allocate effects to one single histone modification. 
 
3.3	  Suv4-­‐20h	  enzymes	  in	  heterochromatin	  organization	  
Proper heterochromatin formation is important for stabilizing genomic integrity and 
gene expression programs and upon dysregulation can result in severe diseases. 
However, heterochromatin is not simply a set of chromatin-associated proteins, but 
rather a site of dynamic interactions of a network of heterochromatin proteins. We 
could show that Suv4-20h2 is an important part of this network regulating chromatin 
compaction and cohesin recruitment. We established a fluorescence recovery after 
photobleaching (FRAP) protocol that enabled us to analyze GFP-tagged 
heterochromatin protein mobilities in MEFs and mouse ESCs. The proteins were 
transiently expressed and cells with similar fluorescence intensities were selected for 
FRAP experiments. This was necessary, since the protein-saturation of possible 
binding sites could falsify our measurements. We found HP1α being a relatively 
mobile protein, a finding in agreement with previous studies (Cheutin et al. 2003). 
Suv39h1 and Suv4-20h1 proteins showed intermediate recovery kinetics whereas 
Suv39h2 and Suv4-20h2 associate extremely stable with heterochromatin. Notably, 
we could also demonstrate heterochromatin proteins being less mobile in MEF cells, 
as compared to ESCs, which is consistent with earlier studies (Meshorer et al. 2006). 
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This hyperdynamic binding of proteins to chromatin is a hallmark of pluripotent ESCs 
and is suggested to contribute to chromatin plasticity in undifferentiated ESCs. To 
exclude overexpression-artifacts in the mobility determinations, fluorescence 
correlation spectroscopy analyses (FCS) (Erdel et al. 2010) with a Suv4-20h2-EGFP 
knock-in ESC line was performed. This knock-in cell line expresses Suv4-20h2 from 
the endogenous genomic locus thus minimizing overexpression-artifacts. The FCS 
diffusion coefficient measurements showed that Suv4-20h2 binds more tightly to 
chromatin as HP1α and HP1β. In addition, the immobile pool of Suv4-20h2 was 
about 10 times higher than that of HP1. These FCS experiments could confirm the 
plausibility of our FRAP data. A recent study of Suv4-20h2 demonstrated its stable 
heterochromatin association (Souza et al. 2009), however the detailed binding 
mechanism remained an open question. In our manuscript, we could clearly show 
that a small region in the C-terminal part of Suv4-20h2 harbors multiple interaction 
sites for all three HP1 isoforms. Since HP1 levels at heterochromatin are enriched 
the binding to this short region in the C-terminus of Suv4-20h2 can explain the stable 
heterochromatin association. We therefore termed it „clamp“ domain. By measuring 
mobilities of truncated Suv4-20h2-GFP proteins in wild type cells and MEFs lacking 
HP1α, we confirmed the relevance of HP1 for stable heterochromatin localization. 
We hypothesized that Suv4-20h2 might be a structural component of 
heterochromatin, bridging H3K9me3/HP1-rich chromatin regions. Thus we tested 
cells lacking Suv4-20h for alterations in chromatin organization. Our biochemical 
assays and 3D-SIM super resolution microscopy data could demonstrate that Suv4-
20h2 is a central part of the heterochromatin network regulating nuclear architecture. 
Chromatin in Suv4-20h knock-out cells was more accessible to micrococcal nuclease 
(MNase). Interestingly, the clamp-domain of Suv4-20h2, was sufficient to restore 
chromatin compaction in the MNase accessibility experiments, suggesting that the 
enzymatic activity of Suv4-20h2 is dispensable for chromatin compaction. Two very 
interesting findings of these experiments may open up new possibilities in examining 
the roles of Suv4-20h2 in chromatin architecture. Firstly, the MNase digests in Suv4-
20h mutant cells showed, in addition to the opening of chromatin, also alterations in 
nuclesosomal repeat length. This is an indication, that abrogation of Suv4-20h2 may 
affect linker histone H1 association with chromatin, since a similar phenotype was 
detected in cells that lack linker histone H1 (Fan et al. 2005). Secondly, 3D-SIM 
analysis showed strong chromatin compaction around nucleoli, chromocenters and 
the nuclear periphery upon strong Suv4-20h2 over-expression. Moreover our data in 
Suv4-20h mutant cells revealed a perturbation in nuclear pore arrangement. One of 
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the top hits in our mass-spec analysis of Suv4-20h2 interactors was LaminB1. 
Nuclear pore proteins have been described to interact with A- and B-type lamins (Al-
Haboubi et al. 2011) and a recent publication demonstrated the binding of the lamin-
B receptor to H4K20me2 (Hirano et al. 2012). It will be interesting to follow this lead 
to further elucidate the role of Suv4-20h proteins in organizing nuclear envelope to 
chromatin interactions. Following the idea of Suv4-20h2 being a crucial component in 
ensuring the integrity of nuclear structure, our finding, that Suv4-20h-deficient cells 
display increased number of chromocenters is of notable interest. Similar 
observations have been described recently in Prdm3 and Prdm16 knockdown cells. 
A double knock-down of both Prdms resulted in an extreme chromocenter scattering 
phenotype (Pinheiro et al. 2012), indicating that the loss of Prdm3 and Prdm16 
interferes in a rather initial and elementary step of chromocenter establishment. The 
chromocenter scattering phenotype in Suv4-20h mutant fibroblasts is Suv4-20h2-
dependent, as it can rescued be re-expression of the full length protein. However, the 
expression of the clamp domain could not restore the phenotype. Thus we assume 
that additional proteins, that might bind outside of the clamp domain, are necessary 
for chromocenter clustering. Accordingly the chromocenter scattering in Suv4-20h 
mutant cells could be a consequence of reduced histone H1 levels, as histone H1 
variants participate in higher order heterochromatin formation (Lu et al. 2009b). In 
consequence, future studies should elaborate on the relation of Suv4h-20h2 and 
histone H1 and their functional relevance for heterochromatin assembly. Defective 
heterochromatin can cause genomic instability (Peters et al. 2001). In fact, we could 
detect an increase in mitotic defects in Suv4-20h mutant fibroblasts, which could be 
rescued by Suv4-20h2 re-expression. An interesting observation was the increased 
centromere distance in mitotic Suv4-20h mutant chromosomes, which could be 
rescued by full length Suv4-20h2. To gain more insight into a possible role of Suv4-
20h2 in sister chromatid cohesion, we wanted to identify possible Suv4-20h2 
interacting proteins. Mass-spectrometric analyses of Suv4-20h2 binders and Suv4-
20h2-IP experiments identified cohesin subunits Smc1 and Smc3 as interacting 
proteins. These findings indicated a potential link of Suv4-20h2 and the cohesin 
complex. Cohesin is connecting sister chromatids at pericentromeric regions until 
they are separated in anaphase. Cohesin loading at euchromatin seems to be 
mediated by CTCF chromatin insulator or mediator complex proteins (Parelho et al. 
2008; Kagey et al. 2010). However the loading mechanisms of cohesin to 
pericentromeric heterochromatin were yet unclear. ChIP data demonstrated that cells 
lacking Suv39h or Suv4-20h enzymes show dramatically reduced Rad21/Smc3 
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levels at major satellite repeats. To exclude clonal effects, we had to analyse 
biological replicates of all ChIP experiments. MEF cell lines, that were isolated and 
established from different embryos were used to confirm the data. Thus our results 
imply a substantial function of the Suv39h-Suv4-20h pathway in cohesin recruitment 
to pericentromeric heterochromatin. 
The finding that Suv39h mutant cells display a loss of cohesin at Major Satellite 
Repeats may appear contradictory to a previous study at first glance. (Koch et al. 
2008) could not demonstrate loss of cohesin in Suv39h mutant MEF, however this 
could be explained by the semi-quantitative ChIP assay they used, which is not 
suitable for highly repetitive sequences like mouse major satellites. Strikingly, we 
could rescue pericentric cohesin localization in Suv4-20h deficient cells, not only with 
the full length Suv4-20h2 protein but also with the clamp domain alone. Cell cycle 
synchronized ChIP of cohesin subunits should elucidate, whether Suv4-20h2 is 
important for initial cohesin recruitment or for its maintenance at heterochromatin. 
Wild type and Suv4-20h DKO cell lines have been arrested in G0, S-phase or 
mitosis. In G0 cells we detected a complete loss of cohesin from pericentromeric 
heterochromatin, in the later cell cycle stages cohesin levels increased indicating 
Suv4-20h independent recruitment pathways might exist. Again the observed loss of 
cohesin could be rescued by the clamp domain or by full length Suv4-20h2 
confirming its necessity for proper cohesin loading. Since the clamp domain can 
interact with cohesin and compact chromatin we cannot affirm whether chromatin 
compaction is necessary for cohesin recruitment or not. Based on recent publications 
and our data, we propose the following sequential pathway of cohesin recruitment to 
pericentric heterochromatin (Figure 5).  
 196 
 
Figure 5. Pericentric cohesin recruitment 
Mouse pericentric heterochromatin consists of major satellite repeats. The transcription 
factors Pax3 and Pax9 have been defined as regulators of mouse pericentromeric 
heterochromatin. They can regulate the RNA output from the major satellite repeats 
(Bulut-Karslioglu et al. 2012) which is important for proper heterochromatin 
establishment. Prdm3 and Prdm16 have been demonstrated to play essential roles in 
establishing H3K9me1 (Pinheiro et al. 2012) which is critical for subsequent H3K9me3 via 
the Suv39h KMTs. HP1 proteins bind to H3K9me3 and recruit Suv4-20h enzymes, that 
generate H4K20me3. Suv4-20h2 localization at heterochromatin is necessary for correct 
cohesin recruitment and chromatin architecture. 
 
Our cell cycle ChIP analysis of cohesin subunits demonstrated that Suv4-20h2-
dependent cohesin loading occurs in G0. While the cell progresses through the cell 
cycle, other mechanisms gradually recruit cohesin. In Suv4-20h mutants however, a 
full cohesin loading to pericentromeric chromatin, comparable to WT cells is not 
possible. Taken into account, that already a small reduction of heterochromatin-
associated cohesin results in anomalies of mitotic fidelity (Eckert et al. 2007) the mild 
mitotic defects that we observed in Suv4-20h knock-out cells are comprehensible. 
Dysregulation of heterochromatin can result in genomic instability (see Figure 6), 
which is, together with cohesin defects (Thompson et al. 2010) a hallmark of cancer. 
Reduced H4K20me3 levels, an indirect measure of Suv4-20h2 presence, have been 
correlated with a variety of human cancers (Fraga et al. 2005; Tryndyak et al. 2006; 
Van Den Broeck et al. 2008). We therefore assume that  Suv4-20h-dependent 
cohesin recruitment is crucial to guarantee genomic integrity, and if dysregulated, 
contributes to the transition of a „normal“ cell to cancer cell. The negative survival 
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prognosis of tumors with low H4K20me3 levels supports this hypothesis (Schneider 
et al. 2011). 
 
Figure 6. Heterochromatin dysregulation can increase the risk for developing cancer 
Heterochromatin has important functions in gene regulation and maintenance of genomic 
stability. Dysregulation of heterochromatin-associated modifications, or loss of structural 
components like Suv4-20h2 and cohesin, might perturb these functions, resulting in 
chromosome segregation defects, inefficient DNA damage repair, failure to enter the 
senescence program and reactivation of mobile elements. All these defects increase the 
risk for a “normal” cell to transform into a cancer cell. 
 
3.4	  Heterochromatin	  in	  centromere	  formation	  
Chromosomes have to be accurately distributed in mitosis, to assure genomic 
integrity. Assembly of the kinetochore, that directs mitotic spindle attachment, 
happens at the centromeres. The processes in centromere establishment are poorly 
understood in vertebrates. To which extent the underlying DNA sequence is really 
important for centromere establishment (Harrington et al. 1997) or not (Voullaire et 
al. 1993; Kapoor et al. 1998) is under discussion. However epigenetic factors are 
nowadays more and more believed to play major roles in centromere propagation. 
The incorporation of the histone H3 variant Cenp-A is a critical step in the formation 
of functional centromeres (Regnier et al. 2005). Centromeric chromatin is marked by 
Cenp-A nucleosomes, together with nucleosomes containing H3K4me2, thereby 
differing from the neighboring pericentromeric heterochromatin that carries mainly 
H3K9me3 and H4K20me3 marks. M18bp1/Knl2 a member of the Mis18 complex, 
was demonstrated to be crucial for centromere formation and Cenp-A loading 
 198 
(Maddox et al. 2007). In Dambacher et al. 2012, we generated and analyzed 
endogenous M18bp1-EGFP-tag knock-in mouse ESCs, to learn more about its 
biological functions. With this cell line it was possible for the first time, to study cell 
cycle-dependent localization and protein-protein interactions of the endogenous 
protein. Hence, we could exclude overexpression artifacts that other expression 
systems would induce. We could demonstrate a cell cycle specific association of 
endogenous M18bp1 with chromatin. For these experiments, we had to test several 
ways of attaching and growing living ESCs onto microscope cover slips. Coating of 
cover slips with Matrigel turned out to be the most efficient way to cultivate the cells. 
Using this protocol, we could describe M18bp1 localization and enrichment at 
centromeric chromatin from telophase to G1 cell cycle stage. This is consistent with 
data from earlier studies (Fujita et al. 2007), where the human M18bp1 protein 
showed a similar localization. In addition, we could describe an in vivo interaction of 
M18bp1 with the centromere protein Cenp-C. Our data demonstrated, that the middle 
part of M18bp1 is important for the interaction with Cenp-C. This region of the protein 
contains a SANT domain, a module of ~50 amino acids that can also be found in 
many subunits of chromatin remodelling complexes (Boyer et al. 2004). The SANT 
domain can bind histones, however not much is known about its functions. Testing 
the different M18bp1 truncations for interaction with Cenp-C in the F3H assay 
revealed that the SANT domain alone could not recruit Cenp-C. This might be due to 
an interference of the C-terminal EGFP tag with proper protein folding or that 
additional regions of the M18bp1 middle part are necessary for the interaction. With 
in vitro recombinant protein binding experiments we could show that the C-terminal 
part of Cenp-C mediates the M18bp1 interaction. This finding is in agreement with 
recently published work, demonstrating that X.laevis and human M18bp1 homologs 
can directly bind to human Cenp-C in vitro (Moree et al. 2011). To analyze the role of 
Cenp-C in a functional context, we used a lentiviral knock-down system that was 
established in our lab. After Cenp-C knockdown in the M18bp1-EGFP knock-in 
ESCs, we found a reduction of centromeric M18bp1 localization, independent of the 
cell cycle stage. Interestingly, the microscopic analysis of transient overexpression of 
Cenp-C in the M18bp1-EGFP knock-in ESCs showed, that these proteins not 
necessarily colocalize. This observation suggests the existence of a regulatory 
mechanism, coordinating M18bp1-Cenp-C interactions, potentially in a cell cycle-
controlled way. It was demonstrated in Moree et al. 2011, that Cenp-C is necessary 
for centromeric Cenp-A targeting in Xenopus egg extracts. Accordingly, we also 
detected reduced Cenp-A levels after knock-down of Cenp-C in mouse ESCs. 
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M18bp1 is important for Hjurp-dependent Cenp-A deposition (Dunleavy et al. 2009; 
Foltz et al. 2009). We argue, that Cenp-C facilitates the recruitment of M18bp1 to 
centromeres, which is a critical step for subsequent Hjurp-mediated Cenp-A 
integration. Thus, depletion of Cenp-C eventually results in defective Cenp-A 
deposition. Nevertheless open questions remain concerning the recruitment of Cenp-
C and M18bp1. Since M18bp1 could be identified as a H3K9me3 binder in peptide 
pull-down experiments (unpublished data, Silvia Dambacher), it will be of substantial 
interest, to analyze if H3K9me3 plays a role in M18bp1 recruitment to centromeric 
heterochromatin. Future studies on a potential interplay of pericentromeric and 
centromeric heterochromatin will further help to understand fundamental mechanistic 
principles in centromere formation. 
 
3.5	  Outlook	  
Taken together, this thesis provided novel findings on how centromeric and 
pericentromeric heterochromatin modifications and proteins participate in organismal 
development and cellular processes. 
We investigated the role of Suv4-20h function in developmental differentiation. Given 
the fact, that Suv4-20h-dependent XOct-25 and Oct4 regulation is crucial for proper 
differentiation, it will be interesting to more closely investigate the phenotypes of 
(conditional) Suv4-20h knock-out mice. Some KO phenotypes, like e.g. class switch 
recombination defects in B cells (Schotta et al. 2008) or defects in lung epithelia, 
have already been observed in our lab. Gene expression profiling in these cells and 
tissues could reveal potential targets of Suv4-20h-mediated gene silencing that may 
contribute to the observed phenotypes. 
The characterization of the regulatory network, modulating the novel heterochromatin 
modification H3K56me3, is an entrypoint for future analyses of its biological 
relevance. The human homolog of the mouse pseudogene of the KDM JmjD2e is 
highly expressed in testis. It will be interesting to analyse, if and why the active 
removal of H3K9me3/H3K56me3 is important in this particular tissue. Furthermore, 
pull-down experiments with nucleosomes carrying the H3K56me3 modification may 
be useful to isolate interacting proteins. Knowing these modification “readers” will be 
valuable in identifying potential functions of H3K56me3. 
In Hahn et al. we could demonstrate a severe impact of Suv4-20h depletion on 
organization of chromatin architecture and cohesin recruitment. To identify additional 
(tissue specific) interactors of Suv4-20h proteins, I generated knock-in mice 
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(unpublished data) expressing the endogenous Suv4-20h1 and Suv4-20h2 proteins  
with biochemical tags (HA-FLAG or V5-biotin) at their C-termini (Figure 7). 
 
Figure 7. Suv4-20h knock-in strategy for protein tags 
HA, Flag and V5 are standard affinity tags. The biotin-tag requires biotinylation by the BirA 
biotin ligase which is crossed into the corresponding mouse lines. PreScission protease 
and TEV are protease cleavage sites to elute proteins off beads. The knock-in strategies 
for the Suv4-20h loci are depicted in the lower part of the figure. 
 
The HA-Flag tag is suited for tandem-affinity purification of protein complexes and 
was already successfully used in the Hahn et al. and in preliminary experiments, for 
immunoprecipitation of Suv4-20h1 proteins from knock-in mouse liver and brain 
tissues (data not shown). The V5-bio tag is a high-affinity protein tag and should be 
ideally suited for Chromatin Immunoprecipitation of the proteins (Kim et al. 2008). 
Suv4-20h1HA-FLAG, Suv4-20h1V5-bio and Suv4-20h2V5bio knock-in mice are maintained 
in our lab and different mouse embryonic cell lines have been derived. These mice 
and cell lines, will be helpful in identifying tissue-specific genomic targets and 
interacting proteins, to characterize additional, yet unknown functions of Suv4-20h 
enzymes in cellular operations. Another noteworthy observation was, that nuclear 
pores are more evenly distributed in Suv4-20h knock-out cells. To gain more insight 
into this phenotype, we stained nuclear pores and performed high resolution 
miscroscopy in wild type and Suv4-20h mutant cells. As Lamin-B interacts with 
H4K20me2, we will further investigate Lamin A/B mobilities in Suv4-20h mutant cells. 
A study in a cellular model of progeria, a lamin-associated disease, showed severe 
upregulation of H4K20me3 (Shumaker et al. 2006) suggesting that Suv4-20h 
enzymes are important for nuclear envelope integrity. It will be interesting to 
elaborate on a potential mechanistic link between Suv4-20h enzymes, lamin 
arrangements and nuclear pore distributions. 
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Furthermore, we have established a powerful toolset for M18bp1 analyses, e.g. 
endogenous protein tagging, inducible knock-out cell lines and conditional knock-out 
mice. In preliminary experiments we could detect severe knock-out phenotypes in 
early embryogenesis and adult animals. Detailed analyses of these defects, will 
enhance our understanding of centromere establishment and help describing the 
complex M18bp1 interaction network. 
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